
<html lang="en"     class="pb-page"  data-request-id="4887314f-0f80-45c2-bdd9-66107d386659"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-1;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.0c01775;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice" /></meta><meta name="dc.Creator" content="Elisabet  Viayna" /></meta><meta name="dc.Creator" content="Nicolas  Coquelle" /></meta><meta name="dc.Creator" content="Monika  Cieslikiewicz-Bouet" /></meta><meta name="dc.Creator" content="Pedro  Cisternas" /></meta><meta name="dc.Creator" content="Carolina A.  Oliva" /></meta><meta name="dc.Creator" content="Elena  Sánchez-López" /></meta><meta name="dc.Creator" content="Miren  Ettcheto" /></meta><meta name="dc.Creator" content="Manuela  Bartolini" /></meta><meta name="dc.Creator" content="Angela  De Simone" /></meta><meta name="dc.Creator" content="Mattia  Ricchini" /></meta><meta name="dc.Creator" content="Marisa  Rendina" /></meta><meta name="dc.Creator" content="Mégane  Pons" /></meta><meta name="dc.Creator" content="Omidreza  Firuzi" /></meta><meta name="dc.Creator" content="Belén  Pérez" /></meta><meta name="dc.Creator" content="Luciano  Saso" /></meta><meta name="dc.Creator" content="Vincenza  Andrisano" /></meta><meta name="dc.Creator" content="Florian  Nachon" /></meta><meta name="dc.Creator" content="Xavier  Brazzolotto" /></meta><meta name="dc.Creator" content="Maria Luisa  García" /></meta><meta name="dc.Creator" content="Antoni  Camins" /></meta><meta name="dc.Creator" content="Israel  Silman" /></meta><meta name="dc.Creator" content="Ludovic  Jean" /></meta><meta name="dc.Creator" content="Nibaldo C.  Inestrosa" /></meta><meta name="dc.Creator" content="Jacques-Philippe  Colletier" /></meta><meta name="dc.Creator" content="Pierre-Yves  Renard" /></meta><meta name="dc.Creator" content="Diego  Muñoz-Torrero" /></meta><meta name="dc.Description" content="The combination of the scaffolds of the cholinesterase inhibitor huprine Y and the antioxidant capsaicin results in compounds with nanomolar potencies toward human acetylcholinesterase (AChE) and b..." /></meta><meta name="Description" content="The combination of the scaffolds of the cholinesterase inhibitor huprine Y and the antioxidant capsaicin results in compounds with nanomolar potencies toward human acetylcholinesterase (AChE) and b..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 28, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01775" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01775" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01775" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01775" /></link>
        
    
    

<title>Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01775" /></meta><meta property="og:title" content="Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0021.jpeg" /></meta><meta property="og:description" content="The combination of the scaffolds of the cholinesterase inhibitor huprine Y and the antioxidant capsaicin results in compounds with nanomolar potencies toward human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) that retain or improve the antioxidant properties of capsaicin. Crystal structures of their complexes with AChE and BChE revealed the molecular basis for their high potency. Brain penetration was confirmed by biodistribution studies in C57BL6 mice, with one compound (5i) displaying better brain/plasma ratio than donepezil. Chronic treatment of 10 month-old APP/PS1 mice with 5i (2 mg/kg, i.p., 3 times per week, 4 weeks) rescued learning and memory impairments, as measured by three different behavioral tests, delayed the Alzheimer-like pathology progression, as suggested by a significantly reduced Aβ42/Aβ40 ratio in the hippocampus, improved basal synaptic efficacy, and significantly reduced hippocampal oxidative stress and neuroinflammation. Compound 5i emerges as an interesting anti-Alzheimer lead with beneficial effects on cognitive symptoms and on some underlying disease mechanisms." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01775"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01775">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01775&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01775&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01775&amp;href=/doi/10.1021/acs.jmedchem.0c01775" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 812-839</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01762" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01793" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Elisabet Viayna</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elisabet Viayna</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elisabet++Viayna">Elisabet Viayna</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicolas Coquelle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicolas Coquelle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut de Biologie Structurale, Université Grenoble Alpes, CEA, CNRS UMR 5075, F-38054 Grenoble, France</div><div class="loa-info-affiliations-info">Large Scale Structures Group, Institut Laue-Langevin, F-38042 Grenoble Cedex 9, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas++Coquelle">Nicolas Coquelle</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Monika Cieslikiewicz-Bouet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Monika Cieslikiewicz-Bouet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Normandie University, UNIROUEN, INSA Rouen, CNRS, COBRA (UMR 6014), 76000 Rouen, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Monika++Cieslikiewicz-Bouet">Monika Cieslikiewicz-Bouet</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pedro Cisternas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pedro Cisternas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center of Aging and Regeneration UC (CARE-UC), Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Av. Libertador Bernardo O’Higgins 340, P.O. Box 114, 8331150 Santiago, Chile</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pedro++Cisternas">Pedro Cisternas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carolina A. Oliva</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carolina A. Oliva</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center of Aging and Regeneration UC (CARE-UC), Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Av. Libertador Bernardo O’Higgins 340, P.O. Box 114, 8331150 Santiago, Chile</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carolina+A.++Oliva">Carolina A. Oliva</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elena Sánchez-López</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elena Sánchez-López</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</div><div class="loa-info-affiliations-info">Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, E-28031 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elena++S%C3%A1nchez-L%C3%B3pez">Elena Sánchez-López</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Miren Ettcheto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Miren Ettcheto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, E-28031 Madrid, Spain</div><div class="loa-info-affiliations-info">Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Neuroscience, University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</div><div class="loa-info-affiliations-info">Department of Biochemistry and Biotechnology, Faculty of Medicine and Health Sciences, University Rovira i Virgili, E-43201 Reus, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Miren++Ettcheto">Miren Ettcheto</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4301-7297" title="Orcid link">http://orcid.org/0000-0002-4301-7297</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manuela Bartolini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manuela Bartolini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manuela++Bartolini">Manuela Bartolini</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2890-3856" title="Orcid link">http://orcid.org/0000-0002-2890-3856</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Angela De Simone</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Angela De Simone</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug Science and Technology, University of Turin, I-10125 Torino, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Angela++De+Simone">Angela De Simone</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mattia Ricchini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mattia Ricchini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mattia++Ricchini">Mattia Ricchini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marisa Rendina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marisa Rendina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marisa++Rendina">Marisa Rendina</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mégane Pons</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mégane Pons</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Normandie University, UNIROUEN, INSA Rouen, CNRS, COBRA (UMR 6014), 76000 Rouen, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=M%C3%A9gane++Pons">Mégane Pons</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Omidreza Firuzi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Omidreza Firuzi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, PO Box 3288, 71345 Shiraz, Iran</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Omidreza++Firuzi">Omidreza Firuzi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Belén Pérez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Belén Pérez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, E-08193 Bellaterra, Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bel%C3%A9n++P%C3%A9rez">Belén Pérez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Luciano Saso</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luciano Saso</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luciano++Saso">Luciano Saso</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vincenza Andrisano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vincenza Andrisano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department for Life Quality Studies, University of Bologna, Corso d’Augusto 237, I-47921 Rimini, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vincenza++Andrisano">Vincenza Andrisano</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4396-1904" title="Orcid link">http://orcid.org/0000-0003-4396-1904</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Florian Nachon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Florian Nachon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées BP73, 91993 Brétigny sur Orge, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Florian++Nachon">Florian Nachon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xavier Brazzolotto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xavier Brazzolotto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées BP73, 91993 Brétigny sur Orge, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xavier++Brazzolotto">Xavier Brazzolotto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maria Luisa García</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Luisa García</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</div><div class="loa-info-affiliations-info">Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, E-28031 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Luisa++Garc%C3%ADa">Maria Luisa García</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Antoni Camins</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antoni Camins</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, E-28031 Madrid, Spain</div><div class="loa-info-affiliations-info">Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Neuroscience, University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antoni++Camins">Antoni Camins</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Israel Silman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Israel Silman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurobiology, Weizmann Institute of Science, 76100 Rehovot, Israel</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Israel++Silman">Israel Silman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ludovic Jean</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ludovic Jean</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Normandie University, UNIROUEN, INSA Rouen, CNRS, COBRA (UMR 6014), 76000 Rouen, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ludovic++Jean">Ludovic Jean</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1745-4952" title="Orcid link">http://orcid.org/0000-0002-1745-4952</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nibaldo C. Inestrosa</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nibaldo C. Inestrosa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center of Aging and Regeneration UC (CARE-UC), Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Av. Libertador Bernardo O’Higgins 340, P.O. Box 114, 8331150 Santiago, Chile</div><div class="loa-info-affiliations-info">Centro de Excelencia en Biomedicina de Magallanes (CEBIMA), Universidad de Magallanes, 6200000 Punta Arenas, Chile</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#66080f080315121409150726040f094816130548050a"><span class="__cf_email__" data-cfemail="80eee9eee5f3f4f2eff3e1c0e2e9efaef0f5e3aee3ec">[email protected]</span></a>. Phone: (+56-2) 223542724.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nibaldo+C.++Inestrosa">Nibaldo C. Inestrosa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jacques-Philippe Colletier</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jacques-Philippe Colletier</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut de Biologie Structurale, Université Grenoble Alpes, CEA, CNRS UMR 5075, F-38054 Grenoble, France</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#a6c5c9cacac3d2cfc3d4e6cfc4d588c0d4"><span class="__cf_email__" data-cfemail="5f3c3033333a2b363a2d1f363d2c71392d">[email protected]</span></a>. Phone: (+33) 457428515.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jacques-Philippe++Colletier">Jacques-Philippe Colletier</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pierre-Yves Renard</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pierre-Yves Renard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Normandie University, UNIROUEN, INSA Rouen, CNRS, COBRA (UMR 6014), 76000 Rouen, France</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#a7d7cec2d5d5c28aded1c2d489d5c2c9c6d5c3e7d2c9ced18ad5c8d2c2c989c1d5"><span class="__cf_email__" data-cfemail="87f7eee2f5f5e2aafef1e2f4a9f5e2e9e6f5e3c7f2e9eef1aaf5e8f2e2e9a9e1f5">[email protected]</span></a>. Phone: (+33) 235522476.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pierre-Yves++Renard">Pierre-Yves Renard</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9094-9778" title="Orcid link">http://orcid.org/0000-0001-9094-9778</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Diego Muñoz-Torrero</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Diego Muñoz-Torrero</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#80e4edf5eeeffaf4eff2f2e5f2efc0f5e2aee5e4f5"><span class="__cf_email__" data-cfemail="056168706b6a7f716a777760776a4570672b606170">[email protected]</span></a>. Phone: (+34) 934024533.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Diego++Mu%C3%B1oz-Torrero">Diego Muñoz-Torrero</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8140-8555" title="Orcid link">http://orcid.org/0000-0002-8140-8555</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01775&amp;href=/doi/10.1021%2Facs.jmedchem.0c01775" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 812–839</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 28, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 October 2020</li><li><span class="item_label"><b>Published</b> online</span>28 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01775" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01775</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D812%26pageCount%3D28%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DElisabet%2BViayna%252C%2BNicolas%2BCoquelle%252C%2BMonika%2BCieslikiewicz-Bouet%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D1%26contentID%3Dacs.jmedchem.0c01775%26title%3DDiscovery%2Bof%2Ba%2BPotent%2BDual%2BInhibitor%2Bof%2BAcetylcholinesterase%2Band%2BButyrylcholinesterase%2Bwith%2BAntioxidant%2BActivity%2Bthat%2BAlleviates%2BAlzheimer-like%2BPathology%2Bin%2BOld%2BAPP%252FPS1%2BMice%26numPages%3D28%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D839%26publicationDate%3DJanuary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01775"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1034</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01775" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Elisabet&quot;,&quot;last_name&quot;:&quot;Viayna&quot;},{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;Coquelle&quot;},{&quot;first_name&quot;:&quot;Monika&quot;,&quot;last_name&quot;:&quot;Cieslikiewicz-Bouet&quot;},{&quot;first_name&quot;:&quot;Pedro&quot;,&quot;last_name&quot;:&quot;Cisternas&quot;},{&quot;first_name&quot;:&quot;Carolina&quot;,&quot;last_name&quot;:&quot;A. Oliva&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Sánchez-López&quot;},{&quot;first_name&quot;:&quot;Miren&quot;,&quot;last_name&quot;:&quot;Ettcheto&quot;},{&quot;first_name&quot;:&quot;Manuela&quot;,&quot;last_name&quot;:&quot;Bartolini&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;De Simone&quot;},{&quot;first_name&quot;:&quot;Mattia&quot;,&quot;last_name&quot;:&quot;Ricchini&quot;},{&quot;first_name&quot;:&quot;Marisa&quot;,&quot;last_name&quot;:&quot;Rendina&quot;},{&quot;first_name&quot;:&quot;Mégane&quot;,&quot;last_name&quot;:&quot;Pons&quot;},{&quot;first_name&quot;:&quot;Omidreza&quot;,&quot;last_name&quot;:&quot;Firuzi&quot;},{&quot;first_name&quot;:&quot;Belén&quot;,&quot;last_name&quot;:&quot;Pérez&quot;},{&quot;first_name&quot;:&quot;Luciano&quot;,&quot;last_name&quot;:&quot;Saso&quot;},{&quot;first_name&quot;:&quot;Vincenza&quot;,&quot;last_name&quot;:&quot;Andrisano&quot;},{&quot;first_name&quot;:&quot;Florian&quot;,&quot;last_name&quot;:&quot;Nachon&quot;},{&quot;first_name&quot;:&quot;Xavier&quot;,&quot;last_name&quot;:&quot;Brazzolotto&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Luisa García&quot;},{&quot;first_name&quot;:&quot;Antoni&quot;,&quot;last_name&quot;:&quot;Camins&quot;},{&quot;first_name&quot;:&quot;Israel&quot;,&quot;last_name&quot;:&quot;Silman&quot;},{&quot;first_name&quot;:&quot;Ludovic&quot;,&quot;last_name&quot;:&quot;Jean&quot;},{&quot;first_name&quot;:&quot;Nibaldo&quot;,&quot;last_name&quot;:&quot;C. Inestrosa&quot;},{&quot;first_name&quot;:&quot;Jacques-Philippe&quot;,&quot;last_name&quot;:&quot;Colletier&quot;},{&quot;first_name&quot;:&quot;Pierre-Yves&quot;,&quot;last_name&quot;:&quot;Renard&quot;},{&quot;first_name&quot;:&quot;Diego&quot;,&quot;last_name&quot;:&quot;Muñoz-Torrero&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;812-839&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01775&quot;},&quot;abstract&quot;:&quot;The combination of the scaffolds of the cholinesterase inhibitor huprine Y and the antioxidant capsaicin results in compounds with nanomolar potencies toward human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) that retain or improve the antioxidant properties of capsaicin. Crystal structures of their complexes with AChE and BChE revealed the molecular basis for their high potency. Brain penetration was confirmed by biodistribution studies in C57BL6 mice, with one compound (5i) displaying better brain/plasma ratio than donepezil. Chronic treatment of 10 month-old APP/PS1 mice with 5i (2 mg/kg, i.p., 3 times per week, 4 weeks) rescued learning and memory impairments, as measured by three different behavioral tests, delayed the Alzheimer-like pathology progression, as suggested by a significantly reduced Aβ42/Aβ40 ratio in the hippocampus, improved basal synaptic efficacy, and significantly reduced hippocampal oxidative stress and neuroinflammation. Compound 5i emerges as an interesting anti-Alzhe&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01775&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01775" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01775&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01775" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01775&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01775" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01775&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01775&amp;href=/doi/10.1021/acs.jmedchem.0c01775" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01775" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01775" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (10 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01775%26sid%3Dliteratum%253Aachs%26pmid%3D33356266%26genre%3Darticle%26aulast%3DViayna%26date%3D2021%26atitle%3DDiscovery%2Bof%2Ba%2BPotent%2BDual%2BInhibitor%2Bof%2BAcetylcholinesterase%2Band%2BButyrylcholinesterase%2Bwith%2BAntioxidant%2BActivity%2Bthat%2BAlleviates%2BAlzheimer-like%2BPathology%2Bin%2BOld%2BAPP%252FPS1%2BMice%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D1%26spage%3D812%26epage%3D839%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/jmcmar.2021.64.issue-1/20210114/jmcmar.2021.64.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The combination of the scaffolds of the cholinesterase inhibitor huprine Y and the antioxidant capsaicin results in compounds with nanomolar potencies toward human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) that retain or improve the antioxidant properties of capsaicin. Crystal structures of their complexes with AChE and BChE revealed the molecular basis for their high potency. Brain penetration was confirmed by biodistribution studies in C57BL6 mice, with one compound (<b>5i</b>) displaying better brain/plasma ratio than donepezil. Chronic treatment of 10 month-old APP/PS1 mice with <b>5i</b> (2 mg/kg, i.p., 3 times per week, 4 weeks) rescued learning and memory impairments, as measured by three different behavioral tests, delayed the Alzheimer-like pathology progression, as suggested by a significantly reduced Aβ42/Aβ40 ratio in the hippocampus, improved basal synaptic efficacy, and significantly reduced hippocampal oxidative stress and neuroinflammation. Compound <b>5i</b> emerges as an interesting anti-Alzheimer lead with beneficial effects on cognitive symptoms and on some underlying disease mechanisms.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20450" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20450" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most common form of senile dementia. Its efficient management remains one of our most urgent unmet medical needs due to its ever-increasing prevalence, mortality, and economic burden.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The two main histopathological hallmarks of AD are the intra- and extracellular deposition of the microtubule-associated protein tau and of the β-amyloid peptide (Aβ), into paired helical filaments (PHFs) and amyloid plaques, respectively. Oxidative stress has been also suggested to play a pivotal role in the early stages of AD,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> as it increases deposition of both Aβ and tau.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Accordingly, a number of efforts to curb the progression of AD have focused on the development of drugs reducing oxidative stress, clearing toxic Aβ fibrils and oligomers, or inhibiting the enzyme β-secretase (BACE-1), the first of two enzymes involved in the proteolytic cleavage of the amyloid precursor protein (APP) leading to Aβ production.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Recent failures of these drug candidates in late-stage clinical trials<a onclick="showRef(event, 'ref1 ref4 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref4 ref6">(1,4,6)</a> have led to the hypothesis that neither Aβ production and deposition<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> nor oxidative stress<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> should be taken as individual targets. Rather, action on a given target should be combined with further action on other key targets in AD.</div><div class="NLM_p">The current therapeutic arsenal against AD comprises four drugs that ameliorate the symptoms and decrease the rate of cognitive decline, for a period of 6–12 months, but none of these are disease-modifying agents. One of these drugs antagonizes the glutamate NMDA receptor, while the others compensate for the central cholinergic deficit of AD patients by inhibiting brain acetylcholinesterase (AChE).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> AChE, the enzyme that catalyzes the breakdown of acetylcholine (ACh) in the central (CNS) and peripheral nervous systems, is characterized by a 20 Å-deep gorge near the bottom of which sits the catalytic triad (Ser200-His440-Glu327, <i>Torpedo californica</i> AChE (<i>Tc</i>AChE) numbering), flanked by choline- and acyl-binding pockets. The decreased ACh levels in the brains of AD patients that arise as a consequence of a marked decline in the cholinergic system in regions in charge of cognitive functions (e.g., the enthorhinal cortex and the temporal lobe) provide the rationale underlying the use of AChE inhibitors in the symptomatic treatment of AD. Moreover, both PHFs<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and neuritic plaques<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> display strong cholinesterase activity, stemming from the presence of AChE and its close homologue, butyrylcholinesterase (BChE). AChE brain levels remain at best constant during the progression of AD,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> while BChE activity increases by 180% and also locates in neuritic plaques.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The presence of cholinesterases (ChEs) in the plaques renders the latter more cytotoxic,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> but the underlying mechanism of this increased toxicity remains uncertain. It was shown that AChE accelerates the deposition of Aβ<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> by a mechanism involving a tryptophan residue located in its peripheral anionic site (PAS)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (Trp279 and Trp286 in <i>Tc</i>AChE and human AChE (hAChE), respectively) and the formation of a stable complex that is more toxic to neurons.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Hence, many efforts to develop anticholinesterase agents for AD therapy have focused on dual binding site AChE inhibitors,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> spanning the active site gorge and interacting at both the catalytic anionic site (CAS) and the PAS, in order to inhibit both ACh hydrolysis and AChE-induced Aβ-aggregation. The fact that BChE activity is characteristic of neuritic plaques and increases with disease progression has prompted the re-examination of the candidacy of BChE as a valuable target or co-target for the treatment of AD, which shares the same overall fold of AChE (including a 20 Å-deep active-site gorge) but lacks a tryptophan at the PAS.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Highly potent selective inhibitors that specifically target either AChE or BChE are available,<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a> but molecules that target both enzymes with similar high efficacy are scarce<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> due to differences in the architectures of their active-site gorges.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Such molecules would be highly desirable since they could tackle, from the very outset, the progressive increase in BChE activity in the brains of AD patients, while efficiently inhibiting AChE. Although being inadequate in many respects, inhibition of the ChEs remains one of the very few means of transiently delaying AD progression.</div><div class="NLM_p">A possible way to extend the therapeutic range of ChE inhibitors, thereby producing a more significant reduction in AD symptoms, is to combine their anticholinesterase action with other activities within a single drug molecule, thus generating multitarget directed ligands (MTDL), which feature a number of advantages over drug combinations, such as the lack of drug–drug interactions and simpler development, manufacturing, and intellectual property issues, among others.<a onclick="showRef(event, 'ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28">(25−28)</a> Such compounds should not only inhibit ChE activity but also promote other actions, such as inhibition of Aβ production (<i>e.g.</i>, through inhibition of BACE-1) and self-aggregation, or antioxidant activities.<a onclick="showRef(event, 'ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36">(29−36)</a> In practice, such MTDLs are usually designed by covalently linking a known ChE inhibitor to a second pharmacophoric moiety that can afford additional biological actions arising from the modulation of another key target in AD pathophysiology, such as oxidative stress, among others.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37−40)</a></div><div class="NLM_p">Capsaicin (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is the major bioactive compound in chili peppers. Clinically, it is used mainly in pain management. However, its prominent antioxidant properties have also attracted much attention. Indeed, due to its ability to scavenge reactive oxygen species (ROS), to increase the activity and expression of antioxidant enzymes, and to inhibit protein oxidation and lipid peroxidation, it has been proposed as a protective agent for use in oxidative stress-related diseases, such as AD.<a onclick="showRef(event, 'ref41 ref42 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44 ref45">(41−45)</a> Indeed, in vivo studies have shown that capsaicin improves synaptic function by enhancing long-term potentiation (LTP), a cellular mechanism responsible for learning and memory, in the CA1 area of the hippocampus and reduces oxidative stress and neuroinflammation, exerting beneficial effects on synaptic and cognitive functions in mice and in middle-aged and elderly people.<a onclick="showRef(event, 'ref46 ref47 ref48 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49 ref50 ref51">(46−51)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of capsaicin and huprine Y.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We postulated that the combination of a capsaicin moiety with a ChE inhibitor pharmacophore could result in hybrid compounds with the potential to address several major pathologies associated with AD, namely, cholinergic deficit, oxidative stress, neuroinflammation, synaptic dysfunction, and cognitive impairment. Here, we report the design, synthesis, in vitro evaluation, structural characterization, biodistribution, and in vivo efficacy of a new series of MTDLs, which are based on capsaicin and huprine Y (<b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), a potent ChE inhibitor developed by our group.<a onclick="showRef(event, 'ref52 ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54 ref55">(52−55)</a> Accordingly, we set out to investigate whether huprine–capsaicin (HC) hybrids might serve as valuable MTDLs, preserving the affinity of huprine Y for human AChE and BChE, together with the beneficial properties of capsaicin against synaptic dysfunction, oxidative stress, and neuroinflammation. We further examined whether our compounds would also inhibit BACE-1 since we have found that such inhibitory activity is displayed by several families of huprine-based hybrids.<a onclick="showRef(event, 'ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58">(56−58)</a> Furthermore, we performed extensive structural characterization of the complexes of <i>Tc</i>AChE and human BChE (hBChE) with selected HC hybrids, so as to reveal the molecular basis for their AChE-over-BChE selectivity and to open up new avenues for design of both selective and dual AChE and BChE inhibitors. The brain permeability of all the compounds was first assessed in vitro and then confirmed in vivo by biodistribution studies in C57BL6 mice for two selected compounds. Finally, in vivo chronic efficacy studies were performed with the two selected hybrids in double transgenic APP/PS1 mice to assess their impact on amyloid pathology, synaptic plasticity, oxidative stress, neuroinflammation, and cognition and, hence, their beneficial effects on disease progression and symptomatology.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21075" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21075" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design</h3><div class="NLM_p">The novel HC hybrids were designed by connecting the exocyclic amino group at position 12 of huprine Y with an <i>N</i>-(4-hydroxy-3-methoxybenzyl) alkanamide (hybrids <b>5a</b>–<b>e</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) or alkenamide (hybrids <b>5g</b>,<b>h</b>, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) moiety derived from capsaicin. With the intention of allowing the capsaicin-like <i>N</i>-(4-hydroxy-3-methoxybenzyl)carboxamide moiety of HC hybrids to establish interactions both with the PAS of AChE and within the large catalytic site of BACE-1, various oligomethylene spacers were considered, having 7–12 atoms between the nitrogen atom at position 12 of the huprine moiety and the aromatic ring of the capsaicin moiety. We also designed the benzamide <b>5f</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) with the aim of promoting hydrophobic interactions with the aromatic residues lining the active-site gorge of AChE, again by substitution on position 12 of the huprine unit. Since attachment of a triazolylbutyl substituent at position 9 of huprine was recently reported as a means of obtaining highly potent AChE inhibitors,<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> we designed the HC hybrid <b>5i</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>), in which the <i>N</i>-(4-hydroxy-3-methoxybenzyl)carboxamide moiety of capsaicin was linked, through a triazolylbutyl tether, to huprine position 9. Compounds synthesized by derivatization at positions 12 and 9 of the huprine scaffold are hereafter referred to as 12-HC and 9-HC hybrids, respectively.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the HC Hybrids <b>5a</b>–<b>e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (1) <b>3a</b>–<b>e</b>, 40% methanolic KOH, reflux, 3 h; then H<sub>2</sub>O, reflux, overnight; 0.5 N HCl/Et<sub>2</sub>O; (2) crude carboxylic acid (1 equiv), ClCO<sub>2</sub>Et (1 equiv), Et<sub>3</sub>N (5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; then, <b>4</b>·HCl (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 days, 18% (<b>5a</b>), 38% (<b>5b</b>), 44% (<b>5c</b>), 17% (<b>5d</b>), 9% (<b>5e</b>) overall.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the HC Hybrid <b>5f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (1) <b>3f</b>, 40% methanolic KOH, reflux, 3 h; then H<sub>2</sub>O, reflux, overnight; 0.5 N HCl/Et<sub>2</sub>O; (2) crude carboxylic acid (1 equiv), ClCO<sub>2</sub>Et (1 equiv), Et<sub>3</sub>N (5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; then, <b>4</b>·HCl (1 equiv) or <b>6</b> (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 days, 33% (<b>5f</b>, from <b>3f</b> and <b>4</b>), 81% (<b>7</b>, from <b>3f</b> and <b>6</b>) overall; (ii) 1 M TBAF/THF, THF, rt, 4 h, 94% (76% overall yield of <b>5f</b> via <b>7</b>).</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Chemistry</h3><div class="NLM_p">12-HC hybrids of the alkanamide and benzamide series (<b>5a</b>–<b>e</b>, <b>5f</b>) were synthesized through a two-step sequence from racemic nitriles <b>3a</b>–<b>e</b> and <b>3f</b><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and commercially available amine <b>4</b> (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Saponification of nitriles <b>3a</b>–<b>e</b> and <b>3f</b> followed by amide coupling by reaction of amine <b>4</b> with the mixed anhydrides formed from the resulting carboxylic acids and ethyl chloroformate afforded the target hybrids <b>5a</b>–<b>e</b> and <b>5f</b> in low to moderate overall yields (9–44%). Benzamide <b>5f</b> was synthesized with a higher overall yield (76%) using the O-triisopropylsilyl-protected amine <b>6</b><a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> instead of <b>4</b> for the amide coupling reaction followed by deprotection with tetrabutylammonium fluoride (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><div class="NLM_p">Synthesis of the 12-HC hybrids of the alkenamide series (<b>5g</b>,<b>h</b>), which feature the carbon–carbon double bond of the side chain of capsaicin, was less straightforward. Attempts to synthesize them via the formation of mixed anhydrides were unsuccessful, as cross metathesis between 6-heptenenitrile and allyl bromide in the presence of a 2nd generation Grubbs catalyst did not yield the required, and commercially non-available, 8-bromo-6-octenenitrile. In contrast, 8-bromo-6-octenoic acid was obtained in excellent yield (96%, <i>E</i>/<i>Z</i> 4:1), but did not react with huprine Y in the presence of NaOH in DMSO, hence precluding obtention of the huprine-based alkenoic acid. Therefore, we envisioned an alternative synthetic sequence based on the cross metathesis reaction between the capsaicin-based alkene <b>9</b> and racemic 12-alkenylhuprines <b>10g</b>,<b>h</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the HC Hybrids <b>5g</b>,<b>h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (1) <b>8</b> (1 equiv), ClCO<sub>2</sub>Et (1 equiv), Et<sub>3</sub>N (2.2 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; then, <b>4</b>·HCl (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 days; 2) sat. aq. NaHCO<sub>3</sub>, MeOH, H<sub>2</sub>O, rt, overnight, 78%; (ii) KOH or NaOH (1.6 equiv), 4 Å molecular sieves, DMSO, rt., 2 h; then allyl bromide (1 equiv) or 5-bromo-1-pentene (1.1 equiv), DMSO, rt, overnight, 55% (<b>10g</b>), 27% (<b>10h</b>); (iii) <b>10g</b>,<b>h</b> (1 equiv), <b>9</b> (1.2–1.8 equiv), <i>p</i>-benzoquinone (0.1 equiv), Grubbs–Hoveyda II generation catalyst (0.05 equiv), reflux, 3 days, 9% (<b>5g</b>), 7% (<b>5h</b>).</p></p></figure><div class="NLM_p">First, we prepared alkenamide <b>9</b> by treatment of commercially available 6-heptenoic acid, <b>8</b>, with ethyl chloroformate in the presence of Et<sub>3</sub>N and subsequent reaction of the resulting mixed anhydride with amine <b>4</b>. A small amount of byproduct was formed that arose from the additional acylation of <b>4</b> on its hydroxyl group. Direct treatment of the mixture with saturated aqueous NaHCO<sub>3</sub> in MeOH at rt allowed chemoselective hydrolysis of the ester group of the byproduct, affording alkenamide <b>9</b> in 78% yield. Alkenylhuprines <b>10g</b> and <b>10h</b><a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> were then synthesized in moderate yields by alkylation of racemic huprine Y with allyl bromide and 5-bromo-1-pentene, respectively, using either KOH or NaOH as a base in DMSO at room temperature. Finally, cross metathesis of alkene <b>9</b> with alkenylhuprines <b>10g</b> and <b>10h</b> was performed in the presence of 5 mol % 2nd generation Grubbs–Hoveyda catalyst in refluxing CH<sub>2</sub>Cl<sub>2</sub>, using 10 mol % <i>p</i>-benzoquinone to prevent olefin isomerization.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> A tedious silica gel column chromatography purification allowed us to obtain alkenamide hybrids <b>5g</b> and <b>5h</b> as pure (<i>E</i>)-diastereoisomers, albeit in low yields (9 and 7%, respectively).</div><div class="NLM_p">For the synthesis of the 9-HC hybrid <b>5i</b>, featuring the <i>N</i>-(4-hydroxy-3-methoxybenzyl)carboxamide moiety of capsaicin linked through a triazolylbutyl tether on position 9 of huprine, we first attempted a copper-catalyzed azide–alkyne cycloaddition (CuAAC) of an O-protected capsaicin-based 3-butynamide to the previously reported racemic 9-azidobutylhuprine <b>13</b><a onclick="showRef(event, 'ref60 ref64'); return false;" href="javascript:void(0);" class="ref ref60 ref64">(60,64)</a> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Use of an O-TIPS-protected capsaicin-based 3-butynamide, generated by coupling amine <b>6</b> with 3-butynoic acid, led to an inseparable 25:75 mixture of the desired 3-butynamide and its 2,3-butadienamide isomerization product. Fortunately, the amount of the isomerization byproduct was much lower (12%) when the O-TBDMS-protected amine <b>11</b><a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> was used instead of <b>6</b>. The byproduct and the desired 3-butynamide <b>12</b> could be separated by silica gel column chromatography, affording the latter in 36% yield. The CuAAC reaction of 3-butynamide <b>12</b> and azide <b>13</b> in acetonitrile yielded the O-TBDMS-protected hybrid <b>14</b>, which after acidic deprotection led to the target 9-HC hybrid <b>5i</b> in good yield (58% over two steps).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the HC Hybrid <b>5i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <b>11</b> (1 equiv), 3-butynoic acid (1 equiv), EDC·HCl (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, 36%; (ii) <b>13</b> (1 equiv), <b>12</b> (1.2 equiv), CuI (1 equiv), CH<sub>3</sub>CN, rt, 12 h, 80%; (iii) camphorsulfonic acid (0.02 equiv), CH<sub>2</sub>Cl<sub>2</sub>/MeOH 80:20, rt, 24 h, 73%.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Purity of the Compounds</h3><div class="NLM_p last">The hybrids <b>5a</b>–<b>5h</b> were transformed into the corresponding hydrochloride salts for their chemical characterization and biological profiling. Hybrid <b>5i</b> was characterized and tested as the free base. The analytical samples of all the tested compounds possessed a purity >95%, according to NMR spectra with full assignments and elemental analyses and/or HPLC-UV/HRMS measurements (for more details, see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and Supporting Information).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Biological Activities of the HC Hybrids</h3><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> In Vitro Inhibition of hAChE and hBChE</h4><div class="NLM_p">We first set out to determine whether the HC hybrids were active against human ChEs. To this end, we used the method of Ellman et al.,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> with capsaicin and racemic huprine Y as negative and positive controls, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Activities of the HC Hybrids and Reference Compounds against Human AChE, BChE, and BACE-1, Antioxidant Activity, and PAMPA-BBB Permeabilities</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0020.gif" alt="" id="gr19" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="left" /></col><col align="char" char="(" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hAChE IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">hBChE IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">selectivity ratio<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hBACE-1% inhibition @1 μM<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">DPPH IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="(">PAMPA-BBB permeability<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">5.48 ± 0.28</td><td class="colsep0 rowsep0" align="left">52.2 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td><td class="colsep0 rowsep0" align="center">55.6 ± 20.3</td><td class="colsep0 rowsep0" align="left">68.5 ± 8.2</td><td class="colsep0 rowsep0" align="char" char="(">11.5 ± 1.1 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">4.35 ± 0.18</td><td class="colsep0 rowsep0" align="left">70.0 ± 4.9</td><td class="colsep0 rowsep0" align="char" char=".">16.1</td><td class="colsep0 rowsep0" align="center">34.3 ± 17.2</td><td class="colsep0 rowsep0" align="left">62.6 ± 11.6</td><td class="colsep0 rowsep0" align="char" char="(">14.9 ± 1.2 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">0.77 ± 0.06</td><td class="colsep0 rowsep0" align="left">30.6 ± 1.7</td><td class="colsep0 rowsep0" align="char" char=".">39.7</td><td class="colsep0 rowsep0" align="center">7.4 ± 3.2</td><td class="colsep0 rowsep0" align="left">55.4 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="(">17.2 ± 1.0 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">1.94 ± 0.15</td><td class="colsep0 rowsep0" align="left">51.8 ± 3.0</td><td class="colsep0 rowsep0" align="char" char=".">26.7</td><td class="colsep0 rowsep0" align="center">3.6 ± 1.5</td><td class="colsep0 rowsep0" align="left">70.8 ± 20.8</td><td class="colsep0 rowsep0" align="char" char="(">20.1 ± 1.1 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="left">2.94 ± 0.16</td><td class="colsep0 rowsep0" align="left">36.1 ± 2.2</td><td class="colsep0 rowsep0" align="char" char=".">12.3</td><td class="colsep0 rowsep0" align="center">23.7 ± 8.8</td><td class="colsep0 rowsep0" align="left">64.6 ± 8.6</td><td class="colsep0 rowsep0" align="char" char="(">21.8 ± 1.3 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="left">24.9 ± 1.9</td><td class="colsep0 rowsep0" align="left">290 ± 19</td><td class="colsep0 rowsep0" align="char" char=".">11.6</td><td class="colsep0 rowsep0" align="center">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">71.4 ± 15.5</td><td class="colsep0 rowsep0" align="char" char="(">14.3 ± 0.3 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="left">4.41 ± 0.17</td><td class="colsep0 rowsep0" align="left">78.1 ± 2.9</td><td class="colsep0 rowsep0" align="char" char=".">17.7</td><td class="colsep0 rowsep0" align="center">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">31.7 ± 8.7</td><td class="colsep0 rowsep0" align="char" char="(">16.8 ± 0.1 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5h</b></td><td class="colsep0 rowsep0" align="left">5.64 ± 0.30</td><td class="colsep0 rowsep0" align="left">53.1 ± 2.4</td><td class="colsep0 rowsep0" align="char" char=".">9.4</td><td class="colsep0 rowsep0" align="center">21.6 ± 6.2</td><td class="colsep0 rowsep0" align="left">54.6 ± 12.5</td><td class="colsep0 rowsep0" align="char" char="(">22.3 ± 1.1 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="left">1.06 ± 0.26</td><td class="colsep0 rowsep0" align="left">7.3 ± 0.6</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="center">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">92.0 ± 12.4</td><td class="colsep0 rowsep0" align="char" char="(">8.8 ± 1.3 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">>200,000</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">50.3 ± 8.3</td><td class="colsep0 rowsep0" align="char" char="(">10.3 ± 1.2 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">1.07 ± 0.05</td><td class="colsep0 rowsep0" align="left">181 ± 15</td><td class="colsep0 rowsep0" align="char" char=".">169.2</td><td class="colsep0 rowsep0" align="center">na<a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn10" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="char" char="(">23.8 ± 2.7 (CNS+)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values (nM) for inhibition of human recombinant AChE or BChE from human serum. Values are expressed as mean ± standard error of the mean (SEM) of at least two experiments, each performed in duplicate/triplicate.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">AChE-over-BChE selectivity ratio = IC<sub>50</sub> hBChE/IC<sub>50</sub> hAChE.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">% inhibition of human recombinant BACE-1 with the inhibitor at 1 μM. Values are expressed as mean ± standard deviation (SD) of two independent experiments, each performed in triplicate.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">IC<sub>50</sub> inhibitory concentration (μM) for DPPH radical scavenging activity. Values are expressed as mean ± SD of three experiments, each performed in duplicate.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Permeability values (<i>P</i><sub>e</sub>, 10<sup>–6</sup> cm s<sup>–1</sup>) from the PAMPA-BBB assay. Values are expressed as mean ± SD of three experiments, each performed in triplicate.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Not active.</p></div><div class="footnote" id="t1fn7"><sup><sup>g</sup></sup><p class="last">na = not active; 20% inhibition at 100 μM.</p></div><div class="footnote" id="t1fn8"><sup><sup>h</sup></sup><p class="last">Data from ref <a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> under the same experimental conditions, unless otherwise indicated.</p></div><div class="footnote" id="t1fn9"><sup><sup>i</sup></sup><p class="last">14% inhibition at 5 μM.</p></div><div class="footnote" id="t1fn10"><sup><sup>j</sup></sup><p class="last">Not determined.</p></div></div></div><div class="NLM_p">In agreement with previous reports,<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> we found that capsaicin was inactive against both hAChE and hBChE, whereas huprine Y is a potent inhibitor of both enzymes, with an AChE-over-BChE selectivity ratio of 169. All HC hybrids <b>5a</b>–<b>i</b> retained the high potency of the parent huprine Y against hAChE and hBChE and displayed a reduced AChE-over-BChE selectivity ratio (6.9–39.7).</div><div class="NLM_p last">Compounds <b>5a</b>–<b>5e</b> are 12-HC hybrids that differ only in the length of the alkane chain linking the capsaicin-amide and huprine moieties (7–11 atoms). A hexamethylene linker and, hence, a total tether length of 9 atoms between the nitrogen atom at position 12 of the huprine moiety and the aromatic ring of the capsaicin moiety are optimal for the inhibition of both hAChE and hBChE (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), yielding a compound, <b>5c</b>, that surpassed the nanomolar potency of huprine Y. The effect of linker length was more pronounced for hAChE than for hBChE, resulting in a decreased AChE-over-BChE selectivity ratio for compounds featuring a shorter (<b>5a</b>, <b>5b</b>) or longer (<b>5d</b>, <b>5e</b>) linker than <b>5c</b>. Interestingly, compounds <b>5c</b> and <b>5e</b> displayed similar potency against hBChE but not against hAChE. Compound <b>5f</b>, which features a benzamide linker, was the least potent of all the HC hybrids, while compounds <b>5g</b> and <b>5h</b>, characterized by an alkenamide linker of 10 and 12 atoms in total, respectively, displayed a lower potency against both hAChE and hBChE than their closest alkanamide counterparts, <i>i.e.</i>, compounds <b>5d</b> (10 atoms) and <b>5e</b> (11 atoms). Thus, biochemical data suggest that a flexible, saturated linker is best suited to inhibit ChEs. The observation that compounds <b>5e</b> and <b>5h</b>, which feature a linker of 11 and 12 atoms, respectively, bind to hBChE with higher affinity than their 10-atom counterparts (<b>5d</b> and <b>5g</b>) suggests that a linker length > 11 atoms may allow binding to another subsite at the rim of the hBChE active-site gorge. Compound <b>5i</b>, the 9-HC hybrid, displayed the lowest AChE-over-BChE selectivity ratio of all the HC hybrids. Unlike for the other compounds, this decrease in selectivity ratio does not stem from a decreased potency against hAChE but rather from an increased hBChE inhibitory activity. Importantly, compound <b>5i</b> is the first huprine-based inhibitor displaying one-digit nanomolar inhibitory activity against both hBChE (IC<sub>50</sub> = 7.3 nM, i.e. 25-fold more potent than the parent huprine Y) and hAChE (IC<sub>50</sub> = 1.06 nM, i.e., the same as that of huprine Y).</div></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Kinetic Studies of AChE Inhibition and Propidium Displacement Studies</h4><div class="NLM_p">In light of the subnanomolar inhibition of hAChE by compound <b>5c</b>, we investigated its mode of inhibition by use of Lineweaver–Burk and Cornish–Bowden plots. The interception of the lines in the Lineweaver–Burk plot above the <i>x</i> axis (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, left) suggests a mixed-type inhibition of hAChE by <b>5c</b>. The mixed-type mechanism was further confirmed by the Cornish–Bowden plot (S/<i>v</i> vs [I]).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The inhibition constant (<i>K<sub>i</sub></i>) and the dissociation constant for the enzyme–substrate–inhibitor complex (<i>K</i>′<i><sub>i</sub></i>) of hybrid <b>5c</b> were estimated to be 0.68 and 0.94 nM, respectively. The similarity between the <i>K<sub>i</sub></i> and <i>K</i>′<i><sub>i</sub></i> values is suggestive of dual tight binding at the two binding sites, i.e., CAS and PAS. To verify this hypothesis, we confirmed the interaction of <b>5c</b> with the PAS through displacement studies using propidium iodide, a specific PAS ligand (<i>K</i><sub>D</sub> = 0.70 μM), as a probe and electric eel (<i>Ee</i>)AChE. Back-titration experiments with increasing concentrations of hybrid <b>5c</b> showed a concentration-dependent decrease in the fluorescence intensity associated with the propidium–AChE complex, suggesting that <b>5c</b> can effectively displace propidium from the AChE’s PAS (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, right).<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> We found a low micromolar affinity of <b>5c</b> for the PAS of <i>Ee</i>AChE (<i>K</i><sub>D</sub> = 3.59 μM), confirming that hybrid <b>5c</b> can interact with the PAS of AChE. On the basis of the putative orientation of the HC hybrids within AChE, with the capsaicin moiety pointing toward AChE’s PAS (as confirmed by crystallographic studies, see below), capsaicin was also assayed to evaluate its ability to displace propidium. Unfortunately, in the conditions used for such an assay, spectral interference due to the intrinsic fluorescence of capsaicin was significant and precluded the accurate determination of its affinity for PAS. Nevertheless, from data acquired at the lowest tested concentrations (4–16 μM), at which spectral interference was limited, some qualitative considerations could be made, allowing us to state that also capsaicin is able to bind to AChE’s PAS, albeit in a weaker manner than <b>5c</b> (decrease of fluorescence intensity by <b>5c</b> and capsaicin both tested at 2/1 ratio over propidium = 23 and 11%, respectively).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Left: Kinetic measurements to characterize the mode of inhibition of AChE by <b>5c</b>. Lineweaver–Burk reciprocal plots show the variation of the AChE initial velocity rate with increasing substrate concentrations (acetylthiocholine (ATCh), 0.11–0.57 mM) in the absence and presence of increasing concentrations of <b>5c</b> (0.17–1.36 nM). Lines were derived from a weighted least-squares analysis of the data points. The mechanism of inhibition was assessed by two independent experiments, each performed in triplicate. Right: Determination of the <i>K</i><sub>D</sub> value for <b>5c</b> binding to PAS from the antilog of the <i>Y</i>-intercept value.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Experimental conditions: 2.0 μM <i>Ee</i>AChE, 8.0 μM propidium, 1.0 mM Tris HCl, pH 8.0; P stands for propidium iodide and I stands for the tested inhibitor; Fe is the initial fluorescence intensity when enzyme sites are saturated with P, F<sub>P</sub> is the fluorescence intensity when propidium is completely displaced from the enzyme, and F denotes the fluorescence intensity after adding a determined amount of displacing agent during the titration experiment. Data are the average of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Structural Characterization of hAChE and hBChE Complexes with HC Hybrids</h4><div class="NLM_p">The crystal structure of the complex of <b>5i</b> (9-HC hybrid) with hBChE and those of the complexes of <b>5b</b>, <b>5c</b>, <b>5d</b>, <b>5f</b>, <b>5h</b> (12-HC hybrids), and <b>5i (</b>9-HC hybrid) with <i>Tc</i>AChE were determined (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>–<named-content content-type="anchor" rid="fig4" type="simple"></named-content><a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Data were collected from crystals soaked for 12 h in the mother liquor supplemented with a 1 mM solution of a racemic mixture of the selected compounds. Further details regarding structure determination and refinement are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S1</a> of the Supporting Information and in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures of complexes with <i>Tc</i>AChE of HC hybrids <b>5b</b> (A), <b>5c</b> (B), and <b>5d</b> (C). Compounds (light orange) and key residues of <i>Tc</i>AChE (blue/gray) are shown as sticks. The protein backbone is represented as a light blue cartoon. The type of interaction is color-coded as follows: <i>Tc</i>AChE residues involved in hydrophobic interactions are colored gray, parallel and perpendicular π-stacking interactions are represented as green and magenta sticks between interacting aromatic centers (modeled as white spheres), and hydrogen bonds are represented as red dashes, with amino acid residues involved colored blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of complexes with <i>Tc</i>AChE of HC hybrids <b>5f</b> (A) and <b>5h</b> (B). Residues and interactions are color-coded as in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. (C) Gorge restructuration upon binding of <b>5f</b>. The <i>Tc</i>AChE backbone is shown in a blue cartoon format, and compound <b>5f</b> is shown as light orange sticks. Residues that change conformation upon binding of <b>5f</b> are shown as sticks, with the native conformation shown in blue and the <b>5f</b>-bound conformation in magenta.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structures of <b>5i</b>–<i>Tc</i>AChE (A) and <b>5i</b>–hBChE complexes (B). Residues and interactions are color-coded as in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. (C, D) Surface representations of the hBChE active-site gorge, with key residues shown as gray sticks. The conformation of compound <b>5i</b> observed in the crystal structure of its complex with <i>Tc</i>AChE was modeled into the hBChE active-site gorge (after superimposition of the two structures). Compound <b>5i</b> is shown as cyan spheres (scaled to match the van der Waals radius). This representation clearly shows that the chlorine atom of the huprine Y moiety cannot fit into the hBChE active-site gorge due to steric hindrance by Met437 (black stick). (D) Observed binding mode for <b>5i</b> in its complex with hBChE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The crystal structures of the complexes with <i>Tc</i>AChE of compounds <b>5b</b>, <b>5c</b>, <b>5d</b>, <b>5f</b>, <b>5h</b> (12-HC hybrids), and <b>5i (</b>9-HC hybrid) reveal that the huprine moieties of the specific enantiomers with the (7<i>S</i>,11<i>S</i>)-configuration (eutomers in this structural class for AChE inhibition) bind at the bottom of the gorge, in the choline-binding pocket, in an orientation similar to that of the parent huprines (huprines W, X, Y) and of previously reported huprine derivatives (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref24 ref60 ref71'); return false;" href="javascript:void(0);" class="ref ref24 ref60 ref71">(24,60,71)</a> Briefly, the aromatic system π-stacks to Trp84, while the chlorine atom fits into a hydrophobic groove contributed by Phe330, Tyr334, Trp432, Met437, and Ile439. The linker of the 12-HC hybrids and of the 9-HC hybrid <b>5i</b> traces up to the PAS, orientating toward different sides of the aromatic side gorge—those adjacent to the choline-binding pocket or to the acyl-binding pocket of the active site, respectively. Compounds featuring an alkanamide or a benzamide linker (<b>5b</b>–<b>5d</b>, <b>5f</b>) all benefit from a H-bond interaction of their amide oxygen with either Tyr121(OH) (<b>5b</b>, <b>5f</b>) or Tyr70(OH) (<b>5c</b>, <b>5d</b>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S2</a> of the Supporting Information). At the PAS, none of these compounds interacts by parallel π-stacking; rather, the capsaicin hydroxyl and ether oxygens establish H bonds with residues at the PAS (<b>5d</b>, <b>5f</b>, <b>5h</b>) or with waters H-bonded to them (<b>5b</b>, <b>5c</b>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S2</a> of the Supporting Information). The capsaicin moiety of compounds <b>5b</b> and <b>5c</b> is engaged in perpendicular π stacking with the PAS residue Trp279 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A,B). The observation of a more perpendicular stacking of the capsaicin moiety of <b>5c</b> (89° vs 65° for compounds <b>5c</b> and <b>5b</b>, respectively) may explain why it displays the highest affinity for hAChE of all the HC hybrids. Compound <b>5d</b>, the second best hAChE inhibitor in the 12-HC series, displays two conformations at the PAS, but since one involves a non-physiologically relevant symmetry-related molecule (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S2</a> of the Supporting Information—alternate conformation A), it can be safely discarded as irrelevant to the mode of binding in solution. In the representative conformation (i.e<i>.</i>, alternate conformation B), the hydroxyl and ether oxygen in the capsaicin moiety of <b>5d</b> are H-bonded to Gly335(O) and Ser286(N) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). Compound <b>5f</b>, endowed with a similar linker length but a more rigid structure, fails to adapt to the native active-site gorge structure, and its binding is accompanied by concomitant conformational changes in Tyr121, in the gorge, and Tyr70, Asp72, and Trp279 at the PAS (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). These observations likely explain the 32-fold decreased potency of <b>5f</b> toward AChE, as compared to <b>5c</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). We speculate that the increased linker rigidity in <b>5g</b> and <b>5h</b> also explains their slightly reduced potencies as compared to <b>5d</b> and <b>5e</b>, respectively. Nevertheless, we expect <b>5g</b> binds in a mode similar to that of <b>5d</b>, i.e., with its capsaicin moiety interacting with Gly335(O) and Ser286(N) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). Likewise, compound <b>5e</b> should display a binding mode similar to that of <b>5h</b>, whose capsaicin moiety completely plugs the entrance of the active-site gorge, fitting into a groove contributed by residues 282–289 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S2</a> of the Supporting Information).</div><div class="NLM_p">As mentioned above, compound <b>5i</b> binds to the active site of <i>Tc</i>AChE similarly to the 12-HC compounds but lays on the side of the gorge adjacent to the acyl-binding pocket rather than on that adjacent to the choline-binding pocket (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). As observed earlier in the structure of a complex of a 9-triazolylbutyl derivative of huprine with hAChE,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> the triazole ring π-stacks perpendicular to Phe290 side chain and a H bond forms between a triazole nitrogen of <b>5i</b> and Phe288(N) (Phe295(N) in hAChE). In addition, the amide nitrogen atom of <b>5i</b> H-bonds both to Ser286(N) and to a structural water, which itself is H-bonded to Phe331(O). Finally, a water bridge is formed <i>via</i> water 78 between the ether oxygen of the capsaicin moiety of <b>5i</b> and Tyr121(OH). Taken together, these observations rationalize the high affinity of <b>5i</b> for hAChE and explain its higher affinity than <b>5d</b>, an alkanamide-based 12-HC compound with a similar linker length.</div><div class="NLM_p">No structure was obtained of a complex with hBChE of a 12-HC hybrid due to loss of diffraction. This is in line with the previous report that the absence of a sufficiently deep hydrophobic groove at the bottom of the choline-binding pocket hampers binding of huprine (and thus also of huprine derivatives) to hBChE.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> This groove is contributed by Phe330 (Tyr337), Trp432 (Trp439), Met436 (Met443), Ile439 (Pro446), and Tyr442 (Tyr449) in <i>Tc</i>AChE (hAChE) and by Ala328, Trp430, Met434, Met437, and Tyr440 in hBChE. The replacement of Ile439 (Pro446) in <i>Tc</i>AChE (hAChE) by a methionine in hBChE (Met437) offers an explanation as to why this groove cannot accommodate the chlorine atom of huprines while maintaining a native conformation, as it had been previously suggested for tacrine derivatives on the basis of docking studies.<a onclick="showRef(event, 'ref24 ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref24 ref72 ref73">(24,72,73)</a> The loss of diffraction upon soaking of hBChE crystals with 12-HC derivatives may therefore be due to an incompatibility between the large conformational changes that occur upon binding of these compounds and the preservation of crystal contacts. The structure of the <b>5f</b>/<i>Tc</i>AChE complex indeed demonstrates that binding of huprine derivatives may require large conformational changes in active-site gorge residues. Those induced by binding of the 12-HC hybrids in hBChE are presumably of a greater magnitude since they disrupt crystal-packing interactions.</div><div class="NLM_p last">Nonetheless, the structure of the <b>5i</b>/hBChE complex was determined, revealing a hitherto unobserved binding mode for huprines and their derivatives with ChEs. As observed for a previously reported huprine/hBChE complex,<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> the chlorine atom of huprine is in the acyl-binding pocket, at 4.0 and 4.1 Å, respectively, from Leu286(O) (Phe288 in <i>Tc</i>AChE) and Trp231(NE1) (Trp233 in <i>Tc</i>AChE), with the aromatic system π-stacked against Phe329 (Phe331 in <i>Tc</i>AChE) and Trp231 (Trp233 in <i>Tc</i>AChE), but by contrast, the amine on position 12 fits between Ser198(O) and His438(NE2) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B), effectively disrupting the catalytic triad. Thus, the huprine unit is upside down compared to its position in the previous huprine/hBChE complex and additionally rotated by 90° as compared to complexes of huprines and huprine derivatives with AChEs. This difference arises from the presence of a bromide anion in the earlier huprine/hBChE complex at the position occupied by the primary amino group of <b>5i</b>. The cyclohexene ring of huprine stacks over Trp82 and the linker contorts itself in the hydrophobic groove of the choline-binding pocket, resulting in interactions (i) of the triazole ring with the aromatic ring of Tyr332 (Tyr334 in <i>Tc</i>AChE), (ii) of the amide oxygen with Asp70 (Asp72 in <i>Tc</i>AChE), and (iii) of the capsaicin hydroxyl and ether oxygen with Asn68(OD1) and (ND2), respectively (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S2</a> of the Supporting Information). Differences in <i>Tc</i>AChE vs hBChE active-site gorge architecture at the PAS (Tyr70, Trp279 vs Asn68, Ala277) in the acyl-binding pocket (Phe288, Phe290, Phe330, and Val400 vs Leu286, Val288, Ala328, and Phe398) and in the choline-binding pocket (Ile439 vs Met437) suggest that the binding mode observed in the <b>5i</b>/hBChE complex would not occur in the corresponding <i>Tc</i>AChE complex nor, by analogy, in the hAChE complex.</div></div><div id="sec2_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> In Vitro Antioxidant Activity and hBACE-1 Inhibition</h4><div class="NLM_p">Suitably designed huprine derivatives have already shown to be valuable anti-Alzheimer MTDLs, allowing not only AChE and BChE inhibition but also inhibition of BACE-1.<a onclick="showRef(event, 'ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58">(56−58)</a> For the latter activity, molecular dynamics simulations have suggested that the huprine moiety, protonated in the acidic endosomal compartments where BACE-1 localizes, can establish a salt bridge with the two aspartate residues of the enzyme catalytic dyad, whereas a second pharmacophore containing a hydrogen bond acceptor group might interact at a transient secondary binding site, at the edge of the large catalytic site.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The resulting dual site binding within hBACE-1 would account for the high inhibitory activity of some huprine-based hybrids, which display IC<sub>50</sub> values reaching into the nanomolar range.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> On the basis of these findings and of the structures of the HC hybrids, we hypothesized that their capsaicin moiety might bind at the secondary site in BACE-1, just as it bound at the secondary binding site of AChE, viz., at the PAS. Accordingly, apart from the antioxidant activity of the HC hybrids supposedly imparted by their capsaicin moiety, we also examined their capacity to inhibit BACE-1.</div><div class="NLM_p">The in vitro antioxidant activity of the HC hybrids was assessed by an easy and commonly used method, which is based on the ability of antioxidant compounds to donate a hydrogen atom to scavenge the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> We found that all the compounds retained the antioxidant activity of the parent capsaicin in the DPPH assay, displaying very similar IC<sub>50</sub> values, which demonstrated that hybridization did not result in a loss of function. Indeed, compound <b>5g</b> of the alkenamide series was even slightly more potent than both capsaicin itself and the rest of the compounds of the series.</div><div class="NLM_p last">Regarding hBACE-1 inhibition, all compounds in the alkanamide series were found to be active. Of these, the most active was <b>5a</b> (55.6% inhibition at 1 μM) and a negative correlation was observed between linker length and inhibition of hBACE-1, up to 10 atoms. Compound <b>5e</b> was nevertheless more active than compounds <b>5c</b> and <b>5d</b>, suggesting again that an 11-atom linker might permit binding to a second subsite of the large BACE-1 active site. Indeed, compound <b>5h</b> of the alkenamide series with a linker length similar to that of <b>5e</b> was equipotent to <b>5e</b>. Compounds <b>5f</b>, <b>5g</b>, and <b>5i</b> were not active against hBACE-1 at the tested concentration (1 μM).</div></div><div id="sec2_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> In Vitro Brain Permeation</h4><div class="NLM_p last">As a preliminary assessment of the ability of the novel compounds to enter the brain, where they should exert their effects, their permeabilities were determined using the well-established parallel artificial membrane permeation assay for blood–brain barrier (PAMPA-BBB).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> All compounds had permeabilities (<i>P</i><sub>e</sub>) well above the cutoff value for good brain permeation (CNS+: <i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>) > 5.1), suggesting that they would be able to reach their molecular targets in the brains of both AD patients and animal models. The CNS+ propensity increased with linker length, which indicates that an increased lipophilicity fosters the BBB crossing. In support of this hypothesis, compound <b>5i</b>, which features a hydrophilic triazole ring in the linker, displayed the lowest <i>P</i><sub>e</sub> value, even though still being clearly CNS+.</div></div><div id="sec2_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Biodistribution Studies in C57BL6 Mice</h4><div class="NLM_p">The in vitro biological profiling of the novel HC hybrids puts hybrids <b>5c</b> and <b>5i</b> forward as promising anti-Alzheimer MTDLs by virtue of their highly potent inhibitory activity on hAChE and hBChE combined with decent antioxidant activity and favorable in vitro brain permeability. Indeed, <b>5c</b> and <b>5i</b> emerged as the two most potent hAChE inhibitors (IC<sub>50</sub> = 0.77 and 1.06 nM, respectively) and BChE inhibitors (IC<sub>50</sub> = 30.6 and 7.3 nM, respectively) of the series and retained the antioxidant activity of the parent capsaicin, even though the latter activity, in the micromolar range, was not balanced relative to the highly potent anticholinesterase activities, which might challenge their ability to simultaneously elicit all these activities in vivo.</div><div class="NLM_p">Before advancing the lead HC hybrids to in vivo efficacy studies, we decided to confirm their ability to penetrate the brain in vivo and to assess their potential presence in other important organs. We performed biodistribution studies in wild-type (C57BL6) mice. Instead of a single dose, we mimicked a chronic treatment by applying the same dosing protocol that was to be followed in the subsequent in vivo chronic efficacy studies (i.e., same dose, administration route, and frequency of administration and for enough time as to enable the tested compounds to reach levels in organs corresponding to a chronic treatment). Briefly, compounds <b>5c</b> and <b>5i</b> were administered intraperitoneally (i.p.) to C57BL6 mice at a dose of 2 mg/kg three times a week for 2 weeks. The anti-Alzheimer drug donepezil was used as a reference compound. Four hours after injection of the last dose of <b>5c</b>, <b>5i</b>, or donepezil, the animals were sacrificed and their organs (brain, kidneys, liver, and lungs) and plasma were collected for quantification of the compounds’ levels by HPLC/MS/MS (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) In vivo distribution of compounds <b>5c</b> and <b>5i</b> and of the reference drug, donepezil (DPZ) to various organs in 6 month-old C57BL6 mice. (B) Comparison of brain levels of <b>5c</b>, <b>5i</b>, and donepezil. Data were analyzed using one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test; **<i>p</i> < 0.01 and ***<i>p</i> < 0.001 were considered significant differences.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Four hours after injection of the last dose of <b>5c</b> and <b>5i</b>, these compounds were found to be mainly distributed to the kidneys and the liver, but importantly, both of them were also detected in the brains of C57BL6 mice (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S4</a> of the Supporting Information). Indeed, <b>5c</b> and <b>5i</b> were present in the brains at concentrations of 1.58 and 18.88 μg/g brain tissue, respectively, which were higher than those found in plasma (<3 ng/mL (detection limit) and 35.58 ng/mL, respectively). Thus, both compounds have a favorable brain/plasma ratio. Of note, compound <b>5i</b> attained a higher brain concentration (<i>p</i> < 0.01; <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S4</a> of the Supporting Information) and a lower plasma level than donepezil (6.13 μg donepezil/g brain tissue and 6.46 μg donepezil/mL in plasma, respectively), thus displaying a better brain/plasma ratio than the anti-Alzheimer reference drug at that particular time point. Irrespective of the fact that different amounts of the tested compounds and donepezil could have been found at other time points as a result of their different distribution or half-lives, these results unambiguously confirmed the penetration of the target compounds into the brain and encouraged us to perform chronic in vivo efficacy studies with a transgenic mouse model of AD.</div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chronic In Vivo Efficacy Studies</h3><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Behavioral Studies</h4><div class="NLM_p">After confirming the brain penetration of compounds <b>5c</b> and <b>5i</b> in wild-type mice, we performed chronic efficacy studies in a well-established animal model of AD, namely, double transgenic APPswe/PSEN1dE9 (APP/PS1) mice. Animals of two different ages were used in our study: one group aged 5 months (young mice) at the beginning of the study, when the Alzheimer-like pathology starts developing, and a second group aged 10 months (old mice), with already well-established pathology. Young and old transgenic animals were treated by i.p. injection of either <b>5c</b> or <b>5i</b> at a dose of 2 mg/kg with saline solution as the vehicle, or only the vehicle (control group), three times per week for 4 weeks. Thus, at the end of the treatment young and old animals were 6 and 11 months old, respectively. All the animals of the six experimental groups finished the treatment successfully, remaining healthy in terms of weight, lipid, and hepatic parameters and by visual inspection.</div><div class="NLM_p">To study the effects of <b>5c</b> and <b>5i</b> on cognitive functions, we performed several tests, namely, the large open-field (LOF), novel object recognition (NOR), novel object localization (NOL), and memory flexibility tests. Initially, despite the apparent healthy status of the treated mice, we wanted to additionally rule out movement or stress problems due to treatment. To this end, the general behavior and the locomotor activity of treated and control mice were studied using the LOF test. This test measures the time spent by the animal moving along the field and the number of times that the animal crosses the central area of a transparent cage. No significant change among groups was observed, thereby confirming that treatment with <b>5c</b> and <b>5i</b> did not alter the general behavior of the animals, both young and old (one-way ANOVA, <i>p</i> < 0.05, followed by appropriate post hoc testing) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Thus, the basal status of the treated animals did not affect their performance in the subsequent behavioral tests, in which the effects of the compounds on memory and learning functions were assessed.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Time spent moving and number of crossings by (A, B) young and (C, D) old male APP/PS1 mice treated with the vehicle, <b>5c</b>, and <b>5i</b> in the LOF test. Data are expressed as mean values ± SEM of <i>n</i> = 7 animals in each group. Data were analyzed by one-way ANOVA followed by Bonferroni’s post hoc test; <i>p</i> ≤ 0.05 was considered the threshold for statistical significance with 95% confidence interval (CI).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We then explored whether administration of <b>5c</b> and <b>5i</b> to young and old transgenic animals might delay or rescue their cognitive impairment. To evaluate memory, we performed the NOR and NOL tests, which are both associated with hippocampal function. Briefly, after habituation to the experimental cages, transgenic mice were allowed to explore a platform containing two identical objects at specific locations. Afterward, one of the familiar objects was first moved to a different place within the platform (NOL) and then one of the familiar objects was replaced by a new one (NOR). The preference for each object shown by the mice exposed to these two consecutive changes was registered, and an object preference index was determined by dividing the time spent exploring the relocated/novel object by the total time spent exploring both objects. Thus, a lower preference index when comparing different animal groups is indicative of cognitive impairment, and viceversa, a higher preference index is associated with cognitive enhancement.</div><div class="NLM_p">We did not observe significant changes in the preference index of young transgenic mice treated with <b>5c</b> or <b>5i</b> relative to the control group (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A,B). However, in the group of old APP/PS1 mice treated with compound <b>5i</b>, we observed a significant increase in the preference index relative to vehicle-treated transgenic mice, both in the NOR and NOL tests (one-way ANOVA, <i>p</i> < 0.05, followed by appropriate post hoc testing) (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C,D). Thus, administration of compound <b>5i</b> significantly enhanced learning and memory in old APP/PS1 mice.</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Preference indices in the NOR and NOL tests with (A, B) young and (C, D) old male APP/PS1 mice treated with the vehicle, <b>5c</b>, and <b>5i</b>. Data are expressed as mean values ± SEM of <i>n</i> = 7 animals in each group. Data were analyzed by one-way ANOVA followed by Bonferroni’s post hoc test; *<i>p</i> ≤ 0.05 was considered the threshold for statistical significance with 95% CI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we performed a highly sensitive memory flexibility test to assess learning and memory performance,<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> based on the ability of mice to find a hidden platform within a pool, similar to the Morris Water Maze. In the case of young transgenic mice, we did not observe significant differences among groups (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A). However, some differences were found when comparing the performance of the different groups of old transgenic mice already on the first trial day, with the <b>5i</b>-treated APP/PS1 mice needing 13 trials to reach the criterion, whereas <b>5c</b>- and vehicle-treated mice needed 14 trials. After 4 days of testing, old APP/PS1 mice treated with the vehicle or compound <b>5c</b> needed 13 trials to reach the criterion, whereas those treated with compound <b>5i</b> needed only 7 trials, showing that the treatment with <b>5i</b> significantly delayed the cognitive decline that affected memory/learning of old transgenic mice (one-way ANOVA, <i>p</i> < 0.05, followed by appropriate post hoc testing) (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B).</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Number of trials to reach the criterion in the memory flexibility test in (A) young and (B) old male APP/PS1 mice treated with the vehicle, <b>5c</b>, and <b>5i</b>. Data are expressed as mean values ± SEM of <i>n</i> = 7 animals in each group. Data were analyzed by one-way ANOVA followed by Bonferroni’s post hoc test; *<i>p</i> ≤ 0.05 was considered the threshold for statistical significance with 95% CI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Thus, compound <b>5i</b> significantly enhanced learning and memory in old APP/PS1 mice in all the performed tests (NOR, NOL, and memory flexibility), while neither <b>5i</b> nor <b>5c</b> was effective in young transgenic mice.</div></div><div id="sec2_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Effects on Hippocampal β-Amyloid Levels</h4><div class="NLM_p">After the behavioral studies had been completed, the brains of control and treated transgenic mice were collected for analyses. A specific ELISA assay kit was used to evaluate the levels of Aβ40 and Aβ42 in the hippocampus of young and old APP/PS1 mice treated with the vehicle, <b>5c</b>, or <b>5i</b>. Similar hippocampal levels of both Aβ40 and Aβ42 were found in young transgenic mice treated with <b>5c</b> or <b>5i</b> compared with vehicle-treated mice (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A−C and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S6</a> of the Supporting Information). Actually, a positive tendency, albeit statistically nonsignificant, toward increased Aβ40 and decreased Aβ42 levels and hence toward a reduced Aβ42/Aβ40 ratio was found in APP/PS1 mice treated with <b>5i</b> relative to the control group. Interestingly, the beneficial effects of <b>5i</b> on β-amyloid levels did reach statistical significance in old transgenic mice. Indeed, a significant increase (2.1-fold) in the levels of Aβ40, the less aggregation-prone and less toxic Aβ form, was observed in the hippocampus of old APP/PS1 mice treated with <b>5i</b> (18.4 ± 1.24 pg./mL) compared with vehicle-treated control mice (8.65 ± 0.44 pg/mL) (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>D and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S6</a> of the Supporting Information), whereas the levels of the more neurotoxic Aβ42 remained unaffected by the treatment (62.6 ± 3.68 pg/mL in APP/PS1 mice treated with <b>5i</b> vs 69.0 ± 4.54 pg/mL in vehicle-treated APP/PS1 mice, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>E). Thus, treatment of 11 month-old transgenic mice with compound <b>5i</b> led to a significant decrease in the Aβ42/Aβ40 ratio (3.42 ± 0.36 in APP/PS1 mice treated with <b>5i</b> vs 7.99 ± 0.60 in vehicle-treated APP/PS1 mice, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>F and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S6</a> of the Supporting Information), which is an important marker of the progression of AD, with this reduced ratio being indicative of a delaying effect on disease progression.</div><figure id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Hippocampal levels of Aβ40, Aβ42, and Aβ42/Aβ40 ratio in (A–C) young and (D–F) old male APP/PS1 mice treated with the vehicle, <b>5c</b>, or <b>5i</b>. Data are expressed as mean values ± SEM of <i>n</i> = 7 animals in each group. Data were analyzed by one-way ANOVA followed by Bonferroni’s post hoc test; *<i>p</i> ≤ 0.05 was considered the threshold for statistical significance with 95% CI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Electrophysiological Studies: Effects on Basal Activity and Synaptic Plasticity in APP/PS1 Mice Treated with <b>5c</b> or <b>5i</b></h4><div class="NLM_p">Among the alterations that are described for AD patients and animal models, synaptic anomalies appear long before amyloid plaques and neuronal death can be detected.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79,80)</a> Several AD models have been used to investigate the relationship between synaptic dysfunction and age.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> A reduction in long-term synaptic potentiation with no alteration in basal transmisision has been reported in several variants of the APP/PS1 mouse model.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> To elucidate the effects of treatment with compounds <b>5c</b> and <b>5i</b> on synaptic transmission and plasticity mechanisms, we performed electrophysiological experiments in brain slices obtained from young double transgenic mice that had been treated for 4 weeks with either <b>5c</b>, <b>5i</b>, or saline (control). We stimulated the collateral axons at the CA3 area of the hippocampus and recorded the evoked field excitatory postsynaptic potentials (fEPSPs) at the level of the CA1 region. First, we analyzed the paired pulse facilitation (PPF), which is a presynaptic form of plasticity indicative of short-term plasticity, with the purpose of measuring the probability of release at presynaptic terminals. To do this, we evoked two EPSPs (R1 and R2) separated by time intervals of 10–200 ms. The ratio R2/R1 is the facilitation index, which measures the probability of vesicle release at the presynaptic terminal by effect of the level of accumulated calcium: an index larger than 1 indicates that R2 is larger than R1, showing that more synaptic vesicles are released in the second pulse due to the accumulation of intracellular calcium (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A). This is called facilitation and demonstrates that a synapse has low probability of vesicle release in the first pulse. The longer the time interval between the two pulses, the lower the ratio, indicating that the calcium that entered during R1 had more time to be cleared before R2. In our case, there is a significant difference between treatments, with these differences being more evident at the first interval (at 10 ms stimulus interval). Treatment with <b>5i</b> increased the probability of vesicle release in the first pulse, reducing the facilitation, as compared to vehicle- and <b>5c</b>-treated animals (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A, index at 10 ms time interval: control: 3.18 ± 0.8 ms; transgenic (Tg) + <b>5i</b>: 1.93 ± 0.03 ms; Tg + <b>5c</b>: 3.44 ± 0.6 ms; two-way AVOVA followed by Bonferroni’s post-hoc test, Tg + <b>5i</b> vs Tg + <b>5c</b>, *<i>p</i> < 0.05). Thus, <b>5i</b> transforms a synapse with low release probability into a high release probability synapse. Next, by applying increasing levels of current intensities, we obtained an input–output relationship that determined the maximum capacity of the system to evoke responses when an increasing stimulus is applied (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B). The plots of the fEPSP slope against stimulus amplitude (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>C) show no difference between the curves, indicating that treatment with <b>5c</b> or <b>5i</b> does not affect the basal synaptic activity of young transgenic mice (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>C, values at the maximum current intensity: Tg control = 0.269 ± 0.072 mV/ms; Tg + <b>5i</b> = 0.296 ± 0.089 mV/ms; Tg + <b>5c</b> = 0.262 ± 0.096 mV/ms; <i>p</i> = 0.713). We also built the input–output relationship with the fiber volley (FV) amplitudes, and despite two-way ANOVA analysis suggesting differences among treatments, post-hoc analysis showed that the differences between treated animals and the control group were not significant (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>D, values at the maximum current intensity: Tg control = 0.719 ± 0.175 mV/ms; Tg + <b>5i</b> = 0.738 ± 0.243 mV/ms; Tg + <b>5c</b> = 0.399 ± 0.111 mV/ms; <i>p</i> = 0.088). These data indicate that the treatment with <b>5c</b> and <b>5i</b> does not affect the number of axons recruited and thus the excitability during basal synaptic transmission in young transgenic mice.</div><figure id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Synaptic transmission efficacy and plasticity mechanisms are affected in young male APP/PS1 mice treated with compounds <b>5c</b> and <b>5i</b>. (A) PPF plot shows the ratio of the second versus the first fEPSP slope (R2/R1), recorded at different time intervals (10, 20, 30, 50, 60, 80, 100, 150, and 200 ms), showing that only at the beginning short-term plasticity was different in <b>5i</b>-treated animals compared with vehicle- and <b>5c</b>-treated mice. Tg control (open circles), Tg + <b>5i</b> (black circles), and Tg + <b>5c</b> (black triangles). Representative traces of two evoked fEPSPs separated by 20 ms (inset). (B) Representative traces of postsynaptic potentials evoked by increasing stimulus intensities (μA). Input–output curves of both fEPSP slope (C) and fiber volley amplitude (D) against stimulus intensity. (E) Correlations between the FV amplitude and fEPSP slope were adjusted by linear regressions and found to significantly differ from each other. (F) LTP plot where fEPSPs slopes after TBS (arrow) were normalized to slopes during basal time. (G) Correlation plot between FV amplitudes and fEPSP slopes of three groups before TBS (pre-TBS, open symbols within circle) and after TBS (post-TBS, solid symbols); all comparisons were found to be significant among groups. Data represent the mean ± SEM from nine slices out of three Tg control mice, nine slices out of three Tg + <b>5i</b> mice, and nine slices out of three Tg + <b>5c</b> mice. Analysis by one-way or two-way ANOVA followed by Bonferroni’s post hoc test, *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Then, we studied how effective was the correlation between the axonal recruitment and the evoked response. To do that, we built a plot from FV amplitudes and EPSP slopes. We applied linear regression and then compared the slopes obtained for the three experimental conditions (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>E). A significant positive correlation between FV amplitude and fEPSP slopes was obtained in all three cases and showed that the three groups differ significantly from each other (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>E, see also the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Supporting Information</a> for more details). Thus, in young transgenic mice, treatment with both <b>5c</b> amd <b>5i</b> improved the efficacy of synaptic transmission per activated axon; indeed, both compounds increased the effectiveness in basal transmission relative to vehicle-treated animals, with <b>5c</b> exerting a stronger effect than <b>5i</b>.</div><div class="NLM_p">As it has been extensively studied, APP/PS1 mice show deficient generation of synaptic plasticity in the form of hippocampal long-term potentiation (LTP).<a onclick="showRef(event, 'ref83 ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref83 ref84 ref85">(83−85)</a> We therefore evaluated whether the chronic treatment of APP/PS1 mice with <b>5c</b> or <b>5i</b> could affect LTP in young transgenic mice (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>F). To that end, we first obtained stable recording for at least 15 min and then applied a theta burst stimulation (TBS) protocol to induce LTP. After that, the recording for more than 1 h was compared to the basal time before TBS to quantify the amount of LTP generated, which was shown as the relative change (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>F). Some examples of the evoked fEPSP before and after LTP induction are shown in the inset of <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>F. The graph shows that all three experimental groups can generate a significant amount of LTP, taking into account that these are transgenic animals and that at this age they start to display some synaptic deficiencies. However, young transgenic mice treated with both <b>5i</b> or <b>5c</b> displayed significantly higher LTP compared to the transgenic control group (average of the last 10 min (gray area): Tg control: 134.1 ± 13.1%; Tg + <b>5i</b>: 397.3 ± 23.7%; Tg + <b>5c</b>: 275.6 ± 61.5% of baseline; one-way ANOVA followed by Bonferroni’s post-hoc test, ***<i>p</i> < 0.001). These results indicate that treatment with both <b>5i</b> and <b>5c</b> significantly affects the postsynaptic mechanisms involved in LTP in young transgenic mice, improving plasticity.</div><div class="NLM_p">Furthermore, to determine whether these differences in the level of LTP response were due to the status of the synapses before and after LTP induction in the three treatment groups, we plotted the input–output function before and after LTP induction (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>G). To do this, we averaged the FV amplitudes and the fEPSP slopes of all the experiments used to calculate LTP. We then plotted these measurements of FV amplitude and slopes both before (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>G, open symbols within circle) and after TBS (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>G, closed symbols). The recordings were stable with time because the amplitude of FV did not change before and after LTP induction, which indicates that the same presynaptic fibers are being recruited and that the differences seen are due only to postsynaptic effects (for more details, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Supporting Information</a>). We then determined whether the correlation of FV amplitudes with fEPSP slopes was significantly different across the groups and found that all the correlations were statistically significant (for more details, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Supporting Information</a>). Interestingly, the treatment with compounds <b>5c</b> and <b>5i</b> reduced the number of recruited axons (lower FV amplitudes) compared to the control, to produce almost the same evoked response during basal activity. In all cases, after TBS or during LTP induction, the correlation in all three groups significantly increased after the induction of LTP, especially in mice treated with the compounds. The correlation “<i>r</i>” in all three groups increased after the induction of LTP, especially in the mice groups treated with the compounds, becoming significantly different among groups. Taken together, these data indicate that in young animals, both treatments led to a structural change that made synaptic transmission more efficient, with these changes influencing the postsynaptic mechanisms that induce plasticity.</div><div class="NLM_p">To assess the effects of <b>5c</b> and <b>5i</b> on basal activity and synaptic plasticity of 11 month-old APP/PS1 mice, we performed the same experiments and analyses previously described for the young mice. Thus, we analyzed the PPF curve, which, as previously mentioned, is a presynaptic form of plasticity indicative of short-term plasticity (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>A). In old transgenic mice, no significant difference was found among the groups, indicating that calcium-dependent vesicle release was not affected by treatment with either <b>5c</b> or <b>5i</b> as compared to control (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>A, index at 10 ms time interval: Tg control: 2.05 ± 0.2 ms; Tg + <b>5i</b>: 1.96 ± 0.02 ms; Tg + <b>5c</b>: 2.32 ± 0.1 ms; two-way ANOVA, <i>p</i> = 0.097). Next, the input–output relationship was built in the three cases (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>B) and plotted with the fEPSP slopes (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>C) and the fiber volley (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>D). Interestingly, the plots of the fEPSP slopes against the stimulus amplitude showed that the control curve was significantly lower and different from the other two, indicating that the treatment with both <b>5c</b> and <b>5i</b> did affect basal synaptic activity in old transgenic mice (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>C, values at the maximum current intensity: Tg control = 0.293 ± 0.105 mV/ms; Tg + <b>5i</b> = 0.652 ± 0.107 mV/ms; Tg + <b>5c</b> = 0.545 ± 0.083 mV/ms; two-way ANOVA followed by Bonferroni’s post-hoc test, *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001). In contrast, the FV input–output plot showed no significant difference among the groups (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>D, values at the maximum current intensity: Tg control = 0.826 ± 0.169 mV; Tg + <b>5i</b> = 1.039 ± 0.245 mV; Tg + <b>5c</b> = 0.808 ± 0.069 mV; two-way ANOVA followed by Bonferroni’s post-hoc test, <i>p</i> = 0.088). Unlike what was observed in young mice, old APP/PS1 mice treated with compounds <b>5i</b> and <b>5c</b> showed an enhanced basal synaptic transmission, without the number of axons recruited being affected.</div><figure id="fig12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Synaptic transmission efficacy but not plasticity mechanisms are affected in old male APP/PS1 mice treated with compounds <b>5i</b> and <b>5c</b>. (A) PPF plot shows the ratio of the second versus the first fEPSP slopes (R2/R1), recorded at various time intervals (10, 20, 30, 50, 60, 80, 100, 150, and 200 ms), showing that short-term plasticity was not significantly changed by treatment with <b>5i</b> or <b>5c</b>. Tg control (open circles), Tg + <b>5i</b> (black circles), and Tg + <b>5c</b> (black triangles). Representative traces of two evoked fEPSPs separated by 20 ms (inset). (B) Representative traces of postsynaptic potentials evoked by increasing stimulus intensities (μA). Their input–output curves of both fEPSP slope (C) and fiber volley amplitude (D) against stimulus intensity. (E) Correlations between the FV amplitude and fEPSP slope were adjusted by linear regression and revealed that both <b>5i</b> and <b>5c</b> differ from the control. (F) LTP plot where fEPSP slopes after TBS (arrow) were normalized to slopes during basal time. (G) Correlation plot between FV amplitudes and fEPSP slopes of three groups before TBS (pre-TBS, open symbols within circle) and after TBS (post-TBS, solid symbols); control and Tg + <b>5i</b> do not differ from each other but both differ from Tg + <b>5c</b>. Data represent the mean ± SEM from nine slices out of three Tg control mice, nine slices out of three Tg + <b>5i</b> mice, and nine slices out of three Tg + <b>5c</b> mice. Analysis by two-way ANOVA followed by Bonferroni’s post hoc test, *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We also plotted the correlation between FV amplitude and fEPSP slopes obtained in the input–output protocol. We adjusted the plots by linear regression and then compared them under the three experimental conditions (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>E). There was a positive correlation between FV amplitude and fEPSP slopes in all the three conditions (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>E; for details, see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Supporting Information</a>). Also, the analysis between regressions revealed significant differences across them. The analyses indicated that in the old APP/PS1 mice, treatment with either <b>5i</b> or <b>5c</b> improved the strength of synaptic transmission per activated axon compared to the control, thus increasing the efficacy of basal transmission.</div><div class="NLM_p">Next, we evaluated the effect of <b>5i</b> and <b>5c</b> on LTP in old transgenic mice. Some representative traces of evoked fEPSPs before and after LTP induction are shown in the inset of <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>F. The plot shows that in all three experimental groups, some degree of LTP can be generated but that there are no significant differences among the groups (average of the last 10 min (gray area), Tg control: 83.9 ± 21.1%; Tg + <b>5i</b>: 111.0 ± 45.0%; Tg + <b>5c</b>: 124.3 ± 16.8% of baseline; one-way ANOVA, followed by Bonferroni’s post-hoc test: <i>p</i> = 0.25). Thus, in the old animals, neither <b>5c</b> nor <b>5i</b> significantly improved the postsynaptic mechanisms involved in LTP.</div><div class="NLM_p">As we had done for the young mice, we compared the synaptic status of the old transgenic mice, during induction of long-term plasticity, under the same three conditions. We plotted the input–output function with the average measurements of FV amplitude and slopes before and after TBS (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>G). Unlike what was found in young mice, in old animals, both the FV amplitude and the evoked response values for the control and the <b>5i</b>-treated group were similar and differed from the <b>5c</b>-treated group (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Supporting Information</a>). Thus, the effects of <b>5i</b> in old mice were different from those found in young mice. In contrast, the effects of <b>5c</b> on synaptic activity of old mice were more similar to those exerted by this compound in young animals. Thus, <b>5c</b> can change the effectiveness of synaptic transmission between the FV amplitude and fEPSP slope before and after LTP induction, even though it does not affect the mechanisms to induce LTP.</div><div class="NLM_p last">Taken together, the electrophysiological measurements show that treatment with both <b>5c</b> and <b>5i</b> affects synaptic transmission. Indeed, both compounds improve the efficacy of basal synaptic transmission, with no change in the presynaptic calcium-dependent release mechanism, in either young or old animals. Other mechanisms could be involved in producing the effects observed, such as changes in the number of vesicles or at the active sites. Changes in quantal amplitude may also contribute, by increasing postsynaptic receptors levels. Regarding the plasticity phenomena, both <b>5i</b> and <b>5c</b> improved long-term plasticity in young but not in old mice, suggesting that changes at the level of LTP induced by these compounds can provide a protective mechanism to preserve synaptic plasticity and brain connectivity in young circuits. We cannot, however, rule out the possibility that the old mice might respond to a more prolonged treatment regime.</div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Effects on the Levels of Oxidative Stress and Neuroinflammation Markers in the Hippocampus of APP/PS1 Mice</h3><div class="NLM_p">To determine if chronic treatment of APP/PS1 mice with compounds <b>5i</b> and <b>5c</b> induced beneficial effects against oxidative stress, we measured the levels of 4-hydroxy-2-nonenal (4-HNE). Plasma membrane integrity is essential for neuronal signaling. 4-HNE is a reactive α,β-unsaturated aldehyde arising from lipid peroxidation that serves as a marker of plasma membrane oxidative damage.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> No differences in hippocampal levels of 4-HNE were found among young APP/PS1 mice treated with the vehicle, <b>5i</b>, or <b>5c</b> (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A,C). However, in old APP/PS1 mice, <b>5c</b> and <b>5i</b> induced a significant decrease in the hippocampal levels of 4-HNE compared with the control group (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>B,D). These results suggest that chronic administration of both <b>5c</b> and <b>5i</b> rescues old APP/PS1 mice from the oxidative stress characteristic of their Alzheimer-like pathology. Thus, notwithstanding the fact that the antioxidant activity measured in vitro for <b>5c</b> and <b>5i</b> is not well balanced with their anticholinesterase potencies, an antioxidant effect of these compounds is eventually operating in vivo, even though alternative mechanisms other than a direct antioxidant effect cannot be ruled out.</div><figure id="fig13" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Representative immunofluorescence of the hippocampal levels of 4-HNE (4-HNE, red; nuclear stain Hoechst, blue) in (A, C) young and (B, D) old male APP/PS1 mice treated with vehicle, <b>5i</b>, or <b>5c</b>. Data are expressed as mean values ± SEM of <i>n</i> = 4 animals per group. Data were analyzed statistically by one-way ANOVA followed by Bonferroni’s post hoc test. ***<i>p</i> < 0.001; ****<i>p</i> < 0.0001. Scale bar: 100 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we measured the levels of glial fibrillary acidic protein (GFAP), a well-known marker of astrogliosis, a reactive inflammatory state of astrocytes in response to neurodegeneration during AD progression.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> GFAP levels were significantly reduced in young APP/PS1 mice treated with <b>5c</b> but not with <b>5i</b>, relative to vehicle-treated animals (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>A,C). Chronic treatment of old APP/PS1 mice with both <b>5c</b> and <b>5i</b> led to a significant decrease in hippocampal levels of GFAP compared with vehicle-treated animals, with <b>5i</b> exerting a more pronounced effect (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>B,D). Thus, chronic treatment with <b>5i</b> and <b>5c</b> alleviated neuroinflammation in the hippocampus of APP/PS1 mice, especially in the old animals.</div><figure id="fig14" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Representative immunofluorescence of the hippocampal levels of GFAP (GFAP, red; nuclear stain Hoechst, blue) in (A, C) young and (B, D) old male APP/PS1 mice treated with the vehicle, <b>5i</b>, or <b>5c</b>. Data are expressed as mean values ± SEM of <i>n</i> = 4 animals per group. Data were analyzed statistically by one-way ANOVA followed by Bonferroni’s post hoc test. *<i>p</i> < 0.05; ***<i>p</i> < 0.001. Scale bar: 100 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The difficult-to-refute argument that complex multifactorial diseases, such as AD, may be more efficiently tackled with therapeutic regimes that simultaneously hit several key targets or pathological events has spurred very intensive research on MTDLs. Suitably designed huprine derivatives have already shown to be valuable MTDLs for the treatment of AD, allowing not only AChE and BChE inhibition but also modulation of other targets, such as BACE-1, oxidative stress, and tau pathology.<a onclick="showRef(event, 'ref56 ref57 ref58 ref62'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58 ref62">(56−58,62)</a> Capsaicin has been shown to be endowed with a set of activities of high value in the context of AD treatment, including beneficial effects in vivo against oxidative stress and neuroinflammation,<a onclick="showRef(event, 'ref41 ref42 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44 ref45">(41−45)</a> and enhancement of hippocampal LTP and synaptic function, which eventually lead to improved cognition.<a onclick="showRef(event, 'ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49">(46−49)</a> Based on these premises, we hypothesized that the combination of the scaffolds of capsaicin and a huprine might result in hybrid compounds with the potential to address several major pathologies associated with AD, namely, cholinergic deficit, oxidative stress, neuroinflammation, synaptic dysfunction, and cognitive impairment. HC hybrids were generated by introduction of a variety of linkers (alkanamide, alkenamide, and benzamide) at position 12 of the huprine scaffold or a triazolylbutyl linker at position 9. All compounds retained the in vitro beneficial activities of the two parent moieties; i.e., they potently inhibited both AChE and BChE and showed antioxidative activities comparable to those of capsaicin, demonstrating that derivatization does not result in a loss of function.</div><div class="NLM_p">The observation that all 12-HC compounds are potent hBChE inhibitors shows that they are able to bind efficiently to hBChE, although presumably in a non-native conformation that differs from the canonical binding mode of huprines in complexes with <i>Tc</i>AChE substantially enough to eliminate crystal packing interactions. In the 12-HC series, compound <b>5c</b> stands out, displaying subnanomolar inhibitory activity against hAChE, a reduced AChE-over-BChE selectivity ratio of 40, relative to the parent huprine Y (selectivity ratio = 169), antioxidant properties comparable to those of the parent capsacin, and a strong predicted permeability across the BBB.</div><div class="NLM_p">While compounds derivatized on position 12 were, in general, active against BACE-1, derivatization at position 9 resulted in a compound, <b>5i</b>, which was inactive against BACE-1, but displayed comparably high affinity for hAChE and hBChE. With an AChE-over-BChE selectivity ratio of 6.9, <b>5i</b> presents a 25-fold improvement in affinity for hBChE, with respect to the parent huprine Y. The structure of its complex with hBChE rationalized this observation, revealing a completely new binding mode, in which the chorine atom of the huprine moiety fits in the acyl- instead of the choline-binding pocket, while its primary amino group is stabilized between the catalytic serine (Ser198 in hBChE) and histidine (His438 in hBChE), effectively disrupting the triad. Since derivatization at position 12 involves the amino group, this peculiar binding mode is inaccessible to compounds of the 12-HC series. Interestingly, binding of <b>5i</b> to BChE exploits all the differences in the active-site gorge architecture between hAChE and hBChE, i.e., differences in the acyl- and choline-binding pocket of the CAS, and at the PAS. It is therefore unlikely that this binding mode would occur in AChE. Indeed, the structures of six HC hybrid–<i>Tc</i>AChE complexes (including <b>5i</b>) revealed the canonical binding mode, i.e., with the chlorine atom fitting into the choline-binding pocket and the amine facing the upper part of the gorge. Derivatization at position 9 of huprines thus emerges as a viable option for overcoming the AChE-over-BChE specificity of huprine derivatives and could be further exploited to produce BChE-specific MTDLs, e.g., by further functionalization of the triazole linker. Since hBChE activity increases and co-localizes with plaques and neurofibrillary tangles in the brains of AD patients,<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> hBChE-specific inhibitors could prove to be valuable tools for both treatment and diagnosis of AD. Nonetheless, a compound such as <b>5i</b>, which displays similar affinity for hAChE and hBChE, could already prove to be beneficial in the clinic, allowing simultaneous inhibition of the two enzymes involved in cholinergic breakdown by use of a single, highly potent compound.</div><div class="NLM_p">The good brain permeability of the novel compounds, measured in vitro by the PAMPA-BBB assay, was confirmed for compounds <b>5c</b> and <b>5i</b> by biodistribution studies in wild-type mice, using the same dosing protocol that was later used for the in vivo efficacy studies. Despite the apparent higher polarity and lower PAMPA-BBB permeability of hybrid <b>5i</b>, its brain concentration and brain/plasma ratio were significantly higher than those of both <b>5c</b> and the reference anti-AD drug donepezil.</div><div class="NLM_p">Chronic administration of <b>5c</b> and <b>5i</b> (2 mg/kg, i.p., 3 times per week, 4 weeks) to 5 and 10 month-old APP/PS1 mice was well tolerated, with all the animals remaining healthy at the end of the treatment, according to weight, lipid, and hepatic parameters, and by visual inspection. Moreover, chronic treatment did not induce locomotor or stress problems, as found in LOF tests, thereby ruling out potential interferences of the basal status of the animals when assessing the effects of the compounds on learning and memory in the subsequent behavioral assays.</div><div class="NLM_p">Neither <b>5c</b> nor <b>5i</b> exerted beneficial effects in young transgenic mice as compared with the vehicle-treated group. Only in electrophysiological studies were positive effects found, with both compounds increasing the effectiveness of basal synaptic transmission relative to vehicle-treated animals and both increasing LTP as well, thereby improving synaptic plasticity. In addition, <b>5c</b> was found to significantly reduce the neuroinflammation marker GFAP in the hippocampus of young transgenic mice, compared with the control group.</div><div class="NLM_p">The beneficial in vivo effects were much more prominent in the old APP/PS1 mice, especially for <b>5i</b>. This compound significantly enhanced learning and memory of the old transgenic mice, compared to the control group, in three behavioral tests (NOR, NOL, and the memory flexibility tests). Furthermore, <b>5i</b> significantly increased the hippocampal levels of the less neurotoxic Aβ40 (2.1-fold relative to vehicle-treated mice), while leaving unaltered the levels of the more aggregation-prone and neurotoxic Aβ42. Thus, <b>5i</b> treatment led to a significant decrease of the Aβ42/Aβ40 ratio, which is a marker of AD progression, with this reduced ratio being indicative of a delayed disease progression and, hence, of a disease-modifying effect. In addition, it was found that <b>5i</b> significantly increased the strength of synaptic transmission, without affecting LTP, in contrast to its effects in young mice. The beneficial effect on basal synaptic efficacy was also found in old mice treated with <b>5c</b>. Finally, chronic treatment with both <b>5i</b> and <b>5c</b> significantly reduced hippocampal levels of the oxidative stress marker 4-HNE and the neuroinflammation (astrogliosis) marker GFAP, with <b>5i</b> exerting a more pronounced effect on both markers.</div><div class="NLM_p last">Likely, the very strong hAChE and hBChE inhibitory activity of <b>5i</b> as well as other modes of action due to the presence of the capsaicin moiety account for its cognition-enhancing effect. The in vivo effects of <b>5i</b> on several underlying disease mechanisms, especially its beneficial effects on synaptic function, oxidative stress, and neuroinflammation, might also result from the presence of the capsaicin scaffold in its structure. Indeed, capsaicin has been reported to improve synaptic and cognitive functions and to reduce oxidative stress and neuroinflammation, by activation of transient receptor potential vanillin 1 (TRPV1).<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> This mechanism might be also underlying the disease-modifying effects exerted by compound <b>5i</b>, which emerges as a promising new anti-Alzheimer lead compound.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div class="NLM_p last">Melting points were determined in open capillary tubes with MFB 595010 M Gallenkamp melting point apparatus. 400 MHz <sup>1</sup>H/101 MHz <sup>13</sup>C NMR spectra were recorded on a Varian Mercury 400 spectrometer, and 200 MHz <sup>1</sup>H NMR and 300 MHz <sup>1</sup>H/75 MHz <sup>13</sup>C NMR spectra were recorded on a Bruker 200 or 300 MHz spectrometer. The chemical shifts are reported in ppm (δ scale), and coupling constants are reported in Hertz (Hz). Assignments given for the NMR spectra of the new compounds were made by comparison with the NMR data of hybrids <b>5b</b>, <b>5f</b>, <b>5g</b>, <b>5i</b>, <b>7</b>, and <b>14</b> as model compounds, which in turn were assigned on the basis of DEPT, COSY <sup>1</sup>H/<sup>1</sup>H (standard procedures), and COSY <sup>1</sup>H/<sup>13</sup>C (gHSQC and gHMBC sequences) experiments. The <i>syn</i> (<i>anti</i>) notation of the protons at position 13 of the huprine moiety of the hybrids means that the corresponding proton at position 13 is on the same (different) side of the quinoline moiety with respect to the cyclohexene ring. IR spectra were run on a Perkin-Elmer Spectrum RX I spectrophotometer. Absorption values are expressed as wavenumbers (cm<sup>–1</sup>); only significant absorption bands are given. Column chromatography was performed on silica gel 60AC.C (40–60 mesh, SDS, ref 2000027). Thin-layer chromatography was performed with aluminum-backed sheets with silica gel 60F<sub>254</sub> (Merck, ref 1.05554), and spots were visualized with UV light and 1% aqueous KMnO<sub>4</sub>. Elemental analyses were carried out at the Mycroanalysis Service of the IIQAB (CSIC, Barcelona, Spain) with a Carlo Erba 1106 analyzer. HPLC purity measurements were performed with a Thermo Scientific Surveyor Plus instrument equipped with a PDA detector (method A, acetonitrile/H<sub>2</sub>O (0.10% TFA), flow rate 1 mL/min, det. 254–330 nm). HRMS were obtained with LC/MSD TOF Agilent Technologies or Varian MAT 311 spectrometers, using an electrospray source. The analytical samples of the HC hybrids that were subjected to pharmacological evaluation possess a purity ≥95% as indicated by their elemental analyses or HPLC measurements.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 5-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]-<i>N</i>-(4-hydroxy-3-methoxybenzyl)pentanamide (<b>5a</b>)</h3><div class="NLM_p">A solution of nitrile <b>3a</b> (1.43 g, 3.91 mmol) in MeOH (5 mL) was treated with a 40% solution of KOH in MeOH (10 mL), and the mixture was stirred under reflux for 3 h and treated with H<sub>2</sub>O (16 mL). The reaction mixture was stirred under reflux overnight, cooled to rt, and evaporated under reduced pressure. The resulting residue was treated with HCl/Et<sub>2</sub>O (0.5 N, 156 mL) and concentrated under reduced pressure to give the carboxylic acid, in the form of its hydrochloride salt (6.00 g), as a white solid that was used in the next step without further purification.</div><div class="NLM_p">A suspension of crude carboxylic acid (3.00 g) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was cooled to 0 °C in an ice bath and treated dropwise with freshly distilled Et<sub>3</sub>N (1.32 mL, 958 mg, 9.47 mmol) and ClCO<sub>2</sub>Et (0.18 mL, 204 mg, 1.90 mmol). The resulting suspension was stirred at 0 °C for 30 min and then treated with amine <b>4</b> (360 mg, 1.90 mmol). The reaction mixture was stirred at rt for 3 days, diluted with 10% aq. Na<sub>2</sub>CO<sub>3</sub> (60 mL), and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 40 mL). The combined organic extracts were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and evaporated under reduced pressure to give a yellow solid (740 mg), which was purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 99:1:0.2, hybrid <b>5a</b> (180 mg, 18% overall yield from <b>3a</b>) was isolated; <i>R<sub>f</sub></i> = 0.19 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last">A solution of <b>5a</b> (180 mg, 0.35 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) was filtered through a 0.2 μm PTFE filter, treated with methanolic HCl (0.43 N, 2.42 mL), and evaporated under reduced pressure. The resulting solid was washed with pentane (3 × 2 mL) to give, after drying at 65 °C/2 torr for 48 h, <b>5a</b>·HCl (176 mg) as a beige solid: mp 132–133 °C; IR (KBr) ν 3500–2500 (max at 3250, 3061, 3012, 2925, 2857, 2801, O–H, N–H, N<sup>+</sup>–H, and C–H st), 1632, 1584, 1514 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.56 (s, 3H, 9′-CH<sub>3</sub>), 1.77 (tt, <i>J</i> = 7.2 Hz, <i>J</i>′ = 6.8 Hz, 2H, 3-H<sub>2</sub>), superimposed in part 1.88 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 4-H<sub>2</sub>), 1.90 (br d, <i>J</i> = 18.0 Hz, 1H, 10′-H<i><sub>endo</sub></i>), superimposed in part 1.92 (dm, <i>J</i> = 11.2 Hz, 1H, 13′-H<i><sub>syn</sub></i>), 2.06 (dm, <i>J</i> = 11.2 Hz, 1H, 13′-H<i><sub>anti</sub></i>), 2.34 (t, <i>J</i> = 6.8 Hz, 2H, 2-H<sub>2</sub>), 2.54 (dd, <i>J</i> = 18.0 Hz, <i>J</i>′ = 5.2 Hz 1H, 10′-H<i><sub>exo</sub></i>), 2.75 (m, 1H, 7′-H), 2.87 (br d, <i>J</i> = 18.0 Hz, 1H, 6′-H<i><sub>endo</sub></i>), 3.19 (dd, <i>J</i> = 18.0 Hz, <i>J</i>′ = 5.2 Hz, 1H, 6′-H<i><sub>exo</sub></i>), 3.44 (m, 1H, 11′-H), 3.76 (s, 3H, 3″-OCH<sub>3</sub>), 3.95 (t, <i>J</i> = 7.6 Hz, 2H, 5-H<sub>2</sub>), 4.23 (br d, <i>J</i> = 4.0 Hz, 2H, CONHC<i>H</i><sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 5.56 (br d, <i>J</i> = 4.8 Hz, 1H, 8′-H), 6.61 (d, <i>J</i> = 8.0 Hz, 1H, 5″-H), 6.66 (br d, <i>J</i> = 8.0 Hz, 1H, 6″-H), 6.80 (s, 1H, 2″-H), 7.48 (br d, <i>J</i> = 9.2 Hz, 1H, 2′-H), 7.74 (br s, 1H, 4′-H), 8.30 (d, <i>J</i> = 9.2 Hz, 1H, 1′-H), 8.39 (t, <i>J</i> = 4.0 Hz, 1H, CON<i>H</i>CH<sub>2</sub>); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 23.5 (CH<sub>3</sub>, 9′-CH<sub>3</sub>), 23.8 (CH<sub>2</sub>, C3), 27.2 (CH, C11′), 27.8 (CH, C7′), 29.3 (CH<sub>2</sub>, C13′), 30.7 (CH<sub>2</sub>, C4), 36.0 (CH<sub>2</sub>, C6′), 36.1 (2CH<sub>2</sub>, C2, C10′), 43.9 (CH<sub>2</sub>, major rotamer CONH<i>C</i>H<sub>2</sub>), 44.1 (CH<sub>2</sub>, minor rotamer CONH<i>C</i>H<sub>2</sub>), 49.1 (CH<sub>2</sub>, C5), 56.3 (CH<sub>3</sub>, 3″-OCH<sub>3</sub>), 112.4 (CH, C2″), 115.5 (C, C12a′), 116.0 (CH, C5″), 117.6 (C, C11a′), 119.1 (CH, C4′), 121.3 (CH, C6″), 125.1 (CH, C8′), 126.7 (CH, C2′), 129.3 (CH, C1′), 131.5 (C, C1″), 134.6 (C, C9′), 140.0 (C, C3′), 140.9 (C, C4a′), 146.7 (C, C4″), 148.8 (C, C3″), 151.2 (C, C5a′), 156.7 (C, C12′), 175.26 (C, major rotamer C1), 175.35 (C, minor rotamer C1); HRMS (ESI) calcd for (C<sub>30</sub>H<sub>34</sub><sup>35</sup>ClN<sub>3</sub>O<sub>3</sub> + H<sup>+</sup>): 520.2361, found 520.2357. Anal. (C<sub>30</sub>H<sub>34</sub>ClN<sub>3</sub>O<sub>3</sub>·HCl·3/4H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 6-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]-<i>N</i>-(4-hydroxy-3-methoxybenzyl)hexanamide (<b>5b</b>)</h3><div class="NLM_p"><b>5b</b> was prepared as described for <b>5a</b>. From nitrile <b>3b</b> (1.60 g, 4.21 mmol), crude carboxylic acid (6.61 g) was obtained as a white solid, which was used in the next step without further purification. From this crude carboxylic acid (6.26 g) and amine <b>4</b> (757 mg, 3.99 mmol), a yellowish solid residue (2.00 g) was obtained and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 98.5:1.5:0.2, hybrid <b>5b</b> (800 mg, 38% overall yield from <b>3b</b>) was obtained; <i>R<sub>f</sub></i> = 0.20 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last"><b>5b</b>·HCl: mp 134–135 °C; IR (KBr) ν 3500–2500 (max at 3233, 3054, 3012, 2924, 2855, 2791, O–H, N–H, N<sup>+</sup>–H, and C–H st), 1632, 1601, 1583, 1569, 1513 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.46 (tt, <i>J</i> = <i>J</i>′ = 7.6 Hz, 2H, 4-H<sub>2</sub>), 1.57 (s, 3H, 9′-CH<sub>3</sub>), 1.71 (tt, <i>J</i> = <i>J</i>′ = 7.6 Hz, 2H, 3-H<sub>2</sub>), 1.87 (tt, <i>J</i> = <i>J</i>′ = 7.6 Hz, 2H, 5-H<sub>2</sub>), 1.91 (br d, <i>J</i> = 18.0 Hz, 1H, 10′-H<i><sub>endo</sub></i>), superimposed in part 1.93 (dm, <i>J</i> = 12.4 Hz, 1H, 13′-H<i><sub>syn</sub></i>), 2.06 (dm, <i>J</i> = 12.4 Hz, 1H, 13′-H<i><sub>anti</sub></i>), 2.27 (t, <i>J</i> = 7.6 Hz, 2H, 2-H<sub>2</sub>), 2.54 (dd, <i>J</i> = 18.0 Hz, <i>J</i>′ = 4.8 Hz, 1H, 10′-H<i><sub>exo</sub></i>), 2.75 (m, 1H, 7′-H), 2.86 (br d, <i>J</i> = 18.0 Hz, 1H, 6′-H<i><sub>endo</sub></i>), 3.19 (dd, <i>J</i> = 18.0 Hz, <i>J</i>′ = 5.6 Hz, 1H, 6′-H<i><sub>exo</sub></i>), 3.43 (m, 1H, 11′-H), 3.80 (s, 3H, 3″-OCH<sub>3</sub>), 3.94 (t, <i>J</i> = 7.2 Hz, 2H, 6-H<sub>2</sub>), 4.24 (d, <i>J</i> = 6.0 Hz) and 4.25 (d, <i>J</i> = 4.4 Hz) (2H, rotamers of CONHC<i>H</i><sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 5.57 (br d, <i>J</i> = 4.8 Hz, 1H, 8′-H), 6.67 (d, <i>J</i> = 8.0 Hz, 1H, 5″-H), 6.69 (dd, <i>J</i> = 8.0 Hz, <i>J</i>′ = 1.6 Hz, 1H, 6″-H), 6.84 (br s, 1H, 2″-H), 7.53 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 2′-H), 7.76 (d, <i>J</i> = 2.0 Hz, 1H, 4′-H), superimposed in part 8.30 (t, <i>J</i> = 4.4 Hz) and 8.33 (t, <i>J</i> = 6.0 Hz) (1H, rotamers of CON<i>H</i>CH<sub>2</sub>), 8.35 (d, <i>J</i> = 9.2 Hz, 1H, 1′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 23.5 (CH<sub>3</sub>, 9′-CH<sub>3</sub>), 26.4 (CH<sub>2</sub>, C3), 27.3 (CH<sub>2</sub> + CH, C4, C11′), 27.8 (CH, C7′), 29.3 (CH<sub>2</sub>, C13′), 30.9 (CH<sub>2</sub>, C5), 36.0 (CH<sub>2</sub>, C6′), 36.1 (CH<sub>2</sub>, C10′), 36.7 (CH<sub>2</sub>, major rotamer C2), 36.8 (CH<sub>2</sub>, minor rotamer C2), 43.9 (CH<sub>2</sub>, major rotamer CONH<i>C</i>H2), 44.1 (CH<sub>2</sub>, minor rotamer CONH<i>C</i>H2), 49.5 (CH<sub>2</sub>, C6), 56.4 (CH<sub>3</sub>, 3″-OCH<sub>3</sub>), 112.5 (CH, C2″), 115.7 (C, C12a′), 116.1 (CH, C5″), 117.6 (C, C11a′), 119.1 (CH, C4′), 121.3 (CH, C6″), 125.1 (CH, C8′), 126.7 (CH, C2′), 129.4 (CH, C1′), 131.5 (C, C1″), 134.6 (C, C9′), 140.2 (C, C3′), 140.9 (C, C4a′), 146.8 (C, C4″), 148.9 (C, C3″), 151.2 (C, C5a′), 156.8 (C, C12′), 175.6 (C, major rotamer C1), 175.7 (C, minor rotamer C1); HRMS (ESI) calcd for (C<sub>31</sub>H<sub>36</sub><sup>35</sup>ClN<sub>3</sub>O<sub>3</sub> + H<sup>+</sup>): 534.2518, found 534.2527. Anal. (C<sub>31</sub>H<sub>36</sub>ClN<sub>3</sub>O<sub>3</sub>·HCl·1/2H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 7-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]-<i>N</i>-(4-hydroxy-3-methoxybenzyl)heptanamide (<b>5c</b>)</h3><div class="NLM_p"><b>5c</b> was prepared as described for <b>5a</b>. From nitrile <b>3c</b> (800 mg, 2.03 mmol), crude carboxylic acid (3.43 g) was obtained as a white solid, which was used in the next step without further purification. From this crude carboxylic acid (3.43 g) and amine <b>4</b> (385 mg, 2.03 mmol), a yellowish solid residue (1.09 g) was obtained and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 99:1:0.2, hybrid <b>5c</b> (490 mg, 44% overall yield from <b>3c</b>) was obtained; <i>R<sub>f</sub></i> = 0.24 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last"><b>5c</b>·HCl: mp 133–135 °C; IR (KBr) ν 3500–2500 (max at 3233, 3057, 3007, 2925, 2854, 2785, O–H, N–H, N<sup>+</sup>–H, and C–H st), 1630, 1599, 1583, 1566, 1513 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.36–1.48 (complex signal, 4H, 4-H<sub>2</sub>, 5-H<sub>2</sub>), 1.58 (s, 3H, 9′-CH<sub>3</sub>), 1.65 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 3-H<sub>2</sub>), 1.84 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 6-H<sub>2</sub>), 1.92 (br d, <i>J</i> = 18.0 Hz, 1H, 10′-H<i><sub>endo</sub></i>), superimposed in part 1.95 (dm, <i>J</i> = 12.8 Hz, 1H, 13′-H<i><sub>syn</sub></i>), 2.08 (dm, <i>J</i> = 12.8 Hz, 1H, 13′-H<i><sub>anti</sub></i>), 2.23 (t, <i>J</i> = 7.2 Hz, 2H, 2-H<sub>2</sub>), 2.55 (dd, <i>J</i> = 18.0 Hz, <i>J</i>′ = 4.4 Hz, 1H, 10′-H<i><sub>exo</sub></i>), 2.77 (m, 1H, 7′-H), 2.86 (br d, <i>J</i> = 18.0 Hz, 1H, 6′-H<i><sub>endo</sub></i>), 3.20 (dd, <i>J</i> = 18.0 Hz, <i>J</i>′ = 5.6 Hz, 1H, 6′-H<i><sub>exo</sub></i>), 3.44 (m, 1H, 11′-H), 3.81 (s, 3H, 3″-OCH<sub>3</sub>), 3.93 (br t, <i>J</i> = 6.8 Hz, 2H, 7-H<sub>2</sub>), 4.24 (d, <i>J</i> = 5.6 Hz, 2H, CONHC<i>H</i><sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 5.58 (br d, <i>J</i> = 4.4 Hz, 1H, 8′-H), 6.68 (d, <i>J</i> = 8.0 Hz, 1H, 5″-H), 6.70 (br d, <i>J</i> = 8.0 Hz, 1H, 6″-H), 6.84 (br s, 1H, 2″-H), 7.54 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 2′-H), 7.75 (d, <i>J</i> = 2.0 Hz, 1H, 4′-H), 8.30 (t, <i>J</i> = 5.6 Hz, 1H, CON<i>H</i>CH<sub>2</sub>), 8.35 (d, <i>J</i> = 9.2 Hz, 1H, 1′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 23.5 (CH<sub>3</sub>, 9′-CH<sub>3</sub>), 26.8 (CH<sub>2</sub>, C3), 27.3 (CH, C11′), 27.5 (CH<sub>2</sub>, C4), 27.9 (CH, C7′), 29.3 (CH<sub>2</sub>, C13′), 29.6 (CH<sub>2</sub>, C5), 31.0 (CH<sub>2</sub>, C6), 36.0 (CH<sub>2</sub>, C6′), 36.1 (CH<sub>2</sub>, C10′), 36.9 (CH<sub>2</sub>, C2), 43.9 (CH<sub>2</sub>, major rotamer CONH<i>C</i>H2), 44.1 (CH<sub>2</sub>, minor rotamer CONH<i>C</i>H2), 49.6 (CH<sub>2</sub>, C7), 56.4 (CH<sub>3</sub>, 3″-OCH<sub>3</sub>), 112.6 (CH, C2″), 115.7 (C, C12a′), 116.1 (CH, C5″), 117.6 (C, C11a′), 119.2 (CH, C4′), 121.4 (CH, C6″), 125.1 (CH, C8′), 126.7 (CH, C2′), 129.4 (CH, C1′), 131.6 (C, C1″), 134.6 (C, C9′), 140.2 (C, C3′), 141.0 (C, C4a′), 146.8 (C, C4″), 148.9 (C, C3″), 151.2 (C, C5a′), 156.9 (C, C12′), 175.8 (C, major rotamer C1), 175.9 (C, minor rotamer C1); HRMS (ESI) calcd for (C<sub>32</sub>H<sub>38</sub><sup>35</sup>ClN<sub>3</sub>O<sub>3</sub> + H<sup>+</sup>): 548.2674, found 548.2677. Anal. (C<sub>32</sub>H<sub>38</sub>ClN<sub>3</sub>O<sub>3</sub>·HCl·3/4H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 8-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]-<i>N</i>-(4-hydroxy-3-methoxybenzyl)octanamide (<b>5d</b>)</h3><div class="NLM_p"><b>5d</b> was prepared as described for <b>5a</b>. From nitrile <b>3d</b> (540 g, 1.32 mmol), crude carboxylic acid (2.32 g) was obtained as a white solid, which was used in the next step without further purification. From crude carboxylic acid (2.00 g) and amine <b>4</b> (216 mg, 1.14 mmol), a yellowish solid residue (0.75 g) was obtained and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 99.5:0.5:0.2, hybrid <b>5d</b> (110 mg, 17% overall yield from <b>3d</b>) was obtained; <i>R<sub>f</sub></i> = 0.29 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last"><b>5d</b>·HCl: mp 126–127 °C; IR (KBr) ν 3500–2500 (max at 3253, 3056, 3012, 2927, 2854, 2790, O–H, N–H, N<sup>+</sup>–H, and C–H st), 1630, 1583, 1514 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.29–1.45 (complex signal, 6H, 4-H<sub>2</sub>, 5-H<sub>2</sub>, 6-H<sub>2</sub>), 1.58 (s, 3H, 9′-CH<sub>3</sub>), 1.62 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 3-H<sub>2</sub>), 1.83 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 7-H<sub>2</sub>), 1.92 (br d, <i>J</i> = 18.0 Hz, 1H, 10′-H<i><sub>endo</sub></i>), superimposed in part 1.94 (dm, <i>J</i> = 12.4 Hz, 1H, 13′-H<i><sub>syn</sub></i>), 2.08 (dm, <i>J</i> = 12.4 Hz, 1H, 13′-H<i><sub>anti</sub></i>), 2.21 (t, <i>J</i> = 7.2 Hz, 2H, 2-H<sub>2</sub>), 2.54 (dd, <i>J</i> = 18.0 Hz, <i>J</i>′ = 4.0 Hz, 1H, 10′-H<i><sub>exo</sub></i>), 2.76 (m, 1H, 7′-H), 2.85 (dm, <i>J</i> = 18.0 Hz, 1H, 6′-H<i><sub>endo</sub></i>), 3.20 (dd, <i>J</i> = 18.0 Hz, <i>J</i>′ = 5.6 Hz, 1H, 6′-H<i><sub>exo</sub></i>), 3.44 (m, 1H, 11′-H), 3.82 (s, 3H, 3″-OCH<sub>3</sub>), 3.95 (br t, <i>J</i> = 7.2 Hz, 2H, 8-H<sub>2</sub>), 4.25 (d, <i>J</i> = 4.4 Hz, 2H, CONHC<i>H</i><sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 5.58 (br d, <i>J</i> = 4.4 Hz, 1H, 8′-H), 6.69–6.71 (complex signal, 2H, 5″-H, 6″-H), 6.85 (br s, 1H, 2″-H), 7.55 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 2′-H), 7.75 (d, <i>J</i> = 2.0 Hz, 1H, 4′-H), 8.29 (br t, <i>J</i> = 4.4 Hz, 1H, CON<i>H</i>CH<sub>2</sub>), 8.37 (d, <i>J</i> = 9.2 Hz, 1H, 1′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 23.5 (CH<sub>3</sub>, 9′-CH<sub>3</sub>), 26.8 (CH<sub>2</sub>, C3), 27.3 (CH, C11′), 27.6 (CH<sub>2</sub>, C4), 27.9 (CH, C7′), 29.3 (CH<sub>2</sub>, C13′), 29.9 (CH<sub>2</sub>), 30.0 (CH<sub>2</sub>) (C5, C6), 31.1 (CH<sub>2</sub>, C7), 36.06 (CH<sub>2</sub>, C6′), 36.10 (CH<sub>2</sub>, C10′), 37.0 (CH<sub>2</sub>, C2), 43.9 (CH<sub>2</sub>, CONH<i>C</i>H2), 49.6 (CH<sub>2</sub>, C8), 56.4 (CH<sub>3</sub>, 3″-OCH<sub>3</sub>), 112.5 (CH, C2″), 115.7 (C, C12a′), 116.1 (CH, C5″), 117.6 (C, C11a′), 119.2 (CH, C4′), 121.4 (CH, C6″), 125.1 (CH, C8′), 126.7 (CH, C2′), 129.4 (CH, C1′), 131.6 (C, C1″), 134.6 (C, C9′), 140.2 (C, C3′), 141.0 (C, C4a′), 146.8 (C, C4″), 149.0 (C, C3″), 151.3 (C, C5a′), 156.9 (C, C12′), 175.9 (C, C1); HRMS (ESI) calcd for (C<sub>33</sub>H<sub>40</sub><sup>35</sup>ClN<sub>3</sub>O<sub>3</sub> + H<sup>+</sup>): 562.2831, found 562.2828. Anal. (C<sub>33</sub>H<sub>40</sub>ClN<sub>3</sub>O<sub>3</sub>·HCl·1/2H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 9-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]-<i>N</i>-(4-hydroxy-3-methoxybenzyl)nonanamide (<b>5e</b>)</h3><div class="NLM_p"><b>5e</b> was prepared as described for <b>5a</b>. From nitrile <b>3e</b> (400 mg, 0.95 mmol), crude carboxylic acid (1.71 g) was obtained as a white solid, which was used in the next step without further purification. From crude carboxylic acid (1.55 g) and amine <b>4</b> (163 mg, 0.86 mmol), a yellowish solid residue (450 mg) was obtained and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 99.5:0.5:0.2, hybrid <b>5e</b> (45 mg, 9% overall yield from <b>3e</b>) was isolated; <i>R<sub>f</sub></i> = 0.33 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last"><b>5e</b>·HCl: mp 122–123 °C; IR (KBr) ν 3500–2500 (max at 3250, 3059, 3002, 2926, 2854, 2795, O–H, N–H, N<sup>+</sup>–H, and C–H st), 1630, 1583, 1514 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.28–1.44 (complex signal, 8H, 4-H<sub>2</sub>, 5-H<sub>2</sub>, 6-H<sub>2</sub>, 7-H<sub>2</sub>), 1.58 (s, 3H, 9′-CH<sub>3</sub>), superimposed in part 1.61 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 3-H<sub>2</sub>), 1.84 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 8-H<sub>2</sub>), 1.94 (br d, <i>J</i> = 17.2 Hz, 1H, 10′-H<i><sub>endo</sub></i>), superimposed in part 1.95 (dm, <i>J</i> = 12.4 Hz, 1H, 13′-H<i><sub>syn</sub></i>), 2.08 (dm, <i>J</i> = 12.4 Hz, 1H, 13′-H<i><sub>anti</sub></i>), 2.21 (t, <i>J</i> = 7.2 Hz, 2H, 2-H<sub>2</sub>), 2.55 (dd, <i>J</i> = 17.2 Hz, <i>J</i>′ = 4.4 Hz, 1H, 10′-H<i><sub>exo</sub></i>), 2.77 (m, 1H, 7′-H), 2.86 (dm, <i>J</i> = 17.6 Hz, 1H, 6′-H<i><sub>endo</sub></i>), 3.20 (dd, <i>J</i> = 17.6 Hz, <i>J</i>′ = 5.6 Hz, 1H, 6′-H<i><sub>exo</sub></i>), 3.44 (m, 1H, 11′-H), 3.82 (s, 3H, 3″-OCH<sub>3</sub>), 3.96 (br t, <i>J</i> = 6.8 Hz, 2H, 9-H<sub>2</sub>), 4.24 (br s, 2H, CONHC<i>H</i><sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 5.58 (br d, <i>J</i> = 4.8 Hz, 1H, 8′-H), 6.70 (complex signal, 2H, 5″-H, 6″-H), 6.85 (s, 1H, 2″-H), 7.55 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 2′-H), 7.75 (d, <i>J</i> = 2.0 Hz, 1H, 4′-H), 8.28 (m, 1H, CON<i>H</i>CH<sub>2</sub>), 8.38 (d, <i>J</i> = 9.2 Hz, 1H, 1′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 23.5 (CH<sub>3</sub>, 9′-CH<sub>3</sub>), 27.0 (CH<sub>2</sub>, C3), 27.3 (CH, C11′), 27.7 (CH<sub>2</sub>, C4), 27.9 (CH, C7′), 29.3 (CH<sub>2</sub>, C13′), 30.0 (CH<sub>2</sub>), 30.1 (CH<sub>2</sub>), 30.2 (CH<sub>2</sub>) (C5, C6, C7), 31.2 (CH<sub>2</sub>, C8), 36.0 (CH<sub>2</sub>, C6′), 36.1 (CH<sub>2</sub>, C10′), 37.0 (CH<sub>2</sub>, C2), 43.9 (CH<sub>2</sub>, CONH<i>C</i>H2), 49.7 (CH<sub>2</sub>, C9), 56.4 (CH<sub>3</sub>, 3″-OCH<sub>3</sub>), 112.5 (CH, C2″), 115.7 (C, C12a′), 116.1 (CH, C5″), 117.6 (C, C11a′), 119.1 (CH, C4′), 121.4 (CH, C6″), 125.1 (CH, C8′), 126.7 (CH, C2′), 129.5 (CH, C1′), 131.6 (C, C1″), 134.6 (C, C9′), 140.2 (C, C3′), 141.0 (C, C4a′), 146.8 (C, C4″), 149.0 (C, C3″), 151.2 (C, C5a′), 156.9 (C, C12′), 175.9 (C, C1); HRMS (ESI) calcd for (C<sub>34</sub>H<sub>42</sub><sup>35</sup>ClN<sub>3</sub>O<sub>3</sub> + H<sup>+</sup>): 576.2987, found 576.2995. Anal. (C<sub>34</sub>H<sub>42</sub>ClN<sub>3</sub>O<sub>3</sub>·HCl·3/4H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-{[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]methyl}-<i>N</i>-(4-hydroxy-3-methoxybenzyl)benzamide (<b>5f</b>)</h3><div class="NLM_p"><b>5f</b> was prepared as described for <b>5a</b>. From nitrile <b>3f</b> (870 g, 2.18 mmol), crude carboxylic acid (3.50 g) was obtained as a white solid, which was used in the next step without further purification. From this crude carboxylic acid (3.50 g) and amine <b>4</b> (394 mg, 2.08 mmol), a yellowish solid residue (1.12 g) was obtained and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 99.5:0.5:0.2, hybrid <b>5f</b> (380 mg, 33% overall yield from <b>3f</b>) was obtained; <i>R<sub>f</sub></i> = 0.24 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last"><b>5f</b>·HCl: mp 209–211 °C; IR (KBr) ν 3500–2500 (max at 3229, 3105, 3052, 3002, 2925, 2852, 2790, O–H, N–H, N<sup>+</sup>–H, and C–H st), 1635, 1602, 1583, 1560, 1508, 1501 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.60 (s, 3H, 9′-CH<sub>3</sub>), superimposed in part 1.97 (dm, <i>J</i> = 12.8 Hz, 1H, 13′-H<i><sub>syn</sub></i>), 1.98 (br d, <i>J</i> = 17.2 Hz, 1H, 10′-H<i><sub>endo</sub></i>), 2.09 (dm, <i>J</i> = 12.8 Hz, 1H, 13′-H<i><sub>anti</sub></i>), 2.55 (dd, <i>J</i> = 17.2 Hz, <i>J</i>′ = 4.4 Hz, 1H, 10′-H<i><sub>exo</sub></i>), 2.78 (m, 1H, 7′-H), 2.91 (br d, <i>J</i> = 17.6 Hz, 1H, 6′-H<i><sub>endo</sub></i>), 3.24 (dd, <i>J</i> = 17.6 Hz, <i>J</i>′ = 5.6 Hz, 1H, 6′-H<i><sub>exo</sub></i>), 3.51 (m, 1H, 11′-H), 3.82 (s, 3H, 3″-OCH<sub>3</sub>), 4.47 (br d, <i>J</i> = 5.6 Hz, 2H, CONHC<i>H</i><sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 5.24 (s, 2H, benzamide C4-C<i>H</i><sub>2</sub>NH), 5.59 (br d, <i>J</i> = 4.8 Hz, 1H, 8′-H), 6.72 (d, <i>J</i> = 8.4 Hz, 1H, 5″-H), 6.78 (dd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 2.0 Hz, 1H, 6″-H), 6.93 (d, <i>J</i> = 2.0 Hz, 1H, 2″-H), 7.35 (dd, <i>J</i> = 8.8 Hz, <i>J</i>′ = 2.0 Hz, 1H, 2′-H), 7.52 [d, <i>J</i> = 8.0 Hz, 2H, benzamide C3(5)-H], 7.76 (d, <i>J</i> = 2.0 Hz, 1H, 4′-H), 7.90 [d, <i>J</i> = 8.0 Hz, 2H, benzamide C2(6)-H], 8.16 (d, <i>J</i> = 8.8 Hz, 1H, 1′-H), 8.89 (t, <i>J</i> = 5.6 Hz, 1H, CON<i>H</i>CH<sub>2</sub>); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 23.5 (CH<sub>3</sub>, 9′-CH<sub>3</sub>), 27.5 (CH, C11′), 27.9 (CH, C7′), 29.3 (CH<sub>2</sub>, C13′), 36.1 (CH<sub>2</sub>, C6′), 36.2 (CH<sub>2</sub>, C10′), 44.4 (CH<sub>2</sub>, CONH<i>C</i>H<sub>2</sub>), 52.0 (CH<sub>2</sub>, benzamide C4-<i>C</i>H<sub>2</sub>NH), 56.4 (CH<sub>3</sub>, 3″-OCH<sub>3</sub>), 112.6 (CH, C2″), 115.7 (C, C12a′), 116.1 (CH, C5″), 118.4 (C, C11a′), 119.3 (CH, C4′), 121.4 (CH, C6″), 125.1 (CH, C8′), 126.8 (CH, C2′), 127.8 [2CH, benzamide C3(5)], 129.1 (CH, C1′), 129.2 [2CH, benzamide C2(6)], 131.6 (C, C1″), 134.7 (C, C9′), 135.4 (C, benzamide C1), 140.3 (C, C3′), 140.8 (C, C4a′), 142.5 (C, benzamide C4), 146.9 (C, C4″), 149.0 (C, C3″), 152.0 (C, C5a′), 157.4 (C, C12′), 169.3 (C, <i>C</i>ONHCH<sub>2</sub>); HRMS (ESI) calcd for (C<sub>33</sub>H<sub>32</sub><sup>35</sup>ClN<sub>3</sub>O<sub>3</sub> + H<sup>+</sup>): 554.2205, found 554.2205. Anal. (C<sub>33</sub>H<sub>32</sub>ClN<sub>3</sub>O<sub>3</sub>·HCl·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-{[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]methyl}-<i>N</i>-[3-methoxy-4-(triisopropylsilyloxy)benzyl]benzamide (<b>7</b>)</h3><div class="NLM_p last">Hybrid <b>7</b> was prepared as described for <b>5a</b>. From nitrile <b>3f</b> (658 mg, 1.65 mmol), crude carboxylic acid (3.40 g) was obtained as a white solid, which was used in the next step without further purification. From this crude carboxylic acid (3.30 g) and 3-methoxy-4-(triisopropylsilyloxy)benzylamine, <b>6</b><a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> (494 mg, 1.60 mmol), a yellowish solid residue (1.39 g), was obtained and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 99.5:0.5:0.2, hybrid <b>7</b> (919 mg, 81% overall yield from <b>3f</b>) was obtained as a colorless oil; <i>R<sub>f</sub></i> = 0.36 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 9:1:0.05); IR (KBr) ν 3296 (N–H st), 1640, 1607, 1583, 1553, 1514 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.08 [d, <i>J</i> = 7.2 Hz, 18H, OSi[CH(C<i>H</i><sub>3</sub>)<sub>2</sub>]<sub>3</sub>], 1.24 [m, 3H, OSi[C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>]<sub>3</sub>], 1.49 (s, 3H, 9′-CH<sub>3</sub>), 1.73 (br d, <i>J</i> = 16.8 Hz, 1H 10′-H<i><sub>endo</sub></i>) 1.82 (dm, <i>J</i> = 12.4 Hz, 1H, 13′-H<i><sub>syn</sub></i>), 1.97 (dm, <i>J</i> = 12.4 Hz, 1H, 13′-H<i><sub>anti</sub></i>), 2.45 (dd, <i>J</i> = 16.8 Hz, <i>J</i>′ = 4.0 Hz, 1H, 10′-H<i><sub>exo</sub></i>), 2.71 (m, 1H, 7′-H), 3.10–3.22 (complex signal, 3H, 6′-H<i><sub>endo</sub></i>, 6′-H<i><sub>exo</sub></i>, 11′-H), 3.79 (s, 3H, 3″-OCH<sub>3</sub>), 4.57 (d, <i>J</i> = 5.6 Hz, 2H, CONHC<i>H</i><sub>2</sub>), 4.76 (m, 2H, benzamide C4-C<i>H</i><sub>2</sub>NH), 5.51 (br d, <i>J</i> = 5.6 Hz, 1H, 8′-H), 6.45 (br signal, 1H, CON<i>H</i>CH<sub>2</sub>), 6.78 (dd, <i>J</i> = 8.0 Hz, <i>J</i>′ = 2.0 Hz, 1H, 6″-H), 6.83 (d, <i>J</i> = 8.0 Hz, 1H, 5″-H), 6.85 (d, <i>J</i> = 2.0 Hz, 1H, 2″-H), 7.24 (dd, <i>J</i> = 8.8 Hz, <i>J</i>′ = 2.0 Hz, 1H, 2′-H), 7.42 [d, <i>J</i> = 8.0 Hz, 2H, benzamide C3(5)-H], 7.81 [d, <i>J</i> = 8.0 Hz, 2H, benzamide C2(6)-H], 7.91 (d, <i>J</i> = 8.8 Hz, 1H, 1′-H), 8.04 (br s, 1H, 4′-H); <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ 13.0 [3CH, OSi[<i>C</i>H(CH<sub>3</sub>)<sub>2</sub>]<sub>3</sub>], 18.0 [6CH<sub>3</sub>, OSi[CH(<i>C</i>H<sub>3</sub>)<sub>2</sub>]<sub>3</sub>], 23.5 (CH<sub>3</sub>, 9′-CH<sub>3</sub>), 27.7 (CH, C11′), 28.3 (CH, C7′), 29.1 (CH<sub>2</sub>, C13′), 37.4 (CH<sub>2</sub>, C10′), 40.2 (CH<sub>2</sub>, C6′), 44.3 (CH<sub>2</sub>, CONH<i>C</i>H<sub>2</sub>), 54.0 (CH<sub>2</sub>, benzamide C4-<i>C</i>H<sub>2</sub>NH), 55.7 (CH<sub>3</sub>, 3″-OCH<sub>3</sub>), 112.3 (CH, C2″), 119.3 (C, C12a′), 120.4 (CH, C6″), 120.5 (CH, C5″), 122.7 (C, C11a′), 124.9 (CH, C2′), 125.1 (CH, C1′), 125.7 (CH, C8′), 127.7 [2CH, benzamide C3(5)], 127.8 [2CH, benzamide C2(6)], 128.0 (CH, C4′), 131.1 (C, C1″), 131.7 (C, C9′), 134.2 (C, benzamide C1), 134.3 (C, C3′), 143.0 (C, benzamide C4), 145.3 (C, C4″), 148.7 (C, C4a′), 149.7 (C, C12′), 151.2 (C, C3″), 159.1 (C, C5a′), 166.8 (C, <i>C</i>ONHCH<sub>2</sub>); HRMS (ESI) calcd for (C<sub>42</sub>H<sub>52</sub><sup>35</sup>ClN<sub>3</sub>O<sub>3</sub>Si + H<sup>+</sup>): 710.3539, found 710.3549.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Hybrid <b>5f</b> by Deprotection of <b>7</b></h3><div class="NLM_p last">A solution of hybrid <b>7</b> (520 mg, 0.73 mmol) in anhydrous THF (15 mL) was treated dropwise with TBAF (1 M solution in THF, 1.10 mL, 1.10 mmol,) and the reaction mixture was stirred at rt for 4 h, diluted with 10% aq. Na<sub>2</sub>CO<sub>3</sub> (70 mL), and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 50 mL). The combined organic extracts were washed with H<sub>2</sub>O (3 × 70 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure, to give hybrid <b>5f</b> (380 mg, 94% yield).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(4-Hydroxy-3-methoxybenzyl)-6-heptenamide (<b>9</b>)</h3><div class="NLM_p last">A solution of 6-heptenoic acid, <b>8</b> (0.71 mL, 675 mg, 5.25 mmol), in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL), was cooled to 0 °C in an ice bath and then treated dropwise with freshly distilled Et<sub>3</sub>N (1.61 mL, 1.17 g, 11.6 mmol) and ClCO<sub>2</sub>Et (0.50 mL, 567 mg, 5.25 mmol). The resulting solution was stirred at 0 °C for 30 min and treated with amine <b>4</b> (1.00 g, 5.25 mmol). The reaction mixture was stirred at rt for 3 days, diluted with 10% aq. Na<sub>2</sub>CO<sub>3</sub> (60 mL), and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 40 mL). The combined organic extracts were washed with H<sub>2</sub>O (3 × 60 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure to give a colorless oil (1.53 g), which consisted of a mixture of amide <b>9</b> and the corresponding <i>O</i>-acylated byproduct in an approximate ratio of 9:1 (<sup>1</sup>H NMR). This mixture was taken up in MeOH (108 mL), and H<sub>2</sub>O (59 mL) and saturated aq. NaHCO<sub>3</sub> (80 mL) were added. The resulting mixture was stirred at rt overnight, concentrated under reduced pressure, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 90 mL). The combined organic extracts were washed with H<sub>2</sub>O (3 × 150 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure to provide <b>9</b> (1.08 g, 78% yield) as a white solid; <i>R<sub>f</sub></i> 0.65 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 9:1:0.05); mp 57–59 °C; IR (KBr) ν 3379, 3344, 3076 (O–H and N–H st), 1640, 1601, 1549, 1522 (C═O and Ar–C–C st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.41 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 4-H<sub>2</sub>), 1.66 (tt, <i>J</i> = 7.6 Hz, <i>J</i>′ = 7.2 Hz, 2H, 3-H<sub>2</sub>), 2.05 (tddd, <i>J</i> = 7.2 Hz, <i>J</i>′ = 6.8 Hz, <i>J</i>″ = 1.6 Hz, <i>J‴</i> = 1.2 Hz, 2H, 5-H<sub>2</sub>), 2.19 (t, <i>J</i> = 7.6 Hz, 2H, 2-H<sub>2</sub>), 3.85 (s, 3H, 3′-OCH<sub>3</sub>), 4.33 (d, <i>J</i> = 6.0 Hz, 2H, CONHC<i>H</i><sub>2</sub>), 4.93 (ddt, <i>J</i> = 10.0 Hz, <i>J</i>′ = 2.0 Hz, <i>J</i>″ = 1.2 Hz, 1H, 7-H<sub>a</sub>), 4.98 (ddt, <i>J</i> = 17.2 Hz, <i>J</i>′ = 2.0 Hz, <i>J</i>″ = 1.6 Hz, 1H, 7-H<sub>b</sub>), 5.77 (ddt, <i>J</i> = 17.2 Hz, <i>J</i>′ = 10.0 Hz, <i>J</i>″ = 6.8 Hz, 1H, 6-H), 5.79 (br s, 1H, CON<i>H</i>CH<sub>2</sub>), 6.74 (dd, <i>J</i> = 8.0 Hz, <i>J</i>′ = 2.0 Hz, 1H, 6′-H), 6.79 (d, <i>J</i> = 2.0 Hz, 1H, 2′-H), 6.84 (d, <i>J</i> = 8.0 Hz, 1H, 5′-H); <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ 25.2 (CH<sub>2</sub>, C3), 28.5 (CH<sub>2</sub>, C4), 33.4 (CH<sub>2</sub>, C5), 36.6 (CH<sub>2</sub>, C2), 43.5 (CH<sub>2</sub>, CONH<i>C</i>H<sub>2</sub>), 55.9 (CH<sub>3</sub>, 3′-OCH<sub>3</sub>), 110.7 (CH, C2′), 114.4 (CH, C5′), 114.7 (CH<sub>2</sub>, C7), 120.7 (CH, C6′), 130.3 (C, C1′), 138.4 (CH, C6), 145.1 (C, C4′), 146.7 (C, C3′), 172.7 (C, C1); HRMS (ESI) calcd for (C<sub>15</sub>H<sub>21</sub>NO<sub>3</sub> + H<sup>+</sup>): 264.1594, found 264.1592.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-Chloro-6,7,10,11-tetrahydro-9-methyl-12-(2-propenylamino)-7,11-methanocycloocta[<i>b</i>]quinoline (<b>10g</b>)</h3><div class="NLM_p">A suspension of huprine Y, <b>2</b> (500 mg, 1.76 mmol), finely powdered KOH (85% purity, 186 mg, 2.82 mmol), and 4 Å molecular sieves in anhydrous DMSO (6 mL) was stirred, heating approximately every 10 min with a heat gun for 1 h and at rt for an additional 1 h and then treated with allyl bromide (0.15 mL, 213 mg, 1.76 mmol). The reaction mixture was stirred at rt overnight, diluted with 2 N NaOH (15 mL), and extracted with EtOAc (3 × 35 mL). The combined organic extracts were washed with H<sub>2</sub>O (3 × 25 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure to give a yellow oil (654 mg), which was purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 99.5:0.5:0.2 to 99:1:0.2, alkene <b>10g</b> (314 mg, 55% yield) was obtained; <i>R<sub>f</sub></i> = 0.60 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last"><b>10g</b>·HCl: mp 228–230 °C; IR (KBr) ν 3500–2500 (max at 3401, 3215, 3113, 3078, 3051, 3015, 2925, 2903, 2882, 2852, 2703, 2685, N–H, N<sup>+</sup>–H, and C–H st), 1634, 1604, 1583, 1562, 1519 (Ar–C–C and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.59 (s, 3H, 9-CH<sub>3</sub>), 1.94 (br d, <i>J</i> = 17.6 Hz, 1H, 10-H<i><sub>endo</sub></i>), superimposed in part 1.96 (dm, <i>J</i> = 12.8 Hz, 1H, 13-H<i><sub>syn</sub></i>), 2.09 (dm, <i>J</i> = 12.8 Hz, 1H, 13-H<i><sub>anti</sub></i>), 2.55 (dd, <i>J</i> = 17.6 Hz, <i>J</i>′ = 4.8 Hz, 1H, 10-H<i><sub>exo</sub></i>), 2.79 (m, 1H, 7-H), 2.88 (dm, <i>J</i> = 18.0 Hz, 1H, 6-H<i><sub>endo</sub></i>), 3.22 (dd, <i>J</i> = 18.0 Hz, <i>J</i>′ = 5.2 Hz, 1H, 6-H<i><sub>exo</sub></i>), 3.45 (m, 1H, 11-H), 4.58 (m, 2H, 1′-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH), superimposed in part 5.39 (ddt, <i>J</i> = 10.4 Hz, <i>J</i>′ = 2.0 Hz, <i>J</i>″ = 1.2 Hz, 1H, 3′-H<sub>a</sub>), superimposed in part 5.41 (ddt, <i>J</i> = 17.2 Hz, <i>J</i>′ = 2.0 Hz, <i>J</i>″ = 1.2 Hz, 1H, 3′-H<sub>b</sub>), 5.59 (br d, <i>J</i> = 4.4 Hz, 1H, 8-H), 6.19 (ddt, <i>J</i> = 17.2 Hz, <i>J</i>′ = 10.4 Hz, <i>J</i>″ = 4.4 Hz, 1H, 2′-H), 7.51 (dd, <i>J</i> = 9.6 Hz, <i>J</i>′ = 2.0 Hz, 1H, 2-H), 7.76 (d, <i>J</i> = 2.0 Hz, 1H, 4-H), 8.36 (d, <i>J</i> = 9.6 Hz, 1H, 1-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ: 23.4 (CH<sub>3</sub>, 9-CH<sub>3</sub>), 27.4 (CH, C11), 27.9 (CH, C7), 29.3 (CH<sub>2</sub>, C13), 36.1 (CH<sub>2</sub>, C6), 36.2 (CH<sub>2</sub>, C10), 50.9 (CH<sub>2</sub>, C1′), 115.5 (C, C12a), 117.8 (CH<sub>2</sub>, C3′), 118.0 (C, C11a), 119.1 (CH, C4), 125.1 (CH, C8), 126.7 (CH, C2), 129.5 (CH, C1), 134.7 (C, C9), 135.1 (CH, C2′), 140.3 (C, C3), 140.9 (C, C4a), 151.5 (C, C5a), 157.4 (C, C12); HRMS (ESI) calcd for (C<sub>20</sub>H<sub>21</sub><sup>35</sup>ClN<sub>2</sub> + H<sup>+</sup>): 325.1466, found 325.1466.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>E</i>)-8-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]-<i>N</i>-(4-hydroxy-3-methoxybenzyl)-6-octenamide (<b>5g</b>)</h3><div class="NLM_p">To a solution of alkene <b>10g</b> (80 mg, 0.25 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL), alkene <b>9</b> (118 mg, 0.45 mmol), <i>p</i>-benzoquinone (3 mg, 27.8 μmol), and a Grubbs–Hoveyda II generation catalyst (8 mg, 12.8 μmol) were added. The reaction mixture was stirred under reflux for 3 days and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 99.5:0.5:0.2, hybrid <b>5g</b> (12 mg, 9% yield) was obtained; <i>R<sub>f</sub></i> = 0.42 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last"><b>5g</b>·HCl: mp 135–136 °C; IR (KBr) ν 3500–2500 (max at 3234, 3105, 3056, 3007, 2927, 2863, 2790, O–H, N–H, N<sup>+</sup>–H, and C–H st), 1633, 1599, 1583, 1566, 1514 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.40 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 4-H<sub>2</sub>), 1.58 (s, 3H, 9′-CH<sub>3</sub>), superimposed in part 1.60 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 3-H<sub>2</sub>), 1.92 (br d, <i>J</i> = 18.4 Hz, 1H, 10′-H<i><sub>endo</sub></i>), superimposed in part 1.94 (dm, <i>J</i> = 12.4 Hz, 1H, 13′-H<i><sub>syn</sub></i>), 2.07 (dm, <i>J</i> = 12.4 Hz, 1H, 13′-H<i><sub>anti</sub></i>), 2.14 (dt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 5-H<sub>2</sub>), 2.20 (t, <i>J</i> = 7.2 Hz, 2H, 2-H<sub>2</sub>), 2.45 (dd, <i>J</i> = 18.4 Hz, <i>J</i>′ = 4.8 Hz, 1H, 10′-H<i><sub>exo</sub></i>), 2.77 (m, 1H, 7′-H), 2.87 (br d, <i>J</i> = 17.6 Hz, 1H, 6′-H<i><sub>endo</sub></i>), 3.21 (dd, <i>J</i> = 17.6 Hz, <i>J</i>′ = 5.6 Hz, 1H, 6′-H<i><sub>exo</sub></i>), 3.44 (m, 1H, 11′-H), 3.80 (s, 3H, 3″-OCH<sub>3</sub>), 4.25 (d, <i>J</i> = 6.0 Hz, 2H, CONHC<i>H</i><sub>2</sub>), 4.51 (br d, <i>J</i> = 4.0 Hz, 2H, 8-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 5.58 (br d, <i>J</i> = 4.8 Hz, 1H, 8′-H), 5.73 (dt, <i>J</i> = 15.6 Hz, <i>J</i>′ = 4.0 Hz, 1H, 7-H), 5.80 (dt, <i>J</i> = 15.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 6-H), 6.67–6.71 (complex signal, 2H, 5″-H, 6″-H), 6.84 (s, 1H, 2″-H), 7.50 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.4 Hz, 1H, 2′-H), 7.74 (d, <i>J</i> = 2.4 Hz, 1H, 4′-H), 8.35 (m, 1H, CON<i>H</i>CH<sub>2</sub>), 8.38 (d, <i>J</i> = 9.2 Hz, 1H, 1′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ: 23.5 (CH<sub>3</sub>, 9′-CH<sub>3</sub>), 26.3 (CH<sub>2</sub>, C3), 27.3 (CH, C11′), 27.9 (CH, C7′), 29.3 (CH<sub>2</sub>, C13′), 29.6 (CH<sub>2</sub>, C4), 32.9 (CH<sub>2</sub>, C5), 36.0 (CH<sub>2</sub>, C6′), 36.2 (CH<sub>2</sub>, C10′), 36.7 (CH<sub>2</sub>, C2), 43.9 (CH<sub>2</sub>, CONH<i>C</i>H2), 50.4 (CH<sub>2</sub>, C8), 56.4 (CH<sub>3</sub>, 3″-OCH<sub>3</sub>), 112.5 (CH, C2″), 115.5 (C, C12a′), 116.1 (CH, C5″), 117.8 (C, C11a′), 119.1 (CH, C4′), 121.3 (CH, C6″), 125.1 (CH, C8′), 126.6 (CH, C2′), 126.8 (CH, C7), 129.7 (CH, C1′), 131.5 (C, C1″), 134.7 (C, C9′), 135.1 (CH, C6), 140.3 (C, C3′), 140.9 (C, C4a′), 146.8 (C, C4″), 148.9 (C, C3″), 151.3 (C, C5a′), 157.2 (C, C12′), 175.7 (C, C1); HRMS (ESI) calcd for (C<sub>33</sub>H<sub>38</sub><sup>35</sup>ClN<sub>3</sub>O<sub>3</sub> + H<sup>+</sup>): 560.2674, found 560.2671. Anal. (C<sub>33</sub>H<sub>38</sub>ClN<sub>3</sub>O<sub>3</sub>·HCl·2H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>E</i>)-10-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]-<i>N</i>-(4-hydroxy-3-methoxybenzyl)-6-decenamide (<b>5h</b>)</h3><div class="NLM_p"><b>5h</b> was prepared as described for <b>5g</b>. From alkenes <b>10h</b><a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> (613 mg, 1.74 mmol) and <b>9</b> (547 mg, 2.08 mmol) and after purification of the resulting mixture by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH mixtures, gradient elution), hybrid <b>5h</b> (73 mg, 7% yield) was obtained on elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 99.5:0.5:0.2; <i>R<sub>f</sub></i> = 0.32 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq. NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last"><b>5h</b>·HCl: mp 129–130 °C; IR (KBr) ν 3500–2500 (max at 3253, 3061, 2997, 2926, 2857, 2795, O–H, N–H, N<sup>+</sup>–H, and C–H st), 1651, 1635, 1598, 1583, 1568, 1558, 1515 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.30 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 4-H<sub>2</sub>), 1.576 (s, 3H, 9′-CH<sub>3</sub>), superimposed in part 1.582 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 3-H<sub>2</sub>), 1.93 (br d, <i>J</i> = 16.4 Hz, 1H, 10′-H<i><sub>endo</sub></i>), superimposed in part 1.95 (dm, <i>J</i> = 12.0 Hz, 1H, 13′-H<i><sub>syn</sub></i>), superimposed 1.92–1.99 (m, 2H, 9-H<sub>2</sub>), superimposed 2.02–2.10 (m, 2H, 8-H<sub>2</sub>), 2.07 (dm, <i>J</i> = 12.0 Hz, 13′-H<i><sub>anti</sub></i>), 2.12 (dt, <i>J</i> = <i>J</i>′ = 6.4 Hz, 2H, 5-H<sub>2</sub>), 2.19 (t, <i>J</i> = 7.2 Hz, 2H, 2-H<sub>2</sub>), 2.55 (dm, <i>J</i> = 16.4 Hz, 1H, 10′-H<i><sub>exo</sub></i>), 2.76 (m, 1H, 7′-H), 2.86 (br d, <i>J</i> = 18.0 Hz, 1H, 6′-H<i><sub>endo</sub></i>), 3.19 (dm, <i>J</i> = 18.0 Hz, 1H, 6′-H<i><sub>exo</sub></i>), 3.44 (m, 1H, 11′-H), 3.81 (s, 3H, 3″-OCH<sub>3</sub>), 3.96 (m, 2H, 10-H<sub>2</sub>), 4.23 (m, 2H, CONHC<i>H</i><sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 5.36 (dt, <i>J</i> = 15.6 Hz, <i>J</i>′ = 6.0 Hz, 1H) and 5.42 (dt, <i>J</i> = 15.6 Hz, <i>J</i>′ = 5.6 Hz, 1H) (6-H, 7-H), 5.57 (m, 1H, 8′-H), 6.67–6.71 (complex signal, 2H, 5″-H, 6″-H), 6.83 (br s, 1H, 2″-H), 7.52 (br d, <i>J</i> = 8.8 Hz, 1H, 2′-H), 7.76 (br s, 1H, 4′-H), 8.29 (m, 1H, CON<i>H</i>CH<sub>2</sub>), 8.34 (d, <i>J</i> = 8.8 Hz, 1H, 1′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 23.5 (CH<sub>3</sub>, 9′-CH<sub>3</sub>), 26.5 (CH<sub>2</sub>, C3), 27.3 (CH, C11′), 27.8 (CH, C7’), 29.3 (CH<sub>2</sub>, C13′), 30.0 (CH<sub>2</sub>, C4), 30.6 (CH<sub>2</sub>), 30.9 (CH<sub>2</sub>), 33.1 (CH<sub>2</sub>) (C5, C8, C9), 36.0 (CH<sub>2</sub>, C6′), 36.2 (CH<sub>2</sub>, C10′), 36.9 (CH<sub>2</sub>, C2), 43.9 (CH<sub>2</sub>, CONH<i>C</i>H<sub>2</sub>), 49.1 (CH<sub>2</sub>, C10), 56.4 (CH<sub>3</sub>, 3″-OCH<sub>3</sub>), 112.4 (CH, C2″), 115.6 (C, C12a′), 116.0 (CH, C5″), 117.6 (C, C11a′), 119.1 (CH, C4′), 121.3 (CH, C6″), 125.1 (CH, C8′), 126.6 (CH, C2′), 129.4 (CH, C1′), 130.0 (CH) and 132.8 (CH) (C6, C7), 131.6 (C, C1″), 134.5 (C, C9′), 140.2 (C, C3′), 140.9 (C, C4a′), 146.8 (C, C4″), 148.9 (C, C3″), 151.2 (C, C5a′), 157.0 (C, C12′), 175.8 (C, C1); HRMS (ESI) calcd for (C<sub>35</sub>H<sub>42</sub><sup>35</sup>ClN<sub>3</sub>O<sub>3</sub> + H<sup>+</sup>): 588.2987, found 588.2969. Anal. (C<sub>35</sub>H<sub>42</sub>ClN<sub>3</sub>O<sub>3</sub>·HCl·1/2H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-[4-(<i>tert</i>-Butyldimethylsilyloxy)-3-methoxybenzyl]-3-butynamide (<b>12</b>)</h3><div class="NLM_p last">To a solution of 3-methoxy-4-(<i>tert</i>-butyldimethylsilyloxy)benzylamine, <b>11</b><a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> (2.10 g, 7.83 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (40 mL), 3-butynoic acid (658 mg, 7.83 mmol), and EDC hydrochloride (1.18 g, 6.16 mmol) were successively added. The reaction mixture was stirred at rt for 2 h until complete consumption of the amine. The mixture was diluted with H<sub>2</sub>O and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 100 mL). The combined organic extracts were washed with H<sub>2</sub>O, then with brine, dried over anhydrous MgSO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by column chromatography (40–60 μm silica gel, cyclohexane/EtOAc 80:20 to 70:30 mixtures, gradient elution) to yield amide <b>12</b> (950 mg, 36% yield) as a yellow-orange solid and the corresponding allene derivative (430 mg, 16% yield) as an off-white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.14 [s, 6H, OSi(C<i>H</i><sub>3</sub>)<sub>2</sub>C(CH<sub>3</sub>)<sub>3</sub>], 0.98 [s, 9H, OSi(CH<sub>3</sub>)<sub>2</sub>C(C<i>H</i><sub>3</sub>)<sub>3</sub>], 2.33 (t, <i>J</i> = 2.7 Hz, 1H, 4-H), 3.26 (d, <i>J</i> = 2.7 Hz, 2H, 2-H<sub>2</sub>), 3.79 (s, 3H, 3′-OCH<sub>3</sub>), 4.39 (d, <i>J</i> = 5.7 Hz, 2H, CONHC<i>H</i><sub>2</sub>), 6.67–6.85 (complex signal, 3H, 2′-H, 5′-H, 6′-H); <sup>13</sup>C NMR (75.4 MHz, CDCl<sub>3</sub>) δ – 4.5 [2CH<sub>3</sub>, OSi(<i>C</i>H<sub>3</sub>)<sub>2</sub>C(CH<sub>3</sub>)<sub>3</sub>], 18.6 [C, OSi(CH<sub>3</sub>)<sub>2</sub><i>C</i>(CH<sub>3</sub>)<sub>3</sub>], 25.8 [3CH<sub>3</sub>, OSi(CH<sub>3</sub>)<sub>2</sub>C(<i>C</i>H<sub>3</sub>)<sub>3</sub>], 27.5 (CH<sub>2</sub>, C2), 43.9 (CH<sub>2</sub>, CONH<i>C</i>H<sub>2</sub>), 55.6 (CH<sub>3</sub>, 3′-OCH<sub>3</sub>), 74.4 (CH, C4), 77.5 (C, C3), 111.9 (CH, C2′), 120.2 (CH, C5′), 121.0 (CH, C6′), 131.1 (C, C1′), 144.7 (C, C4′), 151.2 (C, C3′), 166.0 (C, C1); MS (ESI+) <i>m</i>/<i>z</i> = 334 [M + H]<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-{1-[4-(12-Amino-3-chloro-6,7,10,11-tetrahydro-7,11-methanocycloocta[<i>b</i>]quinolin-9-yl)butyl]-1<i>H</i>-1,2,3-triazol-4-yl}-<i>N</i>-[4-(<i>tert</i>-butyldimethylsilyloxy)-3-methoxybenzyl]acetamide (<b>14</b>)</h3><div class="NLM_p last">To a solution of azide <b>13</b><a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> (50 mg, 136 μmol) and alkyne <b>12</b> (54 mg, 162 μmol) in acetonitrile (5.4 mL), CuI (26 mg, 136 μmol) was added. The reaction mixture was stirred with protection from light at rt for 12 h and concentrated at reduced pressure. The resulting crude was purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH 98:2 to 80:20 mixtures, gradient elution) to afford the hybrid <b>14</b> (76 mg, 80% yield) as a yellowish solid: <sup>1</sup>H NMR (200 MHz, CD<sub>3</sub>OD) δ 0.10 [s, 6H, OSi(C<i>H</i><sub>3</sub>)<sub>2</sub>C(CH<sub>3</sub>)<sub>3</sub>], 0.97 [s, 9H, OSi(CH<sub>3</sub>)<sub>2</sub>C(C<i>H</i><sub>3</sub>)<sub>3</sub>], 1.29 (m, 2H, 9′-CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.60 (complex signal, 2H, 9′-CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.90–2.10 (complex signal, 5H, 9′-C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>, 13′-H<i><sub>syn</sub></i>, 13′-H<i><sub>anti</sub></i>, 10′-H<i><sub>endo</sub></i>), 2.38 (dd, <i>J</i> = 17.0 Hz, <i>J</i> = 3.3 Hz, 1H, 10′-H<i><sub>exo</sub></i>), 2.77 (m, 1H, 7′-H), 2.87 (d, <i>J</i> = 18.0 Hz, 1H, 6′-H<i><sub>endo</sub></i>), 3.17 (dd, <i>J</i> = 18.0 Hz, <i>J</i> = 6.0 Hz, 1H, 6′-H<i><sub>exo</sub></i>), superimposed 3.30 (m, 1H, 11′-H), 3.67 (s, 2H, 2-H<sub>2</sub>), 3.80 (s, 3H, 3″-OCH<sub>3</sub>), 4.18 (t, <i>J</i> = 7.0 Hz, 2H, 9′-CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>), 4.33 (s, 2H, CONHC<i>H</i><sub>2</sub>), 5.58 (d, <i>J</i> = 4.5 Hz, 8′-H), 6.73 (complex signal, 2H, 5″-H, 6″-H), 6.88 (s, 1H, 2″-H), 7.49 (dd, <i>J</i> = 9.0 Hz, <i>J</i> = 1.5 Hz, 1H, 2′-H), 7.67 (s, 1H, triazole C5-H), 7.70 (d, <i>J</i> = 1.5 Hz, 1H, 4′-H), 8.27 (d, <i>J</i> = 9.0 Hz, 1H, 1′-H); <sup>13</sup>C NMR (75.4 MHz, CD<sub>3</sub>OD) δ – 4.5 [2CH<sub>3</sub>, OSi(<i>C</i>H<sub>3</sub>)<sub>2</sub>C(CH<sub>3</sub>)<sub>3</sub>], 19.3 [C, OSi(CH<sub>3</sub>)<sub>2</sub><i>C</i>(CH<sub>3</sub>)<sub>3</sub>], 24.9 (CH<sub>2</sub>, 9′-CH<sub>2</sub><i>C</i>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 26.2 [3CH<sub>3</sub>, OSi(CH<sub>3</sub>)<sub>2</sub>C(<i>C</i>H<sub>3</sub>)<sub>3</sub>], 27.6 (CH<sub>2</sub>, C10′), 28.4 (CH, C11′), 29.5 (CH<sub>2</sub>, 9′-CH<sub>2</sub>CH<sub>2</sub><i>C</i>H<sub>2</sub>CH<sub>2</sub>), 30.0 (CH, C7′), 33.7 (CH<sub>2</sub>, C13′), 36.8 (CH<sub>2</sub>, C2), 37.1 (CH<sub>2</sub>, 9′-<i>C</i>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 44.2 (CH<sub>2</sub>, C6′), 50.9 (CH<sub>2</sub>, CONH<i>C</i>H<sub>2</sub>), 53.2 (CH<sub>2</sub>, 9′-CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub><i>C</i>H<sub>2</sub>), 55.9 (CH<sub>3</sub>, 3″-OCH<sub>3</sub>), 99.4 (CH, C2″), 112.9 (C, C11a′), 115.4 (C, C12a′), 120.6 (CH, C5″), 121.0 (CH, C6″), 121.7 (CH, C1′), 124.4 (CH, C2′), 124.6 (CH, triazole C5), 125.9 (CH, C8′), 126.0 (C, triazole C4), 127.2 (CH, C4′), 133.5 (C, C1″), 137.8 (C, C3′), 139.5 (C, C9′), 141.1 (C, C4a′), 145.4 (C, C4″), 152.3 (C, C3″), 154.2 (C, C12′), 155.4 (C, C5a′), 171.8 (C, C1); MS (ESI+) (<i>m</i>/<i>z</i>) = 701 [M + H]<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-{1-[4-(12-Amino-3-chloro-6,7,10,11-tetrahydro-7,11-methanocycloocta[<i>b</i>]quinolin-9-yl)butyl]-1<i>H</i>-1,2,3-triazol-4-yl}-<i>N</i>-[4-hydroxy-3-methoxybenzyl]acetamide (<b>5i</b>)</h3><div class="NLM_p last">To a solution of hybrid <b>14</b> (57 mg, 81.3 μmol) in CH<sub>2</sub>Cl<sub>2</sub>/MeOH 80:20 (3.2 mL), camphorsulfonic acid (0.4 mg, 1.72 μmol) was added. The reaction mixture was stirred with protection from light at rt for 24 h. Progress of the reaction was checked by HPLC. The resulting mixture was quenched with sat. aq. NaHCO<sub>3</sub> (10 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 25 mL). The combined organic extracts were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and evaporated at reduced pressure. The crude product was purified by column chromatography (40–60 μm silica gel, EtOAc/MeOH/Et<sub>3</sub>N 95:5:1 to 80:20:1 mixtures, gradient elution) to afford hybrid <b>5i</b> (35 mg, 73% yield) as an orange solid: <sup>1</sup>H NMR (200 MHz, CD<sub>3</sub>OD) δ 1.30 (m, 2H, 9′-CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 1.61 (m, 2H, 9′-CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>), 1.87–2.10 (complex signal, 5H, 9′-C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2,</sub> 10′-H<i><sub>endo</sub></i>, 13′-H<i><sub>syn</sub></i>, 13′-H<i><sub>anti</sub></i>), 2.37 (dd, <i>J</i> = 17.0 Hz, <i>J</i> = 3.3 Hz, 10′-H<i><sub>exo</sub></i>) 2.74 (m, 7′-H), 2.82 (d, <i>J</i> = 18.0 Hz, 6′-H<i><sub>endo</sub></i>), 3.11 (dd, <i>J</i> = 18.0 Hz, <i>J</i> = 5.4 Hz, 6′-H<i><sub>exo</sub></i>), superimposed 3.30 (m, 1H, 11′-H), 3.66 (s, 2H, 2-H<sub>2</sub>), 3.81 (s, 3H, 3″-OCH<sub>3</sub>), 4.17 (t, <i>J</i> = 6.9 Hz, 2H, 9′-CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>), 4.29 (s, 2H, CONHC<i>H</i><sub>2</sub>), 5.59 (d, <i>J</i> = 5.7 Hz, 8′-H), 6.71 (complex signal, 2H, 5″-H, 6″-H), 6.86 (s, 1H, 2″-H), 7.42 (dd, <i>J</i> = 9.1 Hz, <i>J</i> = 1.9 Hz, 1H, 2′-H), 7.63 (s, 1H, triazole C5-H), 7.67 (d, <i>J</i> = 1.9 Hz, 1H, 4′-H), 8.33 (d, <i>J</i> = 9.1 Hz, 1H, 1′-H); <sup>13</sup>C NMR (75.4 MHz, CD<sub>3</sub>OD) δ 24.8 (CH<sub>2</sub>, C6′), 25.4 (CH<sub>2</sub>, 9′-CH<sub>2</sub><i>C</i>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 27.5 (CH<sub>2</sub>, C2), 28.1 (2CH, C7′, C11′), 29.3 (CH<sub>2</sub>, 9′-CH<sub>2</sub>CH<sub>2</sub><i>C</i>H<sub>2</sub>CH<sub>2</sub>), 30.0 (CH<sub>2</sub>, C10′), 33.6 (CH<sub>2</sub>, C13′), 36.0 (CH<sub>2</sub>, CONH<i>C</i>H<sub>2</sub>), 37.0 (CH<sub>2</sub>, 9′-<i>C</i>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>), 50.8 (CH<sub>2</sub>, 9′-CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub><i>C</i>H<sub>2</sub>), 56.4 (CH<sub>3</sub>, 3″-OCH<sub>3</sub>), 112.4 (CH, C2″), 115.4 (2C, C11a′<sub>,</sub> C12a′), 116.1 (CH, triazole C5), 119.3 (CH, C5″), 121.3 (CH, C6″), 125.7 (CH, C1′) (CH, C2′), 126.3 (CH, C8′), 127.7 (CH, C4′), 131.1 (C, C1″), 135.4 (C, triazole C4), 137.9 (C, C3′), 139.5 (C, C9′), 140.5 (C, C3″), 140.6 (C, C4″), 149.0 (C, C4a′), 153.0 (C, C12′), 156.7 (C, C5a′), 171.4 (C, C1); MS (ESI+) = (<i>m</i>/<i>z</i>) 587 [M + H]<sup>+</sup>; HRMS (ESI) calcd for (C<sub>32</sub>H<sub>35</sub><sup>35</sup>ClN<sub>6</sub>O<sub>3</sub> + H<sup>+</sup>): 587.2532, found 587.2534.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> AChE and BChE Inhibition Assays</h3><div class="NLM_p">Inhibition of human cholinesterases was evaluated spectrophotometrically by the method of Ellman <i>et al.</i><a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> An AChE stock solution was prepared by dissolving human recombinant AChE (E.C.3.1.1.7) lyophilized powder (Sigma, Italy) in 0.1 M phosphate buffer (pH = 8.0) containing 0.1% Triton X-100. A stock solution of human serum BChE (E.C. 3.1.1.8, Sigma, Italy) was prepared by dissolving the lyophilized powder in an aqueous solution of 0.1% gelatin. Stock solutions of the tested compounds (1 mM) were prepared and diluted in MeOH. Five increasing concentrations of each inhibitor were used, able to yield inhibition of enzymatic activity in the range of 20–80%. The assay solution consisted of 0.1 M phosphate buffer, pH 8.0, with the addition of 340 μM 5,5′-dithio-bis(2-nitrobenzoic acid), 0.02 unit/mL of human recombinant AChE or BChE from human serum, and a 550 μM substrate (acetylthiocholine iodide (ATCh) or butyrylthiocholine iodide (BTCh), respectively).</div><div class="NLM_p last">Assay solutions, with and without the inhibitor, were preincubated at 37 °C for 20 min followed by addition of the substrate. Control solutions containing all components except AChE or BChE were prepared in parallel to correct for non-enzymatic substrate hydrolysis. Initial rate assays were performed at 37 °C with a Jasco V-530 double beam spectrophotometer: the rate of increase in absorbance at 412 nm was monitored for 210 s. The velocities in the presence and absence of the inhibitor were compared, and the percentage inhibition was calculated. The percentage inhibition was plotted vs the logarithm of the final inhibitor concentration. Linear regression and IC<sub>50</sub> values were calculated using Microcal Origin 3.5 software (Microcal Software, Inc.). Values are expressed as mean ± standard error of the mean (SEM) of at least two experiments, each performed in duplicate/triplicate.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Kinetic Analysis of AChE Inhibition</h3><div class="NLM_p">To assess the mechanism of action of hybrid <b>5c</b>, reciprocal plots of 1/<i>v</i> vs. 1/S (S = substrate) were constructed at relatively low substrate concentrations (0.113–0.566 mM) for inhibition of human recombinant AChE (Sigma, Milan). Four inhibitor concentrations were employed: 0.170, 0.341, 0.681, and 1.363 nM. The plots were assessed by a weighted least-squares analysis that assumed the variance of the velocity (<i>v</i>) to be a constant percentage of <i>v</i> for the entire data set. Data analysis was performed with GraphPad Prism 4.03 software (GraphPad Software Inc.). The mechanism of inhibition was assessed by two independent experiments, each performed in triplicate.</div><div class="NLM_p last">Calculation of the inhibition constant, <i>K<sub>i</sub></i>, was performed by re-plotting slopes of lines from the Lineweaver–Burk plot vs inhibitor concentration, and <i>K<sub>i</sub></i> was determined as the intersection on the negative <i>x</i> axis. The <i>K</i>′<i><sub>i</sub></i> value (dissociation constant for the enzyme–substrate–inhibitor complex) was determined by plotting the apparent 1/<i>v</i><sub>max</sub> vs inhibitor concentration.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Propidium Displacement Studies</h3><div class="NLM_p">The affinity of hybrid <b>5c</b> for the peripheral binding site of <i>Ee</i>AChE (type VI-S, Sigma, Italy) was determined using propidium iodide (P), a PAS-specific ligand, as previously described by Taylor <i>et al.</i><a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> A shift in the excitation wavelength follows formation of the propidium/AChE complex.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Fluorescence intensity was monitored in a Jasco 6200 spectrofluorometer (Jasco Europe, Italy) using a 0.5 mL quartz cuvette at room temperature. <i>Ee</i>AChE (2 μM, assuming 82,000 kDa mass) was first incubated with 8 μM propidium iodide in 1 mM Tris–HCl, pH 8.0, at room temperature. An 8 mM stock solution of hybrid <b>5c</b> was prepared in MeOH. In the back-titration experiments, aliquots of the inhibitor (4–64 μM final concentration) were added successively to the solution of the propidium/AChE complex, and fluorescence emission was monitored at 602 nm upon excitation at 535 nm. Blanks containing propidium alone, inhibitor plus propidium, and <i>Ee</i>AChE were prepared, and fluorescence emission was determined and subtracted. Raw data were processed following the method of Taylor and Lappi<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> to estimate the <i>K<sub>D</sub></i> value, assuming a dissociation constant value for propidium and <i>Ee</i>AChE of 0.7 μM.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Data analysis was performed with GraphPad Prism 4.03 software (GraphPad Software Inc.). Data are the average of three independent experiments.</div><div class="NLM_p last">The same experimental procedure was used in an attempt to also determine the affinity of capsaicin for PAS. An 8 mM stock solution of capsaicin was prepared in MeOH. In the back-titration experiments, aliquots of the inhibitor (4–92 μM final concentration) were added successively to the solution of the propidium/AChE complex. However, fluorescence emission at 602 nm (λ<sub>exc</sub> = 535 nm) of capsaicin blank solutions showed significant intensities, which hampered an accurate quantitative determination of the affinity constant.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> BACE-1 Inhibition Assay</h3><div class="NLM_p last">BACE-1 (Sigma) inhibition studies were performed employing a peptide mimic of the APP sequence as the substrate, methoxycoumarin-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys-dinitrophenyl (M-2420, Bachem, Germany). The following procedure was employed: 5 μL of test compounds (or DMSO in the control well) was pre-incubated with 175 μL of enzyme (in 20 mM sodium acetate, pH 4.5, containing CHAPS 0.1% w/v) for 1 h at rt. The substrate (3 μM, final concentration) was then added and left to react for 15 min. The fluorescence signal was read at λ<sub>em</sub> = 405 nm (λ<sub>exc</sub> = 320 nm). The DMSO concentration in the final mixture was maintained below 5% (v/v) to preclude significant loss of enzyme activity. The background signal was measured in control wells containing all the reagents except BACE-1 and subtracted. The fluorescence intensities with and without the inhibitor were compared, and the percent inhibition due to the presence of test compounds was calculated by the following expression: 100 – (IF<sub>i</sub>/IF<sub>o</sub> × 100), where IF<sub>i</sub> and IF<sub>o</sub> are the fluorescence intensities obtained for BACE-1 in the presence and absence of the inhibitor, respectively. To demonstrate inhibition of BACE-1 activity, a peptidomimetic inhibitor (β-secretase inhibitor IV, Calbiochem) was serially diluted into the reaction wells (IC<sub>50</sub> = 13.0 ± 0.1 nM). Values are expressed as mean ± standard deviation (SD) of two independent experiments, each performed in triplicate.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> DPPH Radical Scavenging Activity Assay</h3><div class="NLM_p last">Radical scavenging activity of the capsaicin–huprine hybrids was determined using the DPPH assay.<a onclick="showRef(event, 'ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref91 ref92">(91,92)</a> Four different amounts of the compounds (3–100 μM), dissolved in DMSO, were incubated with a methanolic solution of DPPH (100 μM). The final concentration of DMSO was kept below 1%. After 30 min of incubation at rt in the dark, the absorbance at 517 nm was measured. The percentage inhibition for each concentration was calculated by comparison with the absorbance of the DPPH solution. Dose–response curves were plotted and IC<sub>50</sub> values were calculated by the software CurveExpert version 1.34 for Windows. Data are expressed as the mean ± SD of three experiments, each performed in duplicate.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Crystallization and Data Collection</h3><div class="NLM_p"><i>Tc</i>AChE<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> was concentrated to 12 mg/mL and crystallized using the hanging-drop vapor diffusion method. At rt, an equal volume (1 μL) of <i>Tc</i>AChE solution was mixed with a mother liquor solution composed of 50 mM MES, pH 5.8–6.2, 28–32% PEG 200. After 10–20 days, crystals were harvested and soaked for 12 h in a solution of the mother liquor complemented with specific compounds (1 mM). All data were collected at the European Synchrotron Radiation Facility (ESRF, Grenoble, France). Data collected on ESRF beamline ID30A1 were from crystals flash-frozen and stored in liquid nitrogen before the experiment. Data were collected on ESRF beamlines ID29 and ID23-2 from crystals directly flash-cooled in the stream of N<sub>2</sub> gas at 100 K.</div><div class="NLM_p last">Recombinant hBChE, purified after expression in insect cells,<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> was concentrated to 6 mg/mL in 20 mM Tris, pH 7.4. Using the hanging-drop vapor diffusion technique, crystals were obtained at rt by mixing equal volumes of protein (2 μL) and of the reservoir solution (250 mM ammonium acetate, 20% polyethylene glycol 4000). Crystals were soaked for 12 h in the reservoir solution complemented with compounds at 1 mM. Cryoprotection of hBChE crystals was carried out via a short soak in the mother liquor solution complemented with 20% glycerol before being flash-cooled at 100 K in liquid nitrogen. Data were collected on ESRF beamline ID30A-3.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Data Processing and Refinement</h3><div class="NLM_p last">Data were indexed and integrated using XDS, and intensity measurements were scaled and merged with XSCALE. Molecular replacement was carried out with PHASER to retrieve the phases. Models of hBChE from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TPK">4TPK</a> and of <i>Tc</i>AChE from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XI4">2XI4</a> were used as search models. Two subunits were placed in the asymmetric unit of all complex structures, except for the <i>Tc</i>AChE–5i complex structure, for which a single subunit was found. Structures were refined by iterative reciprocal-space refinement with phenix.refine and real-space refinement using Coot. Reciprocal space refinement included refinement of atomic positions and individual isotropic temperature factors. All ligand topologies were generated with the PRODRG server, and their occupancies were refined during the last cycles of reciprocal-space refinement. The atomic coordinates and structure factors have been deposited in the protein data bank under accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIS">7AIS</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIT">7AIT</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIU">7AIU</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIV">7AIV</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIW">7AIW</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIX">7AIX</a> for compounds <b>5b</b>, <b>5c</b>, <b>5d</b>, <b>5f</b>, <b>5h</b>, and <b>5i</b> complexed with <i>Tc</i>AChE and under accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIY">7AIY</a> for compound <b>5i</b> complexed with hBChE.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> BBB Permeation Assay</h3><div class="NLM_p last">The parallel artificial membrane permeation assay for blood–brain barrier permeation described by Di <i>et al</i>.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> was used to assess the brain penetration of the HC hybrids. The <i>in vitro</i> permeability (<i>P</i><sub>e</sub>) of the synthesized hybrids and of 14 commercial drugs through the lipid extract of the porcine brain membrane was determined using a mixture of phosphate-buffered saline (PBS)/EtOH (70:30). Assay validation was established by comparison of the experimental and reported <i>P</i><sub>e</sub> values for the commercial drugs (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S3</a> of the Supporting Information), which showed a good correlation: <i>P</i><sub>e</sub> (exp) = 1.4974<i>P</i><sub>e</sub> (lit) – 0.8434 (<i>R</i><sup>2</sup> = 0. 9428). From this equation and taking into account the limits established by Di <i>et al.</i> for BBB permeation, the following ranges of permeability were established: compounds of high BBB permeation (CNS+): <i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>) > 5.1; compounds of low BBB permeation (CNS−): <i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>) < 2.1, and compounds of uncertain BBB permeation (CNS±): 5.1 > <i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>) > 2.1. Values are expressed as mean ± SD of three experiments, each performed in triplicate.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Biodistribution Studies in C57BL6 Mice</h3><div class="NLM_p">This study was carried out using 6 month-old female C57BL6 mice. Animals were housed in the Faculty of Pharmacy and Food Sciences of the University of Barcelona and maintained under controlled light, temperature, and humidity conditions, with access to water and food ad libitum. Every possible effort was made to reduce the number of animals used and to minimize their suffering. Mice were treated in accordance with the European Community Council Directive 86/609/EEC and the procedures established by the Department d’Agricultura, Ramaderia i Pesca of the Generalitat de Catalunya.</div><div class="NLM_p">Each compound was administered in triplicate, and the recovery percentage using spiked standards was studied for each drug in order to normalize the results obtained. In addition, three animals treated with saline serum were used as a blank. Briefly, the drugs were administered intraperitoneally at a dose of 2 mg/kg day for 2 weeks, three times a week. Mice were weighed weekly, and the equivalent volume was administered. Once the 2 week-treatment was finished, 4 h after the last dose, the animals were sacrificed by cervical dislocation and the lungs, liver, kidney, and brain as well as a blood sample were extracted. The plasma was extracted from the blood by centrifugation at 2000 rpm at 4 °C for 20 min. The drugs were extracted from the tissues by adding MeOH/DMSO (75:25) followed by homogenization for 45 min. Then, 800 μL of the mixture was placed in an Eppendorf tube and 40 μL of an internal standard was added. After mixing on a vortex, 2 M NaOH (40 μL) was added and the samples were vortexed for a further 15 min. Then, 2 M HCl (40 μL) was added to each sample and the samples were vortexed for an additional 15 min. Finally, the samples were centrifuged at 14,000 rpm for 15 min and the supernatant was removed and placed in an HPLC vial. The solvents were evaporated, and the drug on the vial walls was dissolved in MeOH. The recovery procedure was carried out using the same methodology, but adding an initial known amount of drug. Finally, the samples were quantified using HPLC coupled with MS in positive mode (HPLC/MS/MS). The mobile phases, used in a gradient described in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">Table S5</a> of the Supporting Information, were acetonitrile with 0.1% formic acid (A) and H<sub>2</sub>O with 0.1% formic acid (B). A Kinetex 2.6 μm C18 100A 50 × 2.1 mm column was employed.</div><div class="NLM_p">For donepezil detection, diphenhydramine was used as the internal standard. The collision-induced transition <i>m</i>/<i>z</i> 380 → 91 was used to analyze donepezil in selected reaction monitoring mode based on the method of Xie and colleagues.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><div class="NLM_p last">Data were analyzed using one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test; **<i>p</i> < 0.01 and ***<i>p</i> < 0.001 were considered significant differences.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> In Vivo Efficacy Studies</h3><div id="sec4_26_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Animals, Drugs, and Treatment</h4><div class="NLM_p">AβPPswe/PS-1 double transgenic male mice, which express the mutant APPswe (K595N/M596L) and PSEN1ΔE9, the deletion of the exon 9 under the control of the mouse prion promoter, were obtained from the Jackson Laboratory (Bar Harbor, ME, Stock no 004462). Animals were maintained at the Animal Facility of the Pontificia Universidad Católica de Chile under a sanitary barrier in ventilated racks and in closed colonies. Experimental procedures were approved by the Bioethical and Biosafety Committee of the Faculty of Biological Sciences of the Pontificia Universidad Católica de Chile with the ethical approval CBB-180703004. The inclusion/exclusion criteria for this study were the health of the animals after treatment. Thus, all the animals finishing the treatment correctly and remaining healthy were to be used to continue the analysis, whereas those showing signs of illness were to be excluded. For implementation of this inclusion/exclusion criterion, we evaluated the weight of the animals and the lipid and hepatic parameters, accompanied by visual inspection. In fact, in this particular study, it was not necessary to exclude any animal. To avoid suffering, the animals were reviewed by technical personnel every day to look for evidence of suffering (NIH tables of supervision). Also, we used isoflurane (4% for induction) before removing the animals’ brains. All the cognitive tests (training and experiments) and the slice experiments were performed in a double-blind manner, between the operator and the designer of the experiment.</div><div class="NLM_p last">The experimental design comprised six groups. Treatment started when groups of mice were 5 month-old (young mice) or 10 month-old (old mice). In both cases, the treatment continued for 4 weeks so that, at the end of the treatment, mice in the two groups were 6 and 11 month-old, respectively. Each set comprised three experimental groups: AβPPswe/PS-1 control, AβPPswe/PS-1 treated with <b>5i</b>, and AβPPswe/PS-1 treated with <b>5c</b>. The treatment consisted of intraperitoneal injection (i.p.) of 2.0 mg/kg of either compound, with saline solution as the vehicle, three times per week for 4 weeks. Transgenic control animals were injected only with the vehicle.</div></div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Large Open-Field (LOF) Test</h3><div class="NLM_p last">A 120 × 120 cm transparent Plexiglas platform with 35 cm-high transparent walls was used to study locomotor and stress behavior in our mouse model. The open field, which measured 40 × 40 cm, was defined as the center area of the field. Data were collected using an automatic tracking system (HVS Imagen, UK). Each mouse was placed alone in the center of the open field, and its behavior was tracked for 20 min. At the end of the session, the mouse was returned to its home cage. The parameters measured included the total time moving and number of times the mouse crossed the center area of the platform.<a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96,97)</a></div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Novel Object Recognition (NOR) and Novel Object Localization (NOL)</h3><div class="NLM_p last">The NOR and NOL tasks were performed as previously described.<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98,99)</a> Mice were habituated to the experimental room in the experimental cages for 3 consecutive days, for 30 min per day, and for 1 h on the testing day. The task occurred in a 120 × 120 cm transparent Plexiglas platform with 35 cm-high transparent walls, which contained two identical objects placed at specific locations. For object familiarization, mice were allowed to explore the platform for 10 min. The animals were subsequently returned to their home cages for 1 h followed by 5 min of exposure to a novel localization of one of the familiar objects (NOL). The mice were again returned to their home cages for 1 h and were subsequently exposed to a novel object (NOR) for 5 min. The mice had no observed baseline preference for the different objects. An object preference index was determined by calculating the time spent near the relocated/novel object divided by the cumulative time spent with both the familiar and relocated/novel objects. The cages were routinely cleaned with EtOH following testing/habituation of the mice.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Memory Flexibility Test</h3><div class="NLM_p last">This test was performed as previously described,<a onclick="showRef(event, 'ref78 ref100'); return false;" href="javascript:void(0);" class="ref ref78 ref100">(78,100)</a> and the pool conditions were the same as those of a Morris Water Maze.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Each animal was trained for one pseudo-random location of the platform per day, for 5 days, with a new platform location each day. Training was conducted for up to 10 trials per day, until the criterion of three successive trials with an escape latency of 20 s was achieved. When testing had been completed, the mouse was removed from the maze, dried, and returned to its cage. Animals were tested for the next location on the following day. Data were collected using a video tracking system (HVS Imagen).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Detection and Quantification of Aβ</h3><div class="NLM_p">To determine the concentrations of Aβ peptides, two sandwich enzyme-linked immunosorbent assays (ELISAs) specific for Aβ40 and Aβ42 were used, as previously described.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Hippocampal and cortical homogenates of each animal were diluted to 1 μg/μL in homogenization buffer containing protease and phosphatase inhibitors. Diluted homogenate (100 μL) was prepared to measure Aβ40/Aβ42 levels according to the manufacturer’s instructions. Plates were read at 450 and 590 nm on a Metertech 960 ELISA analyzer.</div><div class="NLM_p last">To detect soluble Aβ oligomers using western blot analysis, 100 μg of protein of the hippocampal and cortical total protein lysate was separated in a Tris–tricine buffer system (0.2 M Tris, pH 8.9, as the anode buffer and 0.1 M Tris, 0.1 M tricine, 0.1% SDS, pH 8.25, as the cathode buffer) and then transferred to a PVDF membrane. The membranes were incubated with the primary antibody anti-Aβ-4G8 (Biolegend, San Diego, CA) and developed using an ECL kit (Luminata Forte Western HRP Substrate, Millipore Corporation, Burlington, MA). Data are expressed as mean values ± SEM of <i>n</i> = 7 animals in each group.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Electrophysiological Measurements</h3><div id="sec4_31_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Mouse Brain Slice Preparation</h4><div class="NLM_p last">A detailed description of the method for preparing the slices was recently published.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> As mentioned above, all young and old double transgenic mice had been treated with the vehicle, <b>5i</b> or <b>5c</b>, for 4 weeks before they were used to prepare acute coronal brain slices. Every animal was killed by decapitation subsequent to anesthesia with isoflurane. The brain was quickly removed and placed in a beaker of cold artificial cerebrospinal artificial solution (ACSF), modified by replacing a part of the NaCl by sucrose. Its composition, in mM, was as follows: 85 NaCl, 75 sucrose, 3 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 25 NaHCO<sub>3</sub>, 10 dextrose, 3.5 MgSO<sub>4</sub>, 0.5 CaCl<sub>2</sub>, 3 sodium pyruvate, 0.5 sodium <span class="smallcaps smallerCapital">l</span>-ascorbate, and 3 myo-inositol (305 mOsm, pH 7.4). Then, 350 μm coronal sections were cut with a vibratome in the same cold solution. After cutting, the slices were maintained for 1 h in the same solution, but at 36 °C. They were then transferred to “recording solution”, composed of (in mM) 126 NaCl, 3.5 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 25 NaHCO<sub>3</sub>, 10 dextrose, 1 MgSO<sub>4</sub>, 2 CaCl<sub>2</sub>, 3 sodium pyruvate, 0.5 sodium <span class="smallcaps smallerCapital">l</span>-ascorbate, and 3 myo-inositol (305 mOsm, pH 7.4) at room temperature (22 °C), in which they were maintained until recording. The experiments were performed in recording solution that was maintained at 32–34 °C. Picrotoxin (25 μM) was applied to block the γ-aminobutyric acid (GABA<sub>A</sub>)-mediated inhibitory field component. At least three brain slices from each animal were used, which were considered as replicates. Thus, they were averaged to represent a single animal. Therefore, for the group of young mice we had a transgenic (Tg) control (<i>n</i> = 3 mice, three slices each), Tg treated with <b>5i</b> (<i>n</i> = 3 mice, three slices each), and Tg treated with <b>5c</b> (<i>n</i> = 3 mice, three slices each). The same number of animals and slices was used for the old mice. Thus, data represent the mean ± SEM from nine slices out of three Tg control mice, nine slices out of three Tg + <b>5i</b> mice, and nine slices out of three Tg + <b>5c</b> mice.</div></div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Electrophysiology</h3><div class="NLM_p">Electrophysiological recordings were obtained by placing the slice in a recording chamber allocated on an upright infrared-differential interference contrast (IR-DIC) fluorescence microscope (Eclipse FNI, Nikon). Visualization of hippocampal circuits utilized a 40× water objective and a light-sensitive camera (TOPICA CCD Camera). To stimulate the Schaffer collaterals between CA3 and CA1, we used a bipolar concentric electrode (World Precision Instruments, Sarasota, FL, United States) connected to an ISO-Flex stimulus generator (A.M.P.I., Jerusalem, Israel). We recorded the evoked field excitatory postsynaptic potentials (fEPSPs) in the stratum radiatum of CA1, using a borosilicate glass electrode (World Precision Instruments, United States) of 0.5–1 MΩ, pulled on a P-97 Flaming/Brown Micropipette Puller (Sutter Instruments, United States), filled with the recording solution. The signals were recorded using a MultiClamp 700B amplifier (Axon CNS, Molecular Devices LLC, United States) and digitally sampled at 30 kHz using a Digidata-1440A interface (Axon CNS, Molecular Devices). All analyses were done offline, using pClamp 10.3 (Molecular Devices LLC, United States).</div><div class="NLM_p">Several experimental protocols were applied to study the effects of the two target compounds. We obtained the input–output curve to establish the relationship between the stimulus intensity and the extent of the evoked response. To do that, the fEPSP slopes measurements (measured in mV/ms) at increasing levels of current intensity were plotted. The amount of current required to evoke 60% of the maximum slope value was used to perform other protocols in the same slice. To evaluate synaptic plasticity in the slices, we performed long-term potentiation (LTP) experiments. Two pulses of 5 ms duration (R1 and R2) separated by 50 ms were applied with the stimulus generator every 15 s. The fEPSP slope of the first pulse (R1) was averaged during 15 to 20 min once a baseline was obtained. Then, a theta burst stimulation (TBS), consistent of 5 bursts at 100 Hz every 20 s, was applied. After TBS, the same two pulses separated by 50 ms were applied for at least 60 min, considered to be an LTP induction period. Every slope measurement (R1) obtained during the post-TBS period was compared to the averaged slope measurements obtained before TBS, during the basal period. The data thus-obtained represent the degree of potentiation. They were plotted as the relative value of the fEPSP slope as a function of time and compared among the groups. To evaluate the efficacy of synaptic strength before and after LTP induction, we studied the correlation between the fiber volley (FV) amplitudes and their corresponding fEPSP slopes and compared them among groups.</div><div class="NLM_p last">The results are expressed as the means ± standard errors. The data were analyzed by one-way and two-way analysis of variance (ANOVA) followed by Bonferroni’s post hoc test; the threshold for statistical significance was <i>p</i> < 0.05, with a 95% confidence interval (CI). Statistical analyses were performed using Prism software (GraphPad, United States).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Immunofluorescence Determination of Hippocampal Levels of Oxidative Stress Markers</h3><div class="NLM_p last">After the treatment had been terminated, the mouse brains were removed on ice, and one hemisphere was fixed by immersion in 4% paraformaldehyde (PFA) for 7 days at 4 °C. It was then placed in 30% sucrose in PBS at 4 °C overnight and sliced into 30 μm-thick coronal sections using a cryostat (Leitz, 1900) at −20 °C. The slices were washed three times in ice-cold PBS and then permeabilized for 30 min with 0.2% Triton X-100 in PBS. After several rinses in ice-cold PBS, the samples were incubated in blocking solution (0.2% bovine serum albumin in PBS) for 1 h at room temperature followed by overnight incubation at 4 °C with primary antibodies. The primary antibodies included rabbit anti-GFAP (Dako, Denmark, USA) and rabbit anti-4-HNE (Abcam, Cambridge, UK). After primary antibody incubation, the slices were extensively washed with PBS and then incubated with Alexa-conjugated secondary antibodies (Molecular Probes, Carlsbad, CA) for 2 h at 37 °C. Nuclear staining was performed by treating the slices with Hoechst (Sigma-Aldrich). All the immunofluorescence samples were obtained using slices from the midbrain region (bregma −3,–5) The slices were subsequently mounted on slides using mounting medium, and photographs of each slice were taken using a Zeiss LSM 5 Pascal confocal microscope. Four or five slices from each animal were stained, and three animals were examined for each condition. The photographs were analyzed by separating the channels and then measuring the fluorescence intensity, normalized by the area in every 8 bit (black and white) photograph vs the control condition using the average of all the determinations, using NIH ImageJ software.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Statistical Analysis</h3><div class="NLM_p last">All in vivo experiments were performed at least three times, with triplicates for each condition in each experimental run. The results are expressed as means ± standard errors. Data were analyzed by one-way analysis of variance (ANOVA) followed by Bonferroni’s post hoc test; *<i>p</i> ≤ 0.05 and **<i>p</i> ≤ 0.01 were considered significant differences. Statistical analyses were performed using Prism software (GraphPad, USA). For testing normality, we employed the SPSS Statistics software (IBM, USA) using the numerical method.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01775" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01775?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01775</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional data of the crystal structures of target compounds in complex with <i>Tc</i>AChE and hBChE, PAMPA-BBB, biodistribution, hippocampal Aβ levels, and electrophysiological studies, copies of <sup>1</sup>H and <sup>13</sup>C NMR spectra, elemental analysis and HPLC data, and PDB files of the crystal structures of the complexes of compounds <b>5b</b>, <b>5c</b>, <b>5d</b>, <b>5f</b>, <b>5h</b>, and <b>5i</b> with <i>Tc</i>AChE and of compound <b>5i</b> with hBChE (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Inhibitory activities of <b>5a</b>, <b>5b</b>, <b>5c</b>, <b>5d</b>, <b>5e</b>, <b>5f</b>, <b>5g</b>, <b>5h</b>, and <b>5i</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">PDB files of the crystal structures of the complexes of compounds <b>5b</b>, <b>5c</b>, <b>5d</b>, <b>5f</b>, <b>5h</b>, and <b>5i</b> with <i>Tc</i>AChE and of compound <b>5i</b> with hBChE (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_003.zip" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf">jm0c01775_si_001.pdf (1.69 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_002.csv">jm0c01775_si_002.csv (1.05 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_003.zip">jm0c01775_si_003.zip (1.32 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01775" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nibaldo C. Inestrosa</span> - <span class="hlFld-Affiliation affiliation">Center
of Aging and Regeneration UC (CARE-UC), Departamento de Biología
Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Av. Libertador Bernardo O’Higgins
340, P.O. Box 114, 8331150 Santiago, Chile</span>; 
    <span class="hlFld-Affiliation affiliation">Centro de
Excelencia en Biomedicina de Magallanes (CEBIMA), Universidad de Magallanes, 6200000 Punta Arenas, Chile</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#553b3c3b302621273a263415373c3a7b2520367b3639"><span class="__cf_email__" data-cfemail="096760676c7a7d7b667a68496b606627797c6a276a65">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacques-Philippe Colletier</span> - <span class="hlFld-Affiliation affiliation">Institut
de Biologie Structurale, Université
Grenoble Alpes, CEA, CNRS UMR 5075, F-38054 Grenoble, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7c1f131010190815190e3c151e0f521a0e"><span class="__cf_email__" data-cfemail="e2818d8e8e87968b8790a28b8091cc8490">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre-Yves Renard</span> - <span class="hlFld-Affiliation affiliation">Normandie
University, UNIROUEN, INSA Rouen, CNRS, COBRA (UMR 6014), 76000 Rouen, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9094-9778" title="Orcid link">http://orcid.org/0000-0001-9094-9778</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1d6d74786f6f7830646b786e336f78737c6f795d6873746b306f72687873337b6f"><span class="__cf_email__" data-cfemail="b1c1d8d4c3c3d49cc8c7d4c29fc3d4dfd0c3d5f1c4dfd8c79cc3dec4d4df9fd7c3">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diego Muñoz-Torrero</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy
and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8140-8555" title="Orcid link">http://orcid.org/0000-0002-8140-8555</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#33575e465d5c49475c414156415c7346511d565746"><span class="__cf_email__" data-cfemail="12767f677c7d68667d606077607d5267703c777667">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisabet Viayna</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy
and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas Coquelle</span> - <span class="hlFld-Affiliation affiliation">Institut
de Biologie Structurale, Université
Grenoble Alpes, CEA, CNRS UMR 5075, F-38054 Grenoble, France</span>; 
    <span class="hlFld-Affiliation affiliation">Large
Scale Structures Group, Institut Laue-Langevin, F-38042 Grenoble
Cedex 9, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monika Cieslikiewicz-Bouet</span> - <span class="hlFld-Affiliation affiliation">Normandie
University, UNIROUEN, INSA Rouen, CNRS, COBRA (UMR 6014), 76000 Rouen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pedro Cisternas</span> - <span class="hlFld-Affiliation affiliation">Center
of Aging and Regeneration UC (CARE-UC), Departamento de Biología
Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Av. Libertador Bernardo O’Higgins
340, P.O. Box 114, 8331150 Santiago, Chile</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carolina A. Oliva</span> - <span class="hlFld-Affiliation affiliation">Center
of Aging and Regeneration UC (CARE-UC), Departamento de Biología
Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Av. Libertador Bernardo O’Higgins
340, P.O. Box 114, 8331150 Santiago, Chile</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Sánchez-López</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty
of Pharmacy and Food Sciences, and Institute of Nanoscience and Nanotechnology
(IN2UB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Biomedical
Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, E-28031 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miren Ettcheto</span> - <span class="hlFld-Affiliation affiliation">Biomedical
Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, E-28031 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of
Pharmacy and Food Sciences, and Institute of Neuroscience, University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Biotechnology, Faculty of Medicine and Health
Sciences, University Rovira i Virgili, E-43201 Reus, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4301-7297" title="Orcid link">http://orcid.org/0000-0002-4301-7297</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuela Bartolini</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2890-3856" title="Orcid link">http://orcid.org/0000-0002-2890-3856</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela De Simone</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Science and Technology, University
of Turin, I-10125 Torino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mattia Ricchini</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy
and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marisa Rendina</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy
and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mégane Pons</span> - <span class="hlFld-Affiliation affiliation">Normandie
University, UNIROUEN, INSA Rouen, CNRS, COBRA (UMR 6014), 76000 Rouen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Omidreza Firuzi</span> - <span class="hlFld-Affiliation affiliation">Medicinal
and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, PO Box 3288, 71345 Shiraz, Iran</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Belén Pérez</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, E-08193 Bellaterra, Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luciano Saso</span> - <span class="hlFld-Affiliation affiliation">Department
of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincenza Andrisano</span> - <span class="hlFld-Affiliation affiliation">Department
for Life Quality Studies, University of
Bologna, Corso d’Augusto
237, I-47921 Rimini, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4396-1904" title="Orcid link">http://orcid.org/0000-0003-4396-1904</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florian Nachon</span> - <span class="hlFld-Affiliation affiliation">Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées
BP73, 91993 Brétigny sur Orge, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xavier Brazzolotto</span> - <span class="hlFld-Affiliation affiliation">Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées
BP73, 91993 Brétigny sur Orge, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Luisa García</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty
of Pharmacy and Food Sciences, and Institute of Nanoscience and Nanotechnology
(IN2UB), University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Biomedical
Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, E-28031 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antoni Camins</span> - <span class="hlFld-Affiliation affiliation">Biomedical
Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, E-28031 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of
Pharmacy and Food Sciences, and Institute of Neuroscience, University of Barcelona, Av. Joan XXIII 27-31, E-08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Israel Silman</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurobiology, Weizmann Institute of Science, 76100 Rehovot, Israel</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ludovic Jean</span> - <span class="hlFld-Affiliation affiliation">Normandie
University, UNIROUEN, INSA Rouen, CNRS, COBRA (UMR 6014), 76000 Rouen, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1745-4952" title="Orcid link">http://orcid.org/0000-0002-1745-4952</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>E.V. and N.C. contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">The coordinates and structure factors corresponding to the complexes of compounds <b>5b</b>, <b>5c</b>, <b>5d</b>, <b>5f</b>, <b>5h</b>, and <b>5i</b> with <i>Tc</i>AChE and of compound <b>5i</b> with hBChE have been deposited in the Protein Data Bank under accession codes 7AIS, 7AIT, 7AIU, 7AIV, 7AIW, 7AIX, and 7AIY, respectively. The authors will release the atomic coordinates and experimental data upon article publication.</p></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28077" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28077" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Ministerio de Ciencia, Innovación y Universidades (MCIU), Agencia Estatal de Investigación (AEI) and FEDER (SAF2017-82771-R, SAF2014-57094-R), Generalitat de Catalunya (GC) (2017SGR106), the Agence Nationale de la Recherche (ANR) (project Multi-Click, grant number ANR-12-BS07-0008-01), the France Alzheimer Foundation (grant FA-AAP-2013-65-101349 to J.-P.C.), the Italian Ministry of Education, University and Research – MIUR, the Basal Center of Excellence in Aging and Regeneration (CONICYT-AFB 170005 to N.C.I.), FONDECYT (no. 11160651 to P.C.), and MIADES T010131, MIADES T010132 to N.C.I. We also thank the Sociedad Química y Minera de Chile (SQM) for the special grants “The role of K+ on Hypertension and Cognition” and “The role of Lithium in Human Health and Disease”. Fellowships from GC to E.V., from ANR to M.C.-B., from Lifelong Learning Programme/Erasmus to M.Ri., and from and from Leonardo da Vinci Project Unipharma-Graduates 5 to M.Re., and the support of the Vice-Chancellor for Research of the Shiraz University of Medical Sciences to O.F. are gratefully acknowledged.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid peptide</p></td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">ATCh</td><td class="NLM_def"><p class="first last">acetylthiocholine iodide</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">BACE-1</td><td class="NLM_def"><p class="first last">β-site APP cleaving enzyme 1 or β-secretase</p></td></tr><tr><td class="NLM_term">BChE</td><td class="NLM_def"><p class="first last">butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">BTCh</td><td class="NLM_def"><p class="first last">butyrylthiocholine iodide</p></td></tr><tr><td class="NLM_term">CAS</td><td class="NLM_def"><p class="first last">catalytic anionic site</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CuAAC</td><td class="NLM_def"><p class="first last">copper-catalyzed azide–alkyne cycloaddition</p></td></tr><tr><td class="NLM_term"><i>Ee</i>AChE</td><td class="NLM_def"><p class="first last">electric eel acetylcholinesterase</p></td></tr><tr><td class="NLM_term">hAChE</td><td class="NLM_def"><p class="first last">human acetylcholinesterase</p></td></tr><tr><td class="NLM_term">hBChE</td><td class="NLM_def"><p class="first last">human butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">MTDLs</td><td class="NLM_def"><p class="first last">multitarget-directed ligands</p></td></tr><tr><td class="NLM_term">PAMPA-BBB</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeation assay</p></td></tr><tr><td class="NLM_term">PAS</td><td class="NLM_def"><p class="first last">peripheral anionic site</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate-buffered saline</p></td></tr><tr><td class="NLM_term"><i>Tc</i>AChE</td><td class="NLM_def"><p class="first last"><i>Torpedo californica</i> acetylcholinesterase</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48127" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48127" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 101 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Alzheimer’s Disease
International</span>. <span class="NLM_year">2019</span>.  <i>World Alzheimer Report 2019: Attitudes to Dementia</i>. <span class="NLM_publisher-loc">London</span>: <span class="NLM_publisher-name">Alzheimer’s Disease
International</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=Alzheimer%E2%80%99s+Disease%0AInternational&title=World+Alzheimer+Report+2019%3A+Attitudes+to+Dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2019%26jtitle%3DWorld%2520Alzheimer%2520Report%25202019%253A%2520Attitudes%2520to%2520Dementia%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%250AInternational" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taneja, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajput, S. K.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species: friend or foe?</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">57267</span>– <span class="NLM_lpage">57276</span>, <span class="refDoi"> DOI: 10.1039/C5RA07927F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1039%2FC5RA07927F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtV2ksLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=57267-57276&author=A.+K.+Sharmaauthor=G.+Tanejaauthor=D.+Khannaauthor=S.+K.+Rajput&title=Reactive+oxygen+species%3A+friend+or+foe%3F&doi=10.1039%2FC5RA07927F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species: friend or foe?</span></div><div class="casAuthors">Sharma, Arun Kumar; Taneja, Gourav; Khanna, Deepa; Rajput, Satyendra K.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">71</span>),
    <span class="NLM_cas:pages">57267-57276</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) are an inevitable byproduct of cellular metab.  ROS generation can be assocd. with the interaction of ionizing radiation with biol. mols., and devoted enzymes in phagocytic cells (NADPH oxidase and myeloperoxidase) or may be the result of an imbalance between radical generating and scavenging systems.  Typically ROS have been consider as Pandora's box, they have several innovative physiol. roles in the body.  ROS serve as signalling messengers for the activation of transcription factors from cytokine-receptor interactions.  This facilitates the evolution and membrane fusion of spermatozoon and oocyte during fertilization.  NADPH oxidase enzyme and nitric oxide (NO) function as potent vasodilators and immunity boosters.  ROS have been suggested as prevalent regulators of several nuclear factors, including erythroid 2-related factor 2 (Nrf2), nuclear factor kappa-B (NFκB) cells, mitogen-activated protein kinase (MAPK) and p53, which are further assocd. with several signalling cascades.  Under physiol. conditions the amt. of ROS generated in the body can be counterbalanced by natural antioxidants in the body.  However, aberrant augmented levels of ROS predominantly lead to various defined disorders comprising myocardial infarction, autoimmune diseases, atherosclerosis, Alzheimer's and Parkinson's diseases and emphysema.  Ordinarily, it is obsd. that the physiol. roles of ROS are insubstantial compared with their pathol. action.  But there is a need to clearly define the line between pathol. and physiol. functions of ROS.  Of particular worth is to reveal the beneficial responsibilities of ROS in different cellular pathways and metabolic functions, over its injurious consequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaExtahQigqbVg90H21EOLACvtfcHk0lhqP_s75zgf3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtV2ksLzN&md5=023b3c3728c3ba51edd93e5f0048dabc</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1039%2FC5RA07927F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA07927F%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DTaneja%26aufirst%3DG.%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DRajput%26aufirst%3DS.%2BK.%26atitle%3DReactive%2520oxygen%2520species%253A%2520friend%2520or%2520foe%253F%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D57267%26epage%3D57276%26doi%3D10.1039%2FC5RA07927F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, G.</span></span> <span> </span><span class="NLM_article-title">Parallels between major depressive disorder and Alzheimer’s disease: Role of oxidative stress and genetic vulnerability</span>. <i>Cell. Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">925</span>– <span class="NLM_lpage">949</span>, <span class="refDoi"> DOI: 10.1007/s10571-014-0074-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1007%2Fs10571-014-0074-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=24927694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVWhu7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=925-949&author=R.+Rodriguesauthor=R.+B.+Petersenauthor=G.+Perry&title=Parallels+between+major+depressive+disorder+and+Alzheimer%E2%80%99s+disease%3A+Role+of+oxidative+stress+and+genetic+vulnerability&doi=10.1007%2Fs10571-014-0074-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Parallels Between Major Depressive Disorder and Alzheimer's Disease: Role of Oxidative Stress and Genetic Vulnerability</span></div><div class="casAuthors">Rodrigues, Roberto; Petersen, Robert B.; Perry, George</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">925-949</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The thesis of this review is that oxidative stress is the central factor in major depressive disorder (MDD) and Alzheimer's disease (AD).  The major elements involved are inflammatory cytokines, the hypothalamic-pituitary axis, the hypothalamic-pituitary gonadal, and arginine vasopressin systems, which induce glucocorticoid and "oxidopamatergic" cascades when triggered by psychosocial stress, severe life-threatening events, and mental-affective and somatic diseases.  In individuals with a genomic vulnerability to depression, these cascades may result in chronic depression-anxiety-stress spectra, resulting in MDD and other known depressive syndromes.  In contrast, in subjects with genomic vulnerability to AD, oxidative stress-induced brain damage triggers specific antioxidant defenses, i.e., increased levels of amyloid-β (Aβ) and aggregation of hyper-phosphorylated tau, resulting in paired helical filaments and impaired functions related to the ApoEε4 isoform, leading to complex pathol. cascades culminating in AD.  Surprisingly, all the AD-assocd. mol. pathways mentioned in this review have been shown to be similar or analogous to those found in depression, including structural damage, i.e., hippocampal and frontal cortex atrophy.  Other interacting mol. signals, i.e., GSK-3β, convergent survival factors (brain-derived neurotrophic factor and heat shock proteins), and transition redox metals are also mentioned to emphasize the vast array of intermediates that could interact via comparable mechanisms in both MDD and AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopq4Fqxf3AlLVg90H21EOLACvtfcHk0lhqP_s75zgf3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVWhu7%252FF&md5=bdfd98b8cedaf67f58dbbc5b0b3139c7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs10571-014-0074-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-014-0074-5%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DR.%26aulast%3DPetersen%26aufirst%3DR.%2BB.%26aulast%3DPerry%26aufirst%3DG.%26atitle%3DParallels%2520between%2520major%2520depressive%2520disorder%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Role%2520of%2520oxidative%2520stress%2520and%2520genetic%2520vulnerability%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2014%26volume%3D34%26spage%3D925%26epage%3D949%26doi%3D10.1007%2Fs10571-014-0074-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bachurin, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovina, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ustyugov, A. A.</span></span> <span> </span><span class="NLM_article-title">Drugs in clinical trials for Alzheimer’s disease: The major trends</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1186</span>– <span class="NLM_lpage">1225</span>, <span class="refDoi"> DOI: 10.1002/med.21434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fmed.21434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=28084618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yktbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=1186-1225&author=S.+O.+Bachurinauthor=E.+V.+Bovinaauthor=A.+A.+Ustyugov&title=Drugs+in+clinical+trials+for+Alzheimer%E2%80%99s+disease%3A+The+major+trends&doi=10.1002%2Fmed.21434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends</span></div><div class="casAuthors">Bachurin, Sergey O.; Bovina, Elena V.; Ustyugov, Aleksey A.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1186-1225</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by a chronic and progressive neurodegenerative process resulting from the intracellular and extracellular accumulation of fibrillary proteins: beta-amyloid and hyperphosphorylated Tau.  Overaccumulation of these aggregates leads to synaptic dysfunction and subsequent neuronal loss.  The precise mol. mechanisms of AD are still not fully understood but it is clear that AD is a multifactorial disorder and that advanced age is the main risk factor.  Over the last decade, more than 50 drug candidates have successfully passed phase II clin. trials, but none has passed phase III.  Here, we summarize data on current "anti-Alzheimer's" agents currently in clin. trials based on findings available in the Thomson Reuters 'Integrity' database, on the public website, and on database of the website .  As a result, it was possible to outline some major trends in AD drug discovery: (i) the development of compds. acting on the main stages of the pathogenesis of the disease (the so-called "disease-modifying agents") - these drugs could potentially slow the development of structural and functional abnormalities in the central nervous system providing sustainable improvements of cognitive functions, which persist even after drug withdrawal; (ii) focused design of multitargeted drugs acting on multiple mol. targets involved in the pathogenesis of the disease; (3) finally, the repositioning of old drugs for new (anti-Alzheimer's) application offers a very attractive approach to facilitate the completion of clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUgLGjGuc0iLVg90H21EOLACvtfcHk0ljb5PAnBXUJlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yktbvO&md5=a5659940c428ecd50892d80e0c1baa7d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fmed.21434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21434%26sid%3Dliteratum%253Aachs%26aulast%3DBachurin%26aufirst%3DS.%2BO.%26aulast%3DBovina%26aufirst%3DE.%2BV.%26aulast%3DUstyugov%26aufirst%3DA.%2BA.%26atitle%3DDrugs%2520in%2520clinical%2520trials%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520The%2520major%2520trends%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2017%26volume%3D37%26spage%3D1186%26epage%3D1225%26doi%3D10.1002%2Fmed.21434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-based survey of the binding modes of BACE1 inhibitors</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">889</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00420</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00420" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=880-889&author=H.+Huauthor=Z.+Chenauthor=X.+Xuauthor=Y.+Xu&title=Structure-based+survey+of+the+binding+modes+of+BACE1+inhibitors&doi=10.1021%2Facschemneuro.8b00420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Survey of the Binding Modes of BACE1 Inhibitors</span></div><div class="casAuthors">Hu, Hangchen; Chen, Zhaoqiang; Xu, Xiang; Xu, Yechun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">880-889</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  BACE1 is a key aspartic protease that cleaves the amyloid precursor protein to generate of the amyloid peptide that is believed to be responsible for the Alzheimer's disease amyloid cascade.  It is thus recognized as a promising therapeutic target for Alzheimer's disease treatment, and large efforts have been made in the discovery of novel BACE1 inhibitors.  This Review presents a systematic mining of BACE1 inhibitors based on 354 crystal structures of the BACE1 catalytic domain in complex with ligands in the Protein Data Bank.  A thorough exploration on the frequency as well as the patterns of residue-ligand interactions enables us to subdivide the ligand binding pocket into 10 subsites and then identify favorable substructures of ligands for each subsite.  In addn., it is found that the assembly of subsites with an 8-like shape is responsible to bind all inhibitors and four major ligand binding modes are revealed.  Thus, such a systematic survey deepens our understanding of the structural requirements for establishment of BACE1-ligand interactions that det. the affinity of a ligand to BACE1, which is pivotal for structure-based lead optimization and design of novel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwvv_EbX_3ALVg90H21EOLACvtfcHk0ljb5PAnBXUJlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhsrfF&md5=3157eb17033dae864aee238751e055ca</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00420%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DStructure-based%2520survey%2520of%2520the%2520binding%2520modes%2520of%2520BACE1%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D880%26epage%3D889%26doi%3D10.1021%2Facschemneuro.8b00420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doody, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farlow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joffe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieburtz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemers, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu-Seifert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohs, R.</span></span> <span> </span><span class="NLM_article-title">Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1312889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1056%2FNEJMoa1312889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=24450890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=311-321&author=R.+S.+Doodyauthor=R.+G.+Thomasauthor=M.+Farlowauthor=T.+Iwatsuboauthor=B.+Vellasauthor=S.+Joffeauthor=K.+Kieburtzauthor=R.+Ramanauthor=X.+Sunauthor=P.+S.+Aisenauthor=E.+Siemersauthor=H.+Liu-Seifertauthor=R.+Mohs&title=Phase+3+trials+of+solanezumab+for+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1312889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Doody, Rachelle S.; Thomas, Ronald G.; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; Raman, Rema; Sun, Xiaoying; Aisen, Paul S.; Siemers, Eric; Liu-Seifert, Hong; Mohs, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Alzheimer's disease is characterized by amyloid-beta plaques, neurofibrillary tangles, gliosis, and neuronal loss.  Solanezumab, a humanized monoclonal antibody, preferentially binds sol. forms of amyloid and in preclin. studies promoted its clearance from the brain.  METHODS: In two phase 3, double-blind trials (EXPEDITION 1 and EXPEDITION 2), we randomly assigned 1012 and 1040 patients, resp., with mild-to-moderate Alzheimer's disease to receive placebo or solanezumab (administered i.v. at a dose of 400 mg) every 4 wk for 18 mo.  The primary outcomes were the changes from baseline to week 80 in scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11; range, 0 to 70, with higher scores indicating greater cognitive impairment) and the Alzheimer's Disease Cooperative Study-Activities of Daily Living scale (ADCS-ADL; range, 0 to 78, with lower scores indicating worse functioning).  After anal. of data from EXPEDITION 1, the primary outcome for EXPEDITION 2 was revised to the change in scores on the 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog14; range, 0 to 90, with higher scores indicating greater impairment), in patients with mild Alzheimer's disease.  RESULTS: Neither study showed significant improvement in the primary outcomes.  The modeled difference between groups (solanezumab group minus placebo group) in the change from baseline was -0.8 points for the ADAS-cog11 score (95% confidence interval [CI], -2.1 to 0.5; P = 0.24) and -0.4 points for the ADCS-ADL score (95% CI, -2.3 to 1.4; P = 0.64) in EXPEDITION 1 and -1.3 points (95% CI, -2.5 to 0.3; P = 0.06) and 1.6 points (95% CI, -0.2 to 3.3; P = 0.08), resp., in EXPEDITION 2.  Between-group differences in the changes in the ADAS-cog14 score were -1.7 points in patients with mild Alzheimer's disease (95% CI, -3.5 to 0.1; P = 0.06) and -1.5 in patients with moderate Alzheimer's disease (95% CI, -4.1 to 1.1; P = 0.26).  In the combined safety data set, the incidence of amyloid-related imaging abnormalities with edema or hemorrhage was 0.9% with solanezumab and 0.4% with placebo for edema (P = 0.27) and 4.9% and 5.6%, resp., for hemorrhage (P = 0.49).  CONCLUSIONS: Solanezumab, a humanized monoclonal antibody that binds amyloid, failed to improve cognition or functional ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Ej7A_YXNwLVg90H21EOLACvtfcHk0ljJxK0WJ_noUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt70%253D&md5=c993836d4f7374cc78f155f9cedbc594</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1312889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1312889%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DJoffe%26aufirst%3DS.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DLiu-Seifert%26aufirst%3DH.%26aulast%3DMohs%26aufirst%3DR.%26atitle%3DPhase%25203%2520trials%2520of%2520solanezumab%2520for%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D311%26epage%3D321%26doi%3D10.1056%2FNEJMoa1312889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pimplikar, S. W.</span></span> <span> </span><span class="NLM_article-title">Reassessing the amyloid cascade hypothesis of Alzheimer’s disease</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1268</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2008.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.biocel.2008.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=19124085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1261-1268&author=S.+W.+Pimplikar&title=Reassessing+the+amyloid+cascade+hypothesis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.biocel.2008.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Reassessing the amyloid cascade hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Pimplikar, Sanjay W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1261-1268</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Since its inception, the amyloid cascade hypothesis has dominated the field of Alzheimer's disease (AD) research and has provided the intellectual framework for therapeutic intervention.  Although the details of the hypothesis continue to evolve, its core principle has remained essentially unaltered.  It posits that the amyloid-β peptides, derived from amyloid precursor protein (APP), are the root cause of AD.  Substantial genetic and biochem. data support this view, and yet a no. of findings also run contrary to its tenets.  The presence of familial AD mutations in APP and presenilins, demonstration of Aβ toxicity, and studies in mouse models of AD all support the hypothesis, whereas the presence of Aβ plaques in normal individuals, the uncertain nature of the pathogenic Aβ species, and repeated disappointments with Aβ-centered therapeutic trials are inconsistent with the hypothesis.  The current state of knowledge does not prove nor disprove the amyloid hypothesis, but rather points to the need for its reassessment.  A view that Aβ is one of the factors, as opposed to the factor, that causes AD is more consistent with the present knowledge, and is more likely to promote comprehensive and effective therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNZoitUBRzaLVg90H21EOLACvtfcHk0ljJxK0WJ_noUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D&md5=e33973b5f125c34d95cb3f1b477d3ced</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DPimplikar%26aufirst%3DS.%2BW.%26atitle%3DReassessing%2520the%2520amyloid%2520cascade%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D1261%26epage%3D1268%26doi%3D10.1016%2Fj.biocel.2008.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress in Alzheimer’s disease: Are we connecting the dots?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2821</span>– <span class="NLM_lpage">2831</span>, <span class="refDoi"> DOI: 10.1021/jm400970m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400970m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2821-2831&author=M.+Rosiniauthor=E.+Simoniauthor=A.+Milelliauthor=A.+Minariniauthor=C.+Melchiorre&title=Oxidative+stress+in+Alzheimer%E2%80%99s+disease%3A+Are+we+connecting+the+dots%3F&doi=10.1021%2Fjm400970m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress in Alzheimer's Disease: Are We Connecting the Dots?</span></div><div class="casAuthors">Rosini, Michela; Simoni, Elena; Milelli, Andrea; Minarini, Anna; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2821-2831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Redox impairment is a prominent feature of Alzheimer's disease (AD).  It has led to the "oxidative stress hypothesis", which proposes antioxidants as beneficial therapeutic tools in AD treatment.  To date, a wide variety of antioxidants have been examd. as neuroprotectants.  However, success has been elusive in clin. trials.  Several factors have contributed to this failure, including the complexity of the redox system in vivo.  Potentially crit. aspects include the fine-tuned equil. between antioxidant defenses and free radical prodn., the lack of specific antioxidant target(s), and the inherent difficulty in delivering antioxidants where they are needed.  Herein, the authors highlight significant progress in the field.  Future directions of antioxidant research are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonuV4RR1IRPLVg90H21EOLACvtfcHk0ljJxK0WJ_noUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7fM&md5=907927f3b3b6d6bcb1402fedf6080e35</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm400970m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400970m%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DOxidative%2520stress%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Are%2520we%2520connecting%2520the%2520dots%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2821%26epage%3D2831%26doi%3D10.1021%2Fjm400970m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deardorff, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossberg, G. T.</span></span> <span> </span><span class="NLM_article-title">The use of cholinesterase inhibitors across all stages of Alzheimer’s disease</span>. <i>Drugs Aging</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1007/s40266-015-0273-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1007%2Fs40266-015-0273-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=26033268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1elurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=537-547&author=W.+J.+Deardorffauthor=E.+Feenauthor=G.+T.+Grossberg&title=The+use+of+cholinesterase+inhibitors+across+all+stages+of+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs40266-015-0273-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease</span></div><div class="casAuthors">Deardorff, William James; Feen, Eliahu; Grossberg, George T.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">537-547</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Current pharmacol. therapy for Alzheimer's disease (AD) includes the cholinesterase inhibitors (ChEIs) donepezil, rivastigmine, and galantamine and the N-Me D-aspartate receptor antagonist memantine.  Based on the results of randomized controlled trials and several meta-analyses, ChEIs appear to show modest but statistically significant improvements on several measures, including cognition and global functioning.  Given their modest effects, there is a lack of consensus among clinicians regarding issues related to initiation, optimal duration, and discontinuation of ChEI therapy across the spectrum of AD.  There is evidence from long-term observational controlled studies that early initiation and persistent exposure to AD therapy lead to delays in nursing home admission and significantly slower rates of cognitive and functional impairment.  In the moderate to severe stages of AD, therapeutic trials of higher dose ChEIs and the addn. of memantine are recommended for patients who are no longer responding to lower doses.  While side effects are generally mild and gastrointestinal in nature, these events can lead to significant morbidity in more susceptible patients with advanced disease.  Patients should thus be regularly monitored for any potential serious side effects of ChEI therapy, which also may include syncope and bradycardia.  At the terminal stages of AD, such as when patients become hospice eligible, attempts to cautiously discontinue all medications not necessary for quality of life, including AD drugs, should be made.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjHuGZ43A24bVg90H21EOLACvtfcHk0li86ja7kuNbfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1elurfL&md5=a33eb3b03b007ba8c56513713c0cd7f4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs40266-015-0273-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-015-0273-x%26sid%3Dliteratum%253Aachs%26aulast%3DDeardorff%26aufirst%3DW.%2BJ.%26aulast%3DFeen%26aufirst%3DE.%26aulast%3DGrossberg%26aufirst%3DG.%2BT.%26atitle%3DThe%2520use%2520of%2520cholinesterase%2520inhibitors%2520across%2520all%2520stages%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrugs%2520Aging%26date%3D2015%26volume%3D32%26spage%3D537%26epage%3D547%26doi%3D10.1007%2Fs40266-015-0273-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lendon, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froelich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houlden, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickering-Brown, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraverty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grover, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lincoln, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaff, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wauters, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Baren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillebrand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joosse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowotny, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neystat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dark, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannenberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreadis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snowden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craufurd, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neary, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oostra, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Swieten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heutink, P.</span></span> <span> </span><span class="NLM_article-title">Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>393</i></span>,  <span class="NLM_fpage">702</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1038/31508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1038%2F31508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=9641683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaK1cXktVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=1998&pages=702-705&author=M.+Huttonauthor=C.+L.+Lendonauthor=P.+Rizzuauthor=M.+Bakerauthor=S.+Froelichauthor=H.+Houldenauthor=S.+Pickering-Brownauthor=S.+Chakravertyauthor=A.+Isaacsauthor=A.+Groverauthor=J.+Hackettauthor=J.+Adamsonauthor=S.+Lincolnauthor=D.+Dicksonauthor=P.+Daviesauthor=R.+C.+Petersenauthor=M.+Stevensauthor=E.+de+Graaffauthor=E.+Wautersauthor=J.+van+Barenauthor=M.+Hillebrandauthor=M.+Joosseauthor=J.+M.+Kwonauthor=P.+Nowotnyauthor=L.+K.+Cheauthor=J.+Nortonauthor=J.+C.+Morrisauthor=L.+A.+Reedauthor=J.+Trojanowskiauthor=H.+Basunauthor=L.+Lannfeltauthor=M.+Neystatauthor=S.+Fahnauthor=F.+Darkauthor=T.+Tannenbergauthor=P.+R.+Doddauthor=N.+Haywardauthor=J.+B.+Kwokauthor=P.+R.+Schofieldauthor=A.+Andreadisauthor=J.+Snowdenauthor=D.+Craufurdauthor=D.+Nearyauthor=F.+Owenauthor=B.+A.+Oostraauthor=J.+Hardyauthor=A.+Goateauthor=J.+van+Swietenauthor=D.+Mannauthor=T.+Lynchauthor=P.+Heutink&title=Association+of+missense+and+5%E2%80%B2-splice-site+mutations+in+tau+with+the+inherited+dementia+FTDP-17&doi=10.1038%2F31508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17</span></div><div class="casAuthors">Hutton, Mike; Lendon, Corinne L.; Rizzu, Patrizia; Baker, Matt; Froelich, Susanne; Houlden, Henry; Pickering-Brown, Stuart; Chakraverty, Sumi; Isaacs, Adrian; Grover, Andrew; Hackett, Jennifer; Adamson, Jennifer; Lincoln, Sarah; Dickson, Dennis; Davies, Peter; Petersen, Ronald C.; Stevens, Martijn; de Graaff, Esther; Wauters, Erwin; van Baren, Jeltje; Hillebrand, Marcel; Joosse, Marijke; Kwon, Jennifer M.; Nowotny, Petra; Che, Lien Kuei; Norton, Joanne; Morris, John C.; Reed, Lee A.; Trojanowski, John; Basun, Hans; Lannfelt, Lars; Neystat, Michael; Fahn, Stanley; Dark, Francis; Tannenberg, Tony; Dodd, Peter R.; Hayward, Nick; Kwok, John B. J.; Schofield, Peter R.; Andreadis, Athena; Snowden, Julie; Craufurd, David; Neary, David; Owen, Frank; Oostra, Ben A.; Hardy, John; Goate, Alison; van Swieten, John; Mann, David; Lynch, Timothy; Heutink, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">6686</span>),
    <span class="NLM_cas:pages">702-705</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Thirteen families have been described with an autosomal dominantly inherited dementia named frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), historically termed Pick's disease.  Most FTDP-17 cases show neuronal and/or glial inclusions that stain pos. with antibodies raised against the microtubule-assocd. protein Tau, although the Tau pathol. varies considerably in both its quantity (or severity) and characteristics.  Previous studies have mapped the FTDP-17 locus to a 2-centimorgan region on chromosome 17q21.11; the tau gene also lies within this region.  We have now sequenced tau in FTDP-17 families and identified three missense mutations (G272V, P301L and R406W) and three mutations in the 5' splice site of exon 10.  The splice-site mutations all destabilize a potential stem-loop structure which is probably involved in regulating the alternative splicing of exon 10.  This causes more frequent usage of the 5' splice site an increased proportion of tau transcripts that include exon 10.  The increase in exon 10+ mRNA will increase the proportion of Tau contg. four microtubule-binding repeats, which is consistent with the neuropathol. described in several families with FTDP-17.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmDAkDTiFru7Vg90H21EOLACvtfcHk0li86ja7kuNbfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVyqsr0%253D&md5=8ec0725fa99708a52022b404dc97a72f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F31508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F31508%26sid%3Dliteratum%253Aachs%26aulast%3DHutton%26aufirst%3DM.%26aulast%3DLendon%26aufirst%3DC.%2BL.%26aulast%3DRizzu%26aufirst%3DP.%26aulast%3DBaker%26aufirst%3DM.%26aulast%3DFroelich%26aufirst%3DS.%26aulast%3DHoulden%26aufirst%3DH.%26aulast%3DPickering-Brown%26aufirst%3DS.%26aulast%3DChakraverty%26aufirst%3DS.%26aulast%3DIsaacs%26aufirst%3DA.%26aulast%3DGrover%26aufirst%3DA.%26aulast%3DHackett%26aufirst%3DJ.%26aulast%3DAdamson%26aufirst%3DJ.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DDickson%26aufirst%3DD.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DStevens%26aufirst%3DM.%26aulast%3Dde%2BGraaff%26aufirst%3DE.%26aulast%3DWauters%26aufirst%3DE.%26aulast%3Dvan%2BBaren%26aufirst%3DJ.%26aulast%3DHillebrand%26aufirst%3DM.%26aulast%3DJoosse%26aufirst%3DM.%26aulast%3DKwon%26aufirst%3DJ.%2BM.%26aulast%3DNowotny%26aufirst%3DP.%26aulast%3DChe%26aufirst%3DL.%2BK.%26aulast%3DNorton%26aufirst%3DJ.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DReed%26aufirst%3DL.%2BA.%26aulast%3DTrojanowski%26aufirst%3DJ.%26aulast%3DBasun%26aufirst%3DH.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DNeystat%26aufirst%3DM.%26aulast%3DFahn%26aufirst%3DS.%26aulast%3DDark%26aufirst%3DF.%26aulast%3DTannenberg%26aufirst%3DT.%26aulast%3DDodd%26aufirst%3DP.%2BR.%26aulast%3DHayward%26aufirst%3DN.%26aulast%3DKwok%26aufirst%3DJ.%2BB.%26aulast%3DSchofield%26aufirst%3DP.%2BR.%26aulast%3DAndreadis%26aufirst%3DA.%26aulast%3DSnowden%26aufirst%3DJ.%26aulast%3DCraufurd%26aufirst%3DD.%26aulast%3DNeary%26aufirst%3DD.%26aulast%3DOwen%26aufirst%3DF.%26aulast%3DOostra%26aufirst%3DB.%2BA.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3Dvan%2BSwieten%26aufirst%3DJ.%26aulast%3DMann%26aufirst%3DD.%26aulast%3DLynch%26aufirst%3DT.%26aulast%3DHeutink%26aufirst%3DP.%26atitle%3DAssociation%2520of%2520missense%2520and%25205%25E2%2580%25B2-splice-site%2520mutations%2520in%2520tau%2520with%2520the%2520inherited%2520dementia%2520FTDP-17%26jtitle%3DNature%26date%3D1998%26volume%3D393%26spage%3D702%26epage%3D705%26doi%3D10.1038%2F31508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geula, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesulam, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saroff, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. K.</span></span> <span> </span><span class="NLM_article-title">Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer disease</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1097/00005072-199801000-00008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1097%2F00005072-199801000-00008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=9600198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A280%3ADyaK1c3mtVyhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1998&pages=63-75&author=C.+Geulaauthor=M.+M.+Mesulamauthor=D.+M.+Saroffauthor=C.+K.+Wu&title=Relationship+between+plaques%2C+tangles%2C+and+loss+of+cortical+cholinergic+fibers+in+Alzheimer+disease&doi=10.1097%2F00005072-199801000-00008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer disease</span></div><div class="casAuthors">Geula C; Mesulam M M; Saroff D M; Wu C K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuropathology and experimental neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-75</span>
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    </div><div class="casAbstract">Recent observations in our laboratory have indicated substantial and systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer disease (AD).  Previous attempts to study the relationship between cortical cholinergic loss and the density of cortical pathological lesions have resulted in conflicting findings.  Furthermore, most reports have correlated density of plaques and tangles with the residual level of cholinergic innervation rather than its loss.  The purpose of the present study was to determine the relationship between loss of cholinergic axons and density of tangles and beta-amyloid (Abeta) deposits in various cortical areas of AD brains.  Abeta deposits and tangles were observed throughout the cerebral cortex.  Quantitative analysis revealed almost no correlation between loss of cholinergic fibers and the density of Abeta deposits.  Qualitative observations revealed similar results when cored and neuritic plaques were considered separately.  By contrast, cholinergic fiber loss displayed a significant correlation with the density of tangles (r = 0.52-0.79).  However, in a few areas, such as the cingulate cortex, tangle density appeared to be unrelated to the loss of cholinergic fibers.  These results indicate that cortical cholinergic denervation in AD is related to cytoskeletal pathology.  However, the lack of a perfect relationship with cytoskeletal pathology implicates additional factors in the cholinergic pathology of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlzXlkQHnsBySm0e6ZOaemfW6udTcc2eYfiOvMoO8Fj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c3mtVyhtw%253D%253D&md5=132103acbcc93fc3f26f3a2dda8dbb9f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1097%2F00005072-199801000-00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00005072-199801000-00008%26sid%3Dliteratum%253Aachs%26aulast%3DGeula%26aufirst%3DC.%26aulast%3DMesulam%26aufirst%3DM.%2BM.%26aulast%3DSaroff%26aufirst%3DD.%2BM.%26aulast%3DWu%26aufirst%3DC.%2BK.%26atitle%3DRelationship%2520between%2520plaques%252C%2520tangles%252C%2520and%2520loss%2520of%2520cortical%2520cholinergic%2520fibers%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D1998%26volume%3D57%26spage%3D63%26epage%3D75%26doi%3D10.1097%2F00005072-199801000-00008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campanari, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Ayllón, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez-Llorca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, W. K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sáez-Valero, J.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase protein level is preserved in the Alzheimer’s brain</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1007/s12031-013-0183-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1007%2Fs12031-013-0183-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=24318838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFajs7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=446-453&author=M.+L.+Campanariauthor=M.+S.+Garc%C3%ADa-Ayll%C3%B3nauthor=L.+Blazquez-Llorcaauthor=W.+K.+W.+Lukauthor=K.+Tsimauthor=J.+S%C3%A1ez-Valero&title=Acetylcholinesterase+protein+level+is+preserved+in+the+Alzheimer%E2%80%99s+brain&doi=10.1007%2Fs12031-013-0183-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase Protein Level Is Preserved in the Alzheimer's Brain</span></div><div class="casAuthors">Campanari, Maria-Letizia; Garcia-Ayllon, Maria-Salud; Blazquez-Llorca, Lidia; Luk, Wilson K. W.; Tsim, Karl; Saez-Valero, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">446-453</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE) is a key enzyme in the cholinergic nervous system and is one of the most studied proteins in the field of Alzheimer's disease (AD).  Moreover, alternative functions of AChE unrelated with the hydrolysis of acetylcholine are suspected.  Until now, the majority of investigations on AChE in AD pathol. have been focused on the detn. of its enzymic activity level, which is depleted in the AD brain.  Despite this overall decrease, AChE activity increases at the vicinity of the two hallmarks of AD, the amyloid plaques and the neurofibrillary tangles (NFT).  In fact, AChE may directly interact with Aβ in a manner that increases the deposition of Aβ to form plaques.  In the context of protein-protein interactions, we have recently reported that AChE can interact with presenilin-1, the catalytic component of γ-secretase, influencing its expression level and also its activity.  However, the alteration of AChE protein in the AD brain has not been detd.  Here, we demonstrated by Western blotting and immunohistochem. that a prominent pool of enzymically inactive AChE protein existed in the AD brain.  The potential significance of these unexpected levels of inactive AChE protein in the AD brain was discussed, esp. in the context of protein-protein interactions with β-amyloid and presenilin-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodzFyxYuZ47LVg90H21EOLACvtfcHk0liOMqp1ElX28g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFajs7rN&md5=d9b33db50e1f200ad950f441c10580fa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs12031-013-0183-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-013-0183-5%26sid%3Dliteratum%253Aachs%26aulast%3DCampanari%26aufirst%3DM.%2BL.%26aulast%3DGarc%25C3%25ADa-Ayll%25C3%25B3n%26aufirst%3DM.%2BS.%26aulast%3DBlazquez-Llorca%26aufirst%3DL.%26aulast%3DLuk%26aufirst%3DW.%2BK.%2BW.%26aulast%3DTsim%26aufirst%3DK.%26aulast%3DS%25C3%25A1ez-Valero%26aufirst%3DJ.%26atitle%3DAcetylcholinesterase%2520protein%2520level%2520is%2520preserved%2520in%2520the%2520Alzheimer%25E2%2580%2599s%2520brain%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2014%26volume%3D53%26spage%3D446%26epage%3D453%26doi%3D10.1007%2Fs12031-013-0183-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darvesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cash, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitnitski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geula, C.</span></span> <span> </span><span class="NLM_article-title">Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1097/NEN.0b013e31823cc7a6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1097%2FNEN.0b013e31823cc7a6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=22157615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12htrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=2-14&author=S.+Darveshauthor=M.+K.+Cashauthor=G.+A.+Reidauthor=E.+Martinauthor=A.+Mitnitskiauthor=C.+Geula&title=Butyrylcholinesterase+is+associated+with+%CE%B2-amyloid+plaques+in+the+transgenic+APPSWE%2FPSEN1dE9+mouse+model+of+Alzheimer+disease&doi=10.1097%2FNEN.0b013e31823cc7a6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Butyrylcholinesterase Is Associated With β-Amyloid Plaques in the Transgenic APPSWE/PSEN1dE9 Mouse Model of Alzheimer Disease</span></div><div class="casAuthors">Darvesh, Sultan; Cash, Meghan K.; Reid, George Andrew; Martin, Earl; Mitnitski, Arnold; Geula, Changiz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-14</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Histochem. anal. of Alzheimer disease (AD) brain tissues indicates that butyrylcholinesterase (BuChE) is present in β-amyloid (Aβ) plaques.  The role of BuChE in AD pathol. is unknown, but an animal model developing similar BuChE-assocd. Aβ plaques could provide insights.  The APPSWE/PSEN1dE9 transgenic mouse (ADTg), which develops Aβ plaques, was examd. to det. if BuChE assocs. with these plaques, as in AD.  We found that in mature ADTg mice, BuChE activity assocd. with Aβ plaques.  The Aβ-, thioflavin-S- and BuChE-pos. plaques mainly accumulated in the olfactory structures, cerebral cortex, hippocampal formation, amygdala, and cerebellum.  No plaques were stained for acetylcholinesterase activity.  The distribution and abundance of plaque staining in ADTg closely resembled many aspects of plaque staining in AD.  Butyrylcholinesterase staining consistently showed fewer plaques than were detected with Aβ immunostaining but a greater no. of plaques than were visualized with thioflavin-S.  Double-labeling expts. demonstrated that all BuChE-pos. plaques were Aβ pos., whereas only some BuChE-pos. plaques were thioflavin-S pos.  These observations suggest that BuChE is assocd. with a subpopulation of Aβ plaques and may play a role in AD plaque maturation.  A further study of this animal model could clarify the role of BuChE in AD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryaKi0ooPJVLVg90H21EOLACvtfcHk0liOMqp1ElX28g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12htrvE&md5=66948a709f85da947651e5f8bb2fb613</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1097%2FNEN.0b013e31823cc7a6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNEN.0b013e31823cc7a6%26sid%3Dliteratum%253Aachs%26aulast%3DDarvesh%26aufirst%3DS.%26aulast%3DCash%26aufirst%3DM.%2BK.%26aulast%3DReid%26aufirst%3DG.%2BA.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DMitnitski%26aufirst%3DA.%26aulast%3DGeula%26aufirst%3DC.%26atitle%3DButyrylcholinesterase%2520is%2520associated%2520with%2520%25CE%25B2-amyloid%2520plaques%2520in%2520the%2520transgenic%2520APPSWE%252FPSEN1dE9%2520mouse%2520model%2520of%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2012%26volume%3D71%26spage%3D2%26epage%3D14%26doi%3D10.1097%2FNEN.0b013e31823cc7a6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcón, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opazo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderón, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dajas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentry, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doctor, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mello, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer’s fibrils</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3213</span>– <span class="NLM_lpage">3223</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.18-09-03213.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1523%2FJNEUROSCI.18-09-03213.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=9547230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaK1cXivFCht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=3213-3223&author=A.+Alvarezauthor=R.+Alarc%C3%B3nauthor=C.+Opazoauthor=E.+O.+Camposauthor=F.+J.+Mu%C3%B1ozauthor=F.+H.+Calder%C3%B3nauthor=F.+Dajasauthor=M.+K.+Gentryauthor=B.+P.+Doctorauthor=F.+G.+De+Melloauthor=N.+C.+Inestrosa&title=Stable+complexes+involving+acetylcholinesterase+and+amyloid-%CE%B2+peptide+change+the+biochemical+properties+of+the+enzyme+and+increase+the+neurotoxicity+of+Alzheimer%E2%80%99s+fibrils&doi=10.1523%2FJNEUROSCI.18-09-03213.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils</span></div><div class="casAuthors">Alvarez, Alejandra; Alarcon, Rodrigo; Opazo, Carlos; Campos, Eliseo O.; Munoz, Francisco Jose; Calderon, Frances H.; Dajas, Federico; Gentry, Mary K.; Doctor, Bhupendra P.; De Mello, Fernando G.; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3213-3223</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Brain acetylcholinesterase (AChE) forms stable complexes with amyloid-β peptide (Aβ) during its assembly into filaments, in agreement with its colocalization with the Aβ deposits of Alzheimer's brain.  The assocn. of the enzyme with nascent Aβ aggregates occurs as early as after 30 min of incubation.  Anal. of the catalytic activity of the AChE incorporated into these complexes shows an anomalous behavior reminiscent of the AChE assocd. with senile plaques, which includes a resistance to low pH, high substrate concns., and lower sensitivity to AChE inhibitors.  Furthermore, the toxicity of the AChE-amyloid complexes is higher than that of the Aβ aggregates alone.  Thus, in addn. to its possible role as a heterogeneous nucleator during amyloid formation, AChE, by forming such stable complexes, may increase the neurotoxicity of Aβ fibrils and thus may det. the selective neuronal loss obsd. in Alzheimer's brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPyVIcJUubQ7Vg90H21EOLACvtfcHk0ljdpXNQ7-1a0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivFCht70%253D&md5=b8f7c8ab543fa2c30c5a7b6da15f9a5c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.18-09-03213.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.18-09-03213.1998%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DAlarc%25C3%25B3n%26aufirst%3DR.%26aulast%3DOpazo%26aufirst%3DC.%26aulast%3DCampos%26aufirst%3DE.%2BO.%26aulast%3DMu%25C3%25B1oz%26aufirst%3DF.%2BJ.%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%2BH.%26aulast%3DDajas%26aufirst%3DF.%26aulast%3DGentry%26aufirst%3DM.%2BK.%26aulast%3DDoctor%26aufirst%3DB.%2BP.%26aulast%3DDe%2BMello%26aufirst%3DF.%2BG.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DStable%2520complexes%2520involving%2520acetylcholinesterase%2520and%2520amyloid-%25CE%25B2%2520peptide%2520change%2520the%2520biochemical%2520properties%2520of%2520the%2520enzyme%2520and%2520increase%2520the%2520neurotoxicity%2520of%2520Alzheimer%25E2%2580%2599s%2520fibrils%26jtitle%3DJ.%2520Neurosci.%26date%3D1998%26volume%3D18%26spage%3D3213%26epage%3D3223%26doi%3D10.1523%2FJNEUROSCI.18-09-03213.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casanueva, O. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, J.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzyme</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">891</span>, <span class="refDoi"> DOI: 10.1016/s0896-6273(00)80108-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fs0896-6273%2800%2980108-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=8608006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaK28XislCmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=881-891&author=N.+C.+Inestrosaauthor=A.+Alvarezauthor=C.+A.+P%C3%A9rezauthor=R.+D.+Morenoauthor=M.+Vicenteauthor=C.+Linkerauthor=O.+I.+Casanuevaauthor=C.+Sotoauthor=J.+Garrido&title=Acetylcholinesterase+accelerates+assembly+of+amyloid-%CE%B2-peptides+into+Alzheimer%E2%80%99s+fibrils%3A+possible+role+of+the+peripheral+site+of+the+enzyme&doi=10.1016%2Fs0896-6273%2800%2980108-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme</span></div><div class="casAuthors">Inestrosa, Nibaldo C.; Alvarez, Alejandra; Perez, Cristian A.; Moreno, Ricardo D.; Vicente, Matias; Linker, Claudia; Casanueva, Olivia I.; Soto, Claudio; Garrido, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">881-891</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE), an important component of cholinergic synapses, colocalizes with amyloid-β peptide (Aβ) deposits of Alzheimer's brain.  The authors report here that bovine brain AChE, as well as the human and mouse recombinant enzyme, accelerates amyloid formation from wild-type Aβ and a mutant Aβ peptide, which alone produces few amyloid-like fibrils.  The action of AChE was independent of the subunit array of the enzyme, was not affected by edrophonium, an active site inhibitor, but it was affected by propidium, a peripheral anionic binding site ligand.  Butyrylcholinesterase, an enzyme that lacks the peripheral site, did not affect amyloid formation.  Furthermore, AChE is a potent amyloid-promoting factor when compared with other Aβ-assocd. proteins.  Thus, in addn. to its role in cholinergic synapses, AChE may function by accelerating Aβ formation and could play a role during amyloid deposition in Alzheimer's brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2wsrjgQa0LVg90H21EOLACvtfcHk0ljdpXNQ7-1a0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XislCmsLk%253D&md5=299031351f764e5376b98407c3dc7278</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fs0896-6273%2800%2980108-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0896-6273%252800%252980108-7%26sid%3Dliteratum%253Aachs%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%2BA.%26aulast%3DMoreno%26aufirst%3DR.%2BD.%26aulast%3DVicente%26aufirst%3DM.%26aulast%3DLinker%26aufirst%3DC.%26aulast%3DCasanueva%26aufirst%3DO.%2BI.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DJ.%26atitle%3DAcetylcholinesterase%2520accelerates%2520assembly%2520of%2520amyloid-%25CE%25B2-peptides%2520into%2520Alzheimer%25E2%2580%2599s%2520fibrils%253A%2520possible%2520role%2520of%2520the%2520peripheral%2520site%2520of%2520the%2520enzyme%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D881%26epage%3D891%26doi%3D10.1016%2Fs0896-6273%2800%2980108-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opazo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcón, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">361</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1997.1245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1006%2Fjmbi.1997.1245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=9325095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaK2sXmsV2hsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=348-361&author=A.+Alvarezauthor=C.+Opazoauthor=R.+Alarc%C3%B3nauthor=J.+Garridoauthor=N.+C.+Inestrosa&title=Acetylcholinesterase+promotes+the+aggregation+of+amyloid-%CE%B2-peptide+fragments+by+forming+a+complex+with+the+growing+fibrils&doi=10.1006%2Fjmbi.1997.1245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils</span></div><div class="casAuthors">Alvarez, Alejandra; Opazo, Carlos; Alarcon, Rodrigo; Garrido, Jorge; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">348-361</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE), an enzyme involved in the hydrolysis of the neurotransmitter acetylcholine, consistently colocalizes with the amyloid deposits characteristic of Alzheimer's disease and may contribute to the generation of amyloid proteins and/or phys. affect fibril assembly.  In order to identify the structural domains of the amyloid-β-peptide (Aβ) involved in the aggregation induced by AChE, we have studied the effect of this cholinergic enzyme on Aβ peptide fragments of different sizes.  AChE enhanced the aggregation of the aβ(12-28) and Aβ(25-35) peptides but not of the Aβ(1-16) fragment.  The inductive effect of AChE on the aggregation of aβ(12-28) was abolished by the presence of either Aβ(1-16) or Aβ(9-21).  The effect of the enzyme was also analyzed using two different mutant fragments, possessing a low and the other a high capacity for fibrillogenesis.  The fragments used were aβ(12-28)Val18 → Ala and aβ(12-28)Glu22 → Gln, resp.  AChE was able to promote the aggregation of these fragments in a very specific way and both mutant peptides were able to form amyloid fibrils, as revealed by neg. staining under the electron microscope.  Binding assays indicated that AChE was bound to aβ(12-28), as well as to the aβ(1-16) peptide.  AChE was seen to form strong complexes with the Aβ(12-28) fibrils as such complexes stained pos. for both thioflavine-T and AChE activity, were resistant to high ionic strength treatment, and were partially sensitive to detergents, suggesting that hydrophobic interactions may play a role in the stabilization of the AChE-Aβ complex.  Our results suggest that such amyloid-AChE complexes are formed when AChE interacts with the growing amyloid fibrils and accelerates the assembly of Aβ peptides.  This is consistent with the fact that AChE is known to be present within Aβ deposits including the pre-amyloid diffuse and mature senile plaques found in Alzheimer's brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3xL4mECGtNLVg90H21EOLACvtfcHk0ljdpXNQ7-1a0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsV2hsrY%253D&md5=077906f315786101593f092294b360db</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1997.1245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1997.1245%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DOpazo%26aufirst%3DC.%26aulast%3DAlarc%25C3%25B3n%26aufirst%3DR.%26aulast%3DGarrido%26aufirst%3DJ.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DAcetylcholinesterase%2520promotes%2520the%2520aggregation%2520of%2520amyloid-%25CE%25B2-peptide%2520fragments%2520by%2520forming%2520a%2520complex%2520with%2520the%2520growing%2520fibrils%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D272%26spage%3D348%26epage%3D361%26doi%3D10.1006%2Fjmbi.1997.1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenblatt, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase: a multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer’s disease</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1385/JMN:20:3:369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1385%2FJMN%3A20%3A3%3A369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=14501022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslGrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2003&pages=369-383&author=H.+M.+Greenblattauthor=H.+Dvirauthor=I.+Silmanauthor=J.+L.+Sussman&title=Acetylcholinesterase%3A+a+multifaceted+target+for+structure-based+drug+design+of+anticholinesterase+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1385%2FJMN%3A20%3A3%3A369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase. A multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Greenblatt, Harry M.; Dvir, Hay; Silman, Israel; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-383</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  The structure of Torpedo californica acetylcholinesterase is examd. in complex with several inhibitors that are either in use or under development for treating Alzheimer's disease.  The noncovalent inhibitors vary greatly in their structures and bind to different sites of the enzyme, offering many different starting points for future drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp-6D7x0EvC7Vg90H21EOLACvtfcHk0lj3evsKCGZ3xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslGrsbo%253D&md5=d4411e2a8031e7da6d057d54f58a9861</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1385%2FJMN%3A20%3A3%3A369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FJMN%253A20%253A3%253A369%26sid%3Dliteratum%253Aachs%26aulast%3DGreenblatt%26aufirst%3DH.%2BM.%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholinesterase%253A%2520a%2520multifaceted%2520target%2520for%2520structure-based%2520drug%2520design%2520of%2520anticholinesterase%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2003%26volume%3D20%26spage%3D369%26epage%3D383%26doi%3D10.1385%2FJMN%3A20%3A3%3A369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greig, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utsuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingram, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepeu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamczarz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambamurti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahiri, D. K.</span></span> <span> </span><span class="NLM_article-title">Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">17213</span>– <span class="NLM_lpage">17218</span>, <span class="refDoi"> DOI: 10.1073/pnas.0508575102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1073%2Fpnas.0508575102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=16275899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yksLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=17213-17218&author=N.+H.+Greigauthor=T.+Utsukiauthor=D.+K.+Ingramauthor=Y.+Wangauthor=G.+Pepeuauthor=C.+Scaliauthor=Q.+S.+Yuauthor=J.+Mamczarzauthor=H.+W.+Hollowayauthor=T.+Giordanoauthor=D.+Chenauthor=K.+Furukawaauthor=K.+Sambamurtiauthor=A.+Brossiauthor=D.+K.+Lahiri&title=Selective+butyrylcholinesterase+inhibition+elevates+brain+acetylcholine%2C+augments+learning+and+lowers+Alzheimer+beta-amyloid+peptide+in+rodent&doi=10.1073%2Fpnas.0508575102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent</span></div><div class="casAuthors">Greig, Nigel H.; Utsuki, Tadanobu; Ingram, Donald K.; Wang, Yue; Pepeu, Giancarlo; Scali, Carla; Yu, Qian-Sheng; Mamczarz, Jacek; Holloway, Harold W.; Giordano, Tony; Chen, DeMao; Furukawa, Katsutoshi; Sambamurti, Kumar; Brossi, Arnold; Lahiri, Debomoy K.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">17213-17218</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Like acetylcholinesterase, butyrylcholinesterase (BChE) inactivates the neurotransmitter acetylcholine (ACh) and is hence a viable therapeutic target in Alzheimer's disease, which is characterized by a cholinergic deficit.  Potent, reversible, and brain-targeted BChE inhibitors (cymserine analogs) were developed based on binding domain structures to help elucidate the role of this enzyme in the central nervous system.  In rats, cymserine analogs caused long-term inhibition of brain BChE and elevated extracellular ACh levels, without inhibitory effects on acetylcholinesterase.  In rat brain slices, selective BChE inhibition augmented long-term potentiation.  These compds. also improved the cognitive performance (maze navigation) of aged rats.  In cultured human SK-N-SH neuroblastoma cells, intra- and extracellular β-amyloid precursor protein, and secreted β-amyloid peptide levels were reduced without affecting cell viability.  Treatment of transgenic mice that overexpressed human mutant amyloid precursor protein also resulted in lower β-amyloid peptide brain levels than controls.  Selective, reversible inhibition of brain BChE may represent a treatment for Alzheimer's disease, improving cognition and modulating neuropathol. markers of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI6ACIUUc5wrVg90H21EOLACvtfcHk0lj3evsKCGZ3xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yksLfE&md5=a4ac89f6186f77125545c667f9efbe21</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0508575102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0508575102%26sid%3Dliteratum%253Aachs%26aulast%3DGreig%26aufirst%3DN.%2BH.%26aulast%3DUtsuki%26aufirst%3DT.%26aulast%3DIngram%26aufirst%3DD.%2BK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPepeu%26aufirst%3DG.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DQ.%2BS.%26aulast%3DMamczarz%26aufirst%3DJ.%26aulast%3DHolloway%26aufirst%3DH.%2BW.%26aulast%3DGiordano%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DSambamurti%26aufirst%3DK.%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DLahiri%26aufirst%3DD.%2BK.%26atitle%3DSelective%2520butyrylcholinesterase%2520inhibition%2520elevates%2520brain%2520acetylcholine%252C%2520augments%2520learning%2520and%2520lowers%2520Alzheimer%2520beta-amyloid%2520peptide%2520in%2520rodent%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D17213%26epage%3D17218%26doi%3D10.1073%2Fpnas.0508575102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">Discovery and biological evaluation of a novel highly potent selective butyrylcholinsterase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">10030</span>– <span class="NLM_lpage">10044</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c01129</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c01129" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVGnsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=10030-10044&author=Q.+Liauthor=S.+Xingauthor=Y.+Chenauthor=Q.+Liaoauthor=B.+Xiongauthor=S.+Heauthor=W.+Luauthor=Y.+Liuauthor=H.+Yangauthor=Q.+Liauthor=F.+Fengauthor=W.+Liuauthor=Y.+Chenauthor=H.+Sun&title=Discovery+and+biological+evaluation+of+a+novel+highly+potent+selective+butyrylcholinsterase+inhibitor&doi=10.1021%2Facs.jmedchem.0c01129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor</span></div><div class="casAuthors">Li, Qi; Xing, Shuaishuai; Chen, Ying; Liao, Qinghong; Xiong, Baichen; He, Siyu; Lu, Weixuan; Liu, Yang; Yang, Hongyu; Li, Qihang; Feng, Feng; Liu, Wenyuan; Chen, Yao; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">10030-10044</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To discover novel BChE inhibitors, a hierarchical virtual screening protocol followed by biochem. evaluation was applied.  The most potent compd. 8012-9656(I) (eqBChE IC50 = 0.18 ± 0.03 μM, hBChE IC50 = 0.32 ± 0.07 μM) was purchased and synthesized.  It inhibited BChE in a noncompetitive manner and could occupy the binding pocket forming diverse interactions with the target. 8012-9656 was proven to be safe in vivo and in vitro and showed comparable performance in ameliorating the scopolamine-induced cognition impairment to tacrine.  Addnl., treatment with 8012-9656 could almost entirely recover the Aβ1-42 (icv)-impaired cognitive function to the normal level and showed better behavioral performance than donepezil.  The evaluation of the Aβ1-42 total amt. confirmed its anti-amyloidogenic profile.  Moreover, 8012-9656 possessed blood-brain barrier (BBB) penetrating ability, a long T1/2, and low intrinsic clearance.  Hence, the novel potential BChE inhibitor 8012-9656 can be considered as a promising lead compd. for further investigation of anti-AD agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr1Sklwfx9urVg90H21EOLACvtfcHk0lj3evsKCGZ3xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVGnsL%252FI&md5=d09b6e8200bf781d64794897360f74dc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c01129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c01129%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DXing%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DDiscovery%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520highly%2520potent%2520selective%2520butyrylcholinsterase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D10030%26epage%3D10044%26doi%3D10.1021%2Facs.jmedchem.0c01129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Košak, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pišlar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coquelle, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletier, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8167</span>– <span class="NLM_lpage">8179</span>, <span class="refDoi"> DOI: 10.1021/jm501195e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501195e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKnsrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8167-8179&author=B.+Brusauthor=U.+Ko%C5%A1akauthor=S.+Turkauthor=A.+Pi%C5%A1larauthor=N.+Coquelleauthor=J.+Kosauthor=J.+Stojanauthor=J.-P.+Colletierauthor=S.+Gobec&title=Discovery%2C+biological+evaluation%2C+and+crystal+structure+of+a+novel+nanomolar+selective+butyrylcholinesterase+inhibitor&doi=10.1021%2Fjm501195e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor</span></div><div class="casAuthors">Brus, Boris; Kosak, Urban; Turk, Samo; Pislar, Anja; Coquelle, Nicolas; Kos, Janko; Stojan, Jure; Colletier, Jacques-Philippe; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8167-8179</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Butyrylcholinesterase (BChE) is regarded as a promising drug target as its levels and activity significantly increase in the late stages of Alzheimer's disease.  To discover novel BChE inhibitors, the authors used a hierarchical virtual screening protocol followed by biochem. evaluation of 40 highest scoring hit compds.  Three of the compds. identified showed significant inhibitory activities against BChE.  The most potent, compd. I (IC50 = 21.3 nM), was resynthesized and resolved into its pure enantiomers.  A high degree of stereoselective activity was revealed, and a dissocn. const. of 2.7 nM was detd. for the most potent stereoisomer (+)-I.  The crystal structure of human BChE in complex with compd. (+)-I was solved, revealing the binding mode and providing clues for potential optimization.  Addnl., compd. I inhibited amyloid β1-42 peptide self-induced aggregation into fibrils (by 61.7% at 10 μM) and protected cultured SH-SY5Y cells against amyloid-β-induced toxicity.  These data suggest that compd. 1 represents a promising candidate for hit-to-lead follow-up in the drug-discovery process against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKkU3pmuNPfrVg90H21EOLACvtfcHk0lhERAbIdwnofQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKnsrjM&md5=2d21e5e601e2e8793058c1c34360a82b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm501195e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501195e%26sid%3Dliteratum%253Aachs%26aulast%3DBrus%26aufirst%3DB.%26aulast%3DKo%25C5%25A1ak%26aufirst%3DU.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DPi%25C5%25A1lar%26aufirst%3DA.%26aulast%3DCoquelle%26aufirst%3DN.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DStojan%26aufirst%3DJ.%26aulast%3DColletier%26aufirst%3DJ.-P.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DDiscovery%252C%2520biological%2520evaluation%252C%2520and%2520crystal%2520structure%2520of%2520a%2520novel%2520nanomolar%2520selective%2520butyrylcholinesterase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8167%26epage%3D8179%26doi%3D10.1021%2Fjm501195e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coquelle, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosič, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brazzolotto, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mravljak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletier, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4442</span>– <span class="NLM_lpage">4452</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bmc.2015.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=26116179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVeiur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=4442-4452&author=D.+Knezauthor=B.+Brusauthor=N.+Coquelleauthor=I.+Sosi%C4%8Dauthor=R.+%C5%A0inkauthor=X.+Brazzolottoauthor=J.+Mravljakauthor=J.+P.+Colletierauthor=S.+Gobec&title=Structure-based+development+of+nitroxoline+derivatives+as+potential+multifunctional+anti-Alzheimer+agents&doi=10.1016%2Fj.bmc.2015.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents</span></div><div class="casAuthors">Knez, Damijan; Brus, Boris; Coquelle, Nicolas; Sosic, Izidor; Sink, Roman; Brazzolotto, Xavier; Mravljak, Janez; Colletier, Jacques-Philippe; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4442-4452</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tremendous efforts have been dedicated to the development of effective therapeutics against Alzheimer's disease, which represents the most common debilitating neurodegenerative disease.  Multifunctional agents are mols. designed to have simultaneous effects on different pathol. processes.  Such compds. represent an emerging strategy for the development of effective treatments against Alzheimer's disease.  Here, we report on the synthesis and biol. evaluation of a series of nitroxoline-based analogs that were designed by merging the scaffold of 8-hydroxyquinoline with that of a known selective butyrylcholinesterase inhibitor that has promising anti-Alzheimer properties.  Most strikingly, compd.(I) inhibits self-induced aggregation of the amyloid beta peptide (Aβ1-42), inhibits with sub-micromolar potency butyrylcholinesterase (IC50 = 215 nM), and also selectively complexes Cu2+.  Our study thus designates this compd. as a promising multifunctional agent for therapeutic treatment of Alzheimer's disease.  The crystal structure of human butyrylcholinesterase in complex with compd. I is also solved, which suggests ways to further optimize compds. featuring the 8-hydroxyquinoline scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3E6NDidmZlbVg90H21EOLACvtfcHk0lhERAbIdwnofQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVeiur3J&md5=caf59141911f78984fc859674a88c6a6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DKnez%26aufirst%3DD.%26aulast%3DBrus%26aufirst%3DB.%26aulast%3DCoquelle%26aufirst%3DN.%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3D%25C5%25A0ink%26aufirst%3DR.%26aulast%3DBrazzolotto%26aufirst%3DX.%26aulast%3DMravljak%26aufirst%3DJ.%26aulast%3DColletier%26aufirst%3DJ.%2BP.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DStructure-based%2520development%2520of%2520nitroxoline%2520derivatives%2520as%2520potential%2520multifunctional%2520anti-Alzheimer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D4442%26epage%3D4452%26doi%3D10.1016%2Fj.bmc.2015.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Bachiller, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span> <span> </span><span class="NLM_article-title">New tacrine–4-oxo-4<i>H</i>-chromene hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with cholinergic, antioxidant, and β-amyloid-reducing properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1303</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1021/jm201460y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201460y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1303-1317&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=L.+Monjasauthor=J.+Rademannauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+tacrine%E2%80%934-oxo-4H-chromene+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+%CE%B2-amyloid-reducing+properties&doi=10.1021%2Fjm201460y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">New Tacrine-4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties</span></div><div class="casAuthors">Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Monjas, Leticia; Rademann, Jorg; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1303-1317</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By using fragments endowed with interesting and complementary properties for the treatment of Alzheimer's disease (AD), a new family of tacrine-4-oxo-4H-chromene hybrids has been designed, synthesized, and evaluated biol.  The tacrine fragment was selected for its inhibition of cholinesterases, and the flavonoid scaffold derived from 4-oxo-4H -chromene was chosen for its radical capture and β-secretase 1 (BACE-1) inhibitory activities.  At nano- and picomolar concns., the new tacrine-4-oxo-4H-chromene hybrids inhibit human acetyl- and butyrylcholinesterase (h-AChE and h-BuChE), being more potent than the parent inhibitor, tacrine.  They are also potent inhibitors of human BACE-1, better than the parent flavonoid, apigenin.  They show interesting antioxidant properties and could be able to penetrate into the CNS according to the in vitro PAMPA-BBB assay.  Among the hybrids investigated, 6-hydroxy-4-oxo- N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}-4 H-chromene-2-carboxamide (I) shows potent combined inhibition of human BACE-1 and ChEs, as well as good antioxidant and CNS-permeable properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiMx-NagCpeLVg90H21EOLACvtfcHk0lhERAbIdwnofQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFKisw%253D%253D&md5=9391af9439e43f5eda518919839bd473</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201460y%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520tacrine%25E2%2580%25934-oxo-4H-chromene%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520%25CE%25B2-amyloid-reducing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1303%26epage%3D1317%26doi%3D10.1021%2Fjm201460y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Bachiller, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Páez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Muñoz, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usán, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Palomero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarroya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span> <span> </span><span class="NLM_article-title">Tacrine-melatonin hybrids as multifunctional agents for Alzheimer’s disease, with cholinergic, antioxidant, and neuroprotective properties</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200800414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fcmdc.200800414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=19308922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Kgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=828-841&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=N.+E.+Campilloauthor=J.+A.+P%C3%A1ezauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=P.+Us%C3%A1nauthor=E.+Garc%C3%ADa-Palomeroauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=A.+G.+Garc%C3%ADaauthor=A.+Mart%C3%ADnezauthor=M.+I.+Rodr%C3%ADguez-Franco&title=Tacrine-melatonin+hybrids+as+multifunctional+agents+for+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+neuroprotective+properties&doi=10.1002%2Fcmdc.200800414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties</span></div><div class="casAuthors">Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Campillo, Nuria Eugenia; Paez, Juan Antonio; Gonzalez-Munoz, Gema Cristina; Usan, Paola; Garcia-Palomero, Esther; Lopez, Manuela G.; Villarroya, Mercedes; Garcia, Antonio G.; Martinez, Ana; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">828-841</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Tacrine-melatonin hybrids are potential multifunctional drugs for Alzheimer's disease that may simultaneously palliate intellectual deficits and protect the brain against both β-amyloid peptide and oxidative stress.  Mol. modeling studies show that they target both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE.  They are nontoxic and may be able to penetrate the CNS, according to in vitro PAMPA-BBB assays.  Tacrine-melatonin hybrids were designed and synthesized as new multifunctional drug candidates for Alzheimer's disease.  These compds. may simultaneously palliate intellectual deficits and protect the brain against both β-amyloid (Aβ) peptide and oxidative stress.  They show improved cholinergic and antioxidant properties, and are more potent and selective inhibitors of human acetylcholinesterase (hAChE) than tacrine.  They also capture free radicals better than melatonin.  Mol. modeling studies show that these hybrids target both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE.  At sub-micromolar concns. they efficiently displace the binding of propidium iodide from the PAS and could thus inhibit Aβ peptide aggregation promoted by AChE.  Moreover, they also inhibit Aβ self-aggregation and display neuroprotective properties in a human neuroblastoma line against cell death induced by various toxic insults, such as Aβ25-35, H2O2, and rotenone.  Finally, they exhibit low toxicity and may be able to penetrate the central nervous system according to an in vitro parallel artificial membrane permeability assay for the blood-brain barrier (PAMPA-BBB).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf8mEFq1tgJ7Vg90H21EOLACvtfcHk0liOo8QlZhluPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Kgt7g%253D&md5=67c7f37e4d3ec3b28387d1b2d19abbbd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800414%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DP%25C3%25A1ez%26aufirst%3DJ.%2BA.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DTacrine-melatonin%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520neuroprotective%2520properties%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D828%26epage%3D841%26doi%3D10.1002%2Fcmdc.200800414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trovaslet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer’s drugs targeting acetyl- and butyryl-cholinesterase</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>453</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1042/BJ20130013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1042%2FBJ20130013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=23679855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2it7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2013&pages=393-399&author=F.+Nachonauthor=E.+Carlettiauthor=C.+Roncoauthor=M.+Trovasletauthor=Y.+Nicoletauthor=L.+Jeanauthor=P.-Y.+Renard&title=Crystal+structures+of+human+cholinesterases+in+complex+with+huprine+W+and+tacrine%3A+elements+of+specificity+for+anti-Alzheimer%E2%80%99s+drugs+targeting+acetyl-+and+butyryl-cholinesterase&doi=10.1042%2FBJ20130013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase</span></div><div class="casAuthors">Nachon, Florian; Carletti, Eugenie; Ronco, Cyril; Trovaslet, Marie; Nicolet, Yvain; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">453</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-399</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The multifunctional nature of Alzheimer's disease calls for MTDLs (multitarget-directed ligands) to act on different components of the pathol., like the cholinergic dysfunction and amyloid aggregation.  Such MTDLs are usually on the basis of cholinesterase inhibitors (e.g. tacrine or huprine) coupled with another active mol. aimed at a different target.  To aid in the design of these MTDLs, the authors report the crystal structures of hAChE (human acetylcholinesterase) in complex with FAS-2 (fasciculin 2) and a hydroxylated deriv. of huprine (huprine W), and of hBChE (human butyrylcholinesterase) in complex with tacrine.  Huprine W in hAChE and tacrine in hBChE reside in strikingly similar positions highlighting the conservation of key interactions, namely, π-π/cation-π interactions with Trp86 (Trp82), and hydrogen bonding with the main chain carbonyl of the catalytic histidine residue.  Huprine W forms addnl. interactions with hAChE, which explains its superior affinity: the isoquinoline moiety is assocd. with a group of arom. residues (Tyr337, Phe338 and Phe295 not present in hBChE) in addn. to Trp86; the hydroxyl group is hydrogen bonded to both the catalytic serine residue and residues in the oxyanion hole; and the chlorine substituent is nested in a hydrophobic pocket interacting strongly with Trp439.  There is no pocket in hBChE that is able to accommodate the chlorine substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovCptRaIZE_rVg90H21EOLACvtfcHk0liOo8QlZhluPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2it7fM&md5=a36d3b1007c83c59c639a08f17d26bb7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1042%2FBJ20130013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20130013%26sid%3Dliteratum%253Aachs%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DCarletti%26aufirst%3DE.%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DTrovaslet%26aufirst%3DM.%26aulast%3DNicolet%26aufirst%3DY.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DCrystal%2520structures%2520of%2520human%2520cholinesterases%2520in%2520complex%2520with%2520huprine%2520W%2520and%2520tacrine%253A%2520elements%2520of%2520specificity%2520for%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%2520targeting%2520acetyl-%2520and%2520butyryl-cholinesterase%26jtitle%3DBiochem.%2520J.%26date%3D2013%26volume%3D453%26spage%3D393%26epage%3D399%26doi%3D10.1042%2FBJ20130013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recanatini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0liOo8QlZhluPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mesiti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">The chemistry toolbox of multitarget-directed ligands for Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">111572</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.ejmech.2019.111572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31404859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyjsrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2019&pages=111572&author=F.+Mesitiauthor=D.+Chavarriaauthor=A.+Gasparauthor=S.+Alcaroauthor=F.+Borges&title=The+chemistry+toolbox+of+multitarget-directed+ligands+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.111572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease</span></div><div class="casAuthors">Mesiti, Francesco; Chavarria, Daniel; Gaspar, Alexandra; Alcaro, Stefano; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111572</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  The discovery and development of multitarget-directed ligands (MTDLs) is a promising strategy to find new therapeutic solns. for neurodegenerative diseases (NDs), in particular for Alzheimer's disease (AD).  Currently approved drugs for the clin. management of AD are based on a single-target strategy and focus on restoring neurotransmitter homeostasis.  Finding disease-modifying therapies AD and other NDs remains an urgent unmet clin. need.  The growing consensus that AD is a multifactorial disease, with several interconnected and deregulated pathol. pathways, boosted an intensive research in the design of MTDLs.  Due to this scientific boom, the knowledge behind the development of MTDLs remains diffuse and lacks balanced guidelines.  To rationalize the large amt. of data obtained in this field, the authors herein revise the progress made over the last 5 years on the development of MTDLs inspired by drugs approved for AD.  Due to their putative therapeutic benefit in AD, MTDLs based on MAO-B inhibitors will also be discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGret0oXDxuClLVg90H21EOLACvtfcHk0li38rbfhgGZZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyjsrvE&md5=e2703287dc0dbdc2be5ea7b5e9e9fee1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111572%26sid%3Dliteratum%253Aachs%26aulast%3DMesiti%26aufirst%3DF.%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DThe%2520chemistry%2520toolbox%2520of%2520multitarget-directed%2520ligands%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D181%26spage%3D111572%26doi%3D10.1016%2Fj.ejmech.2019.111572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.02.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.ejmech.2019.02.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=30884327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltFGhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2019&pages=200-223&author=T.+Wangauthor=X.+Liuauthor=J.+Guanauthor=S.+Geauthor=M.-B.+Wuauthor=J.+Linauthor=L.+Yang&title=Advancement+of+multi-target+drug+discoveries+and+promising+applications+in+the+field+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.02.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease</span></div><div class="casAuthors">Wang, Tao; Liu, Xiao-huan; Guan, Jing; Ge, Shun; Wu, Mian-Bin; Lin, Jian-ping; Yang, Li-rong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">200-223</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Complex diseases (e.g., Alzheimer's disease) or infectious diseases are usually caused by complicated and varied factors, including environmental and genetic factors.  Multi-target (polypharmacol.) drugs have been suggested and have emerged as powerful and promising alternative paradigms in modern medicinal chem. for the development of versatile chemotherapeutic agents to solve these medical challenges.  The multifunctional agents capable of modulating multiple biol. targets simultaneously display great advantages of higher efficacy, improved safety profile, and simpler administration compared to single-targeted agents.  Therefore, multifunctional agents would certainly open novel avenues to rationally design the next generation of more effective but less toxic therapeutic agents.  Herein, the authors review the recent progress made in the discovery and design processes of selective multi-targeted agents, esp. the successful application of multi-target drugs for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraLSyazoHkBbVg90H21EOLACvtfcHk0li38rbfhgGZZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltFGhs7g%253D&md5=11e82288f25c5b2421184be0c568f9f8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.02.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.02.076%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DM.-B.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DAdvancement%2520of%2520multi-target%2520drug%2520discoveries%2520and%2520promising%2520applications%2520in%2520the%2520field%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D169%26spage%3D200%26epage%3D223%26doi%3D10.1016%2Fj.ejmech.2019.02.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gontijo, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viegas, F. P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, C. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Freitas Silva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damasio, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couto, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranches Dias, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viegas, C.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.2174/1385272823666191021124443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.2174%2F1385272823666191021124443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31631821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVyiurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2020&pages=348-407&author=V.+S.+Gontijoauthor=F.+P.+D.+Viegasauthor=C.+J.+C.+Ortizauthor=M.+de+Freitas+Silvaauthor=C.+M.+Damasioauthor=M.+C.+Rosaauthor=T.+G.+Camposauthor=D.+S.+Coutoauthor=K.+S.+Tranches+Diasauthor=C.+Viegas&title=Molecular+hybridization+as+a+tool+in+the+design+of+multi-target+directed+drug+candidates+for+neurodegenerative+diseases&doi=10.2174%2F1385272823666191021124443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases</span></div><div class="casAuthors">Gontijo, Vanessa Silva; Dias Viegas, Flavia P.; Cristancho Ortiz, Cindy Juliet; de Freitas Silva, Matheus; Damasio, Caio Miranda; Rosa, Mayara Chagas; Campos, Thamara Gaspar; Couto, Dyecika Souza; Tranches Dias, Kris Simone; Viegas, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">348-407</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative Diseases (NDs) are progressive multifactorial neurol. pathologies related to neuronal impairment and functional loss from different brain regions.  Currently, no effective treatments are available for any NDs, and this lack of efficacy has been attributed to the multitude of interconnected factors involved in their pathophysiol.  In the last two decades, a new approach for the rational design of new drug candidates, also called multitarget-directed ligands (MTDLs) strategy, has emerged and has been used in the design and for the development of a variety of hybrid compds. capable to act simultaneously in diverse biol. targets.  Based on the polypharmacol. concept, this new paradigm has been thought as a more secure and effective way for modulating concomitantly two or more biochem. pathways responsible for the onset and progress of NDs, trying to overcome low therapeutical effectiveness.  As a complement to our previous review article (Curr. Med. Chem. 2007, 14 (17), 1829-1852. https://doi.org/10.2174/092986707781058805), herein we aimed to cover the period from 2008 to 2019 and highlight the most recent advances of the exploitation of Mol. Hybridization (MH) as a tool in the rational design of innovative multifunctional drug candidate prototypes for the treatment of NDs, specially focused on AD, PD, HD and ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMj4ASlxgG-LVg90H21EOLACvtfcHk0li38rbfhgGZZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVyiurfI&md5=82ca2f766a86b5329719aa4ae2bb1d6c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1385272823666191021124443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1385272823666191021124443%26sid%3Dliteratum%253Aachs%26aulast%3DGontijo%26aufirst%3DV.%2BS.%26aulast%3DViegas%26aufirst%3DF.%2BP.%2BD.%26aulast%3DOrtiz%26aufirst%3DC.%2BJ.%2BC.%26aulast%3Dde%2BFreitas%2BSilva%26aufirst%3DM.%26aulast%3DDamasio%26aufirst%3DC.%2BM.%26aulast%3DRosa%26aufirst%3DM.%2BC.%26aulast%3DCampos%26aufirst%3DT.%2BG.%26aulast%3DCouto%26aufirst%3DD.%2BS.%26aulast%3DTranches%2BDias%26aufirst%3DK.%2BS.%26aulast%3DViegas%26aufirst%3DC.%26atitle%3DMolecular%2520hybridization%2520as%2520a%2520tool%2520in%2520the%2520design%2520of%2520multi-target%2520directed%2520drug%2520candidates%2520for%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2020%26volume%3D18%26spage%3D348%26epage%3D407%26doi%3D10.2174%2F1385272823666191021124443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabr, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span> <span> </span><span class="NLM_article-title">MicroRNA-based multitarget approach for Alzheimer’s disease: Discovery of the first-in-class dual inhibitor of acetylcholinesterase and MicroRNA-15b biogenesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">9695</span>– <span class="NLM_lpage">9704</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00756</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00756" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVOrs7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=9695-9704&author=M.+T.+Gabrauthor=S.+Brogi&title=MicroRNA-based+multitarget+approach+for+Alzheimer%E2%80%99s+disease%3A+Discovery+of+the+first-in-class+dual+inhibitor+of+acetylcholinesterase+and+MicroRNA-15b+biogenesis&doi=10.1021%2Facs.jmedchem.0c00756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">MicroRNA-Based Multitarget Approach for Alzheimer's Disease: Discovery of the First-In-Class Dual Inhibitor of Acetylcholinesterase and MicroRNA-15b Biogenesis</span></div><div class="casAuthors">Gabr, Moustafa T.; Brogi, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9695-9704</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multitarget approach in drug design is a powerful strategy in tackling the multifactorial nature of Alzheimer's disease (AD).  Herein, we report a novel strategy in the design of multitargeted therapeutics for AD through dual inhibition of acetylcholinesterase (AChE) and microRNA-15b biogenesis.  We performed high-throughput screening (HTS) of a chem. library to identify binders of mircoRNA-15b which is identified as a biomarker and potential therapeutic target of AD.  The hits from HTS were further screened for their AChE inhibitory activity, the most widely investigated target for the development of AD therapeutics.  MG-6267(I) was identified as the first dual inhibitor of AChE and microRNA-15b biogenesis.  Cellular assays revealed the superiority of MG-6267 to single-targeted inhibitors of AChE and microRNA-15b in protecting SH-SY5Y neuroblastoma cells from amyloid-beta (Aβ)-induced cytotoxicity.  This work paves the way for future research efforts aiming at the development of microRNA-based multitargeted therapeutics for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpojUJB-mCFlbVg90H21EOLACvtfcHk0liJJvIEkoZoLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVOrs7vN&md5=19937c89c04fe79adb177076f6bab7c3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00756%26sid%3Dliteratum%253Aachs%26aulast%3DGabr%26aufirst%3DM.%2BT.%26aulast%3DBrogi%26aufirst%3DS.%26atitle%3DMicroRNA-based%2520multitarget%2520approach%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Discovery%2520of%2520the%2520first-in-class%2520dual%2520inhibitor%2520of%2520acetylcholinesterase%2520and%2520MicroRNA-15b%2520biogenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D9695%26epage%3D9704%26doi%3D10.1021%2Facs.jmedchem.0c00756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arribas, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino-Antolin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demougeot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobrlova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez-Iriepa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godyń, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gł̷uch-Lutwin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordyl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siwek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabchoub, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiec-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de los Ríos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span> <span> </span><span class="NLM_article-title">New dual small molecules for Alzheimer’s disease therapy combining histamine H<sub>3</sub> receptor (H3R) antagonism and calcium channels blockade with additional cholinesterase inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">11416</span>– <span class="NLM_lpage">11422</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00937</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFKksLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=11416-11422&author=R.+Malekauthor=R.+L.+Arribasauthor=A.+Palomino-Antolinauthor=P.+Totosonauthor=C.+Demougeotauthor=T.+Kobrlovaauthor=O.+Soukupauthor=I.+Iriepaauthor=I.+Moraledaauthor=D.+Diez-Iriepaauthor=J.+Gody%C5%84author=D.+Panekauthor=B.+Malawskaauthor=M.+G%C5%82%CC%B7uch-Lutwinauthor=B.+Mordylauthor=A.+Siwekauthor=F.+Chabchoubauthor=J.+Marco-Contellesauthor=K.+Kiec-Kononowiczauthor=J.+Egeaauthor=C.+de+los+R%C3%ADosauthor=L.+Ismaili&title=New+dual+small+molecules+for+Alzheimer%E2%80%99s+disease+therapy+combining+histamine+H3+receptor+%28H3R%29+antagonism+and+calcium+channels+blockade+with+additional+cholinesterase+inhibition&doi=10.1021%2Facs.jmedchem.9b00937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition</span></div><div class="casAuthors">Malek, Rim; Arribas, Raquel L.; Palomino-Antolin, Alejandra; Totoson, Perle; Demougeot, Celine; Kobrlova, Tereza; Soukup, Ondrej; Iriepa, Isabel; Moraleda, Ignacio; Diez-Iriepa, Daniel; Godyn, Justyna; Panek, Dawid; Malawska, Barbara; Gluch-Lutwin, Monika; Mordyl, Barbara; Siwek, Agata; Chabchoub, Fakher; Marco-Contelles, Jose; Kiec-Kononowicz, Katarzyna; Egea, Javier; de los Rios, Cristobal; Ismaili, Lhassane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11416-11422</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New tritarget small mols. combining Ca2+ channels blockade, cholinesterase, and H3 receptor inhibition were obtained by multicomponent synthesis.  Compd. 3p has been identified as a very promising lead, showing good Ca2+ channels blockade activity (IC50 = 21 ± 1 μM), potent affinity against hH3R (Ki = 565 ± 62 nM), a moderate but selective hBuChE inhibition (IC50 = 7.83 ± 0.10 μM), strong antioxidant power (3.6 TE), and ability to restore cognitive impairment induced by lipopolysaccharide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvTNg2ULN-ZrVg90H21EOLACvtfcHk0liJJvIEkoZoLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFKksLjL&md5=ba17509f9a9fc77e5e7183842c5dfe3f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00937%26sid%3Dliteratum%253Aachs%26aulast%3DMalek%26aufirst%3DR.%26aulast%3DArribas%26aufirst%3DR.%2BL.%26aulast%3DPalomino-Antolin%26aufirst%3DA.%26aulast%3DTotoson%26aufirst%3DP.%26aulast%3DDemougeot%26aufirst%3DC.%26aulast%3DKobrlova%26aufirst%3DT.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DDiez-Iriepa%26aufirst%3DD.%26aulast%3DGody%25C5%2584%26aufirst%3DJ.%26aulast%3DPanek%26aufirst%3DD.%26aulast%3DMalawska%26aufirst%3DB.%26aulast%3DG%25C5%2582%25CC%25B7uch-Lutwin%26aufirst%3DM.%26aulast%3DMordyl%26aufirst%3DB.%26aulast%3DSiwek%26aufirst%3DA.%26aulast%3DChabchoub%26aufirst%3DF.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DKiec-Kononowicz%26aufirst%3DK.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DC.%26aulast%3DIsmaili%26aufirst%3DL.%26atitle%3DNew%2520dual%2520small%2520molecules%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%2520combining%2520histamine%2520H3%2520receptor%2520%2528H3R%2529%2520antagonism%2520and%2520calcium%2520channels%2520blockade%2520with%2520additional%2520cholinesterase%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D11416%26epage%3D11422%26doi%3D10.1021%2Facs.jmedchem.9b00937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheiner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falkeis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Dual-acting cholinesterase–human cannabinoid receptor 2 ligands show pronounced neuroprotection in vitro and overadditive and disease-modifying neuroprotective effects in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9078</span>– <span class="NLM_lpage">9102</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9078-9102&author=M.+Scheinerauthor=D.+Dollesauthor=S.+Guneschauthor=M.+Hoffmannauthor=M.+Nabissiauthor=O.+Marinelliauthor=M.+Naldiauthor=M.+Bartoliniauthor=S.+Petrallaauthor=E.+Poetaauthor=B.+Montiauthor=C.+Falkeisauthor=M.+Viethauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=R.+Maitraauthor=T.+Mauriceauthor=M.+Decker&title=Dual-acting+cholinesterase%E2%80%93human+cannabinoid+receptor+2+ligands+show+pronounced+neuroprotection+in+vitro+and+overadditive+and+disease-modifying+neuroprotective+effects+in+vivo&doi=10.1021%2Facs.jmedchem.9b00623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo</span></div><div class="casAuthors">Scheiner, Matthias; Dolles, Dominik; Gunesch, Sandra; Hoffmann, Matthias; Nabissi, Massimo; Marinelli, Oliviero; Naldi, Marina; Bartolini, Manuela; Petralla, Sabrina; Poeta, Eleonora; Monti, Barbara; Falkeis, Christina; Vieth, Michael; Huebner, Harald; Gmeiner, Peter; Maitra, Rangan; Maurice, Tangui; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9078-9102</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed and synthesized a series of 14 hybrid mols. out of the cholinesterase (ChE) inhibitor tacrine and a benzimidazole-based human cannabinoid receptor subtype 2 (hCB2R) agonist and investigated them in vitro and in vivo.  The compds. are potent ChE inhibitors, and for the most promising hybrids, the mechanism of human acetylcholinesterase (hAChE) inhibition as well as their ability to interfere with AChE-induced aggregation of β-amyloid (Aβ), and Aβ self-aggregation was assessed.  All hybrids were evaluated for affinity and selectivity for hCB1R and hCB2R.  To ensure that the hybrids retained their agonist character, the expression of cAMP-regulated genes was quantified, and potency and efficacy were detd.  Addnl., the effects of the hybrids on microglia activation and neuroprotection on HT-22 cells were investigated.  The most promising in vitro hybrids showed pronounced neuroprotection in an Alzheimer's mouse model at low dosage (0.1 mg/kg, i.p.), lacking hepatotoxicity even at high dose (3 mg/kg, i.p.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGRfz6xatTXLVg90H21EOLACvtfcHk0liJJvIEkoZoLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7%252FM&md5=f0148c8ba51a2d0cbe83a26bb388a446</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00623%26sid%3Dliteratum%253Aachs%26aulast%3DScheiner%26aufirst%3DM.%26aulast%3DDolles%26aufirst%3DD.%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DMarinelli%26aufirst%3DO.%26aulast%3DNaldi%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DPetralla%26aufirst%3DS.%26aulast%3DPoeta%26aufirst%3DE.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DFalkeis%26aufirst%3DC.%26aulast%3DVieth%26aufirst%3DM.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DDual-acting%2520cholinesterase%25E2%2580%2593human%2520cannabinoid%2520receptor%25202%2520ligands%2520show%2520pronounced%2520neuroprotection%2520in%2520vitro%2520and%2520overadditive%2520and%2520disease-modifying%2520neuroprotective%2520effects%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9078%26epage%3D9102%26doi%3D10.1021%2Facs.jmedchem.9b00623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James Chou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer’s disease: design, synthesis, and biological evaluation</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">103721</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bioorg.2020.103721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=32193030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlt1eltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2020&pages=103721&author=A.+Xuauthor=F.+Heauthor=X.+Zhangauthor=X.+Liauthor=Y.+Ranauthor=C.+Weiauthor=C.+James+Chouauthor=R.+Zhangauthor=J.+Wu&title=Tacrine-hydroxamate+derivatives+as+multitarget-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+design%2C+synthesis%2C+and+biological+evaluation&doi=10.1016%2Fj.bioorg.2020.103721"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation</span></div><div class="casAuthors">Xu, Ana; He, Feng; Zhang, Xiangna; Li, Xiaoyang; Ran, Yingying; Wei, Chao; James Chou, C.; Zhang, Rui; Wu, Jingde</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103721</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to develop multitarget-directed ligands as potential treatments for Alzheimer's disease, twenty-eight new tacrine-hydroxamate derivs. were designed, synthesized, and biol. evaluated.  As expected, most of the compds. exhibited inhibitory activities against cholinesterases (ChEs) and histone deacetylase (HDACs).  Among the tested compds., I showed not only potent and selective inhibition on AChE at sub-nanomolar potency (AChEIC50 = 0.12 nM, BChEIC50 = 361.52 nM) but also potent inhibition on HDAC (IC50 = 0.23 nM).  Moreover, I exhibited inhibitory activity on Aβ1-42 self-aggregation as well as disaggregation activity on pre-formed Aβ fibrils.  Furthermore, I exhibited antioxidant activity and metal chelating properties.  Further mechanistic studies demonstrated that I is a pan-inhibitor of HDACs and a mixed-type inhibitor for AChE.  It was shown that I is a BBB penetrant by online prediction.  Taken together, the results indicate that I can serve as a lead compd. to develop promising candidate analogs as AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLE3wLayb4i7Vg90H21EOLACvtfcHk0ljAnuyHA4x9Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlt1eltLw%253D&md5=e2b820af806ce7651f90fc66d4a1f1cb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103721%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DJames%2BChou%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DTacrine-hydroxamate%2520derivatives%2520as%2520multitarget-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D98%26spage%3D103721%26doi%3D10.1016%2Fj.bioorg.2020.103721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adasme-Carreño, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Gutierrez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzate-Morales, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span> <span> </span><span class="NLM_article-title">Novel coumarin-quinoline hybrids: design of multitarget compounds for Alzheimer’s disease</span>. <i>ChemistrySelect</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1002/slct.201803222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fslct.201803222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVOgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=551-558&author=Y.+Duarteauthor=A.+Fonsecaauthor=M.+Guti%C3%A9rrezauthor=F.+Adasme-Carre%C3%B1oauthor=C.+Mu%C3%B1oz-Gutierrezauthor=J.+Alzate-Moralesauthor=L.+Santanaauthor=E.+Uriarteauthor=R.+%C3%81lvarezauthor=M.+J.+Matos&title=Novel+coumarin-quinoline+hybrids%3A+design+of+multitarget+compounds+for+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fslct.201803222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Coumarin-Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease</span></div><div class="casAuthors">Duarte, Yorley; Fonseca, Andre; Gutierrez, Margarita; Adasme-Carreno, Francisco; Munoz-Gutierrez, Camila; Alzate-Morales, Jans; Santana, Lourdes; Uriarte, Eugenio; Alvarez, Rocio; Matos, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">ChemistrySelect</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">551-558</span>CODEN:
                <span class="NLM_cas:coden">CHEMUD</span>;
        ISSN:<span class="NLM_cas:issn">2365-6549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most prevalent neurodegenerative disease, presenting the most devastating consequences on human health and life quality.  Coumarin-quinoline hybrids were synthesized following a very efficient and versatile strategy.  Small structural variations contributed to dual acetyl/butyrylcholinesterases (AChE/BuChE) activity or selectivity towards one of these enzymes.  In addn., some of the studied compds. are interesting iron chelators, presenting a tendency to be neuroprotective.  Moreover, the compds. are not cytotoxic for SH-SY5Y neuroblastoma cells.  Compd. 9c proved to be the most interesting compd. of the studied series.  This compd. is selective against AChE and proved to be an excellent iron chelating agent (iron chelation at 100 μM=72.87%).  Mol. docking studies were performed to establish the nature of the interaction between the studied compds. and the binding pockets, leading to a rationalization of structure-activity relationships.  Compd. 9c forms a well-defined π-stacking interaction with Phe330 and interacts with Tyr121 residue via a hydrogen bond, while the inactive compds. cannot establish these interactions.  Important preliminary results against different targets, as well as some structure-activity relationships, were concluded from the exptl. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO_EBmjZxDfbVg90H21EOLACvtfcHk0ljAnuyHA4x9Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVOgtbw%253D&md5=299c5cfca47a068c32fe204044cc31bd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fslct.201803222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fslct.201803222%26sid%3Dliteratum%253Aachs%26aulast%3DDuarte%26aufirst%3DY.%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DM.%26aulast%3DAdasme-Carre%25C3%25B1o%26aufirst%3DF.%26aulast%3DMu%25C3%25B1oz-Gutierrez%26aufirst%3DC.%26aulast%3DAlzate-Morales%26aufirst%3DJ.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3D%25C3%2581lvarez%26aufirst%3DR.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26atitle%3DNovel%2520coumarin-quinoline%2520hybrids%253A%2520design%2520of%2520multitarget%2520compounds%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChemistrySelect%26date%3D2019%26volume%3D4%26spage%3D551%26epage%3D558%26doi%3D10.1002%2Fslct.201803222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lalut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecoutey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legay, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopkova-de Oliveira Santos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallemagne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochais, C.</span></span> <span> </span><span class="NLM_article-title">Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer’s disease</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3014</span>, <span class="refDoi"> DOI: 10.1038/s41598-020-59805-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1038%2Fs41598-020-59805-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=32080261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvVKltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=3014&author=J.+Lalutauthor=H.+Payanauthor=A.+Davisauthor=C.+Lecouteyauthor=R.+Legayauthor=J.+Sopkova-de+Oliveira+Santosauthor=S.+Claeysenauthor=P.+Dallemagneauthor=C.+Rochais&title=Rational+design+of+novel+benzisoxazole+derivatives+with+acetylcholinesterase+inhibitory+and+serotoninergic+5-HT4+receptors+activities+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fs41598-020-59805-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Lalut, Julien; Payan, Hugo; Davis, Audrey; Lecoutey, Cedric; Legay, Remi; Sopkova-de Oliveira Santos, Jana; Claeysen, Sylvie; Dallemagne, Patrick; Rochais, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3014</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: A rigidification strategy was applied to the preclin. candidate donecopride, an acetylcholinesterase inhibitor possessing 5-HT4R agonist activity.  Inspired by promising bioactive benzisoxazole compds., we have conducted a pharmacomodulation study to generate a novel series of multitarget directed ligands.  The chem. synthesis of the ligand was optimized and compds. were evaluated in vitro against each target and in cellulo.  Structure-activity relationship was supported by docking anal. in human acetylcholinesterase binding site.  Among the synthesized compds., we have identified a novel hybrid 32a (3-[2-[1-(cyclohexylmethyl)-4-piperidyl]ethyl]-4-methoxy-1,2-benzoxazole) able to display nanomolar acetylcholinesterase inhibitory effects and nanomolar Ki for 5-HT4R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-tPU07OCRbVg90H21EOLACvtfcHk0ljAnuyHA4x9Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvVKltbc%253D&md5=10fd094b64677f16a7f26cc2e21d426b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-59805-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-59805-7%26sid%3Dliteratum%253Aachs%26aulast%3DLalut%26aufirst%3DJ.%26aulast%3DPayan%26aufirst%3DH.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DDallemagne%26aufirst%3DP.%26aulast%3DRochais%26aufirst%3DC.%26atitle%3DRational%2520design%2520of%2520novel%2520benzisoxazole%2520derivatives%2520with%2520acetylcholinesterase%2520inhibitory%2520and%2520serotoninergic%25205-HT4%2520receptors%2520activities%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26spage%3D3014%26doi%3D10.1038%2Fs41598-020-59805-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turcu, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barniol-Xicota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pivetta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">A novel class of multitarget anti-Alzheimer benzohomoadamantane–chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.07.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.ejmech.2019.07.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31351393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVGrsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2019&pages=613-626&author=F.+J.+P%C3%A9rez-Arealesauthor=A.+L.+Turcuauthor=M.+Barniol-Xicotaauthor=C.+Pontauthor=D.+Pivettaauthor=A.+Espargar%C3%B3author=M.+Bartoliniauthor=A.+De+Simoneauthor=V.+Andrisanoauthor=B.+P%C3%A9rezauthor=R.+Sabateauthor=F.+X.+Suredaauthor=S.+V%C3%A1zquezauthor=D.+Mu%C3%B1oz-Torrero&title=A+novel+class+of+multitarget+anti-Alzheimer+benzohomoadamantane%E2%80%93chlorotacrine+hybrids+modulating+cholinesterases+and+glutamate+NMDA+receptors&doi=10.1016%2Fj.ejmech.2019.07.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A novel class of multitarget anti-Alzheimer benzohomoadamantane-chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors</span></div><div class="casAuthors">Perez-Areales, F. Javier; Turcu, Andreea L.; Barniol-Xicota, Marta; Pont, Caterina; Pivetta, Deborah; Espargaro, Alba; Bartolini, Manuela; De Simone, Angela; Andrisano, Vincenza; Perez, Belen; Sabate, Raimon; Sureda, Francesc X.; Vazquez, Santiago; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">613-626</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The development of multitarget compds. against multifactorial diseases, such as Alzheimer's disease, is an area of very intensive research, due to the expected superior therapeutic efficacy that should arise from the simultaneous modulation of several key targets of the complex pathol. network.  Here we describe the synthesis and multitarget biol. profiling of a new class of compds. designed by mol. hybridization of an NMDA receptor antagonist fluorobenzohomoadamantanamine with the potent acetylcholinesterase (AChE) inhibitor 6-chlorotacrine, using two different linker lengths and linkage positions, to preserve or not the memantine-like polycyclic unsubstituted primary amine.  The best hybrids, e.g., I, exhibit greater potencies than parent compds. against AChE (IC50 0.33 nM in the best case, 44-fold increased potency over 6-chlorotacrine), butyrylcholinesterase (IC50 21 nM in the best case, 24-fold increased potency over 6-chlorotacrine), and NMDA receptors (IC50 0.89 μM in the best case, 2-fold increased potency over the parent benzohomoadamantanamine and memantine), which suggests an additive effect of both pharmacophoric moieties in the interaction with the primary targets.  Moreover, most of these compds. have been predicted to be brain permeable.  This set of biol. properties makes them promising leads for further anti-Alzheimer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQXvbwMzIWJbVg90H21EOLACvtfcHk0lhRcTCetm16jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGrsbfP&md5=676e6005d48fa5fdc44a967801d79ca0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.07.051%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DTurcu%26aufirst%3DA.%2BL.%26aulast%3DBarniol-Xicota%26aufirst%3DM.%26aulast%3DPont%26aufirst%3DC.%26aulast%3DPivetta%26aufirst%3DD.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DSureda%26aufirst%3DF.%2BX.%26aulast%3DV%25C3%25A1zquez%26aufirst%3DS.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DA%2520novel%2520class%2520of%2520multitarget%2520anti-Alzheimer%2520benzohomoadamantane%25E2%2580%2593chlorotacrine%2520hybrids%2520modulating%2520cholinesterases%2520and%2520glutamate%2520NMDA%2520receptors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D180%26spage%3D613%26epage%3D626%26doi%3D10.1016%2Fj.ejmech.2019.07.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Estrada-Valencia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera-Arozamena, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viña, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-García, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Castillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pricl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span> <span> </span><span class="NLM_article-title">New flavonoid – <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids: Multi-target-directed agents for Alzheimer′s disease endowed with neurogenic properties</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1080/14756366.2019.1581184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1080%2F14756366.2019.1581184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31852270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksFKisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2019&pages=712-727&author=M.+Estrada-Valenciaauthor=C.+Herrera-Arozamenaauthor=C.+P%C3%A9rezauthor=D.+Vi%C3%B1aauthor=J.+A.+Morales-Garc%C3%ADaauthor=A.+P%C3%A9rez-Castilloauthor=E.+Ramosauthor=A.+Romeroauthor=E.+Lauriniauthor=S.+Priclauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+flavonoid+%E2%80%93+N%2CN-dibenzyl%28N-methyl%29amine+hybrids%3A+Multi-target-directed+agents+for+Alzheimer%E2%80%B2s+disease+endowed+with+neurogenic+properties&doi=10.1080%2F14756366.2019.1581184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New flavonoid - N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer's disease endowed with neurogenic properties</span></div><div class="casAuthors">Estrada-Valencia, Martin; Herrera-Arozamena, Clara; Perez, Concepcion; Vina, Dolores; Morales-Garcia, Jose A.; Perez-Castillo, Ana; Ramos, Eva; Romero, Alejandro; Laurini, Erik; Pricl, Sabrina; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">712-727</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The design of multi-target directed ligands (MTDLs) is a valid approach for obtaining effective drugs for complex pathologies.  MTDLs that combine neuro-repair properties and block the first steps of neurotoxic cascades could be the so long wanted remedies to treat neurodegenerative diseases (NDs).  By linking two privileged scaffolds with well-known activities in ND-targets, the flavonoid and the N,N-dibenzyl(N-methyl)amine (DBMA) fragments, new CNS-permeable flavonoid - DBMA hybrids (-) were obtained.  They were subjected to biol. evaluation in a battery of targets involved in Alzheimer's disease (AD) and other NDs, namely human cholinesterases (hAChE/hBuChE), β-secretase (hBACE-1), monoamine oxidases (hMAO-A/B), lipoxygenase-5 (hLOX-5) and sigma receptors (σ1R/σ2R).  After a funnel-type screening, 6,7-dimethoxychromone - DBMA () was highlighted due to its neurogenic properties and an interesting MTD-profile in hAChE, hLOX-5, hBACE-1 and σ1R.  Mol. dynamic simulations showed the most relevant drug-protein interactions of hybrid , which could synergistically contribute to neuronal regeneration and block neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxvt6TPaP_67Vg90H21EOLACvtfcHk0lhRcTCetm16jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksFKisLk%253D&md5=24e4282e83ea909ffd6fd72a74a8e509</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1080%2F14756366.2019.1581184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2019.1581184%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada-Valencia%26aufirst%3DM.%26aulast%3DHerrera-Arozamena%26aufirst%3DC.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DVi%25C3%25B1a%26aufirst%3DD.%26aulast%3DMorales-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DP%25C3%25A9rez-Castillo%26aufirst%3DA.%26aulast%3DRamos%26aufirst%3DE.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DLaurini%26aufirst%3DE.%26aulast%3DPricl%26aufirst%3DS.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520flavonoid%2520%25E2%2580%2593%2520N%252CN-dibenzyl%2528N-methyl%2529amine%2520hybrids%253A%2520Multi-target-directed%2520agents%2520for%2520Alzheimer%25E2%2580%25B2s%2520disease%2520endowed%2520with%2520neurogenic%2520properties%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2019%26volume%3D34%26spage%3D712%26epage%3D727%26doi%3D10.1080%2F14756366.2019.1581184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginex, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puigoriol-Illamola, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallàs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciruela, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Centrally active multitarget anti-Alzheimer agents derived from the antioxidant lead CR-6</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">9360</span>– <span class="NLM_lpage">9390</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00528</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00528" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVCmtrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=9360-9390&author=F.+J.+P%C3%A9rez-Arealesauthor=M.+Garridoauthor=E.+Asoauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=A.+Espargar%C3%B3author=T.+Ginexauthor=R.+Sabateauthor=B.+P%C3%A9rezauthor=V.+Andrisanoauthor=D.+Puigoriol-Illamolaauthor=M.+Pall%C3%A0sauthor=F.+J.+Luqueauthor=M.+I.+Lozaauthor=J.+Breaauthor=I.+Ferrerauthor=F.+Ciruelaauthor=A.+Messeguerauthor=D.+Mu%C3%B1oz-Torrero&title=Centrally+active+multitarget+anti-Alzheimer+agents+derived+from+the+antioxidant+lead+CR-6&doi=10.1021%2Facs.jmedchem.0c00528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6</span></div><div class="casAuthors">Perez-Areales, F. Javier; Garrido, Maria; Aso, Ester; Bartolini, Manuela; De Simone, Angela; Espargaro, Alba; Ginex, Tiziana; Sabate, Raimon; Perez, Belen; Andrisano, Vincenza; Puigoriol-Illamola, Dolors; Pallas, Merce; Luque, F. Javier; Loza, Maria Isabel; Brea, Jose; Ferrer, Isidro; Ciruela, Francisco; Messeguer, Angel; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9360-9390</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oxidative stress is a major pathogenic factor in Alzheimer's disease, but it should not be tackled alone rather together with other key targets to derive effective treatments.  The combination of the scaffold of the polar antioxidant lead 7-methoxy-2,2-dimethylchroman-6-ol (CR-6) with that of the lipophilic cholinesterase inhibitor 6-chlorotacrine results in compds. with favorable brain permeability and multiple activities in vitro (acetylcholinesterase, butyrylcholinesterase, β-site amyloid precursor protein (APP) cleaving enzyme-1 (BACE-1), and Aβ42 and tau aggregation inhibition).  In in vivo studies on wild-type and APP/presenilin 1 (PS1) mice, two selected compds. were well tolerated and led to pos. trends, albeit statistically nonsignificant in some cases, on memory performance, amyloid pathol. (reduced amyloid burden and potentiated non-amyloidogenic APP processing), and oxidative stress (reduced cortical oxidized proteins and increased antioxidant enzymes superoxide dismutase 2 (SOD2), catalase, glutathione peroxidase 1 (GPX1), and heme oxygenase 1 (Hmox1) and transcription factor nuclear factor-erythroid 2-related factor 2 (Nrf2)).  These compds. emerge as interesting brain-permeable multitarget compds., with a potential as anti-Alzheimer agents beyond that of the original lead CR-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMkXh1l7YWmLVg90H21EOLACvtfcHk0lioj0BLYZnNhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVCmtrzN&md5=9a3e2cb84bfadd500236e8d542291c5a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00528%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DGarrido%26aufirst%3DM.%26aulast%3DAso%26aufirst%3DE.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DGinex%26aufirst%3DT.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DPuigoriol-Illamola%26aufirst%3DD.%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DFerrer%26aufirst%3DI.%26aulast%3DCiruela%26aufirst%3DF.%26aulast%3DMesseguer%26aufirst%3DA.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DCentrally%2520active%2520multitarget%2520anti-Alzheimer%2520agents%2520derived%2520from%2520the%2520antioxidant%2520lead%2520CR-6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D9360%26epage%3D9390%26doi%3D10.1021%2Facs.jmedchem.0c00528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanhed, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansara, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecwan, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upadhyay, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prajapati, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murumkar, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, M. R.</span></span> <span> </span><span class="NLM_article-title">Novel multitarget directed triazinoindole derivatives as anti-Alzheimer agents</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3635</span>– <span class="NLM_lpage">3661</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.9b00226</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.9b00226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2jtLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=3635-3661&author=D.+V.+Patelauthor=N.+R.+Patelauthor=A.+M.+Kanhedauthor=S.+P.+Patelauthor=A.+Sinhaauthor=D.+D.+Kansaraauthor=A.+R.+Mecwanauthor=S.+B.+Patelauthor=P.+N.+Upadhyayauthor=K.+B.+Patelauthor=D.+B.+Shahauthor=N.+K.+Prajapatiauthor=P.+R.+Murumkarauthor=K.+V.+Patelauthor=M.+R.+Yadav&title=Novel+multitarget+directed+triazinoindole+derivatives+as+anti-Alzheimer+agents&doi=10.1021%2Facschemneuro.9b00226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents</span></div><div class="casAuthors">Patel, Dushyant V.; Patel, Nirav R.; Kanhed, Ashish M.; Patel, Sagar P.; Sinha, Anshuman; Kansara, Deep D.; Mecwan, Annie R.; Patel, Sarvangee B.; Upadhyay, Pragnesh N.; Patel, Kishan B.; Shah, Dharti B.; Prajapati, Navnit K.; Murumkar, Prashant R.; Patel, Kirti V.; Yadav, Mange Ram</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3635-3661</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multifaceted nature of Alzheimer's disease (AD) demands treatment with multitarget-directed ligands (MTDLs) to confront the key pathol. aberrations.  A novel series of triazinoindole derivs. were designed and synthesized.  In vitro studies revealed that all the compds. showed moderate to good anticholinesterase activity; the most active compd. 23e showed an IC50 value of 0.56 ± 0.02 μM for AChE and an IC50 value of 1.17 ± 0.09 μM for BuChE.  These derivs. are also endowed with potent antioxidant activity.  To understand the plausible binding mode of the compd. 23e, mol. docking studies and mol. dynamics simulation studies were performed, and the results indicated significant interactions of 23e within the active sites of AChE as well as BuChE.  Compd. 23e successfully diminished H2O2-induced oxidative stress in SH-SY5Y cells and displayed excellent neuroprotective activity against H2O2 as well as Aβ-induced toxicity in SH-SY5Y cells in a concn. dependent manner.  Furthermore, it did not show any significant toxicity in neuronal SH-SY5Y cells in the cytotoxicity assay.  Compd. 23e did not show any acute toxicity in rats at doses up to 2000 mg/kg, and it significantly reversed scopolamine-induced memory deficit in mice model.  Addnl., compd. 23e showed notable in silico ADMET properties.  Taken collectively, these findings project compd. 23e as a potential balanced MTDL in the evolution process of novel anti-AD drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFrn4aKD5fUrVg90H21EOLACvtfcHk0lioj0BLYZnNhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2jtLrP&md5=662353ea8e5f6d29d01ee1e4456dbaee</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.9b00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.9b00226%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DD.%2BV.%26aulast%3DPatel%26aufirst%3DN.%2BR.%26aulast%3DKanhed%26aufirst%3DA.%2BM.%26aulast%3DPatel%26aufirst%3DS.%2BP.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DKansara%26aufirst%3DD.%2BD.%26aulast%3DMecwan%26aufirst%3DA.%2BR.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DUpadhyay%26aufirst%3DP.%2BN.%26aulast%3DPatel%26aufirst%3DK.%2BB.%26aulast%3DShah%26aufirst%3DD.%2BB.%26aulast%3DPrajapati%26aufirst%3DN.%2BK.%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26aulast%3DPatel%26aufirst%3DK.%2BV.%26aulast%3DYadav%26aufirst%3DM.%2BR.%26atitle%3DNovel%2520multitarget%2520directed%2520triazinoindole%2520derivatives%2520as%2520anti-Alzheimer%2520agents%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D3635%26epage%3D3661%26doi%3D10.1021%2Facschemneuro.9b00226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nepovimova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babkova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ondrejicek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepsova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrabinova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bukum, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malinak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span> <span> </span><span class="NLM_article-title">Tacrine–trolox hybrids: A novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8985</span>– <span class="NLM_lpage">9003</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01325</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01325" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWlt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8985-9003&author=E.+Nepovimovaauthor=J.+Korabecnyauthor=R.+Dolezalauthor=K.+Babkovaauthor=A.+Ondrejicekauthor=D.+Junauthor=V.+Sepsovaauthor=A.+Horovaauthor=M.+Hrabinovaauthor=O.+Soukupauthor=N.+Bukumauthor=P.+Jostauthor=L.+Muckovaauthor=J.+Kassaauthor=D.+Malinakauthor=M.+Andrsauthor=K.+Kuca&title=Tacrine%E2%80%93trolox+hybrids%3A+A+novel+class+of+centrally+active%2C+nonhepatotoxic+multi-target-directed+ligands+exerting+anticholinesterase+and+antioxidant+activities+with+low+in+vivo+toxicity&doi=10.1021%2Facs.jmedchem.5b01325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-trolox hybrids: a novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity</span></div><div class="casAuthors">Nepovimova, Eugenie; Korabecny, Jan; Dolezal, Rafael; Babkova, Katerina; Ondrejicek, Ales; Jun, Daniel; Sepsova, Vendula; Horova, Anna; Hrabinova, Martina; Soukup, Ondrej; Bukum, Neslihan; Jost, Petr; Muckova, Lubica; Kassa, Jiri; Malinak, David; Andrs, Martin; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8985-9003</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coupling of two distinct pharmacophores, tacrine and trolox, endowed with different biol. properties, afforded 21 hybrid compds. as novel multifunctional candidates against Alzheimer's disease.  Several of them showed improved inhibitory properties toward acetylcholinesterase (AChE) in relation to tacrine.  These hybrids also scavenged free radicals.  Mol. modeling studies in tandem with kinetic anal. exhibited that these hybrids target both catalytic active site as well as peripheral anionic site of AChE.  In addn., incorporation of the moiety bearing antioxidant abilities displayed negligible toxicity on human hepatic cells.  This striking effect was explained by formation of nontoxic metabolites after 1 h incubation in human liver microsomes system.  Finally, tacrine-trolox hybrids exhibited low in vivo toxicity after i.m. administration in rats and potential to penetrate across blood-brain barrier.  All of these outstanding in vitro results in combination with promising in vivo outcomes highlighted deriv. I as the lead structure worthy of further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWjX4tC8Sy17Vg90H21EOLACvtfcHk0lioj0BLYZnNhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWlt7vI&md5=550bddcd59b5bbb90d77e67faca28839</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01325%26sid%3Dliteratum%253Aachs%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DBabkova%26aufirst%3DK.%26aulast%3DOndrejicek%26aufirst%3DA.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DSepsova%26aufirst%3DV.%26aulast%3DHorova%26aufirst%3DA.%26aulast%3DHrabinova%26aufirst%3DM.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DBukum%26aufirst%3DN.%26aulast%3DJost%26aufirst%3DP.%26aulast%3DMuckova%26aufirst%3DL.%26aulast%3DKassa%26aufirst%3DJ.%26aulast%3DMalinak%26aufirst%3DD.%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DTacrine%25E2%2580%2593trolox%2520hybrids%253A%2520A%2520novel%2520class%2520of%2520centrally%2520active%252C%2520nonhepatotoxic%2520multi-target-directed%2520ligands%2520exerting%2520anticholinesterase%2520and%2520antioxidant%2520activities%2520with%2520low%2520in%2520vivo%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8985%26epage%3D9003%26doi%3D10.1021%2Facs.jmedchem.5b01325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and evaluation of flurbiprofen-clioquinol hybrids as multitarget-directed ligands against Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">115374</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2020.115374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bmc.2020.115374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=32089390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1Ogtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=115374&author=Z.+Yangauthor=Q.+Songauthor=Z.+Caoauthor=G.+Yuauthor=Z.+Liuauthor=Z.+Tanauthor=Y.+Deng&title=Design%2C+synthesis+and+evaluation+of+flurbiprofen-clioquinol+hybrids+as+multitarget-directed+ligands+against+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2020.115374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of flurbiprofen-clioquinol hybrids as multitarget-directed ligands against Alzheimer's disease</span></div><div class="casAuthors">Yang, Ziyi; Song, Qing; Cao, Zhongcheng; Yu, Guangjun; Liu, Zhuoling; Tan, Zhenghuai; Deng, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">115374</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel flurbiprofen-clioquinol hybrids I [R = H, 2-HOC6H4NHCH2, 2-OH-5-BrC6H3NHCH2, etc.; R1 = H, 2-OH-5-(NMe2)C6H3NHCH2] were designed and synthesized as multifunctional agents for Alzheimer's disease therapy and their potential was evaluated through various biol. expts.  In vitro studies showed that compds. I [R = 2-OH-5-(NMe2)C6H3NHCH2 (II), R1 = H; R = H, R1 = 2-OH-5-(NMe2)C6H3NHCH2 (III)] exhibited significant ability to inhibit self- and Cu2+-induced β-amyloid aggregation.  Furthermore, some target compds. II and III also showed biometal chelating abilities, antioxidant activity, anti-neuroinflammatory activity and appropriate BBB permeability.  These biol. activities indicated that the representative compds. II and III might be promising multifunctional agents for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRQ8mmfRcfObVg90H21EOLACvtfcHk0lih01btpshIeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1Ogtro%253D&md5=efa47055452c7f5b82963ab223386f31</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2020.115374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2020.115374%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520flurbiprofen-clioquinol%2520hybrids%2520as%2520multitarget-directed%2520ligands%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2020%26volume%3D28%26spage%3D115374%26doi%3D10.1016%2Fj.bmc.2020.115374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barraza-Garza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-León, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo-Michel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Rosa, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Parrilla, E.</span></span> <span> </span><span class="NLM_article-title">Antioxidant effect of phenolic compounds (PC) at different concentrations in IEC-6 cells: A spectroscopic analysis</span>. <i>Spectrochim. Acta, Part A</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>227</i></span>,  <span class="NLM_fpage">117570</span>, <span class="refDoi"> DOI: 10.1016/j.saa.2019.117570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.saa.2019.117570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31669938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVertLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=2020&pages=117570&author=G.+Barraza-Garzaauthor=J.+A.+P%C3%A9rez-Le%C3%B3nauthor=H.+Castillo-Michelauthor=L.+A.+de+la+Rosaauthor=A.+Martinez-Martinezauthor=M.+Cotteauthor=E.+Alvarez-Parrilla&title=Antioxidant+effect+of+phenolic+compounds+%28PC%29+at+different+concentrations+in+IEC-6+cells%3A+A+spectroscopic+analysis&doi=10.1016%2Fj.saa.2019.117570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant effect of phenolic compounds (PC) at different concentrations in IEC-6 cells: A spectroscopic analysis</span></div><div class="casAuthors">Barraza-Garza, G.; Perez-Leon, J. A.; Castillo-Michel, H.; de la Rosa, L. A.; Martinez-Martinez, A.; Cotte, M.; Alvarez-Parrilla, E.</div><div class="citationInfo"><span class="NLM_cas:title">Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117570</span>CODEN:
                <span class="NLM_cas:coden">SAMCAS</span>;
        ISSN:<span class="NLM_cas:issn">1386-1425</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phenolic compds. (PC) have been proposed as natural antioxidant agents that protect cells against oxidative stress-related diseases.  Nonetheless, their low bioavailability forecasts controversy about mechanisms on their in vivo scavenging activity against reactive oxygen species (ROS).  It has been proposed that PC reduce directly ROS concn.  An alternative or complementary action of PC could be the activation of the cell's antioxidant pathway, involving the regulation of gene expression, like that initiated by the Nrf2 transcription factor.  To date there is not enough exptl. data to support or discard this possibility.  The authors evaluated the use of several PC to prevent peroxidn. of macromols. and to elicit the activation of the Nrf2 transcription factor in H2O2-stresed IEC-6 enterocytic cell line.  Synchrotron microspectroscopy demonstrated that PC compds. protected proteins, lipids and nucleic acids against oxidn. induced by H2O2.  Immunofluorescence results showed that treatment with quercetin (Qc), catechin (Cat) and capsaicin (Cap) induced the translocation of Nrf2 into the nucleus, at the same level as did H2O2 treatment, thus mimicking the action of the endogenous cell response to peroxidn.  Even though the detailed mechanism still needs to be elucidated, the authors demonstrated the activation of Nrf2 by PCs in response to oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEs5jvKtfiJrVg90H21EOLACvtfcHk0lih01btpshIeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVertLbP&md5=0a3295e75e67a9a31ae6f56121edfafa</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.saa.2019.117570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.saa.2019.117570%26sid%3Dliteratum%253Aachs%26aulast%3DBarraza-Garza%26aufirst%3DG.%26aulast%3DP%25C3%25A9rez-Le%25C3%25B3n%26aufirst%3DJ.%2BA.%26aulast%3DCastillo-Michel%26aufirst%3DH.%26aulast%3Dde%2Bla%2BRosa%26aufirst%3DL.%2BA.%26aulast%3DMartinez-Martinez%26aufirst%3DA.%26aulast%3DCotte%26aufirst%3DM.%26aulast%3DAlvarez-Parrilla%26aufirst%3DE.%26atitle%3DAntioxidant%2520effect%2520of%2520phenolic%2520compounds%2520%2528PC%2529%2520at%2520different%2520concentrations%2520in%2520IEC-6%2520cells%253A%2520A%2520spectroscopic%2520analysis%26jtitle%3DSpectrochim.%2520Acta%252C%2520Part%2520A%26date%3D2020%26volume%3D227%26spage%3D117570%26doi%3D10.1016%2Fj.saa.2019.117570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C.-T.</span></span> <span> </span><span class="NLM_article-title">Capsaicin-The major bioactive ingredient of chili peppers: Bio-efficacy and delivery systems</span>. <i>Food Funct.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2848</span>– <span class="NLM_lpage">2860</span>, <span class="refDoi"> DOI: 10.1039/d0fo00351d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1039%2FD0FO00351D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=32246759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkslaqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=2848-2860&author=M.+Luauthor=C.+Chenauthor=Y.+Lanauthor=J.+Xiaoauthor=R.+Liauthor=J.+Huangauthor=Q.+Huangauthor=Y.+Caoauthor=C.-T.+Ho&title=Capsaicin-The+major+bioactive+ingredient+of+chili+peppers%3A+Bio-efficacy+and+delivery+systems&doi=10.1039%2Fd0fo00351d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Capsaicin-the major bioactive ingredient of chili peppers: bio-efficacy and delivery systems</span></div><div class="casAuthors">Lu, Muwen; Chen, Chengyu; Lan, Yaqi; Xiao, Jie; Li, Run; Huang, Junqing; Huang, Qingrong; Cao, Yong; Ho, Chi-Tang</div><div class="citationInfo"><span class="NLM_cas:title">Food & Function</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2848-2860</span>CODEN:
                <span class="NLM_cas:coden">FFOUAI</span>;
        ISSN:<span class="NLM_cas:issn">2042-6496</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Capsaicin is the primary bioactive substance in red chili peppers, which produces the pungent flavor.  During the past few decades, pharmacol. benefits of capsaicin and its underlying mechanisms have been examd. extensively.  In this paper, major biol. efficacies of capsaicin are reviewed, including analgesic, antioxidant, anti-inflammatory, anti-cancer, anti-obesity, cardio-protective, and metabolic modulation effects.  Novel delivery systems, such as liposomes, micelles, micro/nano-emulsions, colloidal capsules and solid nanoparticles, for enhancing the oral bioavailability of capsaicin are also evaluated depending on the stability, encapsulation efficiency and biol. properties.  This review provides a theor. basis for capsaicin to be further developed into a multi-functional ingredient with health-promoting functions in the nutraceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUu6aPOelYbVg90H21EOLACvtfcHk0lih01btpshIeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkslaqurw%253D&md5=501ed8d3f6a0f5196a49baf8f272d880</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2FD0FO00351D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0FO00351D%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DHo%26aufirst%3DC.-T.%26atitle%3DCapsaicin-The%2520major%2520bioactive%2520ingredient%2520of%2520chili%2520peppers%253A%2520Bio-efficacy%2520and%2520delivery%2520systems%26jtitle%3DFood%2520Funct.%26date%3D2020%26volume%3D11%26spage%3D2848%26epage%3D2860%26doi%3D10.1039%2Fd0fo00351d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gour, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, S. I.</span></span> <span> </span><span class="NLM_article-title">Capsaicin has potent anti-oxidative effects <i>in vivo</i> through a mechanism which is non-receptor mediated</span>. <i>Arch. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1080/13813455.2019.1669056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1080%2F13813455.2019.1669056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=1-7&author=A.+Chaudharyauthor=J.+K.+Gourauthor=S.+I.+Rizvi&title=Capsaicin+has+potent+anti-oxidative+effects+in+vivo+through+a+mechanism+which+is+non-receptor+mediated&doi=10.1080%2F13813455.2019.1669056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1080%2F13813455.2019.1669056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13813455.2019.1669056%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhary%26aufirst%3DA.%26aulast%3DGour%26aufirst%3DJ.%2BK.%26aulast%3DRizvi%26aufirst%3DS.%2BI.%26atitle%3DCapsaicin%2520has%2520potent%2520anti-oxidative%2520effects%2520in%2520vivo%2520through%2520a%2520mechanism%2520which%2520is%2520non-receptor%2520mediated%26jtitle%3DArch.%2520Physiol.%2520Biochem.%26date%3D2019%26spage%3D1%26epage%3D7%26doi%3D10.1080%2F13813455.2019.1669056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yancheva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoyanov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anichina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velcheva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamboliyska, B.</span></span> <span> </span><span class="NLM_article-title">Combined infrared spectroscopic and computational study on simpler capsaicin derivatives and their anion intermediates in the scavenging of free radicals</span>. <i>Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>535</i></span>,  <span class="NLM_fpage">110763</span>, <span class="refDoi"> DOI: 10.1016/j.chemphys.2020.110763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.chemphys.2020.110763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmt1Sgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2020&pages=110763&author=D.+Yanchevaauthor=S.+Stoyanovauthor=K.+Anichinaauthor=S.+Nikolovaauthor=E.+Velchevaauthor=B.+Stamboliyska&title=Combined+infrared+spectroscopic+and+computational+study+on+simpler+capsaicin+derivatives+and+their+anion+intermediates+in+the+scavenging+of+free+radicals&doi=10.1016%2Fj.chemphys.2020.110763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Combined infrared spectroscopic and computational study on simpler capsaicin derivatives and their anion intermediates in the scavenging of free radicals</span></div><div class="casAuthors">Yancheva, D.; Stoyanov, S.; Anichina, K.; Nikolova, S.; Velcheva, E.; Stamboliyska, B.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Physics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110763</span>CODEN:
                <span class="NLM_cas:coden">CMPHC2</span>;
        ISSN:<span class="NLM_cas:issn">0301-0104</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two capsaicin analogs - N-(4-hydroxy-3-methoxybenzyl)acetamide and N-(4-hydroxy-3-methoxybenzyl)benzamide, were studied by DFT methods in order to est. their ability to act as antioxidants.  A comparative study on the stability of benzylic, phenoxyl and amide radicals has outlined the most reactive site for hydrogen atom abstraction and proton transfer.  The enthalpies related to the formation of those species were modeled in gas phase, benzene, DMSO and water in order to det. the most probable mechanism of antioxidant action in polar and nonpolar medium.  The formation of phenoxyl anion, energetically favored in polar medium, was investigated by IR spectroscopy methods based on the conversion of the benzamide deriv.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ4mdAyXDmRbVg90H21EOLACvtfcHk0lir_HHg3LUhAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmt1Sgsb0%253D&md5=dac8431338707868bfd7ad0b75d7e795</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.chemphys.2020.110763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chemphys.2020.110763%26sid%3Dliteratum%253Aachs%26aulast%3DYancheva%26aufirst%3DD.%26aulast%3DStoyanov%26aufirst%3DS.%26aulast%3DAnichina%26aufirst%3DK.%26aulast%3DNikolova%26aufirst%3DS.%26aulast%3DVelcheva%26aufirst%3DE.%26aulast%3DStamboliyska%26aufirst%3DB.%26atitle%3DCombined%2520infrared%2520spectroscopic%2520and%2520computational%2520study%2520on%2520simpler%2520capsaicin%2520derivatives%2520and%2520their%2520anion%2520intermediates%2520in%2520the%2520scavenging%2520of%2520free%2520radicals%26jtitle%3DChem.%2520Phys.%26date%3D2020%26volume%3D535%26spage%3D110763%26doi%3D10.1016%2Fj.chemphys.2020.110763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dairam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limson, J. L.</span></span> <span> </span><span class="NLM_article-title">Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3350</span>– <span class="NLM_lpage">3356</span>, <span class="refDoi"> DOI: 10.1021/jf0734931</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf0734931" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVKgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=3350-3356&author=A.+Dairamauthor=R.+Fogelauthor=S.+Dayaauthor=J.+L.+Limson&title=Antioxidant+and+iron-binding+properties+of+curcumin%2C+capsaicin%2C+and+S-allylcysteine+reduce+oxidative+stress+in+rat+brain+homogenate&doi=10.1021%2Fjf0734931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant and Iron-Binding Properties of Curcumin, Capsaicin, and S-Allylcysteine Reduce Oxidative Stress in Rat Brain Homogenate</span></div><div class="casAuthors">Dairam, Amichand; Fogel, Ronen; Daya, Santy; Limson, Janice L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3350-3356</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Research demonstrates that antioxidants and metal chelators may be of beneficial use in the treatment of neurodegenerative diseases, such as Alzheimer's disease (AD).  This study investigated the antioxidant and metal-binding properties of curcumin, capsaicin, and S-allylcysteine, which are major components found in commonly used dietary spice ingredients turmeric, chilli, and garlic, resp.  The DPPH assay demonstrates that these compds. readily scavenge free radicals.  These compds. significantly curtail iron- (Fe2+) and quinolinic acid (QA)-induced lipid peroxidn. and potently scavenge the superoxide anion generated by 1 mM cyanide in rat brain homogenate.  The ferrozine assay was used to measure the extent of Fe2+ chelation, and electrochem. was employed to measure the Fe3+ binding activity of curcumin, capsaicin, and S-allylcysteine.  Both assays demonstrate that these compds. bind Fe2+ and Fe3+ and prevent the redox cycling of iron, suggesting that this may be an addnl. method through which these agents reduce Fe2+-induced lipid peroxidn.  This study demonstrates the antioxidant and metal-binding properties of these spice ingredients, and it is hereby postulate that these compds. have important implications in the prevention or treatment of neurodegenerative diseases such as AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXsr1lxtGA8bVg90H21EOLACvtfcHk0lir_HHg3LUhAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVKgu7w%253D&md5=69dbd1cf4b85319308878a04774e79b4</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjf0734931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf0734931%26sid%3Dliteratum%253Aachs%26aulast%3DDairam%26aufirst%3DA.%26aulast%3DFogel%26aufirst%3DR.%26aulast%3DDaya%26aufirst%3DS.%26aulast%3DLimson%26aufirst%3DJ.%2BL.%26atitle%3DAntioxidant%2520and%2520iron-binding%2520properties%2520of%2520curcumin%252C%2520capsaicin%252C%2520and%2520S-allylcysteine%2520reduce%2520oxidative%2520stress%2520in%2520rat%2520brain%2520homogenate%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2008%26volume%3D56%26spage%3D3350%26epage%3D3356%26doi%3D10.1021%2Fjf0734931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer’s disease</span>. <i>Aging Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>19</i></span>, <span class="NLM_elocation-id">e13113</span> <span class="refDoi"> DOI: 10.1111/acel.13113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1111%2Facel.13113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=32061032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtVegsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2020&author=Y.+Duauthor=M.+Fuauthor=Z.+Huangauthor=X.+Tianauthor=J.+Liauthor=Y.+Pangauthor=W.+Songauthor=Y.+Tian+Wangauthor=Z.+Dong&title=TRPV1+activation+alleviates+cognitive+and+synaptic+plasticity+impairments+through+inhibiting+AMPAR+endocytosis+in+APP23%2FPS45+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1111%2Facel.13113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer's disease</span></div><div class="casAuthors">Du, Yehong; Fu, Min; Huang, Zhilin; Tian, Xin; Li, Junjie; Pang, Yayan; Song, Weihong; Wang, Yu Tian; Dong, Zhifang</div><div class="citationInfo"><span class="NLM_cas:title">Aging Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e13113</span>CODEN:
                <span class="NLM_cas:coden">ACGECQ</span>;
        ISSN:<span class="NLM_cas:issn">1474-9718</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is one of the most common causes of neurodegenerative diseases in the elderly.  The accumulation of amyloid-β (Aβ) peptides is one of the pathol. hallmarks of AD and leads to the impairments of synaptic plasticity and cognitive function.  The transient receptor potential vanilloid 1 (TRPV1), a nonselective cation channel, is involved in synaptic plasticity and memory.  However, the role of TRPV1 in AD pathogenesis remains largely elusive.  Here, we reported that the expression of TRPV1 was decreased in the brain of APP23/PS45 double transgenic AD model mice.  Genetic upregulation of TRPV1 by adeno-assocd. virus (AAV) inhibited the APP processing and Aβ deposition in AD model mice.  Meanwhile, upregulation of TRPV1 ameliorated the deficits of hippocampal CA1 long-term potentiation (LTP) and spatial learning and memory through inhibiting GluA2-contg. α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) endocytosis.  Furthermore, pharmacol. activation of TRPV1 by capsaicin (1 mg/kg, i.p.), an agonist of TRPV1, dramatically reversed the impairments of hippocampal CA1 LTP and spatial learning and memory in AD model mice.  Taken together, these results indicate that TRPV1 activation effectively ameliorates cognitive and synaptic functions through inhibiting AMPAR endocytosis in AD model mice and could be a novel mol. for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH7jCguBiqS7Vg90H21EOLACvtfcHk0ljPvoBbBVUSCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtVegsLo%253D&md5=46fcc27cfb5357583d0af9e1650aa953</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Facel.13113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Facel.13113%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DTian%2BWang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DTRPV1%2520activation%2520alleviates%2520cognitive%2520and%2520synaptic%2520plasticity%2520impairments%2520through%2520inhibiting%2520AMPAR%2520endocytosis%2520in%2520APP23%252FPS45%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAging%2520Cell%26date%3D2020%26volume%3D19%26doi%3D10.1111%2Facel.13113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">Capsaicin attenuates amyloid-β-induced synapse loss and cognitive impairments in mice</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.3233/JAD-170337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3233%2FJAD-170337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=28671132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A280%3ADC%252BC1cjjvFWqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2017&pages=683-694&author=L.+Chenauthor=Z.+Huangauthor=Y.+Duauthor=M.+Fuauthor=H.+Hanauthor=Y.+Wangauthor=Z.+Dong&title=Capsaicin+attenuates+amyloid-%CE%B2-induced+synapse+loss+and+cognitive+impairments+in+mice&doi=10.3233%2FJAD-170337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Capsaicin Attenuates Amyloid-β-Induced Synapse Loss and Cognitive Impairments in Mice</span></div><div class="casAuthors">Chen Long; Huang Zhilin; Du Yehong; Fu Min; Han Huili; Wang Yutian; Dong Zhifang; Chen Long; Huang Zhilin; Du Yehong; Fu Min; Han Huili; Wang Yutian; Dong Zhifang; Wang Yutian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">683-694</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is the most common cause of progressive cognitive impairment in the aged.  The aggregation of the amyloid β-protein (Aβ) is a hallmark of AD and is linked to synapse loss and cognitive impairment.  Capsaicin, a specific agonist of the transient receptor potential vanilloid 1 (TRPV1), has been proven to ameliorate stress-induced AD-like pathological and cognitive impairments, but it is unclear whether TRPV1 activation can affect cognitive and synaptic functions in Aβ-induced mouse model of AD.  In this study, we investigated the effects of TRPV1 activation on spatial memory and synaptic plasticity in mice treated with Aβ.  To induce AD-like pathological and cognitive impairments, adult C57Bl/6 mice were microinjected with Aβ42 (100 μM, 2.5 μl/mouse, i.c.v.).  Two weeks after Aβ42 microinjection, spatial learning and memory as well as hippocampal long-term potentiation (LTP) were examined.  The results showed that Aβ42 microinjection significantly impaired spatial learning and memory in the Morris water maze and novel object recognition tests compared with controls.  These behavioral changes were accompanied by synapse loss and impaired LTP in the CA1 area of hippocampus.  More importantly, daily capsaicin (1 mg/kg, i.p.) treatment throughout the experiment dramatically improved spatial learning and memory and synaptic function, as reflected by enhanced hippocampal LTP and reduced synapse loss, whereas the TRPV1 antagonist capsazepine (1 mg/kg, i.p.) treatment had no effects on cognitive and synaptic function in Aβ42-treated mice.  These results indicate that TRPV1 activation by capsaicin rescues cognitive deficit in the Aβ42-induced mouse model of AD both structurely and functionally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeg7s44RTiDJNiNltV31zlfW6udTcc2ebh4KIzfd5w2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjjvFWqtg%253D%253D&md5=5c4989e9394442fa4cfb7fcf8c94d868</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3233%2FJAD-170337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-170337%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DCapsaicin%2520attenuates%2520amyloid-%25CE%25B2-induced%2520synapse%2520loss%2520and%2520cognitive%2520impairments%2520in%2520mice%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2017%26volume%3D59%26spage%3D683%26epage%3D694%26doi%3D10.3233%2FJAD-170337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">Bioactive compounds in Kimchi improve the cognitive and memory functions impaired by amyloid beta</span>. <i>Nutrients</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1554</span>, <span class="refDoi"> DOI: 10.3390/nu10101554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3390%2Fnu10101554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntFSgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=1554&author=M.+Wooauthor=M.+Kimauthor=Y.+Song&title=Bioactive+compounds+in+Kimchi+improve+the+cognitive+and+memory+functions+impaired+by+amyloid+beta&doi=10.3390%2Fnu10101554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactive compounds in kimchi improve the cognitive and memory functions impaired by amyloid beta</span></div><div class="casAuthors">Woo, Minji; Kim, Mi Jeong; Song, Yeong Ok</div><div class="citationInfo"><span class="NLM_cas:title">Nutrients</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1554/1-1554/11</span>CODEN:
                <span class="NLM_cas:coden">NUTRHU</span>;
        ISSN:<span class="NLM_cas:issn">2072-6643</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">This study investigated the abilities of kimchi and its bioactive compds. to ameliorate amyloid beta (Aβ)-induced memory and cognitive impairments.  Mice were given a single intracerebroventricular injection of Aβ25-35, followed by a daily oral administration of capsaicin (10 mg·kg-bw-1), 3-(40-hydroxyl-3',5'-dimethoxyphenyl)propionic acid (50 mg/kg bw), quercetin (50 mg/kg bw), ascorbic acid (50 mg/kg bw), or kimchi methanol ext. (KME; 200 mg/kg bw) for 2 wk (n = 7 per group).  CM-cellulose was used as a vehicle for the normal and control groups.  Behavioral task tests showed that the learning and memory abilities were significantly waned by the injected Aβ25-35, but these cognitive deficits were recovered by the administrated KME and kimchi bioactive compds. (p < 0.05).  The reactive oxygen species, peroxynitrite, and thiobarbituric acid reactive substances levels were lower, and the glutathione level was higher, in the KME and bioactive compd. groups than in the control group (p < 0.05).  In the KME and bioactive compd. groups, the protein expression levels of antioxidant enzymes (nuclear factor (erythroid-derived 2)-like 2-regulated superoxide dismutase-1 and glutathione peroxidase) were increased, whereas those of inflammation-related enzymes (nuclear factor-kappaB -regulated inducible nitric oxide synthase and cyclooxygenase-2) were decreased (p < 0.05).  Thus, the antioxidative and anti-inflammatory properties of bioactive compds.-rich kimchi might help to attenuate the symptoms of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhMtzgvgqSo7Vg90H21EOLACvtfcHk0lg24q5w1MhgTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntFSgsbg%253D&md5=9f7c02c26f9de6b9293f7fe85ed75b0f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3390%2Fnu10101554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fnu10101554%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DBioactive%2520compounds%2520in%2520Kimchi%2520improve%2520the%2520cognitive%2520and%2520memory%2520functions%2520impaired%2520by%2520amyloid%2520beta%26jtitle%3DNutrients%26date%3D2018%26volume%3D10%26spage%3D1554%26doi%3D10.3390%2Fnu10101554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noh, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y. O.</span></span> <span> </span><span class="NLM_article-title">Bioactive compounds of Kimchi inhibit apoptosis by attenuating endoplasmic reticulum stress in the brain of amyloid β-injected mice</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">4883</span>– <span class="NLM_lpage">4890</span>, <span class="refDoi"> DOI: 10.1021/acs.jafc.8b01686</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jafc.8b01686" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVertr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=4883-4890&author=M.+Wooauthor=J.+S.+Nohauthor=E.+J.+Choauthor=Y.+O.+Song&title=Bioactive+compounds+of+Kimchi+inhibit+apoptosis+by+attenuating+endoplasmic+reticulum+stress+in+the+brain+of+amyloid+%CE%B2-injected+mice&doi=10.1021%2Facs.jafc.8b01686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactive Compounds of Kimchi Inhibit Apoptosis by Attenuating Endoplasmic Reticulum Stress in the Brain of Amyloid β-Injected Mice</span></div><div class="casAuthors">Woo, Minji; Noh, Jeong Sook; Cho, Eun Ju; Song, Yeong Ok</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4883-4890</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This study investigated the inhibitory effects of kimchi bioactive compds. against endoplasmic reticulum (ER) stress-induced apoptosis in amyloid beta (Aβ)-injected mice.  Mice received a single intracerebroventricular injection of Aβ25-35, except for the normal group.  Mice were subjected to oral administration of 10 mg of capsaicin, 50 mg of 3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid (HDMPPA), 50 mg of quercetin, 50 mg of ascorbic acid, or 200 mg of kimchi methanol ext. (KME) per kg of body wt. for 2 wk (n = 7 per group).  In the in vitro blood-brain barrier (BBB) permeability test, all bioactive compds. penetrated the BBB except ascorbic acid.  The protein expression level of APP, BACE, and p-Tau elevated by Aβ injection was decreased by kimchi bioactive compds. (P < 0.05).  Quercetin, HDMPPA, and KME decreased oxidative stress, as indicated by ROS and TBARS levels (P < 0.05).  The protein expression level of ER stress markers GRP78, p-PERK, p-eIF2α, XBP1, and CHOP and the proapoptotic mols. Bax, p-JNK, and cleaved caspases-3 and -9 decreased (P < 0.05).  In contrast, the protein expression level of antiapoptotic mols. Bcl2 and cIAP increased (P < 0.05).  These results were supported by histol. anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq80ecAFqjsCrVg90H21EOLACvtfcHk0lgrFCKj5FzZQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVertr0%253D&md5=a678f64aa7b7cfde402eeb451965a7ef</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jafc.8b01686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jafc.8b01686%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DM.%26aulast%3DNoh%26aufirst%3DJ.%2BS.%26aulast%3DCho%26aufirst%3DE.%2BJ.%26aulast%3DSong%26aufirst%3DY.%2BO.%26atitle%3DBioactive%2520compounds%2520of%2520Kimchi%2520inhibit%2520apoptosis%2520by%2520attenuating%2520endoplasmic%2520reticulum%2520stress%2520in%2520the%2520brain%2520of%2520amyloid%2520%25CE%25B2-injected%2520mice%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2018%26volume%3D66%26spage%3D4883%26epage%3D4890%26doi%3D10.1021%2Facs.jafc.8b01686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-J.</span></span> <span> </span><span class="NLM_article-title">The associations between a capsaicin-rich diet and blood amyloid-β levels and cognitive function</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1088</span>, <span class="refDoi"> DOI: 10.3233/JAD-151079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3233%2FJAD-151079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=27079706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A280%3ADC%252BC28bgtVOqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=1081-1088&author=C.-H.+Liuauthor=X.-L.+Buauthor=J.+Wangauthor=T.+Zhangauthor=Y.+Xiangauthor=L.-L.+Shenauthor=Q.-H.+Wangauthor=B.+Dengauthor=X.+Wangauthor=C.+Zhuauthor=X.-Q.+Yaoauthor=M.+Zhangauthor=H.-D.+Zhouauthor=Y.-J.+Wang&title=The+associations+between+a+capsaicin-rich+diet+and+blood+amyloid-%CE%B2+levels+and+cognitive+function&doi=10.3233%2FJAD-151079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function</span></div><div class="casAuthors">Liu Cheng-Hui; Bu Xian-Le; Wang Jun; Zhang Tao; Xiang Yang; Shen Lin-Lin; Wang Qing-Hua; Deng Bo; Wang Xin; Zhu Chi; Yao Xiu-Qing; Zhang Meng; Zhou Hua-Dong; Wang Yan-Jiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1081-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Capsaicin-rich diets are common worldwide.  Capsaicin has been shown to have favorable effects on various diseases including atherosclerosis, cardiovascular diseases, stroke, obesity, hypertension, cancer, and gastrointestinal and inflammatory diseases.  The impact of capsaicin on Alzheimer's disease (AD), which is the most common form of dementia in the elderly, remains unknown.  OBJECTIVE:  To investigate the correlations of capsaicin intake with cognition and blood markers of AD.  METHODS:  A total of 338 participants aged 40 years or older were enrolled from communities.  Dietary habits regarding chili pepper consumption were collected using a Food Frequency Questionnaire (FFQ).  Cognitive function was measured using the Chinese version of the Mini-Mental State Examination (MMSE).  Blood amyloid-β (Aβ)40 and Aβ42 were measured with ELISA kits.  RESULTS:  In univariate analysis, MMSE scores (r = 0.209, p < 0.001), serum Aβ40 levels (r = -0.149, p = 0.006), the ratio of Aβ42/Aβ40 (r = 0.11, p = 0.043) and total serum Aβ levels (r = -0.097, p = 0.075), but not serum Aβ42 levels (r = 0.17, p = 0.757), were significantly correlated with total capsaicin diet scores.  In multivariate analysis, total capsaicin diet scores were positively associated with MMSE scores and inversely associated with serum Aβ40 levels, and total serum Aβ levels, but not serum Aβ42 levels and the ratio of Aβ42/Aβ40, after adjustment for age, gender, educational level, smoking history, alcohol consumption, body mass index (BMI) and comorbidities.  CONCLUSION:  These findings suggest that a capsaicin-rich diet may exert favorable effects on AD blood biomarkers and cognitive function in middle-aged and elderly adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSp3zRpgU0SovKgEt20y1XfW6udTcc2ebWTgT74k-h1Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bgtVOqsQ%253D%253D&md5=87f957b8e66bd2f51ba92457d7f7a842</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.3233%2FJAD-151079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-151079%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.-H.%26aulast%3DBu%26aufirst%3DX.-L.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DL.-L.%26aulast%3DWang%26aufirst%3DQ.-H.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DYao%26aufirst%3DX.-Q.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.-D.%26aulast%3DWang%26aufirst%3DY.-J.%26atitle%3DThe%2520associations%2520between%2520a%2520capsaicin-rich%2520diet%2520and%2520blood%2520amyloid-%25CE%25B2%2520levels%2520and%2520cognitive%2520function%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2016%26volume%3D52%26spage%3D1081%26epage%3D1088%26doi%3D10.3233%2FJAD-151079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.-W.</span></span> <span> </span><span class="NLM_article-title">Capsaicin ameliorates stress-induced Alzheimer’s disease-like pathological and cognitive impairments in rats</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.3233/JAD-121837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3233%2FJAD-121837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=23340038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A280%3ADC%252BC3szhsV2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2013&pages=91-105&author=X.+Jiangauthor=L.-W.+Jiaauthor=X.-H.+Liauthor=X.-S.+Chengauthor=J.-Z.+Xieauthor=Z.-W.+Maauthor=W.-J.+Xuauthor=Y.+Liuauthor=Y.+Yaoauthor=L.-L.+Duauthor=X.-W.+Zhou&title=Capsaicin+ameliorates+stress-induced+Alzheimer%E2%80%99s+disease-like+pathological+and+cognitive+impairments+in+rats&doi=10.3233%2FJAD-121837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Capsaicin ameliorates stress-induced Alzheimer's disease-like pathological and cognitive impairments in rats</span></div><div class="casAuthors">Jiang Xia; Jia Lin-Wei; Li Xiao-Hong; Cheng Xiang-Shu; Xie Jia-Zhao; Ma Zhi-Wei; Xu Wei-Jie; Liu Yue; Yao Yun; Du Lai-Ling; Zhou Xin-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-105</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hyperphosphorylated tau aggregated into neurofibrillary tangles is a hallmark lesion of Alzheimer's disease (AD) and is linked to synaptic and cognitive impairments.  In animal models, cold water stress (CWS) can cause cognitive disorder and tau hyperphosphorylation.  Capsaicin (CAP), a specific TRPV1 agonist, is neuroprotective against stress-induced impairment, but the detailed mechanisms are still elusive.  Here, we investigated whether CAP mitigates CWS-induced cognitive and AD-like pathological alterations in rats.  The animals were administered CAP (10 mg/kg in 0.2 ml, 0.1% ethanol) or a control (0.2 ml normal saline, 0.1% ethanol) by intragastric infusion 1 h before CWS treatment.  Our results showed that CAP significantly attenuated CWS-induced spatial memory impairment and suppression of PP-DG long-term potentiation; CAP abolished CWS-induced dendritic regression and enhanced several memory-associated proteins decreased by CWS, such as synapsin I and PSD93; CAP also prevented CWS-induced tau hyperphosphorylation by abolishing inhibition of protein phosphatase 2A.  Taken together, this study demonstrated that activation of TRPV1 can mitigate CWS-induced AD-like neuropathological alterations and cognitive impairment and may be a promising target for therapeutic intervention in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOFtVP-kWcL8K3uFsUIZtkfW6udTcc2eYh2XXRhUfbL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szhsV2hsQ%253D%253D&md5=47007316cb4860024cd180bdf1b47da8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3233%2FJAD-121837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-121837%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DL.-W.%26aulast%3DLi%26aufirst%3DX.-H.%26aulast%3DCheng%26aufirst%3DX.-S.%26aulast%3DXie%26aufirst%3DJ.-Z.%26aulast%3DMa%26aufirst%3DZ.-W.%26aulast%3DXu%26aufirst%3DW.-J.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DL.-L.%26aulast%3DZhou%26aufirst%3DX.-W.%26atitle%3DCapsaicin%2520ameliorates%2520stress-induced%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathological%2520and%2520cognitive%2520impairments%2520in%2520rats%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2013%26volume%3D35%26spage%3D91%26epage%3D105%26doi%3D10.3233%2FJAD-121837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Achab, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morral, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baños, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivas, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span> <span> </span><span class="NLM_article-title">New tacrine–huperzine a hybrids (huprines): Highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4657</span>– <span class="NLM_lpage">4666</span>, <span class="refDoi"> DOI: 10.1021/jm000980y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000980y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4657-4666&author=P.+Campsauthor=R.+El+Achabauthor=J.+Morralauthor=D.+Mu%C3%B1oz-Torreroauthor=A.+Badiaauthor=J.+E.+Ba%C3%B1osauthor=N.+M.+Vivasauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luque&title=New+tacrine%E2%80%93huperzine+a+hybrids+%28huprines%29%3A+Highly+potent+tight-binding+acetylcholinesterase+inhibitors+of+interest+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm000980y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Camps, Pelayo; El Achab, Rachid; Morral, Jordi; Munoz-Torrero, Diego; Badia, Albert; Banos, Josep Eladi; Vivas, Nuria Maria; Barril, Xavier; Orozco, Modesto; Luque, Francisco Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4657-4666</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several new 12-amino-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline derivs. (tacrine-huperzine A hybrids, huprines) (I) (R = Me, Et; R1, R3 = H, F, Me, Cl; R2 = H, Cl) have been synthesized and tested as acetylcholinesterase (AChE) inhibitors.  All of the new compds. contain either a Me or Et group at position 9 and one or two (chloro, fluoro, or methyl) substituents at positions 1, 2, or 3.  Among the monosubstituted derivs., the more active are those substituted at position 3, their activity following the order 3-chloro > 3-fluoro > 3-Me > 3-hydrogen.  For the 1,3-difluoro and 1,3-di-Me derivs., the effect of the substituents is roughly additive.  No significant differences were obsd. for the inhibitory activity of 9-Me vs 9-Et derivs. mono- or disubstituted at positions 1 and/or 3.  The levorotatory enantiomers of these hybrid compds. are much more active (eutomers) than the dextrorotatory forms (distomers) as AChE inhibitors.  Compds. rac- and (-)-I (R = Me, R3 = Cl) (II), rac- and (-)-I (R = Et, R3 = F) (III), rac- and (-)-I (R = Et, R3 = Cl) (IV) and rac-I (R = Et; R1, R3 = Cl) (V) showed human AChE inhibitory activities up to 28.5-fold higher than for the corresponding bovine enzyme. Also, rac-I (R = Me; R1, R3 = F) , (-)-II, (-)-IV, and rac-V were very selective for human AChE vs butyrylcholinesterase (BChE), the AChE inhibitory activities being 438-871-fold higher than for BChE.  Several hybrid compds., specially (-)-II and (-)-IV, exhibited tight-binding character, showing higher activity after incubation of the enzyme with the inhibitor than without incubation, though the reversible nature of the enzyme-inhibitor interaction was demonstrated by dialysis.  The results of the ex vivo expts. also supported the tight-binding character of compds. (-)-II and (-)-IV and showed their ability to cross the blood-brain barrier.  Mol. modeling simulations of the AChE-inhibitor complex provided a basis to explain the differences in inhibitory activity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsF13Zjc-Ak7Vg90H21EOLACvtfcHk0liAF4t8420CWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbk%253D&md5=6ec0e45bc36f91124d1ba17f1c1f4957</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm000980y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000980y%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DEl%2BAchab%26aufirst%3DR.%26aulast%3DMorral%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DBa%25C3%25B1os%26aufirst%3DJ.%2BE.%26aulast%3DVivas%26aufirst%3DN.%2BM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DNew%2520tacrine%25E2%2580%2593huperzine%2520a%2520hybrids%2520%2528huprines%2529%253A%2520Highly%2520potent%2520tight-binding%2520acetylcholinesterase%2520inhibitors%2520of%2520interest%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4657%26epage%3D4666%26doi%3D10.1021%2Fjm000980y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusack, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallender, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Achab, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morral, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberry, T. L.</span></span> <span> </span><span class="NLM_article-title">Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer’s disease</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10648652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVaktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=409-417&author=P.+Campsauthor=B.+Cusackauthor=W.+D.+Mallenderauthor=R.+El+Achabauthor=D.+Morralauthor=D.+Mu%C3%B1oz-Torreroauthor=T.+L.+Rosenberry&title=Huprine+X+is+a+novel+high-affinity+inhibitor+of+acetylcholinesterase+that+is+of+interest+for+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease</span></div><div class="casAuthors">Camps, Pelayo; Cusack, Bernadette; Mallender, William D.; El Achab, Rachid; Morral, Jordi; Munoz-Torrero, Diego; Rosenberry, Terrone L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">409-417</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Inhibitors of the enzyme acetylcholinesterase (AChE) slow and sometimes reverse the cognitive decline experienced by individuals with Alzheimer's disease.  Huperzine A, a natural product used in traditional Chinese herbal medicine, and tacrine (Cognex) are among the potent AChE inhibitors used in this treatment, but the search for more selective inhibitors continues.  The authors report herein the synthesis and characterization of (-)-12-amino-3-chloro-9-ethyl-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline hydrochloride (huprine X), a hybrid that combines the carbobicyclic substructure of huperzine A with the 4-aminoquinoline substructure of tacrine.  Huprine X inhibited human AChE with an inhibition const. K1 of 26 pM, indicating that it binds to this enzyme with one of the highest affinities yet reported.  Under equiv. assay conditions, this affinity was 180 times that of huperzine A, 1200 times that of tacrine, and 40 times that of E2020 (donepezil, Aricept), the most selective AChE inhibitor currently approved for therapeutic use.  The assocn. and dissocn. rate consts. for huprine X with AChE were detd., and the location of its binding site on the enzyme was probed in competition studies with the peripheral site inhibitor propidium and the acylation site inhibitor edrophonium.  Huprine X showed no detectable affinity for the edrophonium-AChE complex.  In contrast, huprine X did form a ternary complex with propidium and AChE, although its affinity for the free enzyme was 17 times its affinity for the propidium-AChE complex.  These data indicated that huprine X binds to the enzyme acylation site in the active site gorge but interferes slightly with the binding of peripheral site ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2bDHx0sMs77Vg90H21EOLACvtfcHk0lgvkK_uEV3-8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVaktL8%253D&md5=67367a2cb8be3aac53791ec23662efd8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DCusack%26aufirst%3DB.%26aulast%3DMallender%26aufirst%3DW.%2BD.%26aulast%3DEl%2BAchab%26aufirst%3DR.%26aulast%3DMorral%26aufirst%3DD.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26atitle%3DHuprine%2520X%2520is%2520a%2520novel%2520high-affinity%2520inhibitor%2520of%2520acetylcholinesterase%2520that%2520is%2520of%2520interest%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D409%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alcalá, M. d. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivas, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hospital, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span> <span> </span><span class="NLM_article-title">Characterisation of the anticholinesterase activity of two new tacrine–huperzine A hybrids</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(03)00071-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2FS0028-3908%2803%2900071-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=12681373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1yqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=749-755&author=M.+d.+M.+Alcal%C3%A1author=N.+M.+Vivasauthor=S.+Hospitalauthor=P.+Campsauthor=D.+Mu%C3%B1oz-Torreroauthor=A.+Badia&title=Characterisation+of+the+anticholinesterase+activity+of+two+new+tacrine%E2%80%93huperzine+A+hybrids&doi=10.1016%2FS0028-3908%2803%2900071-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids</span></div><div class="casAuthors">Alcala, Maria del Mar; Vivas, Nuria Maria; Hospital, Susana; Camps, Pelayo; Munoz-Torrero, Diego; Badia, Albert</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">749-755</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The effects of two tacrine-huperzine A hybrids, (±)-huprine Y and (±)-huprine Z, have been evaluated.  Bovine and human acetylcholinesterase (AChE) and human butyrylcholinesterase (BChE) inhibition were assayed by Ellman's method.  The two huprines were more active than both tacrine and (-)-huperzine A as inhibitors of both human and bovine AChE, and they acted as mixed-type AChE inhibitors.  Moreover, (±)-huprine Y exhibited a tight binding character seen in the expts. of reversibility of bovine AChE inhibitory activity.  In addn., both compds. were more active toward AChE than toward BChE.  Also, the selectivity for the human AChE was greater than for the bovine enzyme.  In ex vivo studies performed in mice, both drugs showed a clear inhibitory activity of brain AChE, 20 min after i.p. injection, (±)-huprine Y being more potent than (±)-huprine Z [ID50 1.09 (0.39-2.98) vs. 5.77 (3.29-10.30) μmol/kg].  The time-course study of the inhibitory effect displayed a t1/2 of 1 h for the two compds.  These results show that these drugs are two potent, central AChE inhibitors of potential interest in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUGWagi5oe2LVg90H21EOLACvtfcHk0lgvkK_uEV3-8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1yqs7s%253D&md5=0caba6a05b0b611199c3920e304e46e1</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2803%2900071-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252803%252900071-6%26sid%3Dliteratum%253Aachs%26aulast%3DAlcal%25C3%25A1%26aufirst%3DM.%2Bd.%2BM.%26aulast%3DVivas%26aufirst%3DN.%2BM.%26aulast%3DHospital%26aufirst%3DS.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DBadia%26aufirst%3DA.%26atitle%3DCharacterisation%2520of%2520the%2520anticholinesterase%2520activity%2520of%2520two%2520new%2520tacrine%25E2%2580%2593huperzine%2520A%2520hybrids%26jtitle%3DNeuropharmacology%26date%3D2003%26volume%3D44%26spage%3D749%26epage%3D755%26doi%3D10.1016%2FS0028-3908%2803%2900071-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span> <span> </span><span class="NLM_article-title">Huprines for Alzheimer’s disease drug development</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1517/17460441.3.1.65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1517%2F17460441.3.1.65" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=23480140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVGnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=65-81&author=D.+Mu%C3%B1oz-Torreroauthor=P.+Camps&title=Huprines+for+Alzheimer%E2%80%99s+disease+drug+development&doi=10.1517%2F17460441.3.1.65"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Huprines for Alzheimer's disease drug development</span></div><div class="casAuthors">Munoz-Torrero, Diego; Camps, Pelayo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-81</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: So far, acetylcholinesterase (AChE) inhibitors have dominated the therapeutic arsenal for Alzheimer's disease.  Although conceptually developed as symptomatic drugs, mounting evidence suggests that these compds. can pos. modify the disease progression, which has spurred the development of novel classes of AChE inhibitors.  Objective: This article reviews the development of novel classes of high affinity AChE inhibitors following a design strategy based on mol. hybridization by stepwise incorporation of different fragments of the known AChE inhibitors (-)-huperzine A and tacrine.  Methods: This review covers the existing literature dealing with the design, synthesis and structural and pharmacol. characterization of the title compds.  Results/conclusion: Three novel classes of AChE inhibitors of increasing structural complexity and affinity have been developed, namely huprines, 13-amidohuprines and huprine-tacrine heterodimers.  Particularly, huprines and huprine-tacrine heterodimers exhibit a unique profile encompassing both cholinergic and non-cholinergic disease-modifying effects and, thus, constitute promising anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaOXBUowHpHbVg90H21EOLACvtfcHk0lgvkK_uEV3-8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVGnt7g%253D&md5=b447bd51d96791d19b378ef7cf47a5c4</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1517%2F17460441.3.1.65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.3.1.65%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DP.%26atitle%3DHuprines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520drug%2520development%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D65%26epage%3D81%26doi%3D10.1517%2F17460441.3.1.65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapia-Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juárez-Jiménez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2549</span>– <span class="NLM_lpage">2567</span>, <span class="refDoi"> DOI: 10.1021/jm401824w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401824w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2549-2567&author=E.+Viaynaauthor=I.+Solaauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=C.+Tapia-Rojasauthor=F.+G.+Serranoauthor=R.+Sabat%C3%A9author=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=B.+P%C3%A9rezauthor=F.+J.+Luqueauthor=V.+Andrisanoauthor=M.+V.+Closauthor=N.+C.+Inestrosaauthor=D.+Mu%C3%B1oz-Torrero&title=Synthesis+and+multitarget+biological+profiling+of+a+novel+family+of+rhein+derivatives+as+disease-modifying+anti-Alzheimer+agents&doi=10.1021%2Fjm401824w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span></div><div class="casAuthors">Viayna, Elisabet; Sola, Irene; Bartolini, Manuela; De Simone, Angela; Tapia-Rojas, Cheril; Serrano, Felipe G.; Sabate, Raimon; Juarez-Jimenez, Jordi; Perez, Belen; Luque, F. Javier; Andrisano, Vincenza; Clos, M. Victoria; Inestrosa, Nibaldo C.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2549-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a family of rhein-huprine hybrids I [X = (CH2)n, n = 5-11; X = CH2-p-phenylene-CH2] to hit several key targets for Alzheimer's disease.  Biol. screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Aβ42 and tau antiaggregating activity, and brain permeability.  Ex vivo studies with the leads (+)- and (-)-I [X = (CH2)9] (II) in brain slices of C57bl6 mice have revealed that they efficiently protect against the Aβ-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a pos. effect on the induction of long-term potentiation.  In vivo studies in APP-PS1 transgenic mice treated i.p. for 4 wk with (+)- and (-)-II have shown a central sol. Aβ lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP).  Thus, (+)- and (-)-II emerge as very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeoyGkrcOQArVg90H21EOLACvtfcHk0lhDd__btYFk4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D&md5=711450b3c2289a3fb2037d536e9a7a7b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401824w%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520multitarget%2520biological%2520profiling%2520of%2520a%2520novel%2520family%2520of%2520rhein%2520derivatives%2520as%2520disease-modifying%2520anti-Alzheimer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2549%26epage%3D2567%26doi%3D10.1021%2Fjm401824w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formosa, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minguillón, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Muñoz, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidon-Chanal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Huprine–tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer’s and prion diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1021/jm200840c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200840c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ersLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=661-669&author=C.+Galdeanoauthor=E.+Viaynaauthor=I.+Solaauthor=X.+Formosaauthor=P.+Campsauthor=A.+Badiaauthor=M.+V.+Closauthor=J.+Relatauthor=M.+Ratiaauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+Salmonaauthor=C.+Minguill%C3%B3nauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Huprine%E2%80%93tacrine+heterodimers+as+anti-amyloidogenic+compounds+of+potential+interest+against+Alzheimer%E2%80%99s+and+prion+diseases&doi=10.1021%2Fjm200840c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Huprine-Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer's and Prion Diseases</span></div><div class="casAuthors">Galdeano, Carles; Viayna, Elisabet; Sola, Irene; Formosa, Xavier; Camps, Pelayo; Badia, Albert; Clos, M. Victoria; Relat, Julia; Ratia, Miriam; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Salmona, Mario; Minguillon, Cristina; Gonzalez-Munoz, Gema C.; Rodriguez-Franco, M. Isabel; Bidon-Chanal, Axel; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">661-669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A family of huprine-tacrine heterodimers has been developed to simultaneously block the active and peripheral sites of acetylcholinesterase (AChE).  Their dual site binding for AChE, supported by kinetic and mol. modeling studies, results in a highly potent inhibition of the catalytic activity of human AChE and, more importantly, in the in vitro neutralization of the pathol. chaperoning effect of AChE toward the aggregation of both the β-amyloid peptide (Aβ) and a prion peptide with a key role in the aggregation of the prion protein.  Huprine-tacrine heterodimers take on added value in that they display a potent in vitro inhibitory activity toward human butyrylcholinesterase, self-induced Aβ aggregation, and β-secretase.  Finally, they are able to cross the blood-brain barrier, as predicted in an artificial membrane model assay and demonstrated in ex vivo expts. with OF1 mice, reaching their multiple biol. targets in the central nervous system.  Overall, these compds. are promising lead compds. for the treatment of Alzheimer's and prion diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSrojS0ckMVLVg90H21EOLACvtfcHk0lhDd__btYFk4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ersLnN&md5=e0fbec47bca527df4e8ed73c847383e9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm200840c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200840c%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DRelat%26aufirst%3DJ.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DMinguill%25C3%25B3n%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DHuprine%25E2%2580%2593tacrine%2520heterodimers%2520as%2520anti-amyloidogenic%2520compounds%2520of%2520potential%2520interest%2520against%2520Alzheimer%25E2%2580%2599s%2520and%2520prion%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D661%26epage%3D669%26doi%3D10.1021%2Fjm200840c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramírez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdaguer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junyent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallàs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arce, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidon-Chanal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1855</span>– <span class="NLM_lpage">1870</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fcmdc.201000322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=20859987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlClu73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1855-1870&author=E.+Viaynaauthor=T.+G%C3%B3mezauthor=C.+Galdeanoauthor=L.+Ram%C3%ADrezauthor=M.+Ratiaauthor=A.+Badiaauthor=M.+V.+Closauthor=E.+Verdaguerauthor=F.+Junyentauthor=A.+Caminsauthor=M.+Pall%C3%A0sauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=P.+Campsauthor=D.+Mu%C3%B1oz-Torrero&title=Novel+huprine+derivatives+with+inhibitory+activity+toward+%CE%B2-amyloid+aggregation+and+formation+as+disease-modifying+anti-Alzheimer+drug+candidates&doi=10.1002%2Fcmdc.201000322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Huprine Derivatives with Inhibitory Activity toward β-Amyloid Aggregation and Formation as Disease-Modifying Anti-Alzheimer Drug Candidates</span></div><div class="casAuthors">Viayna, Elisabet; Gomez, Tania; Galdeano, Carles; Ramirez, Lorena; Ratia, Miriam; Badia, Albert; Clos, M. Victoria; Verdaguer, Ester; Junyent, Felix; Camins, Antoni; Pallas, Merce; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Arce, Mariana P.; Rodriguez-Franco, Maria Isabel; Bidon-Chanal, Axel; Luque, F. Javier; Camps, Pelayo; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1855-1870</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A new family of dual binding site acetylcholinesterase (AChE) inhibitors has been designed, synthesized, and tested for their ability to inhibit AChE, butyrylcholinesterase (BChE), AChE-induced and self-induced β-amyloid (Aβ) aggregation and β-secretase (BACE-1), and to cross the blood-brain barrier.  The new heterodimers consist of a unit of racemic or enantiopure huprine Y or X and a donepezil-related 5,6-dimethoxy-2-[(4-piperidinyl)methyl]indane moiety as the active site and peripheral site to mid-gorge-interacting moieties, resp., connected through a short oligomethylene linker.  Mol. dynamics simulations and kinetics studies support the dual site binding to AChE.  The new heterodimers are potent inhibitors of human AChE and moderately potent inhibitors of human BChE, AChE-induced and self-induced Aβ aggregation, and BACE-1, and are predicted to be able to enter the central nervous system (CNS), thus constituting promising multitarget anti-Alzheimer drug candidates with the potential to modify the natural course of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHqjappn2Nv7Vg90H21EOLACvtfcHk0liyfLrRPUrF8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlClu73F&md5=1e25a3705b61ce71762508198a10f044</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000322%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DG%25C3%25B3mez%26aufirst%3DT.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DRam%25C3%25ADrez%26aufirst%3DL.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DVerdaguer%26aufirst%3DE.%26aulast%3DJunyent%26aufirst%3DF.%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DNovel%2520huprine%2520derivatives%2520with%2520inhibitory%2520activity%2520toward%2520%25CE%25B2-amyloid%2520aggregation%2520and%2520formation%2520as%2520disease-modifying%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1855%26epage%3D1870%26doi%3D10.1002%2Fcmdc.201000322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucault, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span> <span> </span><span class="NLM_article-title">New huprine derivatives functionalized at position 9 as highly potent acetylcholinesterase inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000523</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fcmdc.201000523" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=21344648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=876-888&author=C.+Roncoauthor=R.+Foucaultauthor=E.+Gillonauthor=P.+Bohnauthor=F.+Nachonauthor=L.+Jeanauthor=P.-Y.+Renard&title=New+huprine+derivatives+functionalized+at+position+9+as+highly+potent+acetylcholinesterase+inhibitors&doi=10.1002%2Fcmdc.201000523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">New Huprine Derivatives Functionalized at Position 9 as Highly Potent Acetylcholinesterase Inhibitors</span></div><div class="casAuthors">Ronco, Cyril; Foucault, Richard; Gillon, Emilie; Bohn, Pierre; Nachon, Florian; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">876-888</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of 24 huprine derivs. diversely functionalized at position 9 have been synthesized and evaluated for their inhibitory activity against human recombinant acetylcholinesterase (AChE).  These derivs. were prepd. in one to five steps from huprine 1 bearing an ester function at position 9.  Ten analogs (1, 2, 6-9, 13-15, and 23) are active in the low nanomolar range (IC50 <5 nM), very close to the parent compd. huprine X.  Compds. 2, 6, and 7 show a very good selectivity for AChE, with AChE inhibitory activities 700-1160-fold higher than those for butyrylcholinesterase (BChE).  The inhibitory potency of these compds. decreases with the steric bulk of the substituents at position 9.  According to docking simulations, small substituents fit into the acyl-binding pocket, whereas the larger ones stick out of the active site gorge of AChE.  Detn. of the kinetic parameters of three of the most potent huprines (2, 6, and 7) showed that most of the difference in KD is accounted by a decrease in kon, which is correlated to the increase of the substituent size.  A first in vivo evaluation has been performed in mice for the most active compd. 2 (I, IC50=1.1 nM) and showed a rather weak toxicity (LD50=40 mg kg-1) and an ability to cross the blood-brain barrier with doses above 15 mg kg-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmJUII0bHstbVg90H21EOLACvtfcHk0liyfLrRPUrF8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFGis7Y%253D&md5=bea8949ab5693c5698a106965160688f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000523%26sid%3Dliteratum%253Aachs%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DFoucault%26aufirst%3DR.%26aulast%3DGillon%26aufirst%3DE.%26aulast%3DBohn%26aufirst%3DP.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DNew%2520huprine%2520derivatives%2520functionalized%2520at%2520position%25209%2520as%2520highly%2520potent%2520acetylcholinesterase%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D876%26epage%3D888%26doi%3D10.1002%2Fcmdc.201000523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletier, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span> <span> </span><span class="NLM_article-title">Huprine derivatives as sub-nanomolar human acetylcholinesterase inhibitors: From rational design to validation by X-ray crystallography</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">400</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fcmdc.201100438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=22052791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSkurzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=400-405&author=C.+Roncoauthor=E.+Carlettiauthor=J.-P.+Colletierauthor=M.+Weikauthor=F.+Nachonauthor=L.+Jeanauthor=P.-Y.+Renard&title=Huprine+derivatives+as+sub-nanomolar+human+acetylcholinesterase+inhibitors%3A+From+rational+design+to+validation+by+X-ray+crystallography&doi=10.1002%2Fcmdc.201100438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Huprine Derivatives as Sub-Nanomolar Human Acetylcholinesterase Inhibitors: From Rational Design to Validation by X-ray Crystallography</span></div><div class="casAuthors">Ronco, Cyril; Carletti, Eugenie; Colletier, Jacques-Philippe; Weik, Martin; Nachon, Florian; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">400-405</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Huprine derivs. were prepd. and tested for acetylcholinesterase inhibitory activity.  The X-ray crystal structure of the most active analog with mAChE was detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouCO4a9sKh5rVg90H21EOLACvtfcHk0lg2lJ1Sz2F7iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSkurzK&md5=87fb10ade229545e62b6cb5228ea7914</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100438%26sid%3Dliteratum%253Aachs%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DCarletti%26aufirst%3DE.%26aulast%3DColletier%26aufirst%3DJ.-P.%26aulast%3DWeik%26aufirst%3DM.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DHuprine%2520derivatives%2520as%2520sub-nanomolar%2520human%2520acetylcholinesterase%2520inhibitors%253A%2520From%2520rational%2520design%2520to%2520validation%2520by%2520X-ray%2520crystallography%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D400%26epage%3D405%26doi%3D10.1002%2Fcmdc.201100438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carr, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wease, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ryssen, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agate, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roderick, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span> <span> </span><span class="NLM_article-title">In vitro photo-release of a TRPV1 agonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">208</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bmcl.2005.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=16213723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1CitrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=208-212&author=J.+L.+Carrauthor=K.+N.+Weaseauthor=M.+P.+Van+Ryssenauthor=S.+Patersonauthor=B.+Agateauthor=K.+A.+Gallagherauthor=C.+T.+A.+Brownauthor=H.+S.+Roderickauthor=S.+J.+Conway&title=In+vitro+photo-release+of+a+TRPV1+agonist&doi=10.1016%2Fj.bmcl.2005.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro photo-release of a TRPV1 agonist</span></div><div class="casAuthors">Carr, James L.; Wease, Kerrie N.; Van Ryssen, Michael P.; Paterson, Suzanne; Agate, Ben; Gallagher, Katherine A.; Brown, C. Tom A.; Scott, Roderick H.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">208-212</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Intracellular photolysis of a novel 'caged' capsaicin analog results in in vitro activation of the capsaicin receptor TRPV1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJu4EHI00657Vg90H21EOLACvtfcHk0lg2lJ1Sz2F7iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1CitrzO&md5=37552ee365337d99a6bf26a68d6817d6</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DJ.%2BL.%26aulast%3DWease%26aufirst%3DK.%2BN.%26aulast%3DVan%2BRyssen%26aufirst%3DM.%2BP.%26aulast%3DPaterson%26aufirst%3DS.%26aulast%3DAgate%26aufirst%3DB.%26aulast%3DGallagher%26aufirst%3DK.%2BA.%26aulast%3DBrown%26aufirst%3DC.%2BT.%2BA.%26aulast%3DRoderick%26aufirst%3DH.%2BS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DIn%2520vitro%2520photo-release%2520of%2520a%2520TRPV1%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D208%26epage%3D212%26doi%3D10.1016%2Fj.bmcl.2005.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallverdú-Queralt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragusa, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamuela-Raventós, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5298</span>– <span class="NLM_lpage">5307</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.07.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bmc.2014.07.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=25156301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCjurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5298-5307&author=F.+J.+P%C3%A9rez-Arealesauthor=O.+Di+Pietroauthor=A.+Espargar%C3%B3author=A.+Vallverd%C3%BA-Queraltauthor=C.+Galdeanoauthor=I.+M.+Ragusaauthor=E.+Viaynaauthor=C.+Guillouauthor=M.+V.+Closauthor=B.+P%C3%A9rezauthor=R.+Sabat%C3%A9author=R.+M.+Lamuela-Ravent%C3%B3sauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Shogaol-huprine+hybrids%3A+dual+antioxidant+and+anticholinesterase+agents+with+%CE%B2-amyloid+and+tau+anti-aggregating+properties&doi=10.1016%2Fj.bmc.2014.07.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Shogaol-huprine hybrids: Dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties</span></div><div class="casAuthors">Perez-Areales, F. Javier; Di Pietro, Ornella; Espargaro, Alba; Vallverdu-Queralt, Anna; Galdeano, Carles; Ragusa, Ilaria M.; Viayna, Elisabet; Guillou, Catherine; Clos, M. Victoria; Perez, Belen; Sabate, Raimon; Lamuela-Raventos, Rosa M.; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5298-5307</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Multitarget compds. are increasingly being pursued for the effective treatment of complex diseases.  Herein, the authors describe the design and synthesis of a novel class of shogaol-huprine hybrids, e.g. I [R = H, Me2NCH2], purported to hit several key targets involved in Alzheimer's disease.  The hybrids have been tested in vitro for their inhibitory activity against human acetylcholinesterase and butyrylcholinesterase and antioxidant activity (ABTS·+, DPPH and Folin-Ciocalteu assays), and in intact Escherichia coli cells for their Aβ42 and tau antiaggregating activity.  Also, their brain penetration has been assessed (PAMPA-BBB assay).  Even though the hybrids are not as potent AChE inhibitors or antioxidant agents as the parent huprine Y and [4]-shogaol, resp., they still exhibit very potent anticholinesterase and antioxidant activities and are much more potent Aβ42 and tau antiaggregating agents than the parent compds.  Overall, the shogaol-huprine hybrids emerge as interesting brain permeable multitarget anti-Alzheimer leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoviJP_RhoyE7Vg90H21EOLACvtfcHk0ljXDG6WxN-Mdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCjurbK&md5=7dca605e8747562c21962d7cb4a7b5df</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DVallverd%25C3%25BA-Queralt%26aufirst%3DA.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DRagusa%26aufirst%3DI.%2BM.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DGuillou%26aufirst%3DC.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DLamuela-Ravent%25C3%25B3s%26aufirst%3DR.%2BM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DShogaol-huprine%2520hybrids%253A%2520dual%2520antioxidant%2520and%2520anticholinesterase%2520agents%2520with%2520%25CE%25B2-amyloid%2520and%2520tau%2520anti-aggregating%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5298%26epage%3D5307%26doi%3D10.1016%2Fj.bmc.2014.07.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubbs, R. H.</span></span> <span> </span><span class="NLM_article-title">Prevention of undesirable isomerization during olefin metathesis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">17160</span>– <span class="NLM_lpage">17161</span>, <span class="refDoi"> DOI: 10.1021/ja052939w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja052939w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Srsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=17160-17161&author=S.+H.+Hongauthor=D.+P.+Sandersauthor=C.+W.+Leeauthor=R.+H.+Grubbs&title=Prevention+of+undesirable+isomerization+during+olefin+metathesis&doi=10.1021%2Fja052939w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of Undesirable Isomerization during Olefin Metathesis</span></div><div class="casAuthors">Hong, Soon Hyeok; Sanders, Daniel P.; Lee, Choon Woo; Grubbs, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">17160-17161</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In olefin metathesis, ring-closing olefin metathesis, and cross-metathesis reactions catalyzed by ruthenium carbene complexes, the addn. of benzoquinones such as 1,4-benzoquinone to the reaction mixts. inhibits isomerization reactions of the products.  Stereoselective isomerizations of (Z)-Me3CSi(Me)2OCH2CH2CH:CHCO2Me and (Z)-Me3CSi(Me)2OCH2CH:CHCH2OSi(Me)2CMe3 to their corresponding (E)-isomers yield 81% and >95% of silyl enol ether products derived from olefin isomerization in the absence of an additive, while isomerization in the presence of 1,4-benzoquinone yields >95% yields of the desired products.  The ring closing metathesis reactions of N,N-diallylaniline and of diallyl ether in the presence of the 2nd generation Grubbs olefin metathesis catalyst provide >90% yields of the dihydropyrrole and dihydrofuran products in the presence of 1,4-benzoquinone, while yielding 16% and <5% yields of the desired products in the absence of an additive.  Cross-metathesis reactions of meadow foam Me esters RCH:CH(CH2)3CO2Me [R = Me(CH2)13, Me(CH2)15, Me(CH2)7CH:CH(CH2)6] and of Me(CH2)5CH:CH(CH2)10OAc with ethylene in the presence of (benzylidene)bis(tricyclohexylphosphino)ruthenium dichloride provide Me 5-hexenoate and 1-decene and 11-dodecen-1-yl acetate with 1-2% isomerization in the presence of 1,4-benzoquinone, while providing products with 30-49% isomerization in the absence of an additive.  Nine benzoquinones are tried as isomerization inhibitors for ruthenium-catalyzed olefin metathesis reactions; benzoquinones with electron-withdrawing substituents such as tetrafluoro-1,4-benzoquinone and 2,6-dichloro-1,4-benzoquinones are the most effective additives of those tried for inhibiting olefin isomerization reactions.  1,4-Benzoquinone is not effective at preventing isomerization reactions in the ring-closing metathesis of either N-Me diallylamine or N-benzyldiallylamine.  Acetic acid is an effective additive for preventing olefin shifts in the isomerization of (Z)-Me3CSi(Me)2OCH2CH2CH:CHCO2Me and in the ring-closing metathesis of diallyl ether, but is ineffective at preventing undesired isomerization in the stereoisomerization of (Z)-Me3CSi(Me)2OCH2CH:CHCH2OSi(Me)2CMe3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrznNbMnmnI07Vg90H21EOLACvtfcHk0ljXDG6WxN-Mdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Srsb3N&md5=21381b4688a152a1475686db44cfc26c</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fja052939w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja052939w%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DS.%2BH.%26aulast%3DSanders%26aufirst%3DD.%2BP.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DPrevention%2520of%2520undesirable%2520isomerization%2520during%2520olefin%2520metathesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D17160%26epage%3D17161%26doi%3D10.1021%2Fja052939w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oukoloff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieslikiewicz-Bouet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mougeot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span> <span> </span><span class="NLM_article-title">Improved access to huprine derivatives functionalized at position 9</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">1337</span>– <span class="NLM_lpage">1343</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201501433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fejoc.201501433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC28XitF2qtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=1337-1343&author=K.+Oukoloffauthor=S.+Chaoauthor=M.+Cieslikiewicz-Bouetauthor=R.+Mougeotauthor=L.+Jeanauthor=P.-Y.+Renard&title=Improved+access+to+huprine+derivatives+functionalized+at+position+9&doi=10.1002%2Fejoc.201501433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Access to Huprine Derivatives Functionalized at Position 9</span></div><div class="casAuthors">Oukoloff, Killian; Chao, Sovy; Cieslikiewicz-Bouet, Monika; Mougeot, Romain; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1337-1343</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Herein, we present an improved synthetic pathway to huprine derivs. (the most potent family of non-covalent acetylcholinesterase inhibitors described to date) with different functional groups at the C9-position of the scaffold.  Our approach enables selection of the desired terminal function prior to construction of the huprine scaffold and consists of three main steps: enol formation from a bicyclic ketone, Suzuki-Miyaura cross coupling with different borane derivs. and a Friedlaender condensation to access to the quinoline moiety.  This synthetic route was found particularly useful for construction of huprine scaffolds equipped with methylene chains bearing different terminal groups such as hydroxy, azide, nitro, amino and carboxylic groups.  These functionalized huprines are used as key intermediates in the prepn. of multi-target directed ligands for the treatment of Alzheimer's disease or in the prepn. of resins for purifn. of cholinesterases by affinity chromatog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbAdl9DvOCObVg90H21EOLACvtfcHk0lidPhHOWN1soA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitF2qtbY%253D&md5=cd986a7cbb4c52a1378beba8c9b4ed2d</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201501433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201501433%26sid%3Dliteratum%253Aachs%26aulast%3DOukoloff%26aufirst%3DK.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DCieslikiewicz-Bouet%26aufirst%3DM.%26aulast%3DMougeot%26aufirst%3DR.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DImproved%2520access%2520to%2520huprine%2520derivatives%2520functionalized%2520at%2520position%25209%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2016%26volume%3D2016%26spage%3D1337%26epage%3D1343%26doi%3D10.1002%2Fejoc.201501433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brescia, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appell, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brain, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganju, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denholm, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wareing, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacGloinn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBryde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oakley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunez, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gstach, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolle, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, I.</span></span> <span> </span><span class="NLM_article-title">Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bmcl.2008.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=19014884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFCg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=119-122&author=A.+G.+Coleauthor=A.+Metzgerauthor=M.-R.+Bresciaauthor=L.-Y.+Qinauthor=K.+C.+Appellauthor=C.+T.+Brainauthor=A.+Halletauthor=P.+Ganjuauthor=A.+A.+Denholmauthor=J.+R.+Wareingauthor=T.+J.+Ritchieauthor=G.+M.+Drakeauthor=S.+J.+Bevanauthor=A.+MacGloinnauthor=A.+McBrydeauthor=V.+Patelauthor=P.+J.+Oakleyauthor=X.+Nunezauthor=H.+Gstachauthor=P.+Schneiderauthor=J.+J.+Baldwinauthor=R.+E.+Dolleauthor=E.+McDonaldauthor=I.+Henderson&title=Sulfonamido-aryl+ethers+as+bradykinin+B1+receptor+antagonists&doi=10.1016%2Fj.bmcl.2008.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists</span></div><div class="casAuthors">Cole, Andrew G.; Metzger, Axel; Brescia, Marc-Raleigh; Qin, Lan-Ying; Appell, Kenneth C.; Brain, Christopher T.; Hallett, Allan; Ganju, Pam; Denholm, Alastair A.; Wareing, James R.; Ritchie, Timothy J.; Drake, Gillian M.; Bevan, Stuart J.; MacGloinn, Aisling; McBryde, Andrew; Patel, Viral; Oakley, Paul J.; Nunez, Ximena; Gstach, Hubert; Schneider, Peter; Baldwin, John J.; Dolle, Roland E.; McDonald, Edward; Henderson, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-122</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The synthesis and identification of sulfonamido-aryl ethers, i.e. I, as potent bradykinin B1 receptor antagonists from a ∼60,000 member encoded combinatorial library are reported.  Two distinct series of compds. exhibiting different structure-activity relationships were identified in a bradykinin B1 whole-cell receptor-binding assay.  Specific examples exhibit Ki values of ∼10 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozveD1ETF8sbVg90H21EOLACvtfcHk0lidPhHOWN1soA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFCg&md5=f243411a7fc3fe10c8e9c7df087195e4</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DMetzger%26aufirst%3DA.%26aulast%3DBrescia%26aufirst%3DM.-R.%26aulast%3DQin%26aufirst%3DL.-Y.%26aulast%3DAppell%26aufirst%3DK.%2BC.%26aulast%3DBrain%26aufirst%3DC.%2BT.%26aulast%3DHallet%26aufirst%3DA.%26aulast%3DGanju%26aufirst%3DP.%26aulast%3DDenholm%26aufirst%3DA.%2BA.%26aulast%3DWareing%26aufirst%3DJ.%2BR.%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DDrake%26aufirst%3DG.%2BM.%26aulast%3DBevan%26aufirst%3DS.%2BJ.%26aulast%3DMacGloinn%26aufirst%3DA.%26aulast%3DMcBryde%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DOakley%26aufirst%3DP.%2BJ.%26aulast%3DNunez%26aufirst%3DX.%26aulast%3DGstach%26aufirst%3DH.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26aulast%3DDolle%26aufirst%3DR.%2BE.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DHenderson%26aufirst%3DI.%26atitle%3DSulfonamido-aryl%2520ethers%2520as%2520bradykinin%2520B1%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D119%26epage%3D122%26doi%3D10.1016%2Fj.bmcl.2008.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, V.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Featherstone, R. M.</span></span> <span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(61)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity&doi=10.1016%2F0006-2952%2861%2990145-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0ljIMEcL5h1EMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95%26doi%3D10.1016%2F0006-2952%2861%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khorana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markmee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingkaninan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruchirawat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitbunnadaj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullagurla, M. R.</span></span> <span> </span><span class="NLM_article-title">Evaluation of a new lead for acetylcholinesterase inhibition</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1007/s00044-008-9122-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1007%2Fs00044-008-9122-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVShur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=231-241&author=N.+Khoranaauthor=S.+Markmeeauthor=K.+Ingkaninanauthor=S.+Ruchirawatauthor=R.+Kitbunnadajauthor=M.+R.+Pullagurla&title=Evaluation+of+a+new+lead+for+acetylcholinesterase+inhibition&doi=10.1007%2Fs00044-008-9122-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a new lead for acetylcholinesterase inhibition</span></div><div class="casAuthors">Khorana, Nantaka; Markmee, Sutthatip; Ingkaninan, Kornkanok; Ruchirawat, Somsak; Kitbunnadaj, Ruengwit; Pullagurla, Manik Reddy</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-241</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">Acetylcholine is the most common neurotransmitter of the parasympathetic nervous system.  Several cholinergic drugs are widely used in Alzheimer's disease, urinary retention, glaucoma, and myasthenia gravis.  Acetylcholinesterase is the enzyme which destroys naturally occurring acetylcholine, and acetylcholinesterase inhibitors (AChEIs) which block the enzyme are currently used in the treatment of several diseases, most importantly Alzheimer's disease.  Previous studies from our lab. have shown a few isoquinoline analogs to be potential acetylcholinesterase inhibitors.  In the present study we have extended anal. of the structure-activity relationship (SAR) of the isoquinoline ring system as an AChEI.  The corresponding reduced form of 1-(3,4-dimethoxybenzyl)-6,7-dimethoxyisoquinoline, ring-opened analog, and related analogs were evaluated for AChE inhibitory activity.  Our results showed that the dihydroisoquinoline ring analog compd. 6 (IC50 = 7.0 ± 1.4 μM) and compd. 4 (IC50 = 5.5 ± 1.0 μM) displayed potent AChE inhibition.  These compds. are currently the lead compds. for further studies in our lab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA7F-DJD0JwbVg90H21EOLACvtfcHk0ljIMEcL5h1EMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVShur0%253D&md5=9e083abb01be5514d3bf9577ff560c31</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1007%2Fs00044-008-9122-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-008-9122-3%26sid%3Dliteratum%253Aachs%26aulast%3DKhorana%26aufirst%3DN.%26aulast%3DMarkmee%26aufirst%3DS.%26aulast%3DIngkaninan%26aufirst%3DK.%26aulast%3DRuchirawat%26aufirst%3DS.%26aulast%3DKitbunnadaj%26aufirst%3DR.%26aulast%3DPullagurla%26aufirst%3DM.%2BR.%26atitle%3DEvaluation%2520of%2520a%2520new%2520lead%2520for%2520acetylcholinesterase%2520inhibition%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2009%26volume%3D18%26spage%3D231%26epage%3D241%26doi%3D10.1007%2Fs00044-008-9122-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornish-Bowden, A.</span></span> <span> </span><span class="NLM_article-title">A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1042/bj1370143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1042%2Fbj1370143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=4206907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaE2cXnvFGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1974&pages=143-144&author=A.+Cornish-Bowden&title=A+simple+graphical+method+for+determining+the+inhibition+constants+of+mixed%2C+uncompetitive+and+non-competitive+inhibitors&doi=10.1042%2Fbj1370143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Simple graphical method for determining the inhibition constants of mixed, uncompetitive, and noncompetitive inhibitors</span></div><div class="casAuthors">Cornish-Bowden, Athel</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">143-4</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">The title Ki values are obtained from a plot of s/v against i, where s is substrate concn., v is reaction velocity, and i is inhibitor concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBv0H1VCMLP7Vg90H21EOLACvtfcHk0ljIMEcL5h1EMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXnvFGrtQ%253D%253D&md5=c5b5738ba2b3343efbde493cdfbe59bc</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1042%2Fbj1370143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj1370143%26sid%3Dliteratum%253Aachs%26aulast%3DCornish-Bowden%26aufirst%3DA.%26atitle%3DA%2520simple%2520graphical%2520method%2520for%2520determining%2520the%2520inhibition%2520constants%2520of%2520mixed%252C%2520uncompetitive%2520and%2520non-competitive%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D1974%26volume%3D137%26spage%3D143%26epage%3D144%26doi%3D10.1042%2Fbj1370143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappi, S.</span></span> <span> </span><span class="NLM_article-title">Interactions of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1989</span>– <span class="NLM_lpage">1997</span>, <span class="refDoi"> DOI: 10.1021/bi00680a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00680a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaE2MXktVemu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=1989-1997&author=P.+Taylorauthor=S.+Lappi&title=Interactions+of+fluorescence+probes+with+acetylcholinesterase.+The+site+and+specificity+of+propidium+binding&doi=10.1021%2Fbi00680a029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of fluorescence probes with acetylcholinesterase.  Site and specificity of propidium binding</span></div><div class="casAuthors">Taylor, Palmer; Lappi, Shelley</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1989-97</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">A bis-quaternary fluorescence probe, propidium diiodide, exhibited a 10-fold enhancement of fluorescence when bound to acetylcholinesterase from Torpedo californica.  The complex was characterized by a high affinity, KD = 3.0 × 10-7M, and 1:1 stoichiometry with the 82,000 mol. wt. subunit of acetylcholinesterase.  A wide variety of other quaternary ammonium ligands such as decamethonium, gallamine, d-tubocurarine, tetraethylammonium, and tetramethylammonium completely dissocd. propidium from the enzyme as did monovalent and divalent inorg. cations.  Whereas a directly competitive relation was illustrated macroscopically, the various quaternary ligands showed a different susceptibility toward inorg. cation displacement.  The affinity of propidium relative to gallamine increased with ionic strength, indicating that there is not complete equivalence in the neg. subsites to which quaternary groups bind.  Although edrophonium also displaced propidium from the enzyme, the dissocn. const. obtained from this competitive relation was 3 5 orders of magnitude greater than the consts. obtained for inhibition of catalysis.  Based on competitve displacement titrns., the primary binding site of edrophonium was distinct from that of propidium and a ternary complex with the 2 ligands can form on each subunit.  In contrast to edrophonium, the binding of propidium was unaffected by methanesulfonylation of the active center serine and was uncompetitive with the carbamylating substrate, N-methyl-7-dimethylcarbamoxyquinolinium.  Thus, propidium associates with a peripheral anionic center on the enzyme.  Although propidium and edrophonium assocd. at sep. sites on acetylcholinesterase, bis-quaternary ligands where the quaternary N atoms are sepd. by 14 Å displaced both ligands from the enzyme with equal effectiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqaxfzE7WsY7Vg90H21EOLACvtfcHk0ljbJgFybKbz2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXktVemu74%253D&md5=0c4b7b9afdc79270927cb12f79d4168a</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fbi00680a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00680a029%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DLappi%26aufirst%3DS.%26atitle%3DInteractions%2520of%2520fluorescence%2520probes%2520with%2520acetylcholinesterase.%2520The%2520site%2520and%2520specificity%2520of%2520propidium%2520binding%26jtitle%3DBiochemistry%26date%3D1975%26volume%3D14%26spage%3D1989%26epage%3D1997%26doi%3D10.1021%2Fbi00680a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lwebuga-Mukasa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademacher, J.</span></span> <span> </span><span class="NLM_article-title">Propidium – A fluorescent probe for a peripheral anionic site on acetylcholinesterase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">708</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaE2cXltFKmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1974&pages=703-708&author=P.+Taylorauthor=J.+Lwebuga-Mukasaauthor=S.+Lappiauthor=J.+Rademacher&title=Propidium+%E2%80%93+A+fluorescent+probe+for+a+peripheral+anionic+site+on+acetylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Propidium.  Fluorescence probe for a peripheral anionic site on acetylcholinesterase</span></div><div class="casAuthors">Taylor, Palmer; Lwebuga-Mukasa, Jamson; Lappi, Shelley; Rademacher, James</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">703-8</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Propidium [(3,8-diamino-5-(3-diethylmethylaminopropyl)-6-phenylphenanthridium diiodide] (I) was bound with high affinity to a purified acetylcholinesterase isolated by lytic procedures from Torpedo californica.  Complex formation resulted in a 10-fold enhancement of fluorescence for the ligand in the bound state.  The fluorescent ligand could be dissocd. from the enzyme by back-titrn. with d-tubocurarine and gallamine under conditions of low ionic strength (γ/2 ≃ 0.001).  At higher ionic strength, in 0.1M NaCl, 0.04M MgCl2, and 0.01M Tris-Cl, pH 8.0 (γ/2 = 0.23), the above ligands were relatively ineffective in dissocg. propidium from the enzyme.  Edrophonium, an inhibitor that appears specific for the active center, did not dissoc. propidium under conditions of high and low ionic strength.  This specificity is consistent with propidium acting as a fluorescence probe for a peripheral anionic site on acetylcholinesterase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy22LfQ6F2j7Vg90H21EOLACvtfcHk0ljbJgFybKbz2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXltFKmu70%253D&md5=3256818b8da823e9154f830b796616fa</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DLwebuga-Mukasa%26aufirst%3DJ.%26aulast%3DLappi%26aufirst%3DS.%26aulast%3DRademacher%26aufirst%3DJ.%26atitle%3DPropidium%2520%25E2%2580%2593%2520A%2520fluorescent%2520probe%2520for%2520a%2520peripheral%2520anionic%2520site%2520on%2520acetylcholinesterase%26jtitle%3DMol.%2520Pharmacol.%26date%3D1974%26volume%3D10%26spage%3D703%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dvir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberry, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">3D Structure of <i>Torpedo californica</i> acetylcholinesterase complexed with huprine X at 2.1 Å resolution: Kinetic and molecular dynamics correlates</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2970</span>– <span class="NLM_lpage">2981</span>, <span class="refDoi"> DOI: 10.1021/bi011652i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi011652i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1altw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2970-2981&author=H.+Dvirauthor=D.+M.+Wongauthor=M.+Harelauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torreroauthor=P.+Campsauthor=T.+L.+Rosenberryauthor=I.+Silmanauthor=J.+L.+Sussman&title=3D+Structure+of+Torpedo+californica+acetylcholinesterase+complexed+with+huprine+X+at+2.1+%C3%85+resolution%3A+Kinetic+and+molecular+dynamics+correlates&doi=10.1021%2Fbi011652i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">3D Structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 Å resolution: Kinetic and molecular dynamic correlates</span></div><div class="casAuthors">Dvir, H.; Wong, D. M.; Harel, M.; Barril, X.; Orozco, M.; Luque, F. J.; Munoz-Torrero, D.; Camps, P.; Rosenberry, T. L.; Silman, I.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2970-2981</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Huprine X (HX) is a novel acetylcholinesterase (AChE) inhibitor, with one of the highest affinities reported for a reversible inhibitor.  HX is a synthetic hybrid that contains the 4-aminoquinoline substructure of one anti-Alzheimer drug, tacrine, and a carbobicyclic moiety resembling that of another AChE inhibitor, (-)-huperzine A.  Cocrystn. of HX with T. californica AChE yielded crystals whose 3-dimensional (3D) structure was detd. to 2.1 Å resoln.  The inhibitor was found to bind to the anionic site and also to hinder access to the esteratic site.  Its arom. portion occupied the same binding site as tacrine, stacking between the arom. rings of Trp-84 and Phe-330, whereas the carbobicyclic unit occupied the same binding pocket as (-)-huperzine A.  Its Cl substituent was found to lie in a hydrophobic pocket interacting with the rings of arom. residues Trp-432 and Phe-330 and with the Me groups of Met-436 and Ile-439.  Steady-state inhibition data showed that HX bound to human AChE and Torpedo AChE 28- and 54-fold, resp., more tightly than tacrine.  This difference apparently stems from the fact that the aminoquinoline moiety of HX makes interactions similar to those made by tacrine, but that addnl. bonds to the enzyme are made by the huperzine-like substructure and the Cl atom.  Furthermore, both tacrine and HX bound more tightly to Torpedo AChE than to human AChE, suggesting that their quinoline substructures interact better with Phe-330 than with Tyr-337, the corresponding residue in the human AChE structure.  Both (-)-huperzine A and HX displayed slow binding properties, but only binding of the former caused a peptide flip of Gly-117.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqVXtCPjzM1LVg90H21EOLACvtfcHk0liyCk4jbClWTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1altw%253D%253D&md5=ea8b56b44818d899843be48d59fa2553</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fbi011652i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi011652i%26sid%3Dliteratum%253Aachs%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DD.%2BM.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3D3D%2520Structure%2520of%2520Torpedo%2520californica%2520acetylcholinesterase%2520complexed%2520with%2520huprine%2520X%2520at%25202.1%2520%25C3%2585%2520resolution%253A%2520Kinetic%2520and%2520molecular%2520dynamics%2520correlates%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D2970%26epage%3D2981%26doi%3D10.1021%2Fbi011652i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaeta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattorusso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catalanotti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiasserini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellerano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKissic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, A.</span></span> <span> </span><span class="NLM_article-title">Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1021/jm0255668</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0255668" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1yntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1-4&author=L.+Saviniauthor=A.+Gaetaauthor=C.+Fattorussoauthor=B.+Catalanottiauthor=G.+Campianiauthor=L.+Chiasseriniauthor=C.+Pelleranoauthor=E.+Novellinoauthor=D.+McKissicauthor=A.+Saxena&title=Specific+targeting+of+acetylcholinesterase+and+butyrylcholinesterase+recognition+sites.+Rational+design+of+novel%2C+selective%2C+and+highly+potent+cholinesterase+inhibitors&doi=10.1021%2Fjm0255668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Targeting of Acetylcholinesterase and Butyrylcholinesterase Recognition Sites. Rational Design of Novel, Selective, and Highly Potent Cholinesterase Inhibitors</span></div><div class="casAuthors">Savini, Luisa; Gaeta, Alessandra; Fattorusso, Caterina; Catalanotti, Bruno; Campiani, Giuseppe; Chiasserini, Luisa; Pellerano, Cesare; Novellino, Ettore; McKissic, Dawn; Saxena, Ashima</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tacrine-based AChE and BuChE inhibitors were designed by investigating the topol. of the active site gorge of the two enzymes.  The homobivalent ligands characterized by a nitrogen-bridged atom at the tether level could be considered among the most potent and selective cholinesterase inhibitors described to date.  The nitrogen-contg. homobivalent ligands and the sulfur-contg. ligand validated the hypothesis of extra sites of interaction in the AChE and BuChE active site gorges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-lepg2tVtZLVg90H21EOLACvtfcHk0liyCk4jbClWTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1yntb8%253D&md5=1d9abc2e1f63f01686a7c4a79bab57c9</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm0255668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0255668%26sid%3Dliteratum%253Aachs%26aulast%3DSavini%26aufirst%3DL.%26aulast%3DGaeta%26aufirst%3DA.%26aulast%3DFattorusso%26aufirst%3DC.%26aulast%3DCatalanotti%26aufirst%3DB.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DChiasserini%26aufirst%3DL.%26aulast%3DPellerano%26aufirst%3DC.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMcKissic%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DA.%26atitle%3DSpecific%2520targeting%2520of%2520acetylcholinesterase%2520and%2520butyrylcholinesterase%2520recognition%2520sites.%2520Rational%2520design%2520of%2520novel%252C%2520selective%252C%2520and%2520highly%2520potent%2520cholinesterase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1%26epage%3D4%26doi%3D10.1021%2Fjm0255668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elsinghorst, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieslik, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tränkle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gütschow, M.</span></span> <span> </span><span class="NLM_article-title">First gallamine-tacrine hybrid: Design and characterization at cholinesterases and the M<sub>2</sub> muscarinic receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5685</span>– <span class="NLM_lpage">5695</span>, <span class="refDoi"> DOI: 10.1021/jm070859s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070859s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOitbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5685-5695&author=P.+W.+Elsinghorstauthor=J.+S.+Cieslikauthor=K.+Mohrauthor=C.+Tr%C3%A4nkleauthor=M.+G%C3%BCtschow&title=First+gallamine-tacrine+hybrid%3A+Design+and+characterization+at+cholinesterases+and+the+M2+muscarinic+receptor&doi=10.1021%2Fjm070859s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">First Gallamine-Tacrine Hybrid: Design and Characterization at Cholinesterases and the M2 Muscarinic Receptor</span></div><div class="casAuthors">Elsinghorst, Paul W.; Cieslik, Julia S.; Mohr, Klaus; Traenkle, Christian; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5685-5695</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gallamine and tacrine are allosteric antagonists at muscarinic M2 acetylcholine receptors and inhibitors of acetylcholinesterase.  At both acetylcholine-binding proteins, gallamine and tacrine are known to occupy two different binding sites: in M2 receptors within the allosteric binding area and in acetylcholinesterase at its catalytic and its peripheral site.  To find new ligands of both targets, the authors designed a gallamine-tacrine dimer and several derived hybrid compds. to address the two binding sites.  Their M2 receptor allosteric and acetylcholinesterase inhibitory potential was detd.  The hybrid compds. revealed an allosteric potency in the low nanomolar range exceeding the allosteric potency of gallamine and tacrine by factors of 100 and 4800, resp.  Cholinesterase inhibition was augmented by hybrid formation, and all compds. exhibited IC50 values in the lower nanomolar range.  Thus, gallamine-tacrine hybrid formation is a valuable approach toward high affinity ligands concurrently targeting these acetylcholine-binding proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Rozawsc7bLVg90H21EOLACvtfcHk0liQV0qodFvcnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOitbvN&md5=a6497e4ea0a428470c3476ea5ad2700e</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm070859s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070859s%26sid%3Dliteratum%253Aachs%26aulast%3DElsinghorst%26aufirst%3DP.%2BW.%26aulast%3DCieslik%26aufirst%3DJ.%2BS.%26aulast%3DMohr%26aufirst%3DK.%26aulast%3DTr%25C3%25A4nkle%26aufirst%3DC.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DFirst%2520gallamine-tacrine%2520hybrid%253A%2520Design%2520and%2520characterization%2520at%2520cholinesterases%2520and%2520the%2520M2%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5685%26epage%3D5695%26doi%3D10.1021%2Fjm070859s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brazzolotto, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wandhammer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trovaslet-Leroy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darvesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span> <span> </span><span class="NLM_article-title">Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: A crystallographic, kinetic and calorimetric study</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2098</span>, <span class="refDoi"> DOI: 10.3390/molecules22122098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3390%2Fmolecules22122098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslSqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=2098&author=T.+Rosenberryauthor=X.+Brazzolottoauthor=I.+Macdonaldauthor=M.+Wandhammerauthor=M.+Trovaslet-Leroyauthor=S.+Darveshauthor=F.+Nachon&title=Comparison+of+the+binding+of+reversible+inhibitors+to+human+butyrylcholinesterase+and+acetylcholinesterase%3A+A+crystallographic%2C+kinetic+and+calorimetric+study&doi=10.3390%2Fmolecules22122098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: a crystallographic, kinetic and calorimetric study</span></div><div class="casAuthors">Rosenberry, Terrone L.; Brazzolotto, Xavier; MacDonald, Ian R.; Wandhammer, Marielle; Trovaslet-Leroy, Marie; Darvesh, Sultan; Nachon, Florian</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2098/1-2098/20</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) hydrolyze the neurotransmitter acetylcholine and, thereby, function as coregulators of cholinergic neurotransmission.  Although closely related, these enzymes display very different substrate specificities that only partially overlap.  This disparity is largely due to differences in the no. of arom. residues lining the active site gorge, which leads to large differences in the shape of the gorge and potentially to distinct interactions with an individual ligand.  Considerable structural information is available for the binding of a wide diversity of ligands to AChE.  In contrast, structural data on the binding of reversible ligands to BChE are lacking.  In a recent effort, an inhibitor competition approach was used to probe the overlap of ligand binding sites in BChE.  Here, we extend this study by solving the crystal structures of human BChE in complex with five reversible ligands, namely, decamethonium, thioflavin T, propidium, huprine, and ethopropazine.  We compare these structures to equiv. AChE complexes when available in the protein data bank and supplement this comparison with kinetic data and observations from isothermal titrn. calorimetry.  This new information now allows us to define the binding mode of various ligand families and will be of importance in designing specific reversible ligands of BChE that behave as inhibitors or reactivators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTCieO8Tc3bbVg90H21EOLACvtfcHk0liQV0qodFvcnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslSqu70%253D&md5=ede4274ad70a13acfee81bec1da90eb1</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22122098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22122098%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberry%26aufirst%3DT.%26aulast%3DBrazzolotto%26aufirst%3DX.%26aulast%3DMacdonald%26aufirst%3DI.%26aulast%3DWandhammer%26aufirst%3DM.%26aulast%3DTrovaslet-Leroy%26aufirst%3DM.%26aulast%3DDarvesh%26aufirst%3DS.%26aulast%3DNachon%26aufirst%3DF.%26atitle%3DComparison%2520of%2520the%2520binding%2520of%2520reversible%2520inhibitors%2520to%2520human%2520butyrylcholinesterase%2520and%2520acetylcholinesterase%253A%2520A%2520crystallographic%252C%2520kinetic%2520and%2520calorimetric%2520study%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D2098%26doi%3D10.3390%2Fmolecules22122098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juárez-Jiménez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span> <span> </span><span class="NLM_article-title">Unveiling a novel transient druggable pocket in BACE-1 through molecular simulations: conformational analysis and binding mode of multisite inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">e0177683</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0177683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1371%2Fjournal.pone.0177683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=28505196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsF2nsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&author=O.+Di%0APietroauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=D.+Mu%C3%B1oz-Torreroauthor=C.+A.+Laughtonauthor=F.+J.+Luque&title=Unveiling+a+novel+transient+druggable+pocket+in+BACE-1+through+molecular+simulations%3A+conformational+analysis+and+binding+mode+of+multisite+inhibitors&doi=10.1371%2Fjournal.pone.0177683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Unveiling a novel transient druggable pocket in bace-1 through molecular simulations: conformational analysis and binding mode of multisite inhibitors</span></div><div class="casAuthors">Di Pietro, Ornella; Juarez-Jimenez, Jordi; Munoz-Torrero, Diego; Laughton, Charles A.; Luque, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0177683/1-e0177683/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The crit. role of BACE-1 in the formation of neurotoxic β-amyloid peptides in the brain makes it an attractive target for an efficacious treatment of Alzheimer's disease.  However, the development of clin. useful BACE-1 inhibitors has proven to be extremely challenging.  In this study we examine the binding mode of a novel potent inhibitor (compd. 1, with IC50 80 nM) designed by synergistic combination of two fragments-huprine and rhein- that individually are endowed with very low activity against BACE-1.  Examn. of crystal structures reveals no appropriate binding site large enough to accommodate 1.  Therefore we have examd. the conformational flexibility of BACE-1 through extended mol. dynamics simulations, paying attention to the highly flexible region shaped by loops 8-14, 154-169 and 307-318.  The anal. of the protein dynamics, together with studies of pocket druggability, has allowed us to detect the transient formation of a secondary binding site, which contains Arg307 as a key residue for the interaction with small mols., at the edge of the catalytic cleft.  The formation of this druggable "floppy" pocket would enable the binding of multisite inhibitors targeting both catalytic and secondary sites.  Mol. dynamics simulations of BACE-1 bound to huprine-rhein hybrid compds. support the feasibility of this hypothesis.  The results provide a basis to explain the high inhibitory potency of the two enantiomeric forms of 1, together with the large dependence on the length of the oligomethylenic linker.  Furthermore, the multisite hypothesis has allowed us to rationalize the inhibitory potency of a series of tacrine-chromene hybrid compds., specifically regarding the apparent lack of sensitivity of the inhibition const. to the chem. modifications introduced in the chromene unit.  Overall, these findings pave the way for the exploration of novel functionalities in the design of optimized BACE-1 multisite inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPkTHdHnmrSrVg90H21EOLACvtfcHk0liky6q7V79B0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsF2nsrrL&md5=bf8948c5989a213ae21b2570ae96d993</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0177683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0177683%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DLaughton%26aufirst%3DC.%2BA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DUnveiling%2520a%2520novel%2520transient%2520druggable%2520pocket%2520in%2520BACE-1%2520through%2520molecular%2520simulations%253A%2520conformational%2520analysis%2520and%2520binding%2520mode%2520of%2520multisite%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26doi%3D10.1371%2Fjournal.pone.0177683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, R. L.</span></span> <span> </span><span class="NLM_article-title">The chemistry behind antioxidant capacity assays</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1841</span>– <span class="NLM_lpage">1856</span>, <span class="refDoi"> DOI: 10.1021/jf030723c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf030723c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslaltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2005&pages=1841-1856&author=D.+Huangauthor=B.+Ouauthor=R.+L.+Prior&title=The+chemistry+behind+antioxidant+capacity+assays&doi=10.1021%2Fjf030723c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The Chemistry behind Antioxidant Capacity Assays</span></div><div class="casAuthors">Huang, Dejian; Ou, Boxin; Prior, Ronald L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1841-1856</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review summarizing the multifaceted aspects of antioxidants and the basic kinetic models of inhibited autoxidn. and analyzes the chem. principles of antioxidant capacity assays.  Depending upon the reactions involved, these assays can roughly be classified into two types: assays based on hydrogen atom transfer (HAT) reactions and assays based on electron transfer (ET).  The majority of HAT-based assays apply a competitive reaction scheme, in which antioxidant and substrate compete for thermally generated peroxyl radicals through the decompn. of azo compds.  These assays include inhibition of induced low-d. lipoprotein autoxidn., oxygen radical absorbance capacity (ORAC), total radical trapping antioxidant parameter (TRAP), and crocin bleaching assays.  ET-based assays measure the capacity of an antioxidant in the redn. of an oxidant, which changes color when reduced.  The degree of color change is correlated with the sample's antioxidant concns.  ET-based assays include the total phenols assay by Folin-Ciocalteu reagent (FCR), Trolox equivalence antioxidant capacity (TEAC), ferric ion reducing antioxidant power (FRAP), "total antioxidant potential" assay using a Cu(II) complex as an oxidant, and DPPH.  In addn., other assays intended to measure a sample's scavenging capacity of biol. relevant oxidants such as singlet oxygen, superoxide anion, peroxynitrite, and hydroxyl radical are also summarized.  On the basis of this anal., it is suggested that the total phenols assay by FCR be used to quantify an antioxidant's reducing capacity and the ORAC assay to quantify peroxyl radical scavenging capacity.  To comprehensively study different aspects of antioxidants, validated and specific assays are needed in addn. to these two commonly accepted assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJFACfeXfIw7Vg90H21EOLACvtfcHk0liky6q7V79B0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslaltLo%253D&md5=52074f4022f9d83ff8333f31f3d6cc4b</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjf030723c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf030723c%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DOu%26aufirst%3DB.%26aulast%3DPrior%26aufirst%3DR.%2BL.%26atitle%3DThe%2520chemistry%2520behind%2520antioxidant%2520capacity%2520assays%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2005%26volume%3D53%26spage%3D1841%26epage%3D1856%26doi%3D10.1021%2Fjf030723c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood-brain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/s0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood-brain+barrier&doi=10.1016%2Fs0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lhBVm_g8Kza1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2Fs0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Justice, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConlogue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Games, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. G. M.</span></span> <span> </span><span class="NLM_article-title">A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">979</span>, <span class="refDoi"> DOI: 10.1038/35050103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1038%2F35050103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=11140684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=975-979&author=G.+Chenauthor=K.+S.+Chenauthor=J.+Knoxauthor=J.+Inglisauthor=A.+Bernardauthor=S.+J.+Martinauthor=A.+Justiceauthor=L.+McConlogueauthor=D.+Gamesauthor=S.+B.+Freedmanauthor=R.+G.+M.+Morris&title=A+learning+deficit+related+to+age+and+%CE%B2-amyloid+plaques+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2F35050103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Chen, Gulquan; Chen, Karen S.; Knox, Jane; Inglis, Jennifer; Bernard, Andrew; Martin, Stephen J.; Justice, Alan; McConlogue, Lisa; Games, Dora; Freedman, Stephen B.; Morris, Richard G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">975-979</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mice that overexpress the human mutant amyloid precursor protein (hAPP) show learning deficits, but the apparent lack of a relation between these deficits and the progressive β amyloid plaque formation that the hAPP mice display is puzzling.  In the water maze, hAPP mice are impaired before and after amyloid plaque deposition.  Here the authors show, using a new water-maze training protocol, that PDAPP mice also exhibit a sep. age-related deficit in learning a series of spatial locations.  This impairment correlates with β-amyloid plaque burden and is shown in both cross-sectional and longitudinal exptl. designs.  Cued navigation and object-recognition memory are normal.  These findings indicate that Aβ overexpression and/or Aβ plaques are assocd. with disturbed cognitive function and, importantly, suggest that some but not all forms of learning and memory are suitable behavioral assays of the progressive cognitive deficits assocd. with Alzheimer's-disease-type pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPiCvEhUwqt7Vg90H21EOLACvtfcHk0lhBVm_g8Kza1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslWjsQ%253D%253D&md5=873eb06b98d0bc5a68f8b25e6b14329f</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2F35050103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050103%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DKnox%26aufirst%3DJ.%26aulast%3DInglis%26aufirst%3DJ.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26aulast%3DJustice%26aufirst%3DA.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DMorris%26aufirst%3DR.%2BG.%2BM.%26atitle%3DA%2520learning%2520deficit%2520related%2520to%2520age%2520and%2520%25CE%25B2-amyloid%2520plaques%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D975%26epage%3D979%26doi%3D10.1038%2F35050103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease is a synaptic failure</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>298</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1126/science.1074069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1126%2Fscience.1074069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=12399581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFSnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=789-791&author=D.+J.+Selkoe&title=Alzheimer%E2%80%99s+disease+is+a+synaptic+failure&doi=10.1126%2Fscience.1074069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease Is a Synaptic Failure</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5594</span>),
    <span class="NLM_cas:pages">789-791</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In its earliest clin. phase, Alzheimer's disease characteristically produces a remarkably pure impairment of memory.  Mounting evidence suggests that this syndrome begins with subtle alterations of hippocampal synaptic efficacy prior to frank neuronal degeneration, and that the synaptic dysfunction is caused by diffusible oligomeric assemblies of the amyloid β protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsFVFyrx-gM7Vg90H21EOLACvtfcHk0lhBVm_g8Kza1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFSnur0%253D&md5=5927195bd25a2d0fdf1663972f32a139</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1126%2Fscience.1074069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1074069%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520is%2520a%2520synaptic%2520failure%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D789%26epage%3D791%26doi%3D10.1126%2Fscience.1074069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanzi, R. E.</span></span> <span> </span><span class="NLM_article-title">The synaptic Aβ hypothesis of Alzheimer disease</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">977</span>– <span class="NLM_lpage">979</span>, <span class="refDoi"> DOI: 10.1038/nn0805-977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1038%2Fnn0805-977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=16047022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFWmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=977-979&author=R.+E.+Tanzi&title=The+synaptic+A%CE%B2+hypothesis+of+Alzheimer+disease&doi=10.1038%2Fnn0805-977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">The synaptic Aβ hypothesis of Alzheimer disease</span></div><div class="casAuthors">Tanzi, Rudolph E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">977-979</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgtcPxmCwJV7Vg90H21EOLACvtfcHk0lhAc7UfnlziRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFWmtrk%253D&md5=5dc2b2c612a6e2d02bc0bee695cff5a3</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fnn0805-977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn0805-977%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26atitle%3DThe%2520synaptic%2520A%25CE%25B2%2520hypothesis%2520of%2520Alzheimer%2520disease%26jtitle%3DNat.%2520Neurosci.%26date%3D2005%26volume%3D8%26spage%3D977%26epage%3D979%26doi%3D10.1038%2Fnn0805-977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mango, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cisale, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feligioni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nisticò, R.</span></span> <span> </span><span class="NLM_article-title">Targeting synaptic plasticity in experimental models of Alzheimer’s disease</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">778</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3389%2Ffphar.2019.00778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31379566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVart70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=778&author=D.+Mangoauthor=A.+Saidiauthor=G.+Y.+Cisaleauthor=M.+Feligioniauthor=M.+Corboauthor=R.+Nistic%C3%B2&title=Targeting+synaptic+plasticity+in+experimental+models+of+Alzheimer%E2%80%99s+disease&doi=10.3389%2Ffphar.2019.00778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting synaptic plasticity in experimental models of Alzheimer's disease</span></div><div class="casAuthors">Mango, Dalila; Sai, Amira; Cisale, Giusy Ylenia; Feligioni, Marco; Corbo, Massimo; Nistico, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">778</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Long-term potentiation (LTP) and long-term depression (LTD) of hippocampal synaptic transmission represent the principal exptl. models underlying learning and memory.  Alterations of synaptic plasticity are obsd. in several neurodegenerative disorders, including Alzheimer's disease (AD).  Indeed, synaptic dysfunction is an early event in AD, making it an attractive therapeutic target for pharmaceutical intervention.  To date, intensive investigations have characterized hippocampal synaptic transmission, LTP, and LTD in in vitro and in murine models of AD.  In this review, we describe the synaptic alterations across the main AD models generated so far.  We then examine the clin. perspective of LTP/LTD studies and discuss the limitations of non-clin. models and how to improve their predictive validity in the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIifnDt6xTG7Vg90H21EOLACvtfcHk0lhAc7UfnlziRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVart70%253D&md5=c520a1fbe96df03bac063eab694feb3d</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00778%26sid%3Dliteratum%253Aachs%26aulast%3DMango%26aufirst%3DD.%26aulast%3DSaidi%26aufirst%3DA.%26aulast%3DCisale%26aufirst%3DG.%2BY.%26aulast%3DFeligioni%26aufirst%3DM.%26aulast%3DCorbo%26aufirst%3DM.%26aulast%3DNistic%25C3%25B2%26aufirst%3DR.%26atitle%3DTargeting%2520synaptic%2520plasticity%2520in%2520experimental%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D778%26doi%3D10.3389%2Ffphar.2019.00778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trinchese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaglia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">814</span>, <span class="refDoi"> DOI: 10.1002/ana.20101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fana.20101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=15174014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVCktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=801-814&author=F.+Trincheseauthor=S.+Liuauthor=F.+Battagliaauthor=S.+Walterauthor=P.+M.+Mathewsauthor=O.+Arancio&title=Progressive+age-related+development+of+Alzheimer-like+pathology+in+APP%2FPS1+mice&doi=10.1002%2Fana.20101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice</span></div><div class="casAuthors">Trinchese, Fabrizio; Liu, Shumin; Battaglia, Fortunato; Walter, Sean; Mathews, Paul M.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">801-814</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Increasing evidence points to synaptic plasticity impairment as one of the first events in Alzheimer's disease (AD).  However, studies on synaptic dysfunction in different transgenic AD models that overexpress familial AD mutant forms of amyloid precursor protein (APP) and/or presenilin (PS) have provided conflicting results.  Both long-term potentiation (LTP) and basal synaptic transmission (BST) have been found to be both unchanged and altered in different models and under differing exptl. conditions.  Because of their more robust amyloid-β (Aβ) deposition, double transgenic mice currently are used by several labs. as an AD model.  Here, we report that mice overexpressing APP (K670N: M671L) together with PS1 (M146L) have abnormal LTP as early as 3 mo of age.  Interestingly, reduced LTP paralleled plaque appearance and increased Aβ levels and abnormal short-term memory (working memory).  BST and long-term memory (ref. memory) are impaired only later (approx. 6 mo) as amyloid burden increases.  Aβ pathol. across different ages did not correlate with synaptic and cognitive deficits, suggesting that Aβ levels are not a marker of memory decline.  In contrast, progression of LTP impairment correlated with the deterioration of working memory, suggesting that percentage of potentiation might be an indicator of the cognitive decline and disease progression in the APP/PS1 mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-0Sep8mnVgLVg90H21EOLACvtfcHk0li90jqCGGMD9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVCktbc%253D&md5=87f7a6dea17b0d35a775712088213641</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fana.20101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20101%26sid%3Dliteratum%253Aachs%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DBattaglia%26aufirst%3DF.%26aulast%3DWalter%26aufirst%3DS.%26aulast%3DMathews%26aufirst%3DP.%2BM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DProgressive%2520age-related%2520development%2520of%2520Alzheimer-like%2520pathology%2520in%2520APP%252FPS1%2520mice%26jtitle%3DAnn.%2520Neurol.%26date%3D2004%26volume%3D55%26spage%3D801%26epage%3D814%26doi%3D10.1002%2Fana.20101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cisternas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliva, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrera, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Presymptomatic treatment with andrographolide improves brain metabolic markers and cognitive behavior in a model of early-onset Alzheimer’s disease</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">295</span>, <span class="refDoi"> DOI: 10.3389/fncel.2019.00295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3389%2Ffncel.2019.00295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31379502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktV2ksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2019&pages=295&author=P.+Cisternasauthor=C.+A.+Olivaauthor=V.+I.+Torresauthor=D.+P.+Barreraauthor=N.+C.+Inestrosa&title=Presymptomatic+treatment+with+andrographolide+improves+brain+metabolic+markers+and+cognitive+behavior+in+a+model+of+early-onset+Alzheimer%E2%80%99s+disease&doi=10.3389%2Ffncel.2019.00295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Presymptomatic treatment with andrographolide improves brain metabolic markers and cognitive behavior in a model of early-onset Alzheimer's disease</span></div><div class="casAuthors">Cisternas, Pedro; Oliva, Carolina A.; Torres, Viviana I.; Barrera, Daniela P.; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">295</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common type of dementia.  The onset and progression of this pathol. are correlated with several changes in the brain, including the formation of extracellular aggregates of amyloid-βeta (Aβ) peptide and the intracellular accumulation of hyperphosphorylated tau protein.  In addn., dysregulated neuronal plasticity, synapse loss, and a redn. in cellular energy metab. have also been described.  Canonical Wnt signaling has also been shown to be downregulated in AD.  Remarkably, we showed previously that the in vivo inhibition of Wnt signaling accelerates the appearance of AD markers in transgenic (Tg) and wild-type (WT) mice.  Addnl., we found that Wnt signaling stimulates energy metab., which is crit. for the ability of Wnt to promote the recovery of cognitive function in AD.  Therefore, we hypothesized that activation of canonical Wnt signaling in a presymptomatic transgenic animal model of AD would improve some symptoms.  To explore the latter, we used a transgenic mouse model (J20 Tg) with mild AD phenotype expression (high levels of amyloid aggregates) and studied the effect of andrographolide (ANDRO), an activator of canonical Wnt signaling.  We found that presymptomatic administration of ANDRO in J20 Tg mice prevented the redn. in cellular energy metab. markers.  Moreover, treated animals showed improvement in cognitive performance.  At the synaptic level, J20 Tg animals showed severe deficiencies in presynaptic function as detd. by electrophysiol. parameters, all of which were completely restored to normal by ANDRO administration.  Finally, an anal. of hippocampal synaptosomes by electron microscopy revealed that the length of synapses was restored with ANDRO treatment.  Altogether, these data support the idea that the activation of canonical Wnt signaling during presymptomatic stages could represent an interesting pharmacol. strategy to delay the onset of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6qgcSjvcr6bVg90H21EOLACvtfcHk0li90jqCGGMD9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktV2ksr4%253D&md5=7fee3919f5b24643541eb59d61361316</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2019.00295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2019.00295%26sid%3Dliteratum%253Aachs%26aulast%3DCisternas%26aufirst%3DP.%26aulast%3DOliva%26aufirst%3DC.%2BA.%26aulast%3DTorres%26aufirst%3DV.%2BI.%26aulast%3DBarrera%26aufirst%3DD.%2BP.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DPresymptomatic%2520treatment%2520with%2520andrographolide%2520improves%2520brain%2520metabolic%2520markers%2520and%2520cognitive%2520behavior%2520in%2520a%2520model%2520of%2520early-onset%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2019%26volume%3D13%26spage%3D295%26doi%3D10.3389%2Ffncel.2019.00295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition</span>. <i>BMC Complement Altern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">167</span>, <span class="refDoi"> DOI: 10.1186/s12906-018-2237-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1186%2Fs12906-018-2237-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=29843688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjsVCmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=167&author=J.-H.+Zhangauthor=L.-J.+Yuauthor=H.+Yangauthor=Z.+Huiauthor=S.+Jiangauthor=L.+Chenauthor=Y.+Zhaoauthor=S.-L.+Wangauthor=Y.+Liuauthor=Y.+Xu&title=Huatuo+Zaizao+pill+ameliorates+cognitive+impairment+of+APP%2FPS1+transgenic+mice+by+improving+synaptic+plasticity+and+reducing+A%CE%B2+deposition&doi=10.1186%2Fs12906-018-2237-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition</span></div><div class="casAuthors">Zhang, Jing-Hua; Yu, Lin-Jie; Yang, Hui; Hui, Zhen; Jiang, Su; Chen, Ling; Zhao, Yang; Wang, Su-Lei; Liu, Yi; Xu, Yun</div><div class="citationInfo"><span class="NLM_cas:title">BMC Complementary and Alternative Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">167/1-167/13</span>CODEN:
                <span class="NLM_cas:coden">BCAMCV</span>;
        ISSN:<span class="NLM_cas:issn">1472-6882</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: It is well known that Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by memory deficits and cognitive decline.  Amyloid-β (Aβ) deposition and synaptic dysfunction play important roles in the pathophysiol. of Alzheimer's disease (AD).  The Huatuo Zaizao pill (HT) is a Traditional Chinese Medicine (TCM) that has been used clin. for many years in China, mainly for post-stroke rehabilitation and cognitive decline; however, the mechanism of cognitive function is not clear.  In this study, we investigated the effect of HT on hippocampal synaptic function, Amyloid-β (Aβ) deposition in APP/PS1 AD transgenic mice.  Method: Six-month-old APP/PS1 transgenic (Tg) mice were randomly divided into control, HT-treated, and memantine (MEM)-treated groups.  Then, these groups were orally administered vehicle (for the control), HT (0.25 g/kg) and MEM (5 mg/kg) resp. for 4 wk.  The Morris water maze, Novel Object Recognition, and Open field tests were used to assess cognitive behavioral changes.  We evaluated the effects of HT on neuronal excitability, membrane ion channel activity, and synaptic plasticity in acute hippocampal slices by combining electrophysiol. extracellular tests.  Synaptic morphol. in the hippocampus was investigated by electron microscopy.  Western blotting was used to assess synaptic-assocd. protein and Aβ prodn. and degrading levels.  Immunofluorescence staining was used to det. the relative integrated d.  Results: HT can ameliorate hippocampus-dependent memory deficits and improve synaptic dysfunction by reversing LTP impairment in APP/PS1 transgenic mice.  Moreover, HT reduces amyloid plaque deposition by regulating α-secretase and γ-secretase levels.  Conclusion: HT can improve the learning and memory function of APP/PS1 transgenic mice by improving synaptic function and reducing amyloid plaque deposition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF5TAYUOk3ALVg90H21EOLACvtfcHk0li90jqCGGMD9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjsVCmtb0%253D&md5=ac5fe8c162a62a311f4eb56daa9c3473</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1186%2Fs12906-018-2237-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12906-018-2237-2%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DYu%26aufirst%3DL.-J.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHui%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.-L.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DHuatuo%2520Zaizao%2520pill%2520ameliorates%2520cognitive%2520impairment%2520of%2520APP%252FPS1%2520transgenic%2520mice%2520by%2520improving%2520synaptic%2520plasticity%2520and%2520reducing%2520A%25CE%25B2%2520deposition%26jtitle%3DBMC%2520Complement%2520Altern.%2520Med.%26date%3D2018%26volume%3D18%26spage%3D167%26doi%3D10.1186%2Fs12906-018-2237-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapia-Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerpa, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">61</span>, <span class="refDoi"> DOI: 10.1186/1750-1326-9-61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1186%2F1750-1326-9-61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=25524173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislOhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=61&author=F.+G.+Serranoauthor=C.+Tapia-Rojasauthor=F.+J.+Carvajalauthor=J.+Hanckeauthor=W.+Cerpaauthor=N.+C.+Inestrosa&title=Andrographolide+reduces+cognitive+impairment+in+young+and+mature+A%CE%B2PPswe%2FPS-1+mice&doi=10.1186%2F1750-1326-9-61"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice</span></div><div class="casAuthors">Serrano, Felipe G.; Tapia-Rojas, Cheril; Carvajal, Francisco J.; Hancke, Juan; Cerpa, Waldo; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61/1-61/32, 32 pp.</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder in which the amyloid-β (Aβ) oligomers are a key factor in synaptic impairment and in spatial memory decline assocd. with neuronal dysfunction.  This impairment includes synaptic failure assocd. with the loss of synaptic proteins that contribute to AD progression.  Interestingly, the use of natural compds. is an emergent conceptual strategy in the search for drugs with therapeutic potentials for treating neurodegenerative disorders.  In the present study, we report that andrographolide (ANDRO), which is a labdane diterpene extd. from Andrographis paniculata, increases slope of field excitatory postsynaptic potentials (fEPSP) in the CA1 region of hippocampal slices and inhibits long-term depression (LTD), protecting the longterm potentiation (LTP) against the damage induced by Aβ oligomers in vitro, most likely by inhibiting glycogen synthase kinase-3β (GSK-3β).  Addnl., ANDRO prevents changes in neuropathol. in two different age groups (7- and 12-mo-old mice) of an AβPPswe/PS-1 Alzheimer's model.  ANDRO reduces the Aβ levels, changing the ontogeny of amyloid plaques in hippocampi and cortices in 7-mo-old mice, and reduces tau phosphorylation around the Aβ oligomeric species in both age groups.  Addnl., we obsd. that ANDRO recovers spatial memory functions that correlate with protecting synaptic plasticity and synaptic proteins in two different age groups.  Our results suggest that ANDRO could be used in a potential preventive therapy during AD progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWLPjpr6oJrVg90H21EOLACvtfcHk0ljtbvqiRcGZGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislOhu78%253D&md5=00cf5de1a1db358a1b71fdcc2df84324</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-9-61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-9-61%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DCarvajal%26aufirst%3DF.%2BJ.%26aulast%3DHancke%26aufirst%3DJ.%26aulast%3DCerpa%26aufirst%3DW.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DAndrographolide%2520reduces%2520cognitive%2520impairment%2520in%2520young%2520and%2520mature%2520A%25CE%25B2PPswe%252FPS-1%2520mice%26jtitle%3DMol.%2520Neurodegener.%26date%3D2014%26volume%3D9%26spage%3D61%26doi%3D10.1186%2F1750-1326-9-61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perluigi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coccia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterfield, D. A.</span></span> <span> </span><span class="NLM_article-title">4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: A toxic combination illuminated by redox proteomics studies</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1590</span>– <span class="NLM_lpage">1609</span>, <span class="refDoi"> DOI: 10.1089/ars.2011.4406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1089%2Fars.2011.4406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=22114878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1590-1609&author=M.+Perluigiauthor=R.+Cocciaauthor=D.+A.+Butterfield&title=4-Hydroxy-2-nonenal%2C+a+reactive+product+of+lipid+peroxidation%2C+and+neurodegenerative+diseases%3A+A+toxic+combination+illuminated+by+redox+proteomics+studies&doi=10.1089%2Fars.2011.4406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">4-Hydroxy-2-Nonenal, a Reactive Product of Lipid Peroxidation, and Neurodegenerative Diseases: A Toxic Combination Illuminated by Redox Proteomics Studies</span></div><div class="casAuthors">Perluigi, Marzia; Coccia, Raffaella; Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1590-1609</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Significance: Among different forms of oxidative stress, lipid peroxidn. comprises the interaction of free radicals with polyunsatd. fatty acids, which in turn leads to the formation of highly reactive electrophilic aldehydes.  Among these, the most abundant aldehydes are 4-hydroxy-2-nonenal (HNE) and malondialdehyde, while acrolein is the most reactive.  HNE is considered a robust marker of oxidative stress and a toxic compd. for several cell types.  Proteins are particularly susceptible to modification caused by HNE, and adduct formation plays a crit. role in multiple cellular processes.  Recent Advances: With the outstanding progress of proteomics, the identification of putative biomarkers for neurodegenerative disorders has been the main focus of several studies and will continue to be a difficult task.  Crit. Issues: The present review focuses on the role of lipid peroxidn., particularly of HNE-induced protein modification, in neurodegenerative diseases.  By comparing results obtained in different neurodegenerative diseases, it may be possible to identify both similarities and specific differences in addn. to better characterize selective neurodegenerative phenomena assocd. with protein dysfunction.  Results obtained in our lab. and others support the common deregulation of energy metab. and mitochondrial function in neurodegeneration.  Future Directions: Research towards a better understanding of the mol. mechanisms involved in neurodegeneration together with identification of specific targets of oxidative damage is urgently required.  Redox proteomics will contribute to broaden the knowledge in regard to potential biomarkers for disease diagnosis and may also provide insight into damaged metabolic networks and potential targets for modulation of disease progression.  Antioxid. Redox Signal. 17, 1590-1609.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8xhgvE-K1VbVg90H21EOLACvtfcHk0ljtbvqiRcGZGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsLnK&md5=92ed19fca59d7759cacfb93eb8646af2</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1089%2Fars.2011.4406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2011.4406%26sid%3Dliteratum%253Aachs%26aulast%3DPerluigi%26aufirst%3DM.%26aulast%3DCoccia%26aufirst%3DR.%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3D4-Hydroxy-2-nonenal%252C%2520a%2520reactive%2520product%2520of%2520lipid%2520peroxidation%252C%2520and%2520neurodegenerative%2520diseases%253A%2520A%2520toxic%2520combination%2520illuminated%2520by%2520redox%2520proteomics%2520studies%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2012%26volume%3D17%26spage%3D1590%26epage%3D1609%26doi%3D10.1089%2Fars.2011.4406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamphuis, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middeldorp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooijman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sluijs, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooi, E.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freriks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizee, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, E. M.</span></span> <span> </span><span class="NLM_article-title">Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">510</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2013.09.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.neurobiolaging.2013.09.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=24269023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Oqs7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=492-510&author=W.+Kamphuisauthor=J.+Middeldorpauthor=L.+Kooijmanauthor=J.+A.+Sluijsauthor=E.-J.+Kooiauthor=M.+Moetonauthor=M.+Freriksauthor=M.+R.+Mizeeauthor=E.+M.+Hol&title=Glial+fibrillary+acidic+protein+isoform+expression+in+plaque+related+astrogliosis+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2013.09.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease</span></div><div class="casAuthors">Kamphuis, Willem; Middeldorp, Jinte; Kooijman, Lieneke; Sluijs, Jacqueline A.; Kooi, Evert-Jan; Moeton, Martina; Freriks, Michel; Mizee, Mark R.; Hol, Elly M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">492-510</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In Alzheimer's disease (AD), amyloid plaques are surrounded by reactive astrocytes with an increased expression of intermediate filaments including glial fibrillary acidic protein (GFAP).  Different GFAP isoforms have been identified that are differentially expressed by specific subpopulations of astrocytes and that impose different properties to the intermediate filament network.  We studied transcript levels and protein expression patterns of all known GFAP isoforms in human hippocampal AD tissue at different stages of the disease.  Ten different transcripts for GFAP isoforms were detected at different abundancies.  Transcript levels of most isoforms increased with AD progression.  GFAPδ-immunopos. astrocytes were obsd. in subgranular zone, hilus, and stratum-lacunosum-moleculare.  GFAPδ-pos. cells also stained for GFAPα.  In AD donors, astrocytes near plaques displayed increased staining of both GFAPα and GFAPδ.  The reading-frame-shifted isoform, GFAP+1, staining was confined to a subset of astrocytes with long processes, and their no. increased in the course of AD.  In conclusion, the various GFAP isoforms show differential transcript levels and are upregulated in a concerted manner in AD.  The GFAP+1 isoform defines a unique subset of astrocytes, with nos. increasing with AD progression.  These data indicate the need for future exploration of underlying mechanisms concerning the functions of GFAPδ and GFAP+1 isoforms in astrocytes and their possible role in AD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFD1oM8p0UdbVg90H21EOLACvtfcHk0ljGK150xV3DBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Oqs7nJ&md5=269c53d302ffe32f57a5fb68e9945d4c</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2013.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2013.09.035%26sid%3Dliteratum%253Aachs%26aulast%3DKamphuis%26aufirst%3DW.%26aulast%3DMiddeldorp%26aufirst%3DJ.%26aulast%3DKooijman%26aufirst%3DL.%26aulast%3DSluijs%26aufirst%3DJ.%2BA.%26aulast%3DKooi%26aufirst%3DE.-J.%26aulast%3DMoeton%26aufirst%3DM.%26aulast%3DFreriks%26aufirst%3DM.%26aulast%3DMizee%26aufirst%3DM.%2BR.%26aulast%3DHol%26aufirst%3DE.%2BM.%26atitle%3DGlial%2520fibrillary%2520acidic%2520protein%2520isoform%2520expression%2520in%2520plaque%2520related%2520astrogliosis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2014%26volume%3D35%26spage%3D492%26epage%3D510%26doi%3D10.1016%2Fj.neurobiolaging.2013.09.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nordberg, A.</span>; <span class="NLM_string-name">Ballard, C.</span>; <span class="NLM_string-name">Bullock, R.</span>; <span class="NLM_string-name">Darreh-Shori, T.</span>; <span class="NLM_string-name">Somogyi, M.</span></span> <span> </span><span class="NLM_article-title">A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer’s disease</span>.  <i>Prime Care Companion CNS Disord.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume">15</span>, <span class="refDoi"> DOI: 10.4088/PCC.12r01412</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.4088%2FPCC.12r01412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=23930233" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&author=A.+Nordberg&author=C.+Ballard&author=R.+Bullock&author=T.+Darreh-Shori&author=M.+Somogyi&title=A+review+of+butyrylcholinesterase+as+a+therapeutic+target+in+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.4088%2FPCC.12r01412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.4088%2FPCC.12r01412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FPCC.12r01412%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DA.%26atitle%3DA%2520review%2520of%2520butyrylcholinesterase%2520as%2520a%2520therapeutic%2520target%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPrime%2520Care%2520Companion%2520CNS%2520Disord.%26date%3D2013%26volume%3D15%26doi%3D10.4088%2FPCC.12r01412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <i>The Organic Chemistry of Enzyme-Catalyzed Reactions</i>. <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_publisher-loc">San Diego</span>, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=R.+B.+Silverman&title=The+Organic+Chemistry+of+Enzyme-Catalyzed+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26btitle%3DThe%2520Organic%2520Chemistry%2520of%2520Enzyme-Catalyzed%2520Reactions%26pub%3DAcademic%2520Press%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nunes-Tavares, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nery da Matta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista e Silva, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araújo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louro, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassón-Voloch, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of acetylcholinesterase from Electrophorus electricus (L.) by tricyclic antidepressants</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1016/S1357-2725(02)00027-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2FS1357-2725%2802%2900027-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=12009302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFynsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=1071-1079&author=N.+Nunes-Tavaresauthor=A.+Nery+da+Mattaauthor=C.+M.+Batista+e+Silvaauthor=G.+M.+Ara%C3%BAjoauthor=S.+R.+Louroauthor=A.+Hass%C3%B3n-Voloch&title=Inhibition+of+acetylcholinesterase+from+Electrophorus+electricus+%28L.%29+by+tricyclic+antidepressants&doi=10.1016%2FS1357-2725%2802%2900027-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acetylcholinesterase from Electrophorus electricus (L.) by tricyclic antidepressants</span></div><div class="casAuthors">Nunes-Tavares, N.; Nery da Matta, A.; Batista e Silva, C. M.; Araujo, G. M. N.; Louro, S. R. W.; Hasson-Voloch, A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1071-1079</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The effects of tricyclic antidepressants drugs (TCA) amitriptyline, imipramine and nortriptyline, on purified Electrophorus electricus (L.) acetylcholinesterase (AChE; acetylcholine hydrolase, EC 3.1.1.7) were studied using kinetic methods and specific fluorescent probe propidium.  The antidepressants inhibited AChE activity by a non-competitive mechanism.  Inhibition consts. range from 200 to 400 μM.  Dimethylated amitriptyline and imipramine were more potent inhibitors than the monomethylated nortriptyline.  Fluorescence measurements using bis-quaternary ligand propidium were used to monitor ligand-binding properties of these cationic antidepressants to the AChE peripheral anionic site (PAS).  This ligand exhibited an eight-fold fluorescence enhancement upon binding to the peripheral anionic site of AChE from E. electricus (L.) with KD=7×10-7 M.  It was obsd. that TCA drugs displaced propidium from the enzyme.  On the basis of the displacement expts. antidepressant dissocn. consts. were detd.  Similar values for the inhibition consts. suggest that these drugs have similar affinity to the peripheral anionic site.  The results also indicate that the catalytic active center of AChE does not participate in the interaction of enzyme with tricyclic antidepressants.  These studies suggest that the binding site for tricyclic antidepressants is located at the peripheral anionic site of E. electricus (L.) acetylcholinesterase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryPgDAp502jbVg90H21EOLACvtfcHk0ljGK150xV3DBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFynsrw%253D&md5=b9516cc41f34d8d811af0bdf0a73e572</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2FS1357-2725%2802%2900027-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-2725%252802%252900027-4%26sid%3Dliteratum%253Aachs%26aulast%3DNunes-Tavares%26aufirst%3DN.%26aulast%3DNery%2Bda%2BMatta%26aufirst%3DA.%26aulast%3DBatista%2Be%2BSilva%26aufirst%3DC.%2BM.%26aulast%3DAra%25C3%25BAjo%26aufirst%3DG.%2BM.%26aulast%3DLouro%26aufirst%3DS.%2BR.%26aulast%3DHass%25C3%25B3n-Voloch%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520acetylcholinesterase%2520from%2520Electrophorus%2520electricus%2520%2528L.%2529%2520by%2520tricyclic%2520antidepressants%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2002%26volume%3D34%26spage%3D1071%26epage%3D1079%26doi%3D10.1016%2FS1357-2725%2802%2900027-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brand-Williams, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuvelier, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berset, C.</span></span> <span> </span><span class="NLM_article-title">Use of a free radical method to evaluate antioxidant activity</span>. <i>LWT–Food Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/S0023-6438(95)80008-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2FS0023-6438%2895%2980008-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaK2MXjvV2itLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1995&pages=25-30&author=W.+Brand-Williamsauthor=M.+E.+Cuvelierauthor=C.+Berset&title=Use+of+a+free+radical+method+to+evaluate+antioxidant+activity&doi=10.1016%2FS0023-6438%2895%2980008-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a free radical method to evaluate antioxidant activity</span></div><div class="casAuthors">Brand-WIlliams, W.; Cuvelier, M. E.; Berset, C.</div><div class="citationInfo"><span class="NLM_cas:title">Food Science & Technology (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-30</span>CODEN:
                <span class="NLM_cas:coden">LBWTAP</span>;
        ISSN:<span class="NLM_cas:issn">0023-6438</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The antiradical activities of various antioxidants were detd. using the free radical, 2,2-Diphenyl-1-picrylhydrazyl (DPPH•).  In its radical form, DPPH• has an absorption band at 515 nm which disappears upon redn. by an antiradical compd.  Twenty compds. were reacted with the DPPH• and shown to follow one of three possible reaction kinetic types.  Ascorbic acid, isoascorbic acid and isoeugenol reacted quickly with the DPPH•, reaching a steady state immediately.  Rosmarinic acid and δ-tocopherol reacted a little slower and reached a steady state within 30 min.  The remaining compds. reacted more progressively with the DPPH•, reaching a steady state in 1-6 h.  Caffeic acid, gentisic acid and gallic acid showed the highest antiradical activities with a stoichiometry of 4 to 6 reduced DPPH• mols. per mol. of antioxidant.  Vanillin, phenol, γ-resorcylic acid and vanillic acid were found to be poor antiradical compds.  The stoichiometry for the other 13 phenolic compds. varied from one to three reduced DPPH• mols. per mol. of antioxidant.  Possible mechanisms are proposed to explain the exptl. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdgt6zsPPpvLVg90H21EOLACvtfcHk0li0894_j5x8vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvV2itLw%253D&md5=0568c73ee9d55ec1d5b72153416e7e4a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2FS0023-6438%2895%2980008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0023-6438%252895%252980008-5%26sid%3Dliteratum%253Aachs%26aulast%3DBrand-Williams%26aufirst%3DW.%26aulast%3DCuvelier%26aufirst%3DM.%2BE.%26aulast%3DBerset%26aufirst%3DC.%26atitle%3DUse%2520of%2520a%2520free%2520radical%2520method%2520to%2520evaluate%2520antioxidant%2520activity%26jtitle%3DLWT%25E2%2580%2593Food%2520Sci.%2520Technol.%26date%3D1995%26volume%3D28%26spage%3D25%26epage%3D30%26doi%3D10.1016%2FS0023-6438%2895%2980008-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavakkoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saso, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firuzi, O.</span></span> <span> </span><span class="NLM_article-title">Alkyl esters of acids with improved antioxidant activity and lipophilicity protect PC12 cells against oxidative stress</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">961</span>– <span class="NLM_lpage">967</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2011.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.biochi.2011.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=22210493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSgtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2012&pages=961-967&author=J.+Garridoauthor=A.+Gasparauthor=E.+M.+Garridoauthor=R.+Miriauthor=M.+Tavakkoliauthor=S.+Pouraliauthor=L.+Sasoauthor=F.+Borgesauthor=O.+Firuzi&title=Alkyl+esters+of+acids+with+improved+antioxidant+activity+and+lipophilicity+protect+PC12+cells+against+oxidative+stress&doi=10.1016%2Fj.biochi.2011.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Alkyl esters of hydroxycinnamic acids with improved antioxidant activity and lipophilicity protect PC12 cells against oxidative stress</span></div><div class="casAuthors">Garrido, Jorge; Gaspar, Alexandra; Garrido, E. Manuela; Miri, Ramin; Tavakkoli, Marjan; Pourali, Samaneh; Saso, Luciano; Borges, Fernanda; Firuzi, Omidreza</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">961-967</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Hydroxycinnamic acids (HCAs) are phenolic compds. present in dietary plants, which possess considerable antioxidant activity.  In order to increase the lipophilicity of HCAs, with the aim of improving their cellular absorption and expansion of their use in lipophilic media, Me, Et, Pr and Bu esters of caffeic acid and ferulic acid have been synthesized.  All caffeate esters had a slightly lower DPPH IC50 (13.5-14.5 μM) and higher ferric reducing antioxidant power (FRAP) values (1490-1588 mM quercetin/mol [mMQ/mol]) compared to caffeic acid (16.6 μM and 1398 mMQ/mol, resp.) in antioxidant assays.  In contrast, ferulate esters were less active in DPPH (56.3-74.7 μM) and FRAP assays (193-262 mMQ/mol) compared to ferulic acid (44.6 μM and 324 mMQ/mol, resp.).  Redox properties of HCAs were in line with their antioxidant capacities, so that compds. with higher antioxidant activities had lower oxidn. potentials.  Measurement of partition coeffs. disclosed the higher lipophilicity of the esters compared to parent compds.  All esters of caffeic acid significantly inhibited hydrogen peroxide-induced neuronal PC12 cell death assessed by MTT assay at 5 and 25 μM.  However, caffeic acid, ferulic acid and ferulate esters were not able to protect the cells.  In conclusion, these findings suggest that alkyl esterification of some HCAs augments their antioxidant properties as well as their lipophilicity and as a consequence, improves their cell protective activity against oxidative stress.  These compds. could have useful applications in conditions where oxidative stress plays a pathogenic role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF02j2Bw-IabVg90H21EOLACvtfcHk0li0894_j5x8vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSgtrk%253D&md5=602237a94bc021ca41758fe54c96b5ad</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2011.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2011.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DGarrido%26aufirst%3DJ.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DGarrido%26aufirst%3DE.%2BM.%26aulast%3DMiri%26aufirst%3DR.%26aulast%3DTavakkoli%26aufirst%3DM.%26aulast%3DPourali%26aufirst%3DS.%26aulast%3DSaso%26aufirst%3DL.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DFiruzi%26aufirst%3DO.%26atitle%3DAlkyl%2520esters%2520of%2520acids%2520with%2520improved%2520antioxidant%2520activity%2520and%2520lipophilicity%2520protect%2520PC12%2520cells%2520against%2520oxidative%2520stress%26jtitle%3DBiochimie%26date%3D2012%26volume%3D94%26spage%3D961%26epage%3D967%26doi%3D10.1016%2Fj.biochi.2011.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frolow, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span> <span> </span><span class="NLM_article-title">Purification and crystallization of a dimeric form of acetylcholinesterase from <i>Torpedo californica</i> subsequent to solubilization with phosphatidylinositol-specific phospholipase C</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">823</span>, <span class="refDoi"> DOI: 10.1016/0022-2836(88)90213-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2F0022-2836%2888%2990213-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=2850366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaL1MXjs12h" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=1988&pages=821-823&author=J.+L.+Sussmanauthor=M.+Harelauthor=F.+Frolowauthor=L.+Varonauthor=L.+Tokerauthor=A.+H.+Futermanauthor=I.+Silman&title=Purification+and+crystallization+of+a+dimeric+form+of+acetylcholinesterase+from+Torpedo+californica+subsequent+to+solubilization+with+phosphatidylinositol-specific+phospholipase+C&doi=10.1016%2F0022-2836%2888%2990213-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and crystallization of a dimeric form of acetylcholinesterase from Torpedo californica subsequent to solubilization with phosphatidylinositol-specific phospholipase C</span></div><div class="casAuthors">Sussman, J. L.; Harel, M.; Frolow, F.; Varon, L.; Toker, L.; Futerman, A. H.; Silman, I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">821-3</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">A dimeric form of acetylcholinesterase from T. californica was purified to homogeneity by affinity chromatog. subsequent to solubilization with a phosphatidylinositol-specific phospholipase C of bacterial origin.  Bipyramidal crystals of the enzyme were obtained from solns. in polyethylene glycol 200.  The crystals diffract to 2.0 Å resoln.  They were orthorhombic, space group P2221, with a = 163.4, b = 112.1, and c = 81.3 Å.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreLFBumZz6FrVg90H21EOLACvtfcHk0liZtmWL48YoHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXjs12h&md5=977c3d50bccc11592e687b25cc6347b1</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2F0022-2836%2888%2990213-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-2836%252888%252990213-6%26sid%3Dliteratum%253Aachs%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DFrolow%26aufirst%3DF.%26aulast%3DVaron%26aufirst%3DL.%26aulast%3DToker%26aufirst%3DL.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26aulast%3DSilman%26aufirst%3DI.%26atitle%3DPurification%2520and%2520crystallization%2520of%2520a%2520dimeric%2520form%2520of%2520acetylcholinesterase%2520from%2520Torpedo%2520californica%2520subsequent%2520to%2520solubilization%2520with%2520phosphatidylinositol-specific%2520phospholipase%2520C%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1988%26volume%3D203%26spage%3D821%26epage%3D823%26doi%3D10.1016%2F0022-2836%2888%2990213-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brazzolotto, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wandhammer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trovaslet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockridge, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span> <span> </span><span class="NLM_article-title">Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">2905</span>– <span class="NLM_lpage">2916</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2012.08672.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1111%2Fj.1742-4658.2012.08672.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=22726956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOhtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2012&pages=2905-2916&author=X.+Brazzolottoauthor=M.+Wandhammerauthor=C.+Roncoauthor=M.+Trovasletauthor=L.+Jeanauthor=O.+Lockridgeauthor=P.-Y.+Renardauthor=F.+Nachon&title=Human+butyrylcholinesterase+produced+in+insect+cells%3A+huprine-based+affinity+purification+and+crystal+structure&doi=10.1111%2Fj.1742-4658.2012.08672.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure</span></div><div class="casAuthors">Brazzolotto, Xavier; Wandhammer, Marielle; Ronco, Cyril; Trovaslet, Marie; Jean, Ludovic; Lockridge, Oksana; Renard, Pierre-Yves; Nachon, Florian</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2905-2916</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Butyrylcholinesterase (BChE) is a serine hydrolase that is present in all mammalian tissues.  It can accommodate larger substrates or inhibitors than acetylcholinesterase (AChE), the enzyme responsible for hydrolysis of the neurotransmitter acetylcholine in the central nervous system and neuromuscular junctions.  AChE is the specific target of organophosphorous pesticides and warfare nerve agents, and BChE is a stoichiometric bioscavenger.  Conversion of BChE into a catalytic bioscavenger by rational design or designing reactivators specific to BChE required structural data obtained using a recombinant low-glycosylated human BChE expressed in Chinese hamster ovary cells.  This expression system yields ∼ 1 mg of pure enzyme per L of cell culture.  Here, we report an improved expression system using insect cells with a fourfold higher yield for truncated human BChE with all glycosylation sites present.  We developed a fast purifn. protocol for the recombinant protein using huprine-based affinity chromatog., which is superior to the classical procainamide-based affinity.  The purified BChE crystd. under different conditions and space group than the recombinant low-glycosylated protein produced in Chinese hamster ovary cells.  The crystals diffracted to 2.5 Å.  The overall monomer structure is similar to the low-glycosylated structure except for the presence of the addnl. glycans.  Remarkably, the carboxylic acid mol. systematically bound to the catalytic serine in the low-glycosylated structure is also present in this new structure, despite the different expression system, purifn. protocol and crystn. conditions.  Database Structural data have been submitted to the Protein Data Bank under accession no. pdb.  DNA sequence data for the synthetic gene have been submitted to GenBank under accession no.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNCaql_IyZuLVg90H21EOLACvtfcHk0liZtmWL48YoHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOhtr%252FP&md5=197231a2815a654344ad4d1bdf01e4ad</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2012.08672.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2012.08672.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrazzolotto%26aufirst%3DX.%26aulast%3DWandhammer%26aufirst%3DM.%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DTrovaslet%26aufirst%3DM.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DLockridge%26aufirst%3DO.%26aulast%3DRenard%26aufirst%3DP.-Y.%26aulast%3DNachon%26aufirst%3DF.%26atitle%3DHuman%2520butyrylcholinesterase%2520produced%2520in%2520insect%2520cells%253A%2520huprine-based%2520affinity%2520purification%2520and%2520crystal%2520structure%26jtitle%3DFEBS%2520J.%26date%3D2012%26volume%3D279%26spage%3D2905%26epage%3D2916%26doi%3D10.1111%2Fj.1742-4658.2012.08672.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span> <span> </span><span class="NLM_article-title">Rapid and sensitive determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry: Application to a pharmacokinetic study</span>. <i>Rapid Commun. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3193</span>– <span class="NLM_lpage">3198</span>, <span class="refDoi"> DOI: 10.1002/rcm.2718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Frcm.2718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=17016805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKktLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=3193-3198&author=Z.+Xieauthor=Q.+Liaoauthor=X.+Xuauthor=M.+Yaoauthor=J.+Wanauthor=D.+Liu&title=Rapid+and+sensitive+determination+of+donepezil+in+human+plasma+by+liquid+chromatography%2Ftandem+mass+spectrometry%3A+Application+to+a+pharmacokinetic+study&doi=10.1002%2Frcm.2718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid and sensitive determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study</span></div><div class="casAuthors">Xie, Zhiyong; Liao, Qiongfeng; Xu, Xinjun; Yao, Meicun; Wan, Jinzhi; Liu, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3193-3198</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A liq. chromatog./tandem mass spectrometry (LC/MS/MS) method was developed and validated for the detn. of donepezil in human plasma samples.  Diphenhydramine was used as the internal std.  The collision-induced transition m/z 380 → 91 was used to analyze donepezil in selected reaction monitoring mode.  The signal intensity of the m/z 380 → 91 transition was found to relate linearly with donepezil concns. in plasma from 0.1-20.0 ng/mL.  The lower limit of quantification of the LC/MS/MS method was 0.1 ng/mL.  The intra- and inter-day precisions were below 10.2% and the accuracy was between -2.3% and +2.8%.  The validated LC/MS/MS method was applied to a pharmacokinetic study in which healthy Chinese volunteers each received a single oral dose of 5 mg donepezil hydrochloride.  The non-compartmental pharmacokinetic model was used to fit the donepezil plasma concn.-time curve.  Maximum plasma concn. was 12.3 ± 2.73 ng/mL which occurred at 3.50 ± 1.61 h post-dosing.  The apparent elimination half-life and the area under the curve were, resp., 60.86 ± 12.05 h and 609.3 ± 122.2 ng · h/mL.  LC/MS/MS is a rapid, sensitive and specific method for detg. donepezil in human plasma samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeHdiWh6zzOrVg90H21EOLACvtfcHk0ljM9uMqpmDneg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKktLnO&md5=498843a6bb42514cde648b064a604b3b</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1002%2Frcm.2718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.2718%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26atitle%3DRapid%2520and%2520sensitive%2520determination%2520of%2520donepezil%2520in%2520human%2520plasma%2520by%2520liquid%2520chromatography%252Ftandem%2520mass%2520spectrometry%253A%2520Application%2520to%2520a%2520pharmacokinetic%2520study%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2006%26volume%3D20%26spage%3D3193%26epage%3D3198%26doi%3D10.1002%2Frcm.2718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, R. A.</span></span> <span> </span><span class="NLM_article-title">The open-field test: A critical review</span>. <i>Psychol. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1037/0033-2909.83.3.482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1037%2F0033-2909.83.3.482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=17582919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A280%3ADC%252BD2szmvVCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1976&pages=482-504&author=R.+N.+Walshauthor=R.+A.+Cummins&title=The+open-field+test%3A+A+critical+review&doi=10.1037%2F0033-2909.83.3.482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The Open-Field Test: a critical review</span></div><div class="casAuthors">Walsh R N; Cummins R A</div><div class="citationInfo"><span class="NLM_cas:title">Psychological bulletin</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">482-504</span>
        ISSN:<span class="NLM_cas:issn">0033-2909</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYvoIgIf3zKFm8bhe6roZYfW6udTcc2eZol6fj6_0Wjrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szmvVCrsg%253D%253D&md5=60c00d3638695d81c9a738e39a8c4b3d</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1037%2F0033-2909.83.3.482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252F0033-2909.83.3.482%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DR.%2BN.%26aulast%3DCummins%26aufirst%3DR.%2BA.%26atitle%3DThe%2520open-field%2520test%253A%2520A%2520critical%2520review%26jtitle%3DPsychol.%2520Bull.%26date%3D1976%26volume%3D83%26spage%3D482%26epage%3D504%26doi%3D10.1037%2F0033-2909.83.3.482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cisternas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsay, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva-Alvarez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retamales, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vio, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer’s disease</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1852</i></span>,  <span class="NLM_fpage">2630</span>– <span class="NLM_lpage">2644</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2015.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bbadis.2015.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=26391254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeit7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1852&publication_year=2015&pages=2630-2644&author=P.+Cisternasauthor=C.+B.+Lindsayauthor=P.+Salazarauthor=C.+Silva-Alvarezauthor=R.+M.+Retamalesauthor=F.+G.+Serranoauthor=C.+P.+Vioauthor=N.+C.+Inestrosa&title=The+increased+potassium+intake+improves+cognitive+performance+and+attenuates+histopathological+markers+in+a+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bbadis.2015.09.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer's disease</span></div><div class="casAuthors">Cisternas, Pedro; Lindsay, Carolina B.; Salazar, Paulina; Silva-Alvarez, Carmen; Retamales, Rocio M.; Serrano, Felipe G.; Vio, Carlos P.; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1852</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2630-2644</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder characterized by hallmarks that include an accumulation of amyloid-β peptide (Aβ), inflammation, oxidative stress and synaptic dysfunction, which lead to a decrease in cognitive function.  To date, the onset and progression of AD have been assocd. with pathologies such as hypertension and diabetes.  Hypertension, a disease with a high incidence worldwide, is characterized by a chronic increase in blood pressure.  Interestingly, this disease has a close relationship to the eating behavior of patients because high Na+ intake is a significant risk factor for hypertension.  In fact, a decrease in Na+ consumption, along with an increase in K+ intake, is a primary non-pharmacol. approach to preventing hypertension.  In the present work, we examd. whether an increase in K+ intake affects the expression of certain neuropathol. markers or the cognitive performance of a murine model of AD.  We obsd. that an increase in K+ intake leads to a change in the aggregation pattern of the Aβ peptide, a partial decrease in some epitopes of tau phosphorylation and improvement in the cognitive performance.  The recovery in cognitive performance was correlated with a significant improvement in the generation of long-term potentiation.  We also obsd. a decrease in markers related to inflammation and oxidative stress such as glial fibrillary acidic protein (GFAP), interleukin 6 (IL-6) and 4-hydroxynonenal (4-HNE).  Together, our data support the idea that changes in diet, such as an increase in K+ intake, may be important in the prevention of AD onset as a non-pharmacol. therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolFjIznAZrSrVg90H21EOLACvtfcHk0lhaNy_Iujs5NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeit7nO&md5=2adfd4e1284a22ab3bcdca6a2a8d63d5</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2015.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2015.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DCisternas%26aufirst%3DP.%26aulast%3DLindsay%26aufirst%3DC.%2BB.%26aulast%3DSalazar%26aufirst%3DP.%26aulast%3DSilva-Alvarez%26aufirst%3DC.%26aulast%3DRetamales%26aufirst%3DR.%2BM.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DVio%26aufirst%3DC.%2BP.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DThe%2520increased%2520potassium%2520intake%2520improves%2520cognitive%2520performance%2520and%2520attenuates%2520histopathological%2520markers%2520in%2520a%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2015%26volume%3D1852%26spage%3D2630%26epage%3D2644%26doi%3D10.1016%2Fj.bbadis.2015.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bevins, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besheer, J.</span></span> <span> </span><span class="NLM_article-title">Object recognition in rats and mice: A one-trial non-matching-to-sample learning task to study “recognition memory”</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1306</span>– <span class="NLM_lpage">1311</span>, <span class="refDoi"> DOI: 10.1038/nprot.2006.205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1038%2Fnprot.2006.205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=17406415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A280%3ADC%252BD2s3gsVaisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1306-1311&author=R.+A.+Bevinsauthor=J.+Besheer&title=Object+recognition+in+rats+and+mice%3A+A+one-trial+non-matching-to-sample+learning+task+to+study+%E2%80%9Crecognition+memory%E2%80%9D&doi=10.1038%2Fnprot.2006.205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'</span></div><div class="casAuthors">Bevins Rick A; Besheer Joyce</div><div class="citationInfo"><span class="NLM_cas:title">Nature protocols</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1306-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Rats and mice have a tendency to interact more with a novel object than with a familiar object.  This tendency has been used by behavioral pharmacologists and neuroscientists to study learning and memory.  A popular protocol for such research is the object-recognition task.  Animals are first placed in an apparatus and allowed to explore an object.  After a prescribed interval, the animal is returned to the apparatus, which now contains the familiar object and a novel object.  Object recognition is distinguished by more time spent interacting with the novel object.  Although the exact processes that underlie this 'recognition memory' requires further elucidation, this method has been used to study mutant mice, aging deficits, early developmental influences, nootropic manipulations, teratological drug exposure and novelty seeking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCO9YXRnurMlZoq0fPSOTvfW6udTcc2eaKQRWX6GgnlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3gsVaisw%253D%253D&md5=6de357de8e39a8e5076563bbc8f7041d</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.205%26sid%3Dliteratum%253Aachs%26aulast%3DBevins%26aufirst%3DR.%2BA.%26aulast%3DBesheer%26aufirst%3DJ.%26atitle%3DObject%2520recognition%2520in%2520rats%2520and%2520mice%253A%2520A%2520one-trial%2520non-matching-to-sample%2520learning%2520task%2520to%2520study%2520%25E2%2580%259Crecognition%2520memory%25E2%2580%259D%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26spage%3D1306%26epage%3D1311%26doi%3D10.1038%2Fnprot.2006.205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuenzalida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer’s disease model</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2191</span>– <span class="NLM_lpage">2202</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0862-13.2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1523%2FJNEUROSCI.0862-13.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=24501359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVGrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=2191-2202&author=J.+Y.+Vargasauthor=M.+Fuenzalidaauthor=N.+C.+Inestrosa&title=In+vivo+activation+of+Wnt+signaling+pathway+enhances+cognitive+function+of+adult+mice+and+reverses+cognitive+deficits+in+an+Alzheimer%E2%80%99s+disease+model&doi=10.1523%2FJNEUROSCI.0862-13.2014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer's disease model</span></div><div class="casAuthors">Vargas, Jessica Y.; Fuenzalida, Marco; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2191-2202</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The role of the Wnt signaling pathway during synaptic development has been well established.  In the adult brain, different components of Wnt signaling are expressed, but little is known about its role in mature synapses.  Emerging in vitro studies have implicated Wnt signaling in synaptic plasticity.  Furthermore, activation of Wnt signaling has shown to protect against amyloid-β-induced synaptic impairment.  The present study provides the first evidence that in vivo activation of Wnt signaling improves episodic memory, increases excitatory synaptic transmission, and enhances long-term potentiation in adult wild-type mice.  Moreover, the activation of Wnt signaling also rescues memory loss and improves synaptic dysfunction in APP/PS1-transgenic mice that model the amyloid pathol. of Alzheimer's diseases.  These findings indicate that Wnt signaling modulates cognitive function in the adult brain and could be a novel promising target for Alzheimer's disease therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ70P4_bMKjrVg90H21EOLACvtfcHk0ljiWoUD1N_W4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVGrtr4%253D&md5=633b19f0057d4a7faa75962f948b69d1</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0862-13.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0862-13.2014%26sid%3Dliteratum%253Aachs%26aulast%3DVargas%26aufirst%3DJ.%2BY.%26aulast%3DFuenzalida%26aufirst%3DM.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DIn%2520vivo%2520activation%2520of%2520Wnt%2520signaling%2520pathway%2520enhances%2520cognitive%2520function%2520of%2520adult%2520mice%2520and%2520reverses%2520cognitive%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2014%26volume%3D34%26spage%3D2191%26epage%3D2202%26doi%3D10.1523%2FJNEUROSCI.0862-13.2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cisternas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codocedo, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Induction of hypothyroidism during early postnatal stages triggers a decrease in cognitive performance by decreasing hippocampal synaptic plasticity</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">870</span>– <span class="NLM_lpage">883</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2017.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bbadis.2017.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=28088629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2017&pages=870-883&author=P.+Salazarauthor=P.+Cisternasauthor=J.+F.+Codocedoauthor=N.+C.+Inestrosa&title=Induction+of+hypothyroidism+during+early+postnatal+stages+triggers+a+decrease+in+cognitive+performance+by+decreasing+hippocampal+synaptic+plasticity&doi=10.1016%2Fj.bbadis.2017.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of hypothyroidism during early postnatal stages triggers a decrease in cognitive performance by decreasing hippocampal synaptic plasticity</span></div><div class="casAuthors">Salazar, Paulina; Cisternas, Pedro; Codocedo, Juan Francisco; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">870-883</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Thyroid hormones are vital in the control of multiple body functions, including the correct performance of the brain.  Multiple diseases are assocd. with thyroid gland functioning, including hypothyroidism.  To date, little is known regarding the effects of the establishment of this condition at a young age on brain function.  Here, we evaluated the effect of hypothyroidism in an early postnatal stage in cognitive abilities with focus on the hippocampus.  In our model, hypothyroidism was induced in young rats at 21 days of age using 0.05% 6-propyl-2-thiouracil (PTU) for 4 wk reaching significantly lower levels of fT4 (control: 1.337 ng/dL ± 0.115, PTU: 0.050 ng/dL ± 0.001).  Following the induction of hypothyroidism, several cognitive tasks were assessed to investigate the effects of hypothyroidism on cognition performance.  We detd. that hypothyroidism triggers a significant dysfunction in learning and memory processes obsd. in the Morris Water Maze were the latency times were higher in PTU rats (controls: 37 s; PTU: 57 s).  The cognitive impairment was correlated with a redn. in hippocampal plasticity with respect to both long-term potentiation (LTP) (control: 1.45, PTU: 1.00) and depression (LTD) (control: 0.71, PTU: 1.01).  Furthermore, a decrease in the rate of glucose utilization (control: 223 nmol * mg of protein, PTU:148 nmol * mg of protein) was obsd., along with an increase in oxidative stress and a decrease in MAP2 marker in the hippocampus.  Our findings suggest that the induction of hypothyroidism in a young rat model alters numerous functions at the level of the hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI6VB7ByzC6rVg90H21EOLACvtfcHk0ljiWoUD1N_W4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKjtLo%253D&md5=bd4bbb3108404ee39638e31bd849e0ee</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2017.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DSalazar%26aufirst%3DP.%26aulast%3DCisternas%26aufirst%3DP.%26aulast%3DCodocedo%26aufirst%3DJ.%2BF.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DInduction%2520of%2520hypothyroidism%2520during%2520early%2520postnatal%2520stages%2520triggers%2520a%2520decrease%2520in%2520cognitive%2520performance%2520by%2520decreasing%2520hippocampal%2520synaptic%2520plasticity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2017%26volume%3D1863%26spage%3D870%26epage%3D883%26doi%3D10.1016%2Fj.bbadis.2017.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codocedo, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cisternas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozinovic, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Andrographolide recovers cognitive impairment in a natural model of Alzheimer’s disease (<i>Octodon degus</i>)</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2016.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.neurobiolaging.2016.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=27505720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1agt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2016&pages=204-220&author=D.+S.+Riveraauthor=C.+Lindsayauthor=J.+F.+Codocedoauthor=I.+Morelauthor=C.+Pintoauthor=P.+Cisternasauthor=F.+Bozinovicauthor=N.+C.+Inestrosa&title=Andrographolide+recovers+cognitive+impairment+in+a+natural+model+of+Alzheimer%E2%80%99s+disease+%28Octodon+degus%29&doi=10.1016%2Fj.neurobiolaging.2016.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide recovers cognitive impairment in a natural model of Alzheimer's disease (Octodon degus)</span></div><div class="casAuthors">Rivera, Daniela S.; Lindsay, Carolina; Codocedo, Juan Francisco; Morel, Isidora; Pinto, Claudio; Cisternas, Pedro; Bozinovic, Francisco; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">204-220</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The social species Octodon degus (degu) is the only wild-type South American rodent that develops Alzheimer's-like pathol. with age.  Here, we evaluated the ability of a natural product (Andrographolide, ANDRO), a diterpene of the labdane family obtained from the Asian plant Andrographis paniculata, to recover the cognitive decline in this long-lived animal model.  We administered ANDRO to aged degus (56-mo old) for 3 mo.  In addn., in 2 control groups (young degus: 12-mo old and aged degus: 56-mo old), we administrated saline soln. as a vehicle.  We evaluated cognitive performance through several behavioral tests.  We also performed a series of physiol. and biochem. analyses (e.g., electrophysiol. and immunoblotting assessment) to identify possible mechanisms underlying cognitive performance assocd. with age.  Our results suggest that there is an effect of aging on the loss of cognitive function, and this decrease in cognitive function was also related to a decrease in the synaptic functions and an increase in the main hallmarks of Alzheimer's disease (AD).  More importantly, ANDRO treatments showed the following beneficial effects: (1) recovery of spatial memory and learning performance; (2) recovery of synaptic basal transmission; (3) partial or complete protection of certain synaptic proteins; and (4) a specific neuroprotective effect, including the redn. of phosphorylated tau protein and amyloid beta aggregate maturation in aged degus.  Taken together, our results suggest that ANDRO could be used as a potential therapy for AD and support the use of O. degus as a natural model in which to study both neural damage assocd. with aging processes and the behavioral and neuropathol. hallmarks of aging-related diseases such as AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphAg7SLv1Fe7Vg90H21EOLACvtfcHk0ljmyY5rHKnwvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1agt7bO&md5=6144cbf19bbf30a0b9521669234d8fdf</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2016.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2016.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DD.%2BS.%26aulast%3DLindsay%26aufirst%3DC.%26aulast%3DCodocedo%26aufirst%3DJ.%2BF.%26aulast%3DMorel%26aufirst%3DI.%26aulast%3DPinto%26aufirst%3DC.%26aulast%3DCisternas%26aufirst%3DP.%26aulast%3DBozinovic%26aufirst%3DF.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DAndrographolide%2520recovers%2520cognitive%2520impairment%2520in%2520a%2520natural%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520%2528Octodon%2520degus%2529%26jtitle%3DNeurobiol.%2520Aging%26date%3D2016%26volume%3D46%26spage%3D204%26epage%3D220%26doi%3D10.1016%2Fj.neurobiolaging.2016.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Michele Rossi, Michela Freschi, Luciana de Camargo Nascente, Alessandra Salerno, Sarah de Melo Viana Teixeira, Florian Nachon, Fabien Chantegreil, Ondrej Soukup, Lukáš Prchal, Marco Malaguti, Christian Bergamini, Manuela Bartolini, Cristina Angeloni, Silvana Hrelia, Luiz Antonio Soares Romeiro, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4972-4990. <a href="https://doi.org/10.1021/acs.jmedchem.1c00048" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00048%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSustainable%252BDrug%252BDiscovery%252Bof%252BMulti-Target-Directed%252BLigands%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DRossi%26aufirst%3DMichele%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D11012021%26date%3D08042021%26volume%3D64%26issue%3D8%26spage%3D4972%26epage%3D4990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria João  Matos</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget therapeutic approaches for Alzheimer's and Parkinson's diseases: an opportunity or an illusion?. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (15)
                                     , 1301-1309. <a href="https://doi.org/10.4155/fmc-2021-0119" title="DOI URL">https://doi.org/10.4155/fmc-2021-0119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2021-0119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2021-0119%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DMultitarget%252Btherapeutic%252Bapproaches%252Bfor%252BAlzheimer%252527s%252Band%252BParkinson%252527s%252Bdiseases%25253A%252Ban%252Bopportunity%252Bor%252Ban%252Billusion%25253F%26aulast%3DMatos%26aufirst%3DMaria%2BJo%25C3%25A3o%26date%3D2021%26volume%3D13%26issue%3D15%26spage%3D1301%26epage%3D1309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandran  Remya</span>, <span class="hlFld-ContribAuthor ">K.V.  Dileep</span>, <span class="hlFld-ContribAuthor ">Eeda  Koti Reddy</span>, <span class="hlFld-ContribAuthor ">Kumar  Mantosh</span>, <span class="hlFld-ContribAuthor ">Kesavan  Lakshmi</span>, <span class="hlFld-ContribAuthor ">Reena  Sarah Jacob</span>, <span class="hlFld-ContribAuthor ">Ayyiliyath M  Sajith</span>, <span class="hlFld-ContribAuthor ">E.  Jayadevi Variyar</span>, <span class="hlFld-ContribAuthor ">Shaik  Anwar</span>, <span class="hlFld-ContribAuthor ">Kam  Y. J. Zhang</span>, <span class="hlFld-ContribAuthor ">C.  Sadasivan</span>, <span class="hlFld-ContribAuthor ">R.V.  Omkumar</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2021,</strong> <em>44 </em><a href="https://doi.org/10.1016/j.csbj.2021.07.041" title="DOI URL">https://doi.org/10.1016/j.csbj.2021.07.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2021.07.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2021.07.041%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DNeuroprotective%252Bderivatives%252Bof%252Btacrine%252Bthat%252Btarget%252BNMDA%252Breceptor%252Band%252Bacetyl%252Bcholinesterase%252B-%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DRemya%26aufirst%3DChandran%26date%3D2021%26volume%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafael  Dolezal</span>. </span><span class="cited-content_cbyCitation_article-title">Accuracy and precision of binding free energy prediction for a tacrine related lead inhibitor of acetylcholinesterase with an arsenal of supercomputerized molecular modelling methods: a comparative study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>32 </em>, 1-29. <a href="https://doi.org/10.1080/07391102.2021.1957716" title="DOI URL">https://doi.org/10.1080/07391102.2021.1957716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1957716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1957716%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DAccuracy%252Band%252Bprecision%252Bof%252Bbinding%252Bfree%252Benergy%252Bprediction%252Bfor%252Ba%252Btacrine%252Brelated%252Blead%252Binhibitor%252Bof%252Bacetylcholinesterase%252Bwith%252Ban%252Barsenal%252Bof%252Bsupercomputerized%252Bmolecular%252Bmodelling%252Bmethods%25253A%252Ba%252Bcomparative%252Bstudy%26aulast%3DDolezal%26aufirst%3DRafael%26date%3D2021%26date%3D2021%26volume%3D32%26spage%3D1%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giselle  de Andrade Ramos</span>, <span class="hlFld-ContribAuthor ">Andressa  Souza de Oliveira</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Marina  Naldi</span>, <span class="hlFld-ContribAuthor ">Irene  Liparulo</span>, <span class="hlFld-ContribAuthor ">Christian  Bergamini</span>, <span class="hlFld-ContribAuthor ">Elisa  Uliassi</span>, <span class="hlFld-ContribAuthor ">Ling  Wu</span>, <span class="hlFld-ContribAuthor ">Paul E.  Fraser</span>, <span class="hlFld-ContribAuthor ">Monica  Abreu</span>, <span class="hlFld-ContribAuthor ">Alessandra Sofia  Kiametis</span>, <span class="hlFld-ContribAuthor ">Ricardo  Gargano</span>, <span class="hlFld-ContribAuthor ">Edilberto Rocha  Silveira</span>, <span class="hlFld-ContribAuthor ">Guilherme D.  Brand</span>, <span class="hlFld-ContribAuthor ">Lukas  Prchal</span>, <span class="hlFld-ContribAuthor ">Ondřej  Soukup</span>, <span class="hlFld-ContribAuthor ">Jan  Korábečný</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, <span class="hlFld-ContribAuthor ">Luiz Antonio  Soares Romeiro</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1154-1163. <a href="https://doi.org/10.1039/D1MD00046B" title="DOI URL">https://doi.org/10.1039/D1MD00046B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00046B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00046B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bsustainable%252Bdrugs%252Bfor%252BAlzheimer%252527s%252Bdisease%25253A%252Bcardanol-derived%252Bcholinesterase%252Binhibitors%252Bwith%252Bantioxidant%252Band%252Banti-amyloid%252Bproperties%26aulast%3Dde%2BAndrade%2BRamos%26aufirst%3DGiselle%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D7%26spage%3D1154%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Mezeiova</span>, <span class="hlFld-ContribAuthor ">Martina  Hrabinova</span>, <span class="hlFld-ContribAuthor ">Vendula  Hepnarova</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Jana  Janockova</span>, <span class="hlFld-ContribAuthor ">Lubica  Muckova</span>, <span class="hlFld-ContribAuthor ">Lukas  Prchal</span>, <span class="hlFld-ContribAuthor ">Zdena  Kristofikova</span>, <span class="hlFld-ContribAuthor ">Tomas  Kucera</span>, <span class="hlFld-ContribAuthor ">Lukas  Gorecki</span>, <span class="hlFld-ContribAuthor ">Katarina  Chalupova</span>, <span class="hlFld-ContribAuthor ">Jiri  Kunes</span>, <span class="hlFld-ContribAuthor ">Jana  Hroudova</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>. </span><span class="cited-content_cbyCitation_article-title">Huprine Y – Tryptophan heterodimers with potential implication to Alzheimer’s disease treatment. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>43 </em>, 128100. <a href="https://doi.org/10.1016/j.bmcl.2021.128100" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128100%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHuprine%252BY%252B%2525E2%252580%252593%252BTryptophan%252Bheterodimers%252Bwith%252Bpotential%252Bimplication%252Bto%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Btreatment%26aulast%3DMezeiova%26aufirst%3DEva%26date%3D2021%26volume%3D43%26spage%3D128100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atsushi  Nakayama</span>, <span class="hlFld-ContribAuthor ">Tenta  Nakamura</span>, <span class="hlFld-ContribAuthor ">Tabassum  Ara</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Fukuta</span>, <span class="hlFld-ContribAuthor ">Sangita  Karanjit</span>, <span class="hlFld-ContribAuthor ">Takeshi  Harada</span>, <span class="hlFld-ContribAuthor ">Asuka  Oda</span>, <span class="hlFld-ContribAuthor ">Hideo  Sato</span>, <span class="hlFld-ContribAuthor ">Masahiro  Abe</span>, <span class="hlFld-ContribAuthor ">Kentaro  Kogure</span>, <span class="hlFld-ContribAuthor ">Kosuke  Namba</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a novel antioxidant based on a dimeric dihydroisocoumarin derivative. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>74 </em>, 153176. <a href="https://doi.org/10.1016/j.tetlet.2021.153176" title="DOI URL">https://doi.org/10.1016/j.tetlet.2021.153176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2021.153176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2021.153176%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDevelopment%252Bof%252Ba%252Bnovel%252Bantioxidant%252Bbased%252Bon%252Ba%252Bdimeric%252Bdihydroisocoumarin%252Bderivative%26aulast%3DNakayama%26aufirst%3DAtsushi%26date%3D2021%26volume%3D74%26spage%3D153176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of capsaicin and huprine Y.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the HC Hybrids <b>5a</b>–<b>e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (1) <b>3a</b>–<b>e</b>, 40% methanolic KOH, reflux, 3 h; then H<sub>2</sub>O, reflux, overnight; 0.5 N HCl/Et<sub>2</sub>O; (2) crude carboxylic acid (1 equiv), ClCO<sub>2</sub>Et (1 equiv), Et<sub>3</sub>N (5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; then, <b>4</b>·HCl (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 days, 18% (<b>5a</b>), 38% (<b>5b</b>), 44% (<b>5c</b>), 17% (<b>5d</b>), 9% (<b>5e</b>) overall.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the HC Hybrid <b>5f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (1) <b>3f</b>, 40% methanolic KOH, reflux, 3 h; then H<sub>2</sub>O, reflux, overnight; 0.5 N HCl/Et<sub>2</sub>O; (2) crude carboxylic acid (1 equiv), ClCO<sub>2</sub>Et (1 equiv), Et<sub>3</sub>N (5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; then, <b>4</b>·HCl (1 equiv) or <b>6</b> (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 days, 33% (<b>5f</b>, from <b>3f</b> and <b>4</b>), 81% (<b>7</b>, from <b>3f</b> and <b>6</b>) overall; (ii) 1 M TBAF/THF, THF, rt, 4 h, 94% (76% overall yield of <b>5f</b> via <b>7</b>).</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the HC Hybrids <b>5g</b>,<b>h</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (1) <b>8</b> (1 equiv), ClCO<sub>2</sub>Et (1 equiv), Et<sub>3</sub>N (2.2 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; then, <b>4</b>·HCl (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 days; 2) sat. aq. NaHCO<sub>3</sub>, MeOH, H<sub>2</sub>O, rt, overnight, 78%; (ii) KOH or NaOH (1.6 equiv), 4 Å molecular sieves, DMSO, rt., 2 h; then allyl bromide (1 equiv) or 5-bromo-1-pentene (1.1 equiv), DMSO, rt, overnight, 55% (<b>10g</b>), 27% (<b>10h</b>); (iii) <b>10g</b>,<b>h</b> (1 equiv), <b>9</b> (1.2–1.8 equiv), <i>p</i>-benzoquinone (0.1 equiv), Grubbs–Hoveyda II generation catalyst (0.05 equiv), reflux, 3 days, 9% (<b>5g</b>), 7% (<b>5h</b>).</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the HC Hybrid <b>5i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <b>11</b> (1 equiv), 3-butynoic acid (1 equiv), EDC·HCl (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, 36%; (ii) <b>13</b> (1 equiv), <b>12</b> (1.2 equiv), CuI (1 equiv), CH<sub>3</sub>CN, rt, 12 h, 80%; (iii) camphorsulfonic acid (0.02 equiv), CH<sub>2</sub>Cl<sub>2</sub>/MeOH 80:20, rt, 24 h, 73%.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Left: Kinetic measurements to characterize the mode of inhibition of AChE by <b>5c</b>. Lineweaver–Burk reciprocal plots show the variation of the AChE initial velocity rate with increasing substrate concentrations (acetylthiocholine (ATCh), 0.11–0.57 mM) in the absence and presence of increasing concentrations of <b>5c</b> (0.17–1.36 nM). Lines were derived from a weighted least-squares analysis of the data points. The mechanism of inhibition was assessed by two independent experiments, each performed in triplicate. Right: Determination of the <i>K</i><sub>D</sub> value for <b>5c</b> binding to PAS from the antilog of the <i>Y</i>-intercept value.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Experimental conditions: 2.0 μM <i>Ee</i>AChE, 8.0 μM propidium, 1.0 mM Tris HCl, pH 8.0; P stands for propidium iodide and I stands for the tested inhibitor; Fe is the initial fluorescence intensity when enzyme sites are saturated with P, F<sub>P</sub> is the fluorescence intensity when propidium is completely displaced from the enzyme, and F denotes the fluorescence intensity after adding a determined amount of displacing agent during the titration experiment. Data are the average of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures of complexes with <i>Tc</i>AChE of HC hybrids <b>5b</b> (A), <b>5c</b> (B), and <b>5d</b> (C). Compounds (light orange) and key residues of <i>Tc</i>AChE (blue/gray) are shown as sticks. The protein backbone is represented as a light blue cartoon. The type of interaction is color-coded as follows: <i>Tc</i>AChE residues involved in hydrophobic interactions are colored gray, parallel and perpendicular π-stacking interactions are represented as green and magenta sticks between interacting aromatic centers (modeled as white spheres), and hydrogen bonds are represented as red dashes, with amino acid residues involved colored blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of complexes with <i>Tc</i>AChE of HC hybrids <b>5f</b> (A) and <b>5h</b> (B). Residues and interactions are color-coded as in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. (C) Gorge restructuration upon binding of <b>5f</b>. The <i>Tc</i>AChE backbone is shown in a blue cartoon format, and compound <b>5f</b> is shown as light orange sticks. Residues that change conformation upon binding of <b>5f</b> are shown as sticks, with the native conformation shown in blue and the <b>5f</b>-bound conformation in magenta.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structures of <b>5i</b>–<i>Tc</i>AChE (A) and <b>5i</b>–hBChE complexes (B). Residues and interactions are color-coded as in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. (C, D) Surface representations of the hBChE active-site gorge, with key residues shown as gray sticks. The conformation of compound <b>5i</b> observed in the crystal structure of its complex with <i>Tc</i>AChE was modeled into the hBChE active-site gorge (after superimposition of the two structures). Compound <b>5i</b> is shown as cyan spheres (scaled to match the van der Waals radius). This representation clearly shows that the chlorine atom of the huprine Y moiety cannot fit into the hBChE active-site gorge due to steric hindrance by Met437 (black stick). (D) Observed binding mode for <b>5i</b> in its complex with hBChE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) In vivo distribution of compounds <b>5c</b> and <b>5i</b> and of the reference drug, donepezil (DPZ) to various organs in 6 month-old C57BL6 mice. (B) Comparison of brain levels of <b>5c</b>, <b>5i</b>, and donepezil. Data were analyzed using one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test; **<i>p</i> < 0.01 and ***<i>p</i> < 0.001 were considered significant differences.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Time spent moving and number of crossings by (A, B) young and (C, D) old male APP/PS1 mice treated with the vehicle, <b>5c</b>, and <b>5i</b> in the LOF test. Data are expressed as mean values ± SEM of <i>n</i> = 7 animals in each group. Data were analyzed by one-way ANOVA followed by Bonferroni’s post hoc test; <i>p</i> ≤ 0.05 was considered the threshold for statistical significance with 95% confidence interval (CI).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Preference indices in the NOR and NOL tests with (A, B) young and (C, D) old male APP/PS1 mice treated with the vehicle, <b>5c</b>, and <b>5i</b>. Data are expressed as mean values ± SEM of <i>n</i> = 7 animals in each group. Data were analyzed by one-way ANOVA followed by Bonferroni’s post hoc test; *<i>p</i> ≤ 0.05 was considered the threshold for statistical significance with 95% CI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Number of trials to reach the criterion in the memory flexibility test in (A) young and (B) old male APP/PS1 mice treated with the vehicle, <b>5c</b>, and <b>5i</b>. Data are expressed as mean values ± SEM of <i>n</i> = 7 animals in each group. Data were analyzed by one-way ANOVA followed by Bonferroni’s post hoc test; *<i>p</i> ≤ 0.05 was considered the threshold for statistical significance with 95% CI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Hippocampal levels of Aβ40, Aβ42, and Aβ42/Aβ40 ratio in (A–C) young and (D–F) old male APP/PS1 mice treated with the vehicle, <b>5c</b>, or <b>5i</b>. Data are expressed as mean values ± SEM of <i>n</i> = 7 animals in each group. Data were analyzed by one-way ANOVA followed by Bonferroni’s post hoc test; *<i>p</i> ≤ 0.05 was considered the threshold for statistical significance with 95% CI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Synaptic transmission efficacy and plasticity mechanisms are affected in young male APP/PS1 mice treated with compounds <b>5c</b> and <b>5i</b>. (A) PPF plot shows the ratio of the second versus the first fEPSP slope (R2/R1), recorded at different time intervals (10, 20, 30, 50, 60, 80, 100, 150, and 200 ms), showing that only at the beginning short-term plasticity was different in <b>5i</b>-treated animals compared with vehicle- and <b>5c</b>-treated mice. Tg control (open circles), Tg + <b>5i</b> (black circles), and Tg + <b>5c</b> (black triangles). Representative traces of two evoked fEPSPs separated by 20 ms (inset). (B) Representative traces of postsynaptic potentials evoked by increasing stimulus intensities (μA). Input–output curves of both fEPSP slope (C) and fiber volley amplitude (D) against stimulus intensity. (E) Correlations between the FV amplitude and fEPSP slope were adjusted by linear regressions and found to significantly differ from each other. (F) LTP plot where fEPSPs slopes after TBS (arrow) were normalized to slopes during basal time. (G) Correlation plot between FV amplitudes and fEPSP slopes of three groups before TBS (pre-TBS, open symbols within circle) and after TBS (post-TBS, solid symbols); all comparisons were found to be significant among groups. Data represent the mean ± SEM from nine slices out of three Tg control mice, nine slices out of three Tg + <b>5i</b> mice, and nine slices out of three Tg + <b>5c</b> mice. Analysis by one-way or two-way ANOVA followed by Bonferroni’s post hoc test, *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Synaptic transmission efficacy but not plasticity mechanisms are affected in old male APP/PS1 mice treated with compounds <b>5i</b> and <b>5c</b>. (A) PPF plot shows the ratio of the second versus the first fEPSP slopes (R2/R1), recorded at various time intervals (10, 20, 30, 50, 60, 80, 100, 150, and 200 ms), showing that short-term plasticity was not significantly changed by treatment with <b>5i</b> or <b>5c</b>. Tg control (open circles), Tg + <b>5i</b> (black circles), and Tg + <b>5c</b> (black triangles). Representative traces of two evoked fEPSPs separated by 20 ms (inset). (B) Representative traces of postsynaptic potentials evoked by increasing stimulus intensities (μA). Their input–output curves of both fEPSP slope (C) and fiber volley amplitude (D) against stimulus intensity. (E) Correlations between the FV amplitude and fEPSP slope were adjusted by linear regression and revealed that both <b>5i</b> and <b>5c</b> differ from the control. (F) LTP plot where fEPSP slopes after TBS (arrow) were normalized to slopes during basal time. (G) Correlation plot between FV amplitudes and fEPSP slopes of three groups before TBS (pre-TBS, open symbols within circle) and after TBS (post-TBS, solid symbols); control and Tg + <b>5i</b> do not differ from each other but both differ from Tg + <b>5c</b>. Data represent the mean ± SEM from nine slices out of three Tg control mice, nine slices out of three Tg + <b>5i</b> mice, and nine slices out of three Tg + <b>5c</b> mice. Analysis by two-way ANOVA followed by Bonferroni’s post hoc test, *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Representative immunofluorescence of the hippocampal levels of 4-HNE (4-HNE, red; nuclear stain Hoechst, blue) in (A, C) young and (B, D) old male APP/PS1 mice treated with vehicle, <b>5i</b>, or <b>5c</b>. Data are expressed as mean values ± SEM of <i>n</i> = 4 animals per group. Data were analyzed statistically by one-way ANOVA followed by Bonferroni’s post hoc test. ***<i>p</i> < 0.001; ****<i>p</i> < 0.0001. Scale bar: 100 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/medium/jm0c01775_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Representative immunofluorescence of the hippocampal levels of GFAP (GFAP, red; nuclear stain Hoechst, blue) in (A, C) young and (B, D) old male APP/PS1 mice treated with the vehicle, <b>5i</b>, or <b>5c</b>. Data are expressed as mean values ± SEM of <i>n</i> = 4 animals per group. Data were analyzed statistically by one-way ANOVA followed by Bonferroni’s post hoc test. *<i>p</i> < 0.05; ***<i>p</i> < 0.001. Scale bar: 100 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01775/20210107/images/large/jm0c01775_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01775&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52138" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52138" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 101 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Alzheimer’s Disease
International</span>. <span class="NLM_year">2019</span>.  <i>World Alzheimer Report 2019: Attitudes to Dementia</i>. <span class="NLM_publisher-loc">London</span>: <span class="NLM_publisher-name">Alzheimer’s Disease
International</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=Alzheimer%E2%80%99s+Disease%0AInternational&title=World+Alzheimer+Report+2019%3A+Attitudes+to+Dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2019%26jtitle%3DWorld%2520Alzheimer%2520Report%25202019%253A%2520Attitudes%2520to%2520Dementia%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%250AInternational" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taneja, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajput, S. K.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species: friend or foe?</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">57267</span>– <span class="NLM_lpage">57276</span>, <span class="refDoi"> DOI: 10.1039/C5RA07927F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1039%2FC5RA07927F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtV2ksLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=57267-57276&author=A.+K.+Sharmaauthor=G.+Tanejaauthor=D.+Khannaauthor=S.+K.+Rajput&title=Reactive+oxygen+species%3A+friend+or+foe%3F&doi=10.1039%2FC5RA07927F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species: friend or foe?</span></div><div class="casAuthors">Sharma, Arun Kumar; Taneja, Gourav; Khanna, Deepa; Rajput, Satyendra K.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">71</span>),
    <span class="NLM_cas:pages">57267-57276</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) are an inevitable byproduct of cellular metab.  ROS generation can be assocd. with the interaction of ionizing radiation with biol. mols., and devoted enzymes in phagocytic cells (NADPH oxidase and myeloperoxidase) or may be the result of an imbalance between radical generating and scavenging systems.  Typically ROS have been consider as Pandora's box, they have several innovative physiol. roles in the body.  ROS serve as signalling messengers for the activation of transcription factors from cytokine-receptor interactions.  This facilitates the evolution and membrane fusion of spermatozoon and oocyte during fertilization.  NADPH oxidase enzyme and nitric oxide (NO) function as potent vasodilators and immunity boosters.  ROS have been suggested as prevalent regulators of several nuclear factors, including erythroid 2-related factor 2 (Nrf2), nuclear factor kappa-B (NFκB) cells, mitogen-activated protein kinase (MAPK) and p53, which are further assocd. with several signalling cascades.  Under physiol. conditions the amt. of ROS generated in the body can be counterbalanced by natural antioxidants in the body.  However, aberrant augmented levels of ROS predominantly lead to various defined disorders comprising myocardial infarction, autoimmune diseases, atherosclerosis, Alzheimer's and Parkinson's diseases and emphysema.  Ordinarily, it is obsd. that the physiol. roles of ROS are insubstantial compared with their pathol. action.  But there is a need to clearly define the line between pathol. and physiol. functions of ROS.  Of particular worth is to reveal the beneficial responsibilities of ROS in different cellular pathways and metabolic functions, over its injurious consequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaExtahQigqbVg90H21EOLACvtfcHk0lheEDDER3H8Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtV2ksLzN&md5=023b3c3728c3ba51edd93e5f0048dabc</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1039%2FC5RA07927F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA07927F%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DTaneja%26aufirst%3DG.%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DRajput%26aufirst%3DS.%2BK.%26atitle%3DReactive%2520oxygen%2520species%253A%2520friend%2520or%2520foe%253F%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D57267%26epage%3D57276%26doi%3D10.1039%2FC5RA07927F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, G.</span></span> <span> </span><span class="NLM_article-title">Parallels between major depressive disorder and Alzheimer’s disease: Role of oxidative stress and genetic vulnerability</span>. <i>Cell. Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">925</span>– <span class="NLM_lpage">949</span>, <span class="refDoi"> DOI: 10.1007/s10571-014-0074-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1007%2Fs10571-014-0074-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=24927694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVWhu7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=925-949&author=R.+Rodriguesauthor=R.+B.+Petersenauthor=G.+Perry&title=Parallels+between+major+depressive+disorder+and+Alzheimer%E2%80%99s+disease%3A+Role+of+oxidative+stress+and+genetic+vulnerability&doi=10.1007%2Fs10571-014-0074-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Parallels Between Major Depressive Disorder and Alzheimer's Disease: Role of Oxidative Stress and Genetic Vulnerability</span></div><div class="casAuthors">Rodrigues, Roberto; Petersen, Robert B.; Perry, George</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">925-949</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The thesis of this review is that oxidative stress is the central factor in major depressive disorder (MDD) and Alzheimer's disease (AD).  The major elements involved are inflammatory cytokines, the hypothalamic-pituitary axis, the hypothalamic-pituitary gonadal, and arginine vasopressin systems, which induce glucocorticoid and "oxidopamatergic" cascades when triggered by psychosocial stress, severe life-threatening events, and mental-affective and somatic diseases.  In individuals with a genomic vulnerability to depression, these cascades may result in chronic depression-anxiety-stress spectra, resulting in MDD and other known depressive syndromes.  In contrast, in subjects with genomic vulnerability to AD, oxidative stress-induced brain damage triggers specific antioxidant defenses, i.e., increased levels of amyloid-β (Aβ) and aggregation of hyper-phosphorylated tau, resulting in paired helical filaments and impaired functions related to the ApoEε4 isoform, leading to complex pathol. cascades culminating in AD.  Surprisingly, all the AD-assocd. mol. pathways mentioned in this review have been shown to be similar or analogous to those found in depression, including structural damage, i.e., hippocampal and frontal cortex atrophy.  Other interacting mol. signals, i.e., GSK-3β, convergent survival factors (brain-derived neurotrophic factor and heat shock proteins), and transition redox metals are also mentioned to emphasize the vast array of intermediates that could interact via comparable mechanisms in both MDD and AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopq4Fqxf3AlLVg90H21EOLACvtfcHk0lheEDDER3H8Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVWhu7%252FF&md5=bdfd98b8cedaf67f58dbbc5b0b3139c7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs10571-014-0074-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-014-0074-5%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DR.%26aulast%3DPetersen%26aufirst%3DR.%2BB.%26aulast%3DPerry%26aufirst%3DG.%26atitle%3DParallels%2520between%2520major%2520depressive%2520disorder%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Role%2520of%2520oxidative%2520stress%2520and%2520genetic%2520vulnerability%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2014%26volume%3D34%26spage%3D925%26epage%3D949%26doi%3D10.1007%2Fs10571-014-0074-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bachurin, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovina, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ustyugov, A. A.</span></span> <span> </span><span class="NLM_article-title">Drugs in clinical trials for Alzheimer’s disease: The major trends</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1186</span>– <span class="NLM_lpage">1225</span>, <span class="refDoi"> DOI: 10.1002/med.21434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fmed.21434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=28084618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yktbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=1186-1225&author=S.+O.+Bachurinauthor=E.+V.+Bovinaauthor=A.+A.+Ustyugov&title=Drugs+in+clinical+trials+for+Alzheimer%E2%80%99s+disease%3A+The+major+trends&doi=10.1002%2Fmed.21434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends</span></div><div class="casAuthors">Bachurin, Sergey O.; Bovina, Elena V.; Ustyugov, Aleksey A.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1186-1225</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by a chronic and progressive neurodegenerative process resulting from the intracellular and extracellular accumulation of fibrillary proteins: beta-amyloid and hyperphosphorylated Tau.  Overaccumulation of these aggregates leads to synaptic dysfunction and subsequent neuronal loss.  The precise mol. mechanisms of AD are still not fully understood but it is clear that AD is a multifactorial disorder and that advanced age is the main risk factor.  Over the last decade, more than 50 drug candidates have successfully passed phase II clin. trials, but none has passed phase III.  Here, we summarize data on current "anti-Alzheimer's" agents currently in clin. trials based on findings available in the Thomson Reuters 'Integrity' database, on the public website, and on database of the website .  As a result, it was possible to outline some major trends in AD drug discovery: (i) the development of compds. acting on the main stages of the pathogenesis of the disease (the so-called "disease-modifying agents") - these drugs could potentially slow the development of structural and functional abnormalities in the central nervous system providing sustainable improvements of cognitive functions, which persist even after drug withdrawal; (ii) focused design of multitargeted drugs acting on multiple mol. targets involved in the pathogenesis of the disease; (3) finally, the repositioning of old drugs for new (anti-Alzheimer's) application offers a very attractive approach to facilitate the completion of clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUgLGjGuc0iLVg90H21EOLACvtfcHk0li3S3rKhi_WBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yktbvO&md5=a5659940c428ecd50892d80e0c1baa7d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fmed.21434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21434%26sid%3Dliteratum%253Aachs%26aulast%3DBachurin%26aufirst%3DS.%2BO.%26aulast%3DBovina%26aufirst%3DE.%2BV.%26aulast%3DUstyugov%26aufirst%3DA.%2BA.%26atitle%3DDrugs%2520in%2520clinical%2520trials%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520The%2520major%2520trends%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2017%26volume%3D37%26spage%3D1186%26epage%3D1225%26doi%3D10.1002%2Fmed.21434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-based survey of the binding modes of BACE1 inhibitors</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">889</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00420</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00420" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=880-889&author=H.+Huauthor=Z.+Chenauthor=X.+Xuauthor=Y.+Xu&title=Structure-based+survey+of+the+binding+modes+of+BACE1+inhibitors&doi=10.1021%2Facschemneuro.8b00420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Survey of the Binding Modes of BACE1 Inhibitors</span></div><div class="casAuthors">Hu, Hangchen; Chen, Zhaoqiang; Xu, Xiang; Xu, Yechun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">880-889</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  BACE1 is a key aspartic protease that cleaves the amyloid precursor protein to generate of the amyloid peptide that is believed to be responsible for the Alzheimer's disease amyloid cascade.  It is thus recognized as a promising therapeutic target for Alzheimer's disease treatment, and large efforts have been made in the discovery of novel BACE1 inhibitors.  This Review presents a systematic mining of BACE1 inhibitors based on 354 crystal structures of the BACE1 catalytic domain in complex with ligands in the Protein Data Bank.  A thorough exploration on the frequency as well as the patterns of residue-ligand interactions enables us to subdivide the ligand binding pocket into 10 subsites and then identify favorable substructures of ligands for each subsite.  In addn., it is found that the assembly of subsites with an 8-like shape is responsible to bind all inhibitors and four major ligand binding modes are revealed.  Thus, such a systematic survey deepens our understanding of the structural requirements for establishment of BACE1-ligand interactions that det. the affinity of a ligand to BACE1, which is pivotal for structure-based lead optimization and design of novel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwvv_EbX_3ALVg90H21EOLACvtfcHk0li3S3rKhi_WBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhsrfF&md5=3157eb17033dae864aee238751e055ca</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00420%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DStructure-based%2520survey%2520of%2520the%2520binding%2520modes%2520of%2520BACE1%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D880%26epage%3D889%26doi%3D10.1021%2Facschemneuro.8b00420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doody, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farlow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joffe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieburtz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemers, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu-Seifert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohs, R.</span></span> <span> </span><span class="NLM_article-title">Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1312889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1056%2FNEJMoa1312889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=24450890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=311-321&author=R.+S.+Doodyauthor=R.+G.+Thomasauthor=M.+Farlowauthor=T.+Iwatsuboauthor=B.+Vellasauthor=S.+Joffeauthor=K.+Kieburtzauthor=R.+Ramanauthor=X.+Sunauthor=P.+S.+Aisenauthor=E.+Siemersauthor=H.+Liu-Seifertauthor=R.+Mohs&title=Phase+3+trials+of+solanezumab+for+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1312889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Doody, Rachelle S.; Thomas, Ronald G.; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; Raman, Rema; Sun, Xiaoying; Aisen, Paul S.; Siemers, Eric; Liu-Seifert, Hong; Mohs, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Alzheimer's disease is characterized by amyloid-beta plaques, neurofibrillary tangles, gliosis, and neuronal loss.  Solanezumab, a humanized monoclonal antibody, preferentially binds sol. forms of amyloid and in preclin. studies promoted its clearance from the brain.  METHODS: In two phase 3, double-blind trials (EXPEDITION 1 and EXPEDITION 2), we randomly assigned 1012 and 1040 patients, resp., with mild-to-moderate Alzheimer's disease to receive placebo or solanezumab (administered i.v. at a dose of 400 mg) every 4 wk for 18 mo.  The primary outcomes were the changes from baseline to week 80 in scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11; range, 0 to 70, with higher scores indicating greater cognitive impairment) and the Alzheimer's Disease Cooperative Study-Activities of Daily Living scale (ADCS-ADL; range, 0 to 78, with lower scores indicating worse functioning).  After anal. of data from EXPEDITION 1, the primary outcome for EXPEDITION 2 was revised to the change in scores on the 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog14; range, 0 to 90, with higher scores indicating greater impairment), in patients with mild Alzheimer's disease.  RESULTS: Neither study showed significant improvement in the primary outcomes.  The modeled difference between groups (solanezumab group minus placebo group) in the change from baseline was -0.8 points for the ADAS-cog11 score (95% confidence interval [CI], -2.1 to 0.5; P = 0.24) and -0.4 points for the ADCS-ADL score (95% CI, -2.3 to 1.4; P = 0.64) in EXPEDITION 1 and -1.3 points (95% CI, -2.5 to 0.3; P = 0.06) and 1.6 points (95% CI, -0.2 to 3.3; P = 0.08), resp., in EXPEDITION 2.  Between-group differences in the changes in the ADAS-cog14 score were -1.7 points in patients with mild Alzheimer's disease (95% CI, -3.5 to 0.1; P = 0.06) and -1.5 in patients with moderate Alzheimer's disease (95% CI, -4.1 to 1.1; P = 0.26).  In the combined safety data set, the incidence of amyloid-related imaging abnormalities with edema or hemorrhage was 0.9% with solanezumab and 0.4% with placebo for edema (P = 0.27) and 4.9% and 5.6%, resp., for hemorrhage (P = 0.49).  CONCLUSIONS: Solanezumab, a humanized monoclonal antibody that binds amyloid, failed to improve cognition or functional ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Ej7A_YXNwLVg90H21EOLACvtfcHk0li3S3rKhi_WBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt70%253D&md5=c993836d4f7374cc78f155f9cedbc594</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1312889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1312889%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DJoffe%26aufirst%3DS.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DLiu-Seifert%26aufirst%3DH.%26aulast%3DMohs%26aufirst%3DR.%26atitle%3DPhase%25203%2520trials%2520of%2520solanezumab%2520for%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D311%26epage%3D321%26doi%3D10.1056%2FNEJMoa1312889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pimplikar, S. W.</span></span> <span> </span><span class="NLM_article-title">Reassessing the amyloid cascade hypothesis of Alzheimer’s disease</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1268</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2008.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.biocel.2008.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=19124085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1261-1268&author=S.+W.+Pimplikar&title=Reassessing+the+amyloid+cascade+hypothesis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.biocel.2008.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Reassessing the amyloid cascade hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Pimplikar, Sanjay W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1261-1268</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Since its inception, the amyloid cascade hypothesis has dominated the field of Alzheimer's disease (AD) research and has provided the intellectual framework for therapeutic intervention.  Although the details of the hypothesis continue to evolve, its core principle has remained essentially unaltered.  It posits that the amyloid-β peptides, derived from amyloid precursor protein (APP), are the root cause of AD.  Substantial genetic and biochem. data support this view, and yet a no. of findings also run contrary to its tenets.  The presence of familial AD mutations in APP and presenilins, demonstration of Aβ toxicity, and studies in mouse models of AD all support the hypothesis, whereas the presence of Aβ plaques in normal individuals, the uncertain nature of the pathogenic Aβ species, and repeated disappointments with Aβ-centered therapeutic trials are inconsistent with the hypothesis.  The current state of knowledge does not prove nor disprove the amyloid hypothesis, but rather points to the need for its reassessment.  A view that Aβ is one of the factors, as opposed to the factor, that causes AD is more consistent with the present knowledge, and is more likely to promote comprehensive and effective therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNZoitUBRzaLVg90H21EOLACvtfcHk0li3S3rKhi_WBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D&md5=e33973b5f125c34d95cb3f1b477d3ced</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DPimplikar%26aufirst%3DS.%2BW.%26atitle%3DReassessing%2520the%2520amyloid%2520cascade%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D1261%26epage%3D1268%26doi%3D10.1016%2Fj.biocel.2008.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress in Alzheimer’s disease: Are we connecting the dots?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2821</span>– <span class="NLM_lpage">2831</span>, <span class="refDoi"> DOI: 10.1021/jm400970m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400970m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2821-2831&author=M.+Rosiniauthor=E.+Simoniauthor=A.+Milelliauthor=A.+Minariniauthor=C.+Melchiorre&title=Oxidative+stress+in+Alzheimer%E2%80%99s+disease%3A+Are+we+connecting+the+dots%3F&doi=10.1021%2Fjm400970m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress in Alzheimer's Disease: Are We Connecting the Dots?</span></div><div class="casAuthors">Rosini, Michela; Simoni, Elena; Milelli, Andrea; Minarini, Anna; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2821-2831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Redox impairment is a prominent feature of Alzheimer's disease (AD).  It has led to the "oxidative stress hypothesis", which proposes antioxidants as beneficial therapeutic tools in AD treatment.  To date, a wide variety of antioxidants have been examd. as neuroprotectants.  However, success has been elusive in clin. trials.  Several factors have contributed to this failure, including the complexity of the redox system in vivo.  Potentially crit. aspects include the fine-tuned equil. between antioxidant defenses and free radical prodn., the lack of specific antioxidant target(s), and the inherent difficulty in delivering antioxidants where they are needed.  Herein, the authors highlight significant progress in the field.  Future directions of antioxidant research are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonuV4RR1IRPLVg90H21EOLACvtfcHk0lgx5e_-SPmSZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7fM&md5=907927f3b3b6d6bcb1402fedf6080e35</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm400970m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400970m%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DOxidative%2520stress%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Are%2520we%2520connecting%2520the%2520dots%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2821%26epage%3D2831%26doi%3D10.1021%2Fjm400970m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deardorff, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossberg, G. T.</span></span> <span> </span><span class="NLM_article-title">The use of cholinesterase inhibitors across all stages of Alzheimer’s disease</span>. <i>Drugs Aging</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1007/s40266-015-0273-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1007%2Fs40266-015-0273-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=26033268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1elurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=537-547&author=W.+J.+Deardorffauthor=E.+Feenauthor=G.+T.+Grossberg&title=The+use+of+cholinesterase+inhibitors+across+all+stages+of+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs40266-015-0273-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease</span></div><div class="casAuthors">Deardorff, William James; Feen, Eliahu; Grossberg, George T.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">537-547</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Current pharmacol. therapy for Alzheimer's disease (AD) includes the cholinesterase inhibitors (ChEIs) donepezil, rivastigmine, and galantamine and the N-Me D-aspartate receptor antagonist memantine.  Based on the results of randomized controlled trials and several meta-analyses, ChEIs appear to show modest but statistically significant improvements on several measures, including cognition and global functioning.  Given their modest effects, there is a lack of consensus among clinicians regarding issues related to initiation, optimal duration, and discontinuation of ChEI therapy across the spectrum of AD.  There is evidence from long-term observational controlled studies that early initiation and persistent exposure to AD therapy lead to delays in nursing home admission and significantly slower rates of cognitive and functional impairment.  In the moderate to severe stages of AD, therapeutic trials of higher dose ChEIs and the addn. of memantine are recommended for patients who are no longer responding to lower doses.  While side effects are generally mild and gastrointestinal in nature, these events can lead to significant morbidity in more susceptible patients with advanced disease.  Patients should thus be regularly monitored for any potential serious side effects of ChEI therapy, which also may include syncope and bradycardia.  At the terminal stages of AD, such as when patients become hospice eligible, attempts to cautiously discontinue all medications not necessary for quality of life, including AD drugs, should be made.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjHuGZ43A24bVg90H21EOLACvtfcHk0lgx5e_-SPmSZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1elurfL&md5=a33eb3b03b007ba8c56513713c0cd7f4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs40266-015-0273-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-015-0273-x%26sid%3Dliteratum%253Aachs%26aulast%3DDeardorff%26aufirst%3DW.%2BJ.%26aulast%3DFeen%26aufirst%3DE.%26aulast%3DGrossberg%26aufirst%3DG.%2BT.%26atitle%3DThe%2520use%2520of%2520cholinesterase%2520inhibitors%2520across%2520all%2520stages%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrugs%2520Aging%26date%3D2015%26volume%3D32%26spage%3D537%26epage%3D547%26doi%3D10.1007%2Fs40266-015-0273-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lendon, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froelich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houlden, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickering-Brown, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraverty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grover, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lincoln, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaff, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wauters, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Baren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillebrand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joosse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowotny, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neystat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dark, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannenberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreadis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snowden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craufurd, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neary, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oostra, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Swieten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heutink, P.</span></span> <span> </span><span class="NLM_article-title">Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>393</i></span>,  <span class="NLM_fpage">702</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1038/31508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1038%2F31508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=9641683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaK1cXktVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=1998&pages=702-705&author=M.+Huttonauthor=C.+L.+Lendonauthor=P.+Rizzuauthor=M.+Bakerauthor=S.+Froelichauthor=H.+Houldenauthor=S.+Pickering-Brownauthor=S.+Chakravertyauthor=A.+Isaacsauthor=A.+Groverauthor=J.+Hackettauthor=J.+Adamsonauthor=S.+Lincolnauthor=D.+Dicksonauthor=P.+Daviesauthor=R.+C.+Petersenauthor=M.+Stevensauthor=E.+de+Graaffauthor=E.+Wautersauthor=J.+van+Barenauthor=M.+Hillebrandauthor=M.+Joosseauthor=J.+M.+Kwonauthor=P.+Nowotnyauthor=L.+K.+Cheauthor=J.+Nortonauthor=J.+C.+Morrisauthor=L.+A.+Reedauthor=J.+Trojanowskiauthor=H.+Basunauthor=L.+Lannfeltauthor=M.+Neystatauthor=S.+Fahnauthor=F.+Darkauthor=T.+Tannenbergauthor=P.+R.+Doddauthor=N.+Haywardauthor=J.+B.+Kwokauthor=P.+R.+Schofieldauthor=A.+Andreadisauthor=J.+Snowdenauthor=D.+Craufurdauthor=D.+Nearyauthor=F.+Owenauthor=B.+A.+Oostraauthor=J.+Hardyauthor=A.+Goateauthor=J.+van+Swietenauthor=D.+Mannauthor=T.+Lynchauthor=P.+Heutink&title=Association+of+missense+and+5%E2%80%B2-splice-site+mutations+in+tau+with+the+inherited+dementia+FTDP-17&doi=10.1038%2F31508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17</span></div><div class="casAuthors">Hutton, Mike; Lendon, Corinne L.; Rizzu, Patrizia; Baker, Matt; Froelich, Susanne; Houlden, Henry; Pickering-Brown, Stuart; Chakraverty, Sumi; Isaacs, Adrian; Grover, Andrew; Hackett, Jennifer; Adamson, Jennifer; Lincoln, Sarah; Dickson, Dennis; Davies, Peter; Petersen, Ronald C.; Stevens, Martijn; de Graaff, Esther; Wauters, Erwin; van Baren, Jeltje; Hillebrand, Marcel; Joosse, Marijke; Kwon, Jennifer M.; Nowotny, Petra; Che, Lien Kuei; Norton, Joanne; Morris, John C.; Reed, Lee A.; Trojanowski, John; Basun, Hans; Lannfelt, Lars; Neystat, Michael; Fahn, Stanley; Dark, Francis; Tannenberg, Tony; Dodd, Peter R.; Hayward, Nick; Kwok, John B. J.; Schofield, Peter R.; Andreadis, Athena; Snowden, Julie; Craufurd, David; Neary, David; Owen, Frank; Oostra, Ben A.; Hardy, John; Goate, Alison; van Swieten, John; Mann, David; Lynch, Timothy; Heutink, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">6686</span>),
    <span class="NLM_cas:pages">702-705</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Thirteen families have been described with an autosomal dominantly inherited dementia named frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), historically termed Pick's disease.  Most FTDP-17 cases show neuronal and/or glial inclusions that stain pos. with antibodies raised against the microtubule-assocd. protein Tau, although the Tau pathol. varies considerably in both its quantity (or severity) and characteristics.  Previous studies have mapped the FTDP-17 locus to a 2-centimorgan region on chromosome 17q21.11; the tau gene also lies within this region.  We have now sequenced tau in FTDP-17 families and identified three missense mutations (G272V, P301L and R406W) and three mutations in the 5' splice site of exon 10.  The splice-site mutations all destabilize a potential stem-loop structure which is probably involved in regulating the alternative splicing of exon 10.  This causes more frequent usage of the 5' splice site an increased proportion of tau transcripts that include exon 10.  The increase in exon 10+ mRNA will increase the proportion of Tau contg. four microtubule-binding repeats, which is consistent with the neuropathol. described in several families with FTDP-17.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmDAkDTiFru7Vg90H21EOLACvtfcHk0lgVdKGYkIT1og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVyqsr0%253D&md5=8ec0725fa99708a52022b404dc97a72f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F31508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F31508%26sid%3Dliteratum%253Aachs%26aulast%3DHutton%26aufirst%3DM.%26aulast%3DLendon%26aufirst%3DC.%2BL.%26aulast%3DRizzu%26aufirst%3DP.%26aulast%3DBaker%26aufirst%3DM.%26aulast%3DFroelich%26aufirst%3DS.%26aulast%3DHoulden%26aufirst%3DH.%26aulast%3DPickering-Brown%26aufirst%3DS.%26aulast%3DChakraverty%26aufirst%3DS.%26aulast%3DIsaacs%26aufirst%3DA.%26aulast%3DGrover%26aufirst%3DA.%26aulast%3DHackett%26aufirst%3DJ.%26aulast%3DAdamson%26aufirst%3DJ.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DDickson%26aufirst%3DD.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DStevens%26aufirst%3DM.%26aulast%3Dde%2BGraaff%26aufirst%3DE.%26aulast%3DWauters%26aufirst%3DE.%26aulast%3Dvan%2BBaren%26aufirst%3DJ.%26aulast%3DHillebrand%26aufirst%3DM.%26aulast%3DJoosse%26aufirst%3DM.%26aulast%3DKwon%26aufirst%3DJ.%2BM.%26aulast%3DNowotny%26aufirst%3DP.%26aulast%3DChe%26aufirst%3DL.%2BK.%26aulast%3DNorton%26aufirst%3DJ.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DReed%26aufirst%3DL.%2BA.%26aulast%3DTrojanowski%26aufirst%3DJ.%26aulast%3DBasun%26aufirst%3DH.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DNeystat%26aufirst%3DM.%26aulast%3DFahn%26aufirst%3DS.%26aulast%3DDark%26aufirst%3DF.%26aulast%3DTannenberg%26aufirst%3DT.%26aulast%3DDodd%26aufirst%3DP.%2BR.%26aulast%3DHayward%26aufirst%3DN.%26aulast%3DKwok%26aufirst%3DJ.%2BB.%26aulast%3DSchofield%26aufirst%3DP.%2BR.%26aulast%3DAndreadis%26aufirst%3DA.%26aulast%3DSnowden%26aufirst%3DJ.%26aulast%3DCraufurd%26aufirst%3DD.%26aulast%3DNeary%26aufirst%3DD.%26aulast%3DOwen%26aufirst%3DF.%26aulast%3DOostra%26aufirst%3DB.%2BA.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3Dvan%2BSwieten%26aufirst%3DJ.%26aulast%3DMann%26aufirst%3DD.%26aulast%3DLynch%26aufirst%3DT.%26aulast%3DHeutink%26aufirst%3DP.%26atitle%3DAssociation%2520of%2520missense%2520and%25205%25E2%2580%25B2-splice-site%2520mutations%2520in%2520tau%2520with%2520the%2520inherited%2520dementia%2520FTDP-17%26jtitle%3DNature%26date%3D1998%26volume%3D393%26spage%3D702%26epage%3D705%26doi%3D10.1038%2F31508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geula, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesulam, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saroff, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. K.</span></span> <span> </span><span class="NLM_article-title">Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer disease</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1097/00005072-199801000-00008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1097%2F00005072-199801000-00008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=9600198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A280%3ADyaK1c3mtVyhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1998&pages=63-75&author=C.+Geulaauthor=M.+M.+Mesulamauthor=D.+M.+Saroffauthor=C.+K.+Wu&title=Relationship+between+plaques%2C+tangles%2C+and+loss+of+cortical+cholinergic+fibers+in+Alzheimer+disease&doi=10.1097%2F00005072-199801000-00008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer disease</span></div><div class="casAuthors">Geula C; Mesulam M M; Saroff D M; Wu C K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuropathology and experimental neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-75</span>
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    </div><div class="casAbstract">Recent observations in our laboratory have indicated substantial and systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer disease (AD).  Previous attempts to study the relationship between cortical cholinergic loss and the density of cortical pathological lesions have resulted in conflicting findings.  Furthermore, most reports have correlated density of plaques and tangles with the residual level of cholinergic innervation rather than its loss.  The purpose of the present study was to determine the relationship between loss of cholinergic axons and density of tangles and beta-amyloid (Abeta) deposits in various cortical areas of AD brains.  Abeta deposits and tangles were observed throughout the cerebral cortex.  Quantitative analysis revealed almost no correlation between loss of cholinergic fibers and the density of Abeta deposits.  Qualitative observations revealed similar results when cored and neuritic plaques were considered separately.  By contrast, cholinergic fiber loss displayed a significant correlation with the density of tangles (r = 0.52-0.79).  However, in a few areas, such as the cingulate cortex, tangle density appeared to be unrelated to the loss of cholinergic fibers.  These results indicate that cortical cholinergic denervation in AD is related to cytoskeletal pathology.  However, the lack of a perfect relationship with cytoskeletal pathology implicates additional factors in the cholinergic pathology of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlzXlkQHnsBySm0e6ZOaemfW6udTcc2eagLyLXRXFspbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c3mtVyhtw%253D%253D&md5=132103acbcc93fc3f26f3a2dda8dbb9f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1097%2F00005072-199801000-00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00005072-199801000-00008%26sid%3Dliteratum%253Aachs%26aulast%3DGeula%26aufirst%3DC.%26aulast%3DMesulam%26aufirst%3DM.%2BM.%26aulast%3DSaroff%26aufirst%3DD.%2BM.%26aulast%3DWu%26aufirst%3DC.%2BK.%26atitle%3DRelationship%2520between%2520plaques%252C%2520tangles%252C%2520and%2520loss%2520of%2520cortical%2520cholinergic%2520fibers%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D1998%26volume%3D57%26spage%3D63%26epage%3D75%26doi%3D10.1097%2F00005072-199801000-00008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campanari, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Ayllón, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez-Llorca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, W. K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sáez-Valero, J.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase protein level is preserved in the Alzheimer’s brain</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1007/s12031-013-0183-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1007%2Fs12031-013-0183-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=24318838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFajs7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=446-453&author=M.+L.+Campanariauthor=M.+S.+Garc%C3%ADa-Ayll%C3%B3nauthor=L.+Blazquez-Llorcaauthor=W.+K.+W.+Lukauthor=K.+Tsimauthor=J.+S%C3%A1ez-Valero&title=Acetylcholinesterase+protein+level+is+preserved+in+the+Alzheimer%E2%80%99s+brain&doi=10.1007%2Fs12031-013-0183-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase Protein Level Is Preserved in the Alzheimer's Brain</span></div><div class="casAuthors">Campanari, Maria-Letizia; Garcia-Ayllon, Maria-Salud; Blazquez-Llorca, Lidia; Luk, Wilson K. W.; Tsim, Karl; Saez-Valero, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">446-453</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE) is a key enzyme in the cholinergic nervous system and is one of the most studied proteins in the field of Alzheimer's disease (AD).  Moreover, alternative functions of AChE unrelated with the hydrolysis of acetylcholine are suspected.  Until now, the majority of investigations on AChE in AD pathol. have been focused on the detn. of its enzymic activity level, which is depleted in the AD brain.  Despite this overall decrease, AChE activity increases at the vicinity of the two hallmarks of AD, the amyloid plaques and the neurofibrillary tangles (NFT).  In fact, AChE may directly interact with Aβ in a manner that increases the deposition of Aβ to form plaques.  In the context of protein-protein interactions, we have recently reported that AChE can interact with presenilin-1, the catalytic component of γ-secretase, influencing its expression level and also its activity.  However, the alteration of AChE protein in the AD brain has not been detd.  Here, we demonstrated by Western blotting and immunohistochem. that a prominent pool of enzymically inactive AChE protein existed in the AD brain.  The potential significance of these unexpected levels of inactive AChE protein in the AD brain was discussed, esp. in the context of protein-protein interactions with β-amyloid and presenilin-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodzFyxYuZ47LVg90H21EOLACvtfcHk0lgVdKGYkIT1og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFajs7rN&md5=d9b33db50e1f200ad950f441c10580fa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs12031-013-0183-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-013-0183-5%26sid%3Dliteratum%253Aachs%26aulast%3DCampanari%26aufirst%3DM.%2BL.%26aulast%3DGarc%25C3%25ADa-Ayll%25C3%25B3n%26aufirst%3DM.%2BS.%26aulast%3DBlazquez-Llorca%26aufirst%3DL.%26aulast%3DLuk%26aufirst%3DW.%2BK.%2BW.%26aulast%3DTsim%26aufirst%3DK.%26aulast%3DS%25C3%25A1ez-Valero%26aufirst%3DJ.%26atitle%3DAcetylcholinesterase%2520protein%2520level%2520is%2520preserved%2520in%2520the%2520Alzheimer%25E2%2580%2599s%2520brain%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2014%26volume%3D53%26spage%3D446%26epage%3D453%26doi%3D10.1007%2Fs12031-013-0183-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darvesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cash, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitnitski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geula, C.</span></span> <span> </span><span class="NLM_article-title">Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1097/NEN.0b013e31823cc7a6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1097%2FNEN.0b013e31823cc7a6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=22157615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12htrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=2-14&author=S.+Darveshauthor=M.+K.+Cashauthor=G.+A.+Reidauthor=E.+Martinauthor=A.+Mitnitskiauthor=C.+Geula&title=Butyrylcholinesterase+is+associated+with+%CE%B2-amyloid+plaques+in+the+transgenic+APPSWE%2FPSEN1dE9+mouse+model+of+Alzheimer+disease&doi=10.1097%2FNEN.0b013e31823cc7a6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Butyrylcholinesterase Is Associated With β-Amyloid Plaques in the Transgenic APPSWE/PSEN1dE9 Mouse Model of Alzheimer Disease</span></div><div class="casAuthors">Darvesh, Sultan; Cash, Meghan K.; Reid, George Andrew; Martin, Earl; Mitnitski, Arnold; Geula, Changiz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-14</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Histochem. anal. of Alzheimer disease (AD) brain tissues indicates that butyrylcholinesterase (BuChE) is present in β-amyloid (Aβ) plaques.  The role of BuChE in AD pathol. is unknown, but an animal model developing similar BuChE-assocd. Aβ plaques could provide insights.  The APPSWE/PSEN1dE9 transgenic mouse (ADTg), which develops Aβ plaques, was examd. to det. if BuChE assocs. with these plaques, as in AD.  We found that in mature ADTg mice, BuChE activity assocd. with Aβ plaques.  The Aβ-, thioflavin-S- and BuChE-pos. plaques mainly accumulated in the olfactory structures, cerebral cortex, hippocampal formation, amygdala, and cerebellum.  No plaques were stained for acetylcholinesterase activity.  The distribution and abundance of plaque staining in ADTg closely resembled many aspects of plaque staining in AD.  Butyrylcholinesterase staining consistently showed fewer plaques than were detected with Aβ immunostaining but a greater no. of plaques than were visualized with thioflavin-S.  Double-labeling expts. demonstrated that all BuChE-pos. plaques were Aβ pos., whereas only some BuChE-pos. plaques were thioflavin-S pos.  These observations suggest that BuChE is assocd. with a subpopulation of Aβ plaques and may play a role in AD plaque maturation.  A further study of this animal model could clarify the role of BuChE in AD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryaKi0ooPJVLVg90H21EOLACvtfcHk0lgYftXhjrsDLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12htrvE&md5=66948a709f85da947651e5f8bb2fb613</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1097%2FNEN.0b013e31823cc7a6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNEN.0b013e31823cc7a6%26sid%3Dliteratum%253Aachs%26aulast%3DDarvesh%26aufirst%3DS.%26aulast%3DCash%26aufirst%3DM.%2BK.%26aulast%3DReid%26aufirst%3DG.%2BA.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DMitnitski%26aufirst%3DA.%26aulast%3DGeula%26aufirst%3DC.%26atitle%3DButyrylcholinesterase%2520is%2520associated%2520with%2520%25CE%25B2-amyloid%2520plaques%2520in%2520the%2520transgenic%2520APPSWE%252FPSEN1dE9%2520mouse%2520model%2520of%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2012%26volume%3D71%26spage%3D2%26epage%3D14%26doi%3D10.1097%2FNEN.0b013e31823cc7a6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcón, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opazo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderón, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dajas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentry, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doctor, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mello, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer’s fibrils</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3213</span>– <span class="NLM_lpage">3223</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.18-09-03213.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1523%2FJNEUROSCI.18-09-03213.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=9547230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaK1cXivFCht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=3213-3223&author=A.+Alvarezauthor=R.+Alarc%C3%B3nauthor=C.+Opazoauthor=E.+O.+Camposauthor=F.+J.+Mu%C3%B1ozauthor=F.+H.+Calder%C3%B3nauthor=F.+Dajasauthor=M.+K.+Gentryauthor=B.+P.+Doctorauthor=F.+G.+De+Melloauthor=N.+C.+Inestrosa&title=Stable+complexes+involving+acetylcholinesterase+and+amyloid-%CE%B2+peptide+change+the+biochemical+properties+of+the+enzyme+and+increase+the+neurotoxicity+of+Alzheimer%E2%80%99s+fibrils&doi=10.1523%2FJNEUROSCI.18-09-03213.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils</span></div><div class="casAuthors">Alvarez, Alejandra; Alarcon, Rodrigo; Opazo, Carlos; Campos, Eliseo O.; Munoz, Francisco Jose; Calderon, Frances H.; Dajas, Federico; Gentry, Mary K.; Doctor, Bhupendra P.; De Mello, Fernando G.; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3213-3223</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Brain acetylcholinesterase (AChE) forms stable complexes with amyloid-β peptide (Aβ) during its assembly into filaments, in agreement with its colocalization with the Aβ deposits of Alzheimer's brain.  The assocn. of the enzyme with nascent Aβ aggregates occurs as early as after 30 min of incubation.  Anal. of the catalytic activity of the AChE incorporated into these complexes shows an anomalous behavior reminiscent of the AChE assocd. with senile plaques, which includes a resistance to low pH, high substrate concns., and lower sensitivity to AChE inhibitors.  Furthermore, the toxicity of the AChE-amyloid complexes is higher than that of the Aβ aggregates alone.  Thus, in addn. to its possible role as a heterogeneous nucleator during amyloid formation, AChE, by forming such stable complexes, may increase the neurotoxicity of Aβ fibrils and thus may det. the selective neuronal loss obsd. in Alzheimer's brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPyVIcJUubQ7Vg90H21EOLACvtfcHk0lgYftXhjrsDLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivFCht70%253D&md5=b8f7c8ab543fa2c30c5a7b6da15f9a5c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.18-09-03213.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.18-09-03213.1998%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DAlarc%25C3%25B3n%26aufirst%3DR.%26aulast%3DOpazo%26aufirst%3DC.%26aulast%3DCampos%26aufirst%3DE.%2BO.%26aulast%3DMu%25C3%25B1oz%26aufirst%3DF.%2BJ.%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%2BH.%26aulast%3DDajas%26aufirst%3DF.%26aulast%3DGentry%26aufirst%3DM.%2BK.%26aulast%3DDoctor%26aufirst%3DB.%2BP.%26aulast%3DDe%2BMello%26aufirst%3DF.%2BG.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DStable%2520complexes%2520involving%2520acetylcholinesterase%2520and%2520amyloid-%25CE%25B2%2520peptide%2520change%2520the%2520biochemical%2520properties%2520of%2520the%2520enzyme%2520and%2520increase%2520the%2520neurotoxicity%2520of%2520Alzheimer%25E2%2580%2599s%2520fibrils%26jtitle%3DJ.%2520Neurosci.%26date%3D1998%26volume%3D18%26spage%3D3213%26epage%3D3223%26doi%3D10.1523%2FJNEUROSCI.18-09-03213.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casanueva, O. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, J.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzyme</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">891</span>, <span class="refDoi"> DOI: 10.1016/s0896-6273(00)80108-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fs0896-6273%2800%2980108-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=8608006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaK28XislCmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=881-891&author=N.+C.+Inestrosaauthor=A.+Alvarezauthor=C.+A.+P%C3%A9rezauthor=R.+D.+Morenoauthor=M.+Vicenteauthor=C.+Linkerauthor=O.+I.+Casanuevaauthor=C.+Sotoauthor=J.+Garrido&title=Acetylcholinesterase+accelerates+assembly+of+amyloid-%CE%B2-peptides+into+Alzheimer%E2%80%99s+fibrils%3A+possible+role+of+the+peripheral+site+of+the+enzyme&doi=10.1016%2Fs0896-6273%2800%2980108-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme</span></div><div class="casAuthors">Inestrosa, Nibaldo C.; Alvarez, Alejandra; Perez, Cristian A.; Moreno, Ricardo D.; Vicente, Matias; Linker, Claudia; Casanueva, Olivia I.; Soto, Claudio; Garrido, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">881-891</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE), an important component of cholinergic synapses, colocalizes with amyloid-β peptide (Aβ) deposits of Alzheimer's brain.  The authors report here that bovine brain AChE, as well as the human and mouse recombinant enzyme, accelerates amyloid formation from wild-type Aβ and a mutant Aβ peptide, which alone produces few amyloid-like fibrils.  The action of AChE was independent of the subunit array of the enzyme, was not affected by edrophonium, an active site inhibitor, but it was affected by propidium, a peripheral anionic binding site ligand.  Butyrylcholinesterase, an enzyme that lacks the peripheral site, did not affect amyloid formation.  Furthermore, AChE is a potent amyloid-promoting factor when compared with other Aβ-assocd. proteins.  Thus, in addn. to its role in cholinergic synapses, AChE may function by accelerating Aβ formation and could play a role during amyloid deposition in Alzheimer's brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2wsrjgQa0LVg90H21EOLACvtfcHk0lgYftXhjrsDLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XislCmsLk%253D&md5=299031351f764e5376b98407c3dc7278</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fs0896-6273%2800%2980108-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0896-6273%252800%252980108-7%26sid%3Dliteratum%253Aachs%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%2BA.%26aulast%3DMoreno%26aufirst%3DR.%2BD.%26aulast%3DVicente%26aufirst%3DM.%26aulast%3DLinker%26aufirst%3DC.%26aulast%3DCasanueva%26aufirst%3DO.%2BI.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DJ.%26atitle%3DAcetylcholinesterase%2520accelerates%2520assembly%2520of%2520amyloid-%25CE%25B2-peptides%2520into%2520Alzheimer%25E2%2580%2599s%2520fibrils%253A%2520possible%2520role%2520of%2520the%2520peripheral%2520site%2520of%2520the%2520enzyme%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D881%26epage%3D891%26doi%3D10.1016%2Fs0896-6273%2800%2980108-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opazo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcón, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">361</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1997.1245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1006%2Fjmbi.1997.1245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=9325095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaK2sXmsV2hsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=348-361&author=A.+Alvarezauthor=C.+Opazoauthor=R.+Alarc%C3%B3nauthor=J.+Garridoauthor=N.+C.+Inestrosa&title=Acetylcholinesterase+promotes+the+aggregation+of+amyloid-%CE%B2-peptide+fragments+by+forming+a+complex+with+the+growing+fibrils&doi=10.1006%2Fjmbi.1997.1245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils</span></div><div class="casAuthors">Alvarez, Alejandra; Opazo, Carlos; Alarcon, Rodrigo; Garrido, Jorge; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">348-361</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE), an enzyme involved in the hydrolysis of the neurotransmitter acetylcholine, consistently colocalizes with the amyloid deposits characteristic of Alzheimer's disease and may contribute to the generation of amyloid proteins and/or phys. affect fibril assembly.  In order to identify the structural domains of the amyloid-β-peptide (Aβ) involved in the aggregation induced by AChE, we have studied the effect of this cholinergic enzyme on Aβ peptide fragments of different sizes.  AChE enhanced the aggregation of the aβ(12-28) and Aβ(25-35) peptides but not of the Aβ(1-16) fragment.  The inductive effect of AChE on the aggregation of aβ(12-28) was abolished by the presence of either Aβ(1-16) or Aβ(9-21).  The effect of the enzyme was also analyzed using two different mutant fragments, possessing a low and the other a high capacity for fibrillogenesis.  The fragments used were aβ(12-28)Val18 → Ala and aβ(12-28)Glu22 → Gln, resp.  AChE was able to promote the aggregation of these fragments in a very specific way and both mutant peptides were able to form amyloid fibrils, as revealed by neg. staining under the electron microscope.  Binding assays indicated that AChE was bound to aβ(12-28), as well as to the aβ(1-16) peptide.  AChE was seen to form strong complexes with the Aβ(12-28) fibrils as such complexes stained pos. for both thioflavine-T and AChE activity, were resistant to high ionic strength treatment, and were partially sensitive to detergents, suggesting that hydrophobic interactions may play a role in the stabilization of the AChE-Aβ complex.  Our results suggest that such amyloid-AChE complexes are formed when AChE interacts with the growing amyloid fibrils and accelerates the assembly of Aβ peptides.  This is consistent with the fact that AChE is known to be present within Aβ deposits including the pre-amyloid diffuse and mature senile plaques found in Alzheimer's brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3xL4mECGtNLVg90H21EOLACvtfcHk0lhlyL2j5ox7lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsV2hsrY%253D&md5=077906f315786101593f092294b360db</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1997.1245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1997.1245%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DOpazo%26aufirst%3DC.%26aulast%3DAlarc%25C3%25B3n%26aufirst%3DR.%26aulast%3DGarrido%26aufirst%3DJ.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DAcetylcholinesterase%2520promotes%2520the%2520aggregation%2520of%2520amyloid-%25CE%25B2-peptide%2520fragments%2520by%2520forming%2520a%2520complex%2520with%2520the%2520growing%2520fibrils%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D272%26spage%3D348%26epage%3D361%26doi%3D10.1006%2Fjmbi.1997.1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenblatt, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase: a multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer’s disease</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1385/JMN:20:3:369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1385%2FJMN%3A20%3A3%3A369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=14501022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslGrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2003&pages=369-383&author=H.+M.+Greenblattauthor=H.+Dvirauthor=I.+Silmanauthor=J.+L.+Sussman&title=Acetylcholinesterase%3A+a+multifaceted+target+for+structure-based+drug+design+of+anticholinesterase+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1385%2FJMN%3A20%3A3%3A369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase. A multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Greenblatt, Harry M.; Dvir, Hay; Silman, Israel; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-383</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  The structure of Torpedo californica acetylcholinesterase is examd. in complex with several inhibitors that are either in use or under development for treating Alzheimer's disease.  The noncovalent inhibitors vary greatly in their structures and bind to different sites of the enzyme, offering many different starting points for future drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp-6D7x0EvC7Vg90H21EOLACvtfcHk0lhlyL2j5ox7lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslGrsbo%253D&md5=d4411e2a8031e7da6d057d54f58a9861</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1385%2FJMN%3A20%3A3%3A369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FJMN%253A20%253A3%253A369%26sid%3Dliteratum%253Aachs%26aulast%3DGreenblatt%26aufirst%3DH.%2BM.%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholinesterase%253A%2520a%2520multifaceted%2520target%2520for%2520structure-based%2520drug%2520design%2520of%2520anticholinesterase%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2003%26volume%3D20%26spage%3D369%26epage%3D383%26doi%3D10.1385%2FJMN%3A20%3A3%3A369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greig, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utsuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingram, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepeu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamczarz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambamurti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahiri, D. K.</span></span> <span> </span><span class="NLM_article-title">Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">17213</span>– <span class="NLM_lpage">17218</span>, <span class="refDoi"> DOI: 10.1073/pnas.0508575102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1073%2Fpnas.0508575102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=16275899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yksLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=17213-17218&author=N.+H.+Greigauthor=T.+Utsukiauthor=D.+K.+Ingramauthor=Y.+Wangauthor=G.+Pepeuauthor=C.+Scaliauthor=Q.+S.+Yuauthor=J.+Mamczarzauthor=H.+W.+Hollowayauthor=T.+Giordanoauthor=D.+Chenauthor=K.+Furukawaauthor=K.+Sambamurtiauthor=A.+Brossiauthor=D.+K.+Lahiri&title=Selective+butyrylcholinesterase+inhibition+elevates+brain+acetylcholine%2C+augments+learning+and+lowers+Alzheimer+beta-amyloid+peptide+in+rodent&doi=10.1073%2Fpnas.0508575102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent</span></div><div class="casAuthors">Greig, Nigel H.; Utsuki, Tadanobu; Ingram, Donald K.; Wang, Yue; Pepeu, Giancarlo; Scali, Carla; Yu, Qian-Sheng; Mamczarz, Jacek; Holloway, Harold W.; Giordano, Tony; Chen, DeMao; Furukawa, Katsutoshi; Sambamurti, Kumar; Brossi, Arnold; Lahiri, Debomoy K.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">17213-17218</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Like acetylcholinesterase, butyrylcholinesterase (BChE) inactivates the neurotransmitter acetylcholine (ACh) and is hence a viable therapeutic target in Alzheimer's disease, which is characterized by a cholinergic deficit.  Potent, reversible, and brain-targeted BChE inhibitors (cymserine analogs) were developed based on binding domain structures to help elucidate the role of this enzyme in the central nervous system.  In rats, cymserine analogs caused long-term inhibition of brain BChE and elevated extracellular ACh levels, without inhibitory effects on acetylcholinesterase.  In rat brain slices, selective BChE inhibition augmented long-term potentiation.  These compds. also improved the cognitive performance (maze navigation) of aged rats.  In cultured human SK-N-SH neuroblastoma cells, intra- and extracellular β-amyloid precursor protein, and secreted β-amyloid peptide levels were reduced without affecting cell viability.  Treatment of transgenic mice that overexpressed human mutant amyloid precursor protein also resulted in lower β-amyloid peptide brain levels than controls.  Selective, reversible inhibition of brain BChE may represent a treatment for Alzheimer's disease, improving cognition and modulating neuropathol. markers of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI6ACIUUc5wrVg90H21EOLACvtfcHk0lhlyL2j5ox7lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yksLfE&md5=a4ac89f6186f77125545c667f9efbe21</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0508575102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0508575102%26sid%3Dliteratum%253Aachs%26aulast%3DGreig%26aufirst%3DN.%2BH.%26aulast%3DUtsuki%26aufirst%3DT.%26aulast%3DIngram%26aufirst%3DD.%2BK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPepeu%26aufirst%3DG.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DQ.%2BS.%26aulast%3DMamczarz%26aufirst%3DJ.%26aulast%3DHolloway%26aufirst%3DH.%2BW.%26aulast%3DGiordano%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DSambamurti%26aufirst%3DK.%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DLahiri%26aufirst%3DD.%2BK.%26atitle%3DSelective%2520butyrylcholinesterase%2520inhibition%2520elevates%2520brain%2520acetylcholine%252C%2520augments%2520learning%2520and%2520lowers%2520Alzheimer%2520beta-amyloid%2520peptide%2520in%2520rodent%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D17213%26epage%3D17218%26doi%3D10.1073%2Fpnas.0508575102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">Discovery and biological evaluation of a novel highly potent selective butyrylcholinsterase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">10030</span>– <span class="NLM_lpage">10044</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c01129</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c01129" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVGnsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=10030-10044&author=Q.+Liauthor=S.+Xingauthor=Y.+Chenauthor=Q.+Liaoauthor=B.+Xiongauthor=S.+Heauthor=W.+Luauthor=Y.+Liuauthor=H.+Yangauthor=Q.+Liauthor=F.+Fengauthor=W.+Liuauthor=Y.+Chenauthor=H.+Sun&title=Discovery+and+biological+evaluation+of+a+novel+highly+potent+selective+butyrylcholinsterase+inhibitor&doi=10.1021%2Facs.jmedchem.0c01129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor</span></div><div class="casAuthors">Li, Qi; Xing, Shuaishuai; Chen, Ying; Liao, Qinghong; Xiong, Baichen; He, Siyu; Lu, Weixuan; Liu, Yang; Yang, Hongyu; Li, Qihang; Feng, Feng; Liu, Wenyuan; Chen, Yao; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">10030-10044</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To discover novel BChE inhibitors, a hierarchical virtual screening protocol followed by biochem. evaluation was applied.  The most potent compd. 8012-9656(I) (eqBChE IC50 = 0.18 ± 0.03 μM, hBChE IC50 = 0.32 ± 0.07 μM) was purchased and synthesized.  It inhibited BChE in a noncompetitive manner and could occupy the binding pocket forming diverse interactions with the target. 8012-9656 was proven to be safe in vivo and in vitro and showed comparable performance in ameliorating the scopolamine-induced cognition impairment to tacrine.  Addnl., treatment with 8012-9656 could almost entirely recover the Aβ1-42 (icv)-impaired cognitive function to the normal level and showed better behavioral performance than donepezil.  The evaluation of the Aβ1-42 total amt. confirmed its anti-amyloidogenic profile.  Moreover, 8012-9656 possessed blood-brain barrier (BBB) penetrating ability, a long T1/2, and low intrinsic clearance.  Hence, the novel potential BChE inhibitor 8012-9656 can be considered as a promising lead compd. for further investigation of anti-AD agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr1Sklwfx9urVg90H21EOLACvtfcHk0lgSCm30vNivfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVGnsL%252FI&md5=d09b6e8200bf781d64794897360f74dc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c01129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c01129%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DXing%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DDiscovery%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520highly%2520potent%2520selective%2520butyrylcholinsterase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D10030%26epage%3D10044%26doi%3D10.1021%2Facs.jmedchem.0c01129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Košak, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pišlar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coquelle, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletier, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8167</span>– <span class="NLM_lpage">8179</span>, <span class="refDoi"> DOI: 10.1021/jm501195e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501195e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKnsrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8167-8179&author=B.+Brusauthor=U.+Ko%C5%A1akauthor=S.+Turkauthor=A.+Pi%C5%A1larauthor=N.+Coquelleauthor=J.+Kosauthor=J.+Stojanauthor=J.-P.+Colletierauthor=S.+Gobec&title=Discovery%2C+biological+evaluation%2C+and+crystal+structure+of+a+novel+nanomolar+selective+butyrylcholinesterase+inhibitor&doi=10.1021%2Fjm501195e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor</span></div><div class="casAuthors">Brus, Boris; Kosak, Urban; Turk, Samo; Pislar, Anja; Coquelle, Nicolas; Kos, Janko; Stojan, Jure; Colletier, Jacques-Philippe; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8167-8179</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Butyrylcholinesterase (BChE) is regarded as a promising drug target as its levels and activity significantly increase in the late stages of Alzheimer's disease.  To discover novel BChE inhibitors, the authors used a hierarchical virtual screening protocol followed by biochem. evaluation of 40 highest scoring hit compds.  Three of the compds. identified showed significant inhibitory activities against BChE.  The most potent, compd. I (IC50 = 21.3 nM), was resynthesized and resolved into its pure enantiomers.  A high degree of stereoselective activity was revealed, and a dissocn. const. of 2.7 nM was detd. for the most potent stereoisomer (+)-I.  The crystal structure of human BChE in complex with compd. (+)-I was solved, revealing the binding mode and providing clues for potential optimization.  Addnl., compd. I inhibited amyloid β1-42 peptide self-induced aggregation into fibrils (by 61.7% at 10 μM) and protected cultured SH-SY5Y cells against amyloid-β-induced toxicity.  These data suggest that compd. 1 represents a promising candidate for hit-to-lead follow-up in the drug-discovery process against Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKkU3pmuNPfrVg90H21EOLACvtfcHk0lgSCm30vNivfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKnsrjM&md5=2d21e5e601e2e8793058c1c34360a82b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm501195e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501195e%26sid%3Dliteratum%253Aachs%26aulast%3DBrus%26aufirst%3DB.%26aulast%3DKo%25C5%25A1ak%26aufirst%3DU.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DPi%25C5%25A1lar%26aufirst%3DA.%26aulast%3DCoquelle%26aufirst%3DN.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DStojan%26aufirst%3DJ.%26aulast%3DColletier%26aufirst%3DJ.-P.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DDiscovery%252C%2520biological%2520evaluation%252C%2520and%2520crystal%2520structure%2520of%2520a%2520novel%2520nanomolar%2520selective%2520butyrylcholinesterase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8167%26epage%3D8179%26doi%3D10.1021%2Fjm501195e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coquelle, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosič, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brazzolotto, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mravljak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletier, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4442</span>– <span class="NLM_lpage">4452</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bmc.2015.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=26116179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVeiur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=4442-4452&author=D.+Knezauthor=B.+Brusauthor=N.+Coquelleauthor=I.+Sosi%C4%8Dauthor=R.+%C5%A0inkauthor=X.+Brazzolottoauthor=J.+Mravljakauthor=J.+P.+Colletierauthor=S.+Gobec&title=Structure-based+development+of+nitroxoline+derivatives+as+potential+multifunctional+anti-Alzheimer+agents&doi=10.1016%2Fj.bmc.2015.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents</span></div><div class="casAuthors">Knez, Damijan; Brus, Boris; Coquelle, Nicolas; Sosic, Izidor; Sink, Roman; Brazzolotto, Xavier; Mravljak, Janez; Colletier, Jacques-Philippe; Gobec, Stanislav</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4442-4452</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tremendous efforts have been dedicated to the development of effective therapeutics against Alzheimer's disease, which represents the most common debilitating neurodegenerative disease.  Multifunctional agents are mols. designed to have simultaneous effects on different pathol. processes.  Such compds. represent an emerging strategy for the development of effective treatments against Alzheimer's disease.  Here, we report on the synthesis and biol. evaluation of a series of nitroxoline-based analogs that were designed by merging the scaffold of 8-hydroxyquinoline with that of a known selective butyrylcholinesterase inhibitor that has promising anti-Alzheimer properties.  Most strikingly, compd.(I) inhibits self-induced aggregation of the amyloid beta peptide (Aβ1-42), inhibits with sub-micromolar potency butyrylcholinesterase (IC50 = 215 nM), and also selectively complexes Cu2+.  Our study thus designates this compd. as a promising multifunctional agent for therapeutic treatment of Alzheimer's disease.  The crystal structure of human butyrylcholinesterase in complex with compd. I is also solved, which suggests ways to further optimize compds. featuring the 8-hydroxyquinoline scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3E6NDidmZlbVg90H21EOLACvtfcHk0lgSCm30vNivfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVeiur3J&md5=caf59141911f78984fc859674a88c6a6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DKnez%26aufirst%3DD.%26aulast%3DBrus%26aufirst%3DB.%26aulast%3DCoquelle%26aufirst%3DN.%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3D%25C5%25A0ink%26aufirst%3DR.%26aulast%3DBrazzolotto%26aufirst%3DX.%26aulast%3DMravljak%26aufirst%3DJ.%26aulast%3DColletier%26aufirst%3DJ.%2BP.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DStructure-based%2520development%2520of%2520nitroxoline%2520derivatives%2520as%2520potential%2520multifunctional%2520anti-Alzheimer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D4442%26epage%3D4452%26doi%3D10.1016%2Fj.bmc.2015.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Bachiller, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span> <span> </span><span class="NLM_article-title">New tacrine–4-oxo-4<i>H</i>-chromene hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with cholinergic, antioxidant, and β-amyloid-reducing properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1303</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1021/jm201460y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201460y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1303-1317&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=L.+Monjasauthor=J.+Rademannauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+tacrine%E2%80%934-oxo-4H-chromene+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+%CE%B2-amyloid-reducing+properties&doi=10.1021%2Fjm201460y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">New Tacrine-4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties</span></div><div class="casAuthors">Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Monjas, Leticia; Rademann, Jorg; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1303-1317</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By using fragments endowed with interesting and complementary properties for the treatment of Alzheimer's disease (AD), a new family of tacrine-4-oxo-4H-chromene hybrids has been designed, synthesized, and evaluated biol.  The tacrine fragment was selected for its inhibition of cholinesterases, and the flavonoid scaffold derived from 4-oxo-4H -chromene was chosen for its radical capture and β-secretase 1 (BACE-1) inhibitory activities.  At nano- and picomolar concns., the new tacrine-4-oxo-4H-chromene hybrids inhibit human acetyl- and butyrylcholinesterase (h-AChE and h-BuChE), being more potent than the parent inhibitor, tacrine.  They are also potent inhibitors of human BACE-1, better than the parent flavonoid, apigenin.  They show interesting antioxidant properties and could be able to penetrate into the CNS according to the in vitro PAMPA-BBB assay.  Among the hybrids investigated, 6-hydroxy-4-oxo- N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}-4 H-chromene-2-carboxamide (I) shows potent combined inhibition of human BACE-1 and ChEs, as well as good antioxidant and CNS-permeable properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiMx-NagCpeLVg90H21EOLACvtfcHk0lj-8JofVp9uTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFKisw%253D%253D&md5=9391af9439e43f5eda518919839bd473</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201460y%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520tacrine%25E2%2580%25934-oxo-4H-chromene%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520%25CE%25B2-amyloid-reducing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1303%26epage%3D1317%26doi%3D10.1021%2Fjm201460y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Bachiller, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Páez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Muñoz, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usán, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Palomero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarroya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span> <span> </span><span class="NLM_article-title">Tacrine-melatonin hybrids as multifunctional agents for Alzheimer’s disease, with cholinergic, antioxidant, and neuroprotective properties</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200800414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fcmdc.200800414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=19308922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Kgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=828-841&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=N.+E.+Campilloauthor=J.+A.+P%C3%A1ezauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=P.+Us%C3%A1nauthor=E.+Garc%C3%ADa-Palomeroauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=A.+G.+Garc%C3%ADaauthor=A.+Mart%C3%ADnezauthor=M.+I.+Rodr%C3%ADguez-Franco&title=Tacrine-melatonin+hybrids+as+multifunctional+agents+for+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+neuroprotective+properties&doi=10.1002%2Fcmdc.200800414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties</span></div><div class="casAuthors">Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Campillo, Nuria Eugenia; Paez, Juan Antonio; Gonzalez-Munoz, Gema Cristina; Usan, Paola; Garcia-Palomero, Esther; Lopez, Manuela G.; Villarroya, Mercedes; Garcia, Antonio G.; Martinez, Ana; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">828-841</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Tacrine-melatonin hybrids are potential multifunctional drugs for Alzheimer's disease that may simultaneously palliate intellectual deficits and protect the brain against both β-amyloid peptide and oxidative stress.  Mol. modeling studies show that they target both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE.  They are nontoxic and may be able to penetrate the CNS, according to in vitro PAMPA-BBB assays.  Tacrine-melatonin hybrids were designed and synthesized as new multifunctional drug candidates for Alzheimer's disease.  These compds. may simultaneously palliate intellectual deficits and protect the brain against both β-amyloid (Aβ) peptide and oxidative stress.  They show improved cholinergic and antioxidant properties, and are more potent and selective inhibitors of human acetylcholinesterase (hAChE) than tacrine.  They also capture free radicals better than melatonin.  Mol. modeling studies show that these hybrids target both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE.  At sub-micromolar concns. they efficiently displace the binding of propidium iodide from the PAS and could thus inhibit Aβ peptide aggregation promoted by AChE.  Moreover, they also inhibit Aβ self-aggregation and display neuroprotective properties in a human neuroblastoma line against cell death induced by various toxic insults, such as Aβ25-35, H2O2, and rotenone.  Finally, they exhibit low toxicity and may be able to penetrate the central nervous system according to an in vitro parallel artificial membrane permeability assay for the blood-brain barrier (PAMPA-BBB).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf8mEFq1tgJ7Vg90H21EOLACvtfcHk0lj-8JofVp9uTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Kgt7g%253D&md5=67c7f37e4d3ec3b28387d1b2d19abbbd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800414%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DP%25C3%25A1ez%26aufirst%3DJ.%2BA.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DTacrine-melatonin%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520neuroprotective%2520properties%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D828%26epage%3D841%26doi%3D10.1002%2Fcmdc.200800414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trovaslet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer’s drugs targeting acetyl- and butyryl-cholinesterase</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>453</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1042/BJ20130013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1042%2FBJ20130013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=23679855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2it7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2013&pages=393-399&author=F.+Nachonauthor=E.+Carlettiauthor=C.+Roncoauthor=M.+Trovasletauthor=Y.+Nicoletauthor=L.+Jeanauthor=P.-Y.+Renard&title=Crystal+structures+of+human+cholinesterases+in+complex+with+huprine+W+and+tacrine%3A+elements+of+specificity+for+anti-Alzheimer%E2%80%99s+drugs+targeting+acetyl-+and+butyryl-cholinesterase&doi=10.1042%2FBJ20130013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase</span></div><div class="casAuthors">Nachon, Florian; Carletti, Eugenie; Ronco, Cyril; Trovaslet, Marie; Nicolet, Yvain; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">453</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-399</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The multifunctional nature of Alzheimer's disease calls for MTDLs (multitarget-directed ligands) to act on different components of the pathol., like the cholinergic dysfunction and amyloid aggregation.  Such MTDLs are usually on the basis of cholinesterase inhibitors (e.g. tacrine or huprine) coupled with another active mol. aimed at a different target.  To aid in the design of these MTDLs, the authors report the crystal structures of hAChE (human acetylcholinesterase) in complex with FAS-2 (fasciculin 2) and a hydroxylated deriv. of huprine (huprine W), and of hBChE (human butyrylcholinesterase) in complex with tacrine.  Huprine W in hAChE and tacrine in hBChE reside in strikingly similar positions highlighting the conservation of key interactions, namely, π-π/cation-π interactions with Trp86 (Trp82), and hydrogen bonding with the main chain carbonyl of the catalytic histidine residue.  Huprine W forms addnl. interactions with hAChE, which explains its superior affinity: the isoquinoline moiety is assocd. with a group of arom. residues (Tyr337, Phe338 and Phe295 not present in hBChE) in addn. to Trp86; the hydroxyl group is hydrogen bonded to both the catalytic serine residue and residues in the oxyanion hole; and the chlorine substituent is nested in a hydrophobic pocket interacting strongly with Trp439.  There is no pocket in hBChE that is able to accommodate the chlorine substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovCptRaIZE_rVg90H21EOLACvtfcHk0lj-8JofVp9uTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2it7fM&md5=a36d3b1007c83c59c639a08f17d26bb7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1042%2FBJ20130013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20130013%26sid%3Dliteratum%253Aachs%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DCarletti%26aufirst%3DE.%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DTrovaslet%26aufirst%3DM.%26aulast%3DNicolet%26aufirst%3DY.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DCrystal%2520structures%2520of%2520human%2520cholinesterases%2520in%2520complex%2520with%2520huprine%2520W%2520and%2520tacrine%253A%2520elements%2520of%2520specificity%2520for%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%2520targeting%2520acetyl-%2520and%2520butyryl-cholinesterase%26jtitle%3DBiochem.%2520J.%26date%3D2013%26volume%3D453%26spage%3D393%26epage%3D399%26doi%3D10.1042%2FBJ20130013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recanatini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0li4kX2VnvgH5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mesiti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">The chemistry toolbox of multitarget-directed ligands for Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">111572</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.ejmech.2019.111572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31404859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyjsrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2019&pages=111572&author=F.+Mesitiauthor=D.+Chavarriaauthor=A.+Gasparauthor=S.+Alcaroauthor=F.+Borges&title=The+chemistry+toolbox+of+multitarget-directed+ligands+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.111572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease</span></div><div class="casAuthors">Mesiti, Francesco; Chavarria, Daniel; Gaspar, Alexandra; Alcaro, Stefano; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111572</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  The discovery and development of multitarget-directed ligands (MTDLs) is a promising strategy to find new therapeutic solns. for neurodegenerative diseases (NDs), in particular for Alzheimer's disease (AD).  Currently approved drugs for the clin. management of AD are based on a single-target strategy and focus on restoring neurotransmitter homeostasis.  Finding disease-modifying therapies AD and other NDs remains an urgent unmet clin. need.  The growing consensus that AD is a multifactorial disease, with several interconnected and deregulated pathol. pathways, boosted an intensive research in the design of MTDLs.  Due to this scientific boom, the knowledge behind the development of MTDLs remains diffuse and lacks balanced guidelines.  To rationalize the large amt. of data obtained in this field, the authors herein revise the progress made over the last 5 years on the development of MTDLs inspired by drugs approved for AD.  Due to their putative therapeutic benefit in AD, MTDLs based on MAO-B inhibitors will also be discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGret0oXDxuClLVg90H21EOLACvtfcHk0li4kX2VnvgH5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyjsrvE&md5=e2703287dc0dbdc2be5ea7b5e9e9fee1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111572%26sid%3Dliteratum%253Aachs%26aulast%3DMesiti%26aufirst%3DF.%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DThe%2520chemistry%2520toolbox%2520of%2520multitarget-directed%2520ligands%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D181%26spage%3D111572%26doi%3D10.1016%2Fj.ejmech.2019.111572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.02.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.ejmech.2019.02.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=30884327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltFGhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2019&pages=200-223&author=T.+Wangauthor=X.+Liuauthor=J.+Guanauthor=S.+Geauthor=M.-B.+Wuauthor=J.+Linauthor=L.+Yang&title=Advancement+of+multi-target+drug+discoveries+and+promising+applications+in+the+field+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.02.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease</span></div><div class="casAuthors">Wang, Tao; Liu, Xiao-huan; Guan, Jing; Ge, Shun; Wu, Mian-Bin; Lin, Jian-ping; Yang, Li-rong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">200-223</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Complex diseases (e.g., Alzheimer's disease) or infectious diseases are usually caused by complicated and varied factors, including environmental and genetic factors.  Multi-target (polypharmacol.) drugs have been suggested and have emerged as powerful and promising alternative paradigms in modern medicinal chem. for the development of versatile chemotherapeutic agents to solve these medical challenges.  The multifunctional agents capable of modulating multiple biol. targets simultaneously display great advantages of higher efficacy, improved safety profile, and simpler administration compared to single-targeted agents.  Therefore, multifunctional agents would certainly open novel avenues to rationally design the next generation of more effective but less toxic therapeutic agents.  Herein, the authors review the recent progress made in the discovery and design processes of selective multi-targeted agents, esp. the successful application of multi-target drugs for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraLSyazoHkBbVg90H21EOLACvtfcHk0li4kX2VnvgH5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltFGhs7g%253D&md5=11e82288f25c5b2421184be0c568f9f8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.02.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.02.076%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DM.-B.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DAdvancement%2520of%2520multi-target%2520drug%2520discoveries%2520and%2520promising%2520applications%2520in%2520the%2520field%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D169%26spage%3D200%26epage%3D223%26doi%3D10.1016%2Fj.ejmech.2019.02.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gontijo, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viegas, F. P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, C. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Freitas Silva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damasio, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couto, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranches Dias, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viegas, C.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.2174/1385272823666191021124443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.2174%2F1385272823666191021124443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31631821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVyiurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2020&pages=348-407&author=V.+S.+Gontijoauthor=F.+P.+D.+Viegasauthor=C.+J.+C.+Ortizauthor=M.+de+Freitas+Silvaauthor=C.+M.+Damasioauthor=M.+C.+Rosaauthor=T.+G.+Camposauthor=D.+S.+Coutoauthor=K.+S.+Tranches+Diasauthor=C.+Viegas&title=Molecular+hybridization+as+a+tool+in+the+design+of+multi-target+directed+drug+candidates+for+neurodegenerative+diseases&doi=10.2174%2F1385272823666191021124443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases</span></div><div class="casAuthors">Gontijo, Vanessa Silva; Dias Viegas, Flavia P.; Cristancho Ortiz, Cindy Juliet; de Freitas Silva, Matheus; Damasio, Caio Miranda; Rosa, Mayara Chagas; Campos, Thamara Gaspar; Couto, Dyecika Souza; Tranches Dias, Kris Simone; Viegas, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">348-407</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative Diseases (NDs) are progressive multifactorial neurol. pathologies related to neuronal impairment and functional loss from different brain regions.  Currently, no effective treatments are available for any NDs, and this lack of efficacy has been attributed to the multitude of interconnected factors involved in their pathophysiol.  In the last two decades, a new approach for the rational design of new drug candidates, also called multitarget-directed ligands (MTDLs) strategy, has emerged and has been used in the design and for the development of a variety of hybrid compds. capable to act simultaneously in diverse biol. targets.  Based on the polypharmacol. concept, this new paradigm has been thought as a more secure and effective way for modulating concomitantly two or more biochem. pathways responsible for the onset and progress of NDs, trying to overcome low therapeutical effectiveness.  As a complement to our previous review article (Curr. Med. Chem. 2007, 14 (17), 1829-1852. https://doi.org/10.2174/092986707781058805), herein we aimed to cover the period from 2008 to 2019 and highlight the most recent advances of the exploitation of Mol. Hybridization (MH) as a tool in the rational design of innovative multifunctional drug candidate prototypes for the treatment of NDs, specially focused on AD, PD, HD and ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMj4ASlxgG-LVg90H21EOLACvtfcHk0lgZLg94TkGihQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVyiurfI&md5=82ca2f766a86b5329719aa4ae2bb1d6c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1385272823666191021124443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1385272823666191021124443%26sid%3Dliteratum%253Aachs%26aulast%3DGontijo%26aufirst%3DV.%2BS.%26aulast%3DViegas%26aufirst%3DF.%2BP.%2BD.%26aulast%3DOrtiz%26aufirst%3DC.%2BJ.%2BC.%26aulast%3Dde%2BFreitas%2BSilva%26aufirst%3DM.%26aulast%3DDamasio%26aufirst%3DC.%2BM.%26aulast%3DRosa%26aufirst%3DM.%2BC.%26aulast%3DCampos%26aufirst%3DT.%2BG.%26aulast%3DCouto%26aufirst%3DD.%2BS.%26aulast%3DTranches%2BDias%26aufirst%3DK.%2BS.%26aulast%3DViegas%26aufirst%3DC.%26atitle%3DMolecular%2520hybridization%2520as%2520a%2520tool%2520in%2520the%2520design%2520of%2520multi-target%2520directed%2520drug%2520candidates%2520for%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2020%26volume%3D18%26spage%3D348%26epage%3D407%26doi%3D10.2174%2F1385272823666191021124443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabr, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span> <span> </span><span class="NLM_article-title">MicroRNA-based multitarget approach for Alzheimer’s disease: Discovery of the first-in-class dual inhibitor of acetylcholinesterase and MicroRNA-15b biogenesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">9695</span>– <span class="NLM_lpage">9704</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00756</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00756" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVOrs7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=9695-9704&author=M.+T.+Gabrauthor=S.+Brogi&title=MicroRNA-based+multitarget+approach+for+Alzheimer%E2%80%99s+disease%3A+Discovery+of+the+first-in-class+dual+inhibitor+of+acetylcholinesterase+and+MicroRNA-15b+biogenesis&doi=10.1021%2Facs.jmedchem.0c00756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">MicroRNA-Based Multitarget Approach for Alzheimer's Disease: Discovery of the First-In-Class Dual Inhibitor of Acetylcholinesterase and MicroRNA-15b Biogenesis</span></div><div class="casAuthors">Gabr, Moustafa T.; Brogi, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9695-9704</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multitarget approach in drug design is a powerful strategy in tackling the multifactorial nature of Alzheimer's disease (AD).  Herein, we report a novel strategy in the design of multitargeted therapeutics for AD through dual inhibition of acetylcholinesterase (AChE) and microRNA-15b biogenesis.  We performed high-throughput screening (HTS) of a chem. library to identify binders of mircoRNA-15b which is identified as a biomarker and potential therapeutic target of AD.  The hits from HTS were further screened for their AChE inhibitory activity, the most widely investigated target for the development of AD therapeutics.  MG-6267(I) was identified as the first dual inhibitor of AChE and microRNA-15b biogenesis.  Cellular assays revealed the superiority of MG-6267 to single-targeted inhibitors of AChE and microRNA-15b in protecting SH-SY5Y neuroblastoma cells from amyloid-beta (Aβ)-induced cytotoxicity.  This work paves the way for future research efforts aiming at the development of microRNA-based multitargeted therapeutics for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpojUJB-mCFlbVg90H21EOLACvtfcHk0lgZLg94TkGihQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVOrs7vN&md5=19937c89c04fe79adb177076f6bab7c3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00756%26sid%3Dliteratum%253Aachs%26aulast%3DGabr%26aufirst%3DM.%2BT.%26aulast%3DBrogi%26aufirst%3DS.%26atitle%3DMicroRNA-based%2520multitarget%2520approach%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Discovery%2520of%2520the%2520first-in-class%2520dual%2520inhibitor%2520of%2520acetylcholinesterase%2520and%2520MicroRNA-15b%2520biogenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D9695%26epage%3D9704%26doi%3D10.1021%2Facs.jmedchem.0c00756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arribas, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino-Antolin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demougeot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobrlova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraleda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez-Iriepa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godyń, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gł̷uch-Lutwin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordyl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siwek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabchoub, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiec-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de los Ríos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span> <span> </span><span class="NLM_article-title">New dual small molecules for Alzheimer’s disease therapy combining histamine H<sub>3</sub> receptor (H3R) antagonism and calcium channels blockade with additional cholinesterase inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">11416</span>– <span class="NLM_lpage">11422</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00937</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFKksLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=11416-11422&author=R.+Malekauthor=R.+L.+Arribasauthor=A.+Palomino-Antolinauthor=P.+Totosonauthor=C.+Demougeotauthor=T.+Kobrlovaauthor=O.+Soukupauthor=I.+Iriepaauthor=I.+Moraledaauthor=D.+Diez-Iriepaauthor=J.+Gody%C5%84author=D.+Panekauthor=B.+Malawskaauthor=M.+G%C5%82%CC%B7uch-Lutwinauthor=B.+Mordylauthor=A.+Siwekauthor=F.+Chabchoubauthor=J.+Marco-Contellesauthor=K.+Kiec-Kononowiczauthor=J.+Egeaauthor=C.+de+los+R%C3%ADosauthor=L.+Ismaili&title=New+dual+small+molecules+for+Alzheimer%E2%80%99s+disease+therapy+combining+histamine+H3+receptor+%28H3R%29+antagonism+and+calcium+channels+blockade+with+additional+cholinesterase+inhibition&doi=10.1021%2Facs.jmedchem.9b00937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition</span></div><div class="casAuthors">Malek, Rim; Arribas, Raquel L.; Palomino-Antolin, Alejandra; Totoson, Perle; Demougeot, Celine; Kobrlova, Tereza; Soukup, Ondrej; Iriepa, Isabel; Moraleda, Ignacio; Diez-Iriepa, Daniel; Godyn, Justyna; Panek, Dawid; Malawska, Barbara; Gluch-Lutwin, Monika; Mordyl, Barbara; Siwek, Agata; Chabchoub, Fakher; Marco-Contelles, Jose; Kiec-Kononowicz, Katarzyna; Egea, Javier; de los Rios, Cristobal; Ismaili, Lhassane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11416-11422</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New tritarget small mols. combining Ca2+ channels blockade, cholinesterase, and H3 receptor inhibition were obtained by multicomponent synthesis.  Compd. 3p has been identified as a very promising lead, showing good Ca2+ channels blockade activity (IC50 = 21 ± 1 μM), potent affinity against hH3R (Ki = 565 ± 62 nM), a moderate but selective hBuChE inhibition (IC50 = 7.83 ± 0.10 μM), strong antioxidant power (3.6 TE), and ability to restore cognitive impairment induced by lipopolysaccharide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvTNg2ULN-ZrVg90H21EOLACvtfcHk0lgZLg94TkGihQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFKksLjL&md5=ba17509f9a9fc77e5e7183842c5dfe3f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00937%26sid%3Dliteratum%253Aachs%26aulast%3DMalek%26aufirst%3DR.%26aulast%3DArribas%26aufirst%3DR.%2BL.%26aulast%3DPalomino-Antolin%26aufirst%3DA.%26aulast%3DTotoson%26aufirst%3DP.%26aulast%3DDemougeot%26aufirst%3DC.%26aulast%3DKobrlova%26aufirst%3DT.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DDiez-Iriepa%26aufirst%3DD.%26aulast%3DGody%25C5%2584%26aufirst%3DJ.%26aulast%3DPanek%26aufirst%3DD.%26aulast%3DMalawska%26aufirst%3DB.%26aulast%3DG%25C5%2582%25CC%25B7uch-Lutwin%26aufirst%3DM.%26aulast%3DMordyl%26aufirst%3DB.%26aulast%3DSiwek%26aufirst%3DA.%26aulast%3DChabchoub%26aufirst%3DF.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DKiec-Kononowicz%26aufirst%3DK.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DC.%26aulast%3DIsmaili%26aufirst%3DL.%26atitle%3DNew%2520dual%2520small%2520molecules%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%2520combining%2520histamine%2520H3%2520receptor%2520%2528H3R%2529%2520antagonism%2520and%2520calcium%2520channels%2520blockade%2520with%2520additional%2520cholinesterase%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D11416%26epage%3D11422%26doi%3D10.1021%2Facs.jmedchem.9b00937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheiner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falkeis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Dual-acting cholinesterase–human cannabinoid receptor 2 ligands show pronounced neuroprotection in vitro and overadditive and disease-modifying neuroprotective effects in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9078</span>– <span class="NLM_lpage">9102</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9078-9102&author=M.+Scheinerauthor=D.+Dollesauthor=S.+Guneschauthor=M.+Hoffmannauthor=M.+Nabissiauthor=O.+Marinelliauthor=M.+Naldiauthor=M.+Bartoliniauthor=S.+Petrallaauthor=E.+Poetaauthor=B.+Montiauthor=C.+Falkeisauthor=M.+Viethauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=R.+Maitraauthor=T.+Mauriceauthor=M.+Decker&title=Dual-acting+cholinesterase%E2%80%93human+cannabinoid+receptor+2+ligands+show+pronounced+neuroprotection+in+vitro+and+overadditive+and+disease-modifying+neuroprotective+effects+in+vivo&doi=10.1021%2Facs.jmedchem.9b00623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo</span></div><div class="casAuthors">Scheiner, Matthias; Dolles, Dominik; Gunesch, Sandra; Hoffmann, Matthias; Nabissi, Massimo; Marinelli, Oliviero; Naldi, Marina; Bartolini, Manuela; Petralla, Sabrina; Poeta, Eleonora; Monti, Barbara; Falkeis, Christina; Vieth, Michael; Huebner, Harald; Gmeiner, Peter; Maitra, Rangan; Maurice, Tangui; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9078-9102</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed and synthesized a series of 14 hybrid mols. out of the cholinesterase (ChE) inhibitor tacrine and a benzimidazole-based human cannabinoid receptor subtype 2 (hCB2R) agonist and investigated them in vitro and in vivo.  The compds. are potent ChE inhibitors, and for the most promising hybrids, the mechanism of human acetylcholinesterase (hAChE) inhibition as well as their ability to interfere with AChE-induced aggregation of β-amyloid (Aβ), and Aβ self-aggregation was assessed.  All hybrids were evaluated for affinity and selectivity for hCB1R and hCB2R.  To ensure that the hybrids retained their agonist character, the expression of cAMP-regulated genes was quantified, and potency and efficacy were detd.  Addnl., the effects of the hybrids on microglia activation and neuroprotection on HT-22 cells were investigated.  The most promising in vitro hybrids showed pronounced neuroprotection in an Alzheimer's mouse model at low dosage (0.1 mg/kg, i.p.), lacking hepatotoxicity even at high dose (3 mg/kg, i.p.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGRfz6xatTXLVg90H21EOLACvtfcHk0lghRL6ozYSVaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7%252FM&md5=f0148c8ba51a2d0cbe83a26bb388a446</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00623%26sid%3Dliteratum%253Aachs%26aulast%3DScheiner%26aufirst%3DM.%26aulast%3DDolles%26aufirst%3DD.%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DMarinelli%26aufirst%3DO.%26aulast%3DNaldi%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DPetralla%26aufirst%3DS.%26aulast%3DPoeta%26aufirst%3DE.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DFalkeis%26aufirst%3DC.%26aulast%3DVieth%26aufirst%3DM.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DDual-acting%2520cholinesterase%25E2%2580%2593human%2520cannabinoid%2520receptor%25202%2520ligands%2520show%2520pronounced%2520neuroprotection%2520in%2520vitro%2520and%2520overadditive%2520and%2520disease-modifying%2520neuroprotective%2520effects%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9078%26epage%3D9102%26doi%3D10.1021%2Facs.jmedchem.9b00623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James Chou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer’s disease: design, synthesis, and biological evaluation</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">103721</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bioorg.2020.103721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=32193030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlt1eltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2020&pages=103721&author=A.+Xuauthor=F.+Heauthor=X.+Zhangauthor=X.+Liauthor=Y.+Ranauthor=C.+Weiauthor=C.+James+Chouauthor=R.+Zhangauthor=J.+Wu&title=Tacrine-hydroxamate+derivatives+as+multitarget-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+design%2C+synthesis%2C+and+biological+evaluation&doi=10.1016%2Fj.bioorg.2020.103721"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation</span></div><div class="casAuthors">Xu, Ana; He, Feng; Zhang, Xiangna; Li, Xiaoyang; Ran, Yingying; Wei, Chao; James Chou, C.; Zhang, Rui; Wu, Jingde</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103721</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to develop multitarget-directed ligands as potential treatments for Alzheimer's disease, twenty-eight new tacrine-hydroxamate derivs. were designed, synthesized, and biol. evaluated.  As expected, most of the compds. exhibited inhibitory activities against cholinesterases (ChEs) and histone deacetylase (HDACs).  Among the tested compds., I showed not only potent and selective inhibition on AChE at sub-nanomolar potency (AChEIC50 = 0.12 nM, BChEIC50 = 361.52 nM) but also potent inhibition on HDAC (IC50 = 0.23 nM).  Moreover, I exhibited inhibitory activity on Aβ1-42 self-aggregation as well as disaggregation activity on pre-formed Aβ fibrils.  Furthermore, I exhibited antioxidant activity and metal chelating properties.  Further mechanistic studies demonstrated that I is a pan-inhibitor of HDACs and a mixed-type inhibitor for AChE.  It was shown that I is a BBB penetrant by online prediction.  Taken together, the results indicate that I can serve as a lead compd. to develop promising candidate analogs as AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLE3wLayb4i7Vg90H21EOLACvtfcHk0ljNiYZn8zQY-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlt1eltLw%253D&md5=e2b820af806ce7651f90fc66d4a1f1cb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103721%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DJames%2BChou%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DTacrine-hydroxamate%2520derivatives%2520as%2520multitarget-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D98%26spage%3D103721%26doi%3D10.1016%2Fj.bioorg.2020.103721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adasme-Carreño, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Gutierrez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzate-Morales, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span> <span> </span><span class="NLM_article-title">Novel coumarin-quinoline hybrids: design of multitarget compounds for Alzheimer’s disease</span>. <i>ChemistrySelect</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1002/slct.201803222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fslct.201803222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVOgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=551-558&author=Y.+Duarteauthor=A.+Fonsecaauthor=M.+Guti%C3%A9rrezauthor=F.+Adasme-Carre%C3%B1oauthor=C.+Mu%C3%B1oz-Gutierrezauthor=J.+Alzate-Moralesauthor=L.+Santanaauthor=E.+Uriarteauthor=R.+%C3%81lvarezauthor=M.+J.+Matos&title=Novel+coumarin-quinoline+hybrids%3A+design+of+multitarget+compounds+for+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fslct.201803222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Coumarin-Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease</span></div><div class="casAuthors">Duarte, Yorley; Fonseca, Andre; Gutierrez, Margarita; Adasme-Carreno, Francisco; Munoz-Gutierrez, Camila; Alzate-Morales, Jans; Santana, Lourdes; Uriarte, Eugenio; Alvarez, Rocio; Matos, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">ChemistrySelect</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">551-558</span>CODEN:
                <span class="NLM_cas:coden">CHEMUD</span>;
        ISSN:<span class="NLM_cas:issn">2365-6549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most prevalent neurodegenerative disease, presenting the most devastating consequences on human health and life quality.  Coumarin-quinoline hybrids were synthesized following a very efficient and versatile strategy.  Small structural variations contributed to dual acetyl/butyrylcholinesterases (AChE/BuChE) activity or selectivity towards one of these enzymes.  In addn., some of the studied compds. are interesting iron chelators, presenting a tendency to be neuroprotective.  Moreover, the compds. are not cytotoxic for SH-SY5Y neuroblastoma cells.  Compd. 9c proved to be the most interesting compd. of the studied series.  This compd. is selective against AChE and proved to be an excellent iron chelating agent (iron chelation at 100 μM=72.87%).  Mol. docking studies were performed to establish the nature of the interaction between the studied compds. and the binding pockets, leading to a rationalization of structure-activity relationships.  Compd. 9c forms a well-defined π-stacking interaction with Phe330 and interacts with Tyr121 residue via a hydrogen bond, while the inactive compds. cannot establish these interactions.  Important preliminary results against different targets, as well as some structure-activity relationships, were concluded from the exptl. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO_EBmjZxDfbVg90H21EOLACvtfcHk0li8l1rGVElUgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVOgtbw%253D&md5=299c5cfca47a068c32fe204044cc31bd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fslct.201803222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fslct.201803222%26sid%3Dliteratum%253Aachs%26aulast%3DDuarte%26aufirst%3DY.%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DM.%26aulast%3DAdasme-Carre%25C3%25B1o%26aufirst%3DF.%26aulast%3DMu%25C3%25B1oz-Gutierrez%26aufirst%3DC.%26aulast%3DAlzate-Morales%26aufirst%3DJ.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3D%25C3%2581lvarez%26aufirst%3DR.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26atitle%3DNovel%2520coumarin-quinoline%2520hybrids%253A%2520design%2520of%2520multitarget%2520compounds%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChemistrySelect%26date%3D2019%26volume%3D4%26spage%3D551%26epage%3D558%26doi%3D10.1002%2Fslct.201803222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lalut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecoutey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legay, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopkova-de Oliveira Santos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallemagne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochais, C.</span></span> <span> </span><span class="NLM_article-title">Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer’s disease</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3014</span>, <span class="refDoi"> DOI: 10.1038/s41598-020-59805-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1038%2Fs41598-020-59805-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=32080261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvVKltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=3014&author=J.+Lalutauthor=H.+Payanauthor=A.+Davisauthor=C.+Lecouteyauthor=R.+Legayauthor=J.+Sopkova-de+Oliveira+Santosauthor=S.+Claeysenauthor=P.+Dallemagneauthor=C.+Rochais&title=Rational+design+of+novel+benzisoxazole+derivatives+with+acetylcholinesterase+inhibitory+and+serotoninergic+5-HT4+receptors+activities+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fs41598-020-59805-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Lalut, Julien; Payan, Hugo; Davis, Audrey; Lecoutey, Cedric; Legay, Remi; Sopkova-de Oliveira Santos, Jana; Claeysen, Sylvie; Dallemagne, Patrick; Rochais, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3014</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: A rigidification strategy was applied to the preclin. candidate donecopride, an acetylcholinesterase inhibitor possessing 5-HT4R agonist activity.  Inspired by promising bioactive benzisoxazole compds., we have conducted a pharmacomodulation study to generate a novel series of multitarget directed ligands.  The chem. synthesis of the ligand was optimized and compds. were evaluated in vitro against each target and in cellulo.  Structure-activity relationship was supported by docking anal. in human acetylcholinesterase binding site.  Among the synthesized compds., we have identified a novel hybrid 32a (3-[2-[1-(cyclohexylmethyl)-4-piperidyl]ethyl]-4-methoxy-1,2-benzoxazole) able to display nanomolar acetylcholinesterase inhibitory effects and nanomolar Ki for 5-HT4R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-tPU07OCRbVg90H21EOLACvtfcHk0li8l1rGVElUgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvVKltbc%253D&md5=10fd094b64677f16a7f26cc2e21d426b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-59805-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-59805-7%26sid%3Dliteratum%253Aachs%26aulast%3DLalut%26aufirst%3DJ.%26aulast%3DPayan%26aufirst%3DH.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DSopkova-de%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DDallemagne%26aufirst%3DP.%26aulast%3DRochais%26aufirst%3DC.%26atitle%3DRational%2520design%2520of%2520novel%2520benzisoxazole%2520derivatives%2520with%2520acetylcholinesterase%2520inhibitory%2520and%2520serotoninergic%25205-HT4%2520receptors%2520activities%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26spage%3D3014%26doi%3D10.1038%2Fs41598-020-59805-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turcu, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barniol-Xicota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pivetta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">A novel class of multitarget anti-Alzheimer benzohomoadamantane–chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.07.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.ejmech.2019.07.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31351393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVGrsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2019&pages=613-626&author=F.+J.+P%C3%A9rez-Arealesauthor=A.+L.+Turcuauthor=M.+Barniol-Xicotaauthor=C.+Pontauthor=D.+Pivettaauthor=A.+Espargar%C3%B3author=M.+Bartoliniauthor=A.+De+Simoneauthor=V.+Andrisanoauthor=B.+P%C3%A9rezauthor=R.+Sabateauthor=F.+X.+Suredaauthor=S.+V%C3%A1zquezauthor=D.+Mu%C3%B1oz-Torrero&title=A+novel+class+of+multitarget+anti-Alzheimer+benzohomoadamantane%E2%80%93chlorotacrine+hybrids+modulating+cholinesterases+and+glutamate+NMDA+receptors&doi=10.1016%2Fj.ejmech.2019.07.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A novel class of multitarget anti-Alzheimer benzohomoadamantane-chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors</span></div><div class="casAuthors">Perez-Areales, F. Javier; Turcu, Andreea L.; Barniol-Xicota, Marta; Pont, Caterina; Pivetta, Deborah; Espargaro, Alba; Bartolini, Manuela; De Simone, Angela; Andrisano, Vincenza; Perez, Belen; Sabate, Raimon; Sureda, Francesc X.; Vazquez, Santiago; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">613-626</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The development of multitarget compds. against multifactorial diseases, such as Alzheimer's disease, is an area of very intensive research, due to the expected superior therapeutic efficacy that should arise from the simultaneous modulation of several key targets of the complex pathol. network.  Here we describe the synthesis and multitarget biol. profiling of a new class of compds. designed by mol. hybridization of an NMDA receptor antagonist fluorobenzohomoadamantanamine with the potent acetylcholinesterase (AChE) inhibitor 6-chlorotacrine, using two different linker lengths and linkage positions, to preserve or not the memantine-like polycyclic unsubstituted primary amine.  The best hybrids, e.g., I, exhibit greater potencies than parent compds. against AChE (IC50 0.33 nM in the best case, 44-fold increased potency over 6-chlorotacrine), butyrylcholinesterase (IC50 21 nM in the best case, 24-fold increased potency over 6-chlorotacrine), and NMDA receptors (IC50 0.89 μM in the best case, 2-fold increased potency over the parent benzohomoadamantanamine and memantine), which suggests an additive effect of both pharmacophoric moieties in the interaction with the primary targets.  Moreover, most of these compds. have been predicted to be brain permeable.  This set of biol. properties makes them promising leads for further anti-Alzheimer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQXvbwMzIWJbVg90H21EOLACvtfcHk0li8l1rGVElUgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGrsbfP&md5=676e6005d48fa5fdc44a967801d79ca0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.07.051%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DTurcu%26aufirst%3DA.%2BL.%26aulast%3DBarniol-Xicota%26aufirst%3DM.%26aulast%3DPont%26aufirst%3DC.%26aulast%3DPivetta%26aufirst%3DD.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DSureda%26aufirst%3DF.%2BX.%26aulast%3DV%25C3%25A1zquez%26aufirst%3DS.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DA%2520novel%2520class%2520of%2520multitarget%2520anti-Alzheimer%2520benzohomoadamantane%25E2%2580%2593chlorotacrine%2520hybrids%2520modulating%2520cholinesterases%2520and%2520glutamate%2520NMDA%2520receptors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D180%26spage%3D613%26epage%3D626%26doi%3D10.1016%2Fj.ejmech.2019.07.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Estrada-Valencia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera-Arozamena, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viña, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-García, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Castillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pricl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span> <span> </span><span class="NLM_article-title">New flavonoid – <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids: Multi-target-directed agents for Alzheimer′s disease endowed with neurogenic properties</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1080/14756366.2019.1581184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1080%2F14756366.2019.1581184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31852270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksFKisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2019&pages=712-727&author=M.+Estrada-Valenciaauthor=C.+Herrera-Arozamenaauthor=C.+P%C3%A9rezauthor=D.+Vi%C3%B1aauthor=J.+A.+Morales-Garc%C3%ADaauthor=A.+P%C3%A9rez-Castilloauthor=E.+Ramosauthor=A.+Romeroauthor=E.+Lauriniauthor=S.+Priclauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+flavonoid+%E2%80%93+N%2CN-dibenzyl%28N-methyl%29amine+hybrids%3A+Multi-target-directed+agents+for+Alzheimer%E2%80%B2s+disease+endowed+with+neurogenic+properties&doi=10.1080%2F14756366.2019.1581184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New flavonoid - N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer's disease endowed with neurogenic properties</span></div><div class="casAuthors">Estrada-Valencia, Martin; Herrera-Arozamena, Clara; Perez, Concepcion; Vina, Dolores; Morales-Garcia, Jose A.; Perez-Castillo, Ana; Ramos, Eva; Romero, Alejandro; Laurini, Erik; Pricl, Sabrina; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">712-727</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The design of multi-target directed ligands (MTDLs) is a valid approach for obtaining effective drugs for complex pathologies.  MTDLs that combine neuro-repair properties and block the first steps of neurotoxic cascades could be the so long wanted remedies to treat neurodegenerative diseases (NDs).  By linking two privileged scaffolds with well-known activities in ND-targets, the flavonoid and the N,N-dibenzyl(N-methyl)amine (DBMA) fragments, new CNS-permeable flavonoid - DBMA hybrids (-) were obtained.  They were subjected to biol. evaluation in a battery of targets involved in Alzheimer's disease (AD) and other NDs, namely human cholinesterases (hAChE/hBuChE), β-secretase (hBACE-1), monoamine oxidases (hMAO-A/B), lipoxygenase-5 (hLOX-5) and sigma receptors (σ1R/σ2R).  After a funnel-type screening, 6,7-dimethoxychromone - DBMA () was highlighted due to its neurogenic properties and an interesting MTD-profile in hAChE, hLOX-5, hBACE-1 and σ1R.  Mol. dynamic simulations showed the most relevant drug-protein interactions of hybrid , which could synergistically contribute to neuronal regeneration and block neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxvt6TPaP_67Vg90H21EOLACvtfcHk0ljDD-tr2Czosw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksFKisLk%253D&md5=24e4282e83ea909ffd6fd72a74a8e509</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1080%2F14756366.2019.1581184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2019.1581184%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada-Valencia%26aufirst%3DM.%26aulast%3DHerrera-Arozamena%26aufirst%3DC.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DVi%25C3%25B1a%26aufirst%3DD.%26aulast%3DMorales-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DP%25C3%25A9rez-Castillo%26aufirst%3DA.%26aulast%3DRamos%26aufirst%3DE.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DLaurini%26aufirst%3DE.%26aulast%3DPricl%26aufirst%3DS.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520flavonoid%2520%25E2%2580%2593%2520N%252CN-dibenzyl%2528N-methyl%2529amine%2520hybrids%253A%2520Multi-target-directed%2520agents%2520for%2520Alzheimer%25E2%2580%25B2s%2520disease%2520endowed%2520with%2520neurogenic%2520properties%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2019%26volume%3D34%26spage%3D712%26epage%3D727%26doi%3D10.1080%2F14756366.2019.1581184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginex, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puigoriol-Illamola, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallàs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciruela, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Centrally active multitarget anti-Alzheimer agents derived from the antioxidant lead CR-6</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">9360</span>– <span class="NLM_lpage">9390</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00528</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00528" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVCmtrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=9360-9390&author=F.+J.+P%C3%A9rez-Arealesauthor=M.+Garridoauthor=E.+Asoauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=A.+Espargar%C3%B3author=T.+Ginexauthor=R.+Sabateauthor=B.+P%C3%A9rezauthor=V.+Andrisanoauthor=D.+Puigoriol-Illamolaauthor=M.+Pall%C3%A0sauthor=F.+J.+Luqueauthor=M.+I.+Lozaauthor=J.+Breaauthor=I.+Ferrerauthor=F.+Ciruelaauthor=A.+Messeguerauthor=D.+Mu%C3%B1oz-Torrero&title=Centrally+active+multitarget+anti-Alzheimer+agents+derived+from+the+antioxidant+lead+CR-6&doi=10.1021%2Facs.jmedchem.0c00528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6</span></div><div class="casAuthors">Perez-Areales, F. Javier; Garrido, Maria; Aso, Ester; Bartolini, Manuela; De Simone, Angela; Espargaro, Alba; Ginex, Tiziana; Sabate, Raimon; Perez, Belen; Andrisano, Vincenza; Puigoriol-Illamola, Dolors; Pallas, Merce; Luque, F. Javier; Loza, Maria Isabel; Brea, Jose; Ferrer, Isidro; Ciruela, Francisco; Messeguer, Angel; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9360-9390</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oxidative stress is a major pathogenic factor in Alzheimer's disease, but it should not be tackled alone rather together with other key targets to derive effective treatments.  The combination of the scaffold of the polar antioxidant lead 7-methoxy-2,2-dimethylchroman-6-ol (CR-6) with that of the lipophilic cholinesterase inhibitor 6-chlorotacrine results in compds. with favorable brain permeability and multiple activities in vitro (acetylcholinesterase, butyrylcholinesterase, β-site amyloid precursor protein (APP) cleaving enzyme-1 (BACE-1), and Aβ42 and tau aggregation inhibition).  In in vivo studies on wild-type and APP/presenilin 1 (PS1) mice, two selected compds. were well tolerated and led to pos. trends, albeit statistically nonsignificant in some cases, on memory performance, amyloid pathol. (reduced amyloid burden and potentiated non-amyloidogenic APP processing), and oxidative stress (reduced cortical oxidized proteins and increased antioxidant enzymes superoxide dismutase 2 (SOD2), catalase, glutathione peroxidase 1 (GPX1), and heme oxygenase 1 (Hmox1) and transcription factor nuclear factor-erythroid 2-related factor 2 (Nrf2)).  These compds. emerge as interesting brain-permeable multitarget compds., with a potential as anti-Alzheimer agents beyond that of the original lead CR-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMkXh1l7YWmLVg90H21EOLACvtfcHk0ljDD-tr2Czosw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVCmtrzN&md5=9a3e2cb84bfadd500236e8d542291c5a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00528%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DGarrido%26aufirst%3DM.%26aulast%3DAso%26aufirst%3DE.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DGinex%26aufirst%3DT.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DPuigoriol-Illamola%26aufirst%3DD.%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DFerrer%26aufirst%3DI.%26aulast%3DCiruela%26aufirst%3DF.%26aulast%3DMesseguer%26aufirst%3DA.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DCentrally%2520active%2520multitarget%2520anti-Alzheimer%2520agents%2520derived%2520from%2520the%2520antioxidant%2520lead%2520CR-6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D9360%26epage%3D9390%26doi%3D10.1021%2Facs.jmedchem.0c00528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanhed, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansara, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecwan, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upadhyay, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prajapati, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murumkar, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, M. R.</span></span> <span> </span><span class="NLM_article-title">Novel multitarget directed triazinoindole derivatives as anti-Alzheimer agents</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3635</span>– <span class="NLM_lpage">3661</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.9b00226</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.9b00226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2jtLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=3635-3661&author=D.+V.+Patelauthor=N.+R.+Patelauthor=A.+M.+Kanhedauthor=S.+P.+Patelauthor=A.+Sinhaauthor=D.+D.+Kansaraauthor=A.+R.+Mecwanauthor=S.+B.+Patelauthor=P.+N.+Upadhyayauthor=K.+B.+Patelauthor=D.+B.+Shahauthor=N.+K.+Prajapatiauthor=P.+R.+Murumkarauthor=K.+V.+Patelauthor=M.+R.+Yadav&title=Novel+multitarget+directed+triazinoindole+derivatives+as+anti-Alzheimer+agents&doi=10.1021%2Facschemneuro.9b00226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents</span></div><div class="casAuthors">Patel, Dushyant V.; Patel, Nirav R.; Kanhed, Ashish M.; Patel, Sagar P.; Sinha, Anshuman; Kansara, Deep D.; Mecwan, Annie R.; Patel, Sarvangee B.; Upadhyay, Pragnesh N.; Patel, Kishan B.; Shah, Dharti B.; Prajapati, Navnit K.; Murumkar, Prashant R.; Patel, Kirti V.; Yadav, Mange Ram</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3635-3661</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multifaceted nature of Alzheimer's disease (AD) demands treatment with multitarget-directed ligands (MTDLs) to confront the key pathol. aberrations.  A novel series of triazinoindole derivs. were designed and synthesized.  In vitro studies revealed that all the compds. showed moderate to good anticholinesterase activity; the most active compd. 23e showed an IC50 value of 0.56 ± 0.02 μM for AChE and an IC50 value of 1.17 ± 0.09 μM for BuChE.  These derivs. are also endowed with potent antioxidant activity.  To understand the plausible binding mode of the compd. 23e, mol. docking studies and mol. dynamics simulation studies were performed, and the results indicated significant interactions of 23e within the active sites of AChE as well as BuChE.  Compd. 23e successfully diminished H2O2-induced oxidative stress in SH-SY5Y cells and displayed excellent neuroprotective activity against H2O2 as well as Aβ-induced toxicity in SH-SY5Y cells in a concn. dependent manner.  Furthermore, it did not show any significant toxicity in neuronal SH-SY5Y cells in the cytotoxicity assay.  Compd. 23e did not show any acute toxicity in rats at doses up to 2000 mg/kg, and it significantly reversed scopolamine-induced memory deficit in mice model.  Addnl., compd. 23e showed notable in silico ADMET properties.  Taken collectively, these findings project compd. 23e as a potential balanced MTDL in the evolution process of novel anti-AD drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFrn4aKD5fUrVg90H21EOLACvtfcHk0lii3S7SFnrpsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2jtLrP&md5=662353ea8e5f6d29d01ee1e4456dbaee</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.9b00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.9b00226%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DD.%2BV.%26aulast%3DPatel%26aufirst%3DN.%2BR.%26aulast%3DKanhed%26aufirst%3DA.%2BM.%26aulast%3DPatel%26aufirst%3DS.%2BP.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DKansara%26aufirst%3DD.%2BD.%26aulast%3DMecwan%26aufirst%3DA.%2BR.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DUpadhyay%26aufirst%3DP.%2BN.%26aulast%3DPatel%26aufirst%3DK.%2BB.%26aulast%3DShah%26aufirst%3DD.%2BB.%26aulast%3DPrajapati%26aufirst%3DN.%2BK.%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26aulast%3DPatel%26aufirst%3DK.%2BV.%26aulast%3DYadav%26aufirst%3DM.%2BR.%26atitle%3DNovel%2520multitarget%2520directed%2520triazinoindole%2520derivatives%2520as%2520anti-Alzheimer%2520agents%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D3635%26epage%3D3661%26doi%3D10.1021%2Facschemneuro.9b00226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nepovimova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babkova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ondrejicek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepsova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrabinova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bukum, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malinak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span> <span> </span><span class="NLM_article-title">Tacrine–trolox hybrids: A novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8985</span>– <span class="NLM_lpage">9003</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01325</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01325" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWlt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8985-9003&author=E.+Nepovimovaauthor=J.+Korabecnyauthor=R.+Dolezalauthor=K.+Babkovaauthor=A.+Ondrejicekauthor=D.+Junauthor=V.+Sepsovaauthor=A.+Horovaauthor=M.+Hrabinovaauthor=O.+Soukupauthor=N.+Bukumauthor=P.+Jostauthor=L.+Muckovaauthor=J.+Kassaauthor=D.+Malinakauthor=M.+Andrsauthor=K.+Kuca&title=Tacrine%E2%80%93trolox+hybrids%3A+A+novel+class+of+centrally+active%2C+nonhepatotoxic+multi-target-directed+ligands+exerting+anticholinesterase+and+antioxidant+activities+with+low+in+vivo+toxicity&doi=10.1021%2Facs.jmedchem.5b01325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-trolox hybrids: a novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity</span></div><div class="casAuthors">Nepovimova, Eugenie; Korabecny, Jan; Dolezal, Rafael; Babkova, Katerina; Ondrejicek, Ales; Jun, Daniel; Sepsova, Vendula; Horova, Anna; Hrabinova, Martina; Soukup, Ondrej; Bukum, Neslihan; Jost, Petr; Muckova, Lubica; Kassa, Jiri; Malinak, David; Andrs, Martin; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8985-9003</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coupling of two distinct pharmacophores, tacrine and trolox, endowed with different biol. properties, afforded 21 hybrid compds. as novel multifunctional candidates against Alzheimer's disease.  Several of them showed improved inhibitory properties toward acetylcholinesterase (AChE) in relation to tacrine.  These hybrids also scavenged free radicals.  Mol. modeling studies in tandem with kinetic anal. exhibited that these hybrids target both catalytic active site as well as peripheral anionic site of AChE.  In addn., incorporation of the moiety bearing antioxidant abilities displayed negligible toxicity on human hepatic cells.  This striking effect was explained by formation of nontoxic metabolites after 1 h incubation in human liver microsomes system.  Finally, tacrine-trolox hybrids exhibited low in vivo toxicity after i.m. administration in rats and potential to penetrate across blood-brain barrier.  All of these outstanding in vitro results in combination with promising in vivo outcomes highlighted deriv. I as the lead structure worthy of further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWjX4tC8Sy17Vg90H21EOLACvtfcHk0lii3S7SFnrpsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWlt7vI&md5=550bddcd59b5bbb90d77e67faca28839</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01325%26sid%3Dliteratum%253Aachs%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DBabkova%26aufirst%3DK.%26aulast%3DOndrejicek%26aufirst%3DA.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DSepsova%26aufirst%3DV.%26aulast%3DHorova%26aufirst%3DA.%26aulast%3DHrabinova%26aufirst%3DM.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DBukum%26aufirst%3DN.%26aulast%3DJost%26aufirst%3DP.%26aulast%3DMuckova%26aufirst%3DL.%26aulast%3DKassa%26aufirst%3DJ.%26aulast%3DMalinak%26aufirst%3DD.%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DTacrine%25E2%2580%2593trolox%2520hybrids%253A%2520A%2520novel%2520class%2520of%2520centrally%2520active%252C%2520nonhepatotoxic%2520multi-target-directed%2520ligands%2520exerting%2520anticholinesterase%2520and%2520antioxidant%2520activities%2520with%2520low%2520in%2520vivo%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8985%26epage%3D9003%26doi%3D10.1021%2Facs.jmedchem.5b01325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and evaluation of flurbiprofen-clioquinol hybrids as multitarget-directed ligands against Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">115374</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2020.115374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bmc.2020.115374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=32089390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1Ogtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=115374&author=Z.+Yangauthor=Q.+Songauthor=Z.+Caoauthor=G.+Yuauthor=Z.+Liuauthor=Z.+Tanauthor=Y.+Deng&title=Design%2C+synthesis+and+evaluation+of+flurbiprofen-clioquinol+hybrids+as+multitarget-directed+ligands+against+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2020.115374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of flurbiprofen-clioquinol hybrids as multitarget-directed ligands against Alzheimer's disease</span></div><div class="casAuthors">Yang, Ziyi; Song, Qing; Cao, Zhongcheng; Yu, Guangjun; Liu, Zhuoling; Tan, Zhenghuai; Deng, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">115374</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel flurbiprofen-clioquinol hybrids I [R = H, 2-HOC6H4NHCH2, 2-OH-5-BrC6H3NHCH2, etc.; R1 = H, 2-OH-5-(NMe2)C6H3NHCH2] were designed and synthesized as multifunctional agents for Alzheimer's disease therapy and their potential was evaluated through various biol. expts.  In vitro studies showed that compds. I [R = 2-OH-5-(NMe2)C6H3NHCH2 (II), R1 = H; R = H, R1 = 2-OH-5-(NMe2)C6H3NHCH2 (III)] exhibited significant ability to inhibit self- and Cu2+-induced β-amyloid aggregation.  Furthermore, some target compds. II and III also showed biometal chelating abilities, antioxidant activity, anti-neuroinflammatory activity and appropriate BBB permeability.  These biol. activities indicated that the representative compds. II and III might be promising multifunctional agents for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRQ8mmfRcfObVg90H21EOLACvtfcHk0lii3S7SFnrpsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1Ogtro%253D&md5=efa47055452c7f5b82963ab223386f31</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2020.115374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2020.115374%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520flurbiprofen-clioquinol%2520hybrids%2520as%2520multitarget-directed%2520ligands%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2020%26volume%3D28%26spage%3D115374%26doi%3D10.1016%2Fj.bmc.2020.115374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barraza-Garza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-León, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo-Michel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Rosa, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Parrilla, E.</span></span> <span> </span><span class="NLM_article-title">Antioxidant effect of phenolic compounds (PC) at different concentrations in IEC-6 cells: A spectroscopic analysis</span>. <i>Spectrochim. Acta, Part A</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>227</i></span>,  <span class="NLM_fpage">117570</span>, <span class="refDoi"> DOI: 10.1016/j.saa.2019.117570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.saa.2019.117570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31669938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVertLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=2020&pages=117570&author=G.+Barraza-Garzaauthor=J.+A.+P%C3%A9rez-Le%C3%B3nauthor=H.+Castillo-Michelauthor=L.+A.+de+la+Rosaauthor=A.+Martinez-Martinezauthor=M.+Cotteauthor=E.+Alvarez-Parrilla&title=Antioxidant+effect+of+phenolic+compounds+%28PC%29+at+different+concentrations+in+IEC-6+cells%3A+A+spectroscopic+analysis&doi=10.1016%2Fj.saa.2019.117570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant effect of phenolic compounds (PC) at different concentrations in IEC-6 cells: A spectroscopic analysis</span></div><div class="casAuthors">Barraza-Garza, G.; Perez-Leon, J. A.; Castillo-Michel, H.; de la Rosa, L. A.; Martinez-Martinez, A.; Cotte, M.; Alvarez-Parrilla, E.</div><div class="citationInfo"><span class="NLM_cas:title">Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117570</span>CODEN:
                <span class="NLM_cas:coden">SAMCAS</span>;
        ISSN:<span class="NLM_cas:issn">1386-1425</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phenolic compds. (PC) have been proposed as natural antioxidant agents that protect cells against oxidative stress-related diseases.  Nonetheless, their low bioavailability forecasts controversy about mechanisms on their in vivo scavenging activity against reactive oxygen species (ROS).  It has been proposed that PC reduce directly ROS concn.  An alternative or complementary action of PC could be the activation of the cell's antioxidant pathway, involving the regulation of gene expression, like that initiated by the Nrf2 transcription factor.  To date there is not enough exptl. data to support or discard this possibility.  The authors evaluated the use of several PC to prevent peroxidn. of macromols. and to elicit the activation of the Nrf2 transcription factor in H2O2-stresed IEC-6 enterocytic cell line.  Synchrotron microspectroscopy demonstrated that PC compds. protected proteins, lipids and nucleic acids against oxidn. induced by H2O2.  Immunofluorescence results showed that treatment with quercetin (Qc), catechin (Cat) and capsaicin (Cap) induced the translocation of Nrf2 into the nucleus, at the same level as did H2O2 treatment, thus mimicking the action of the endogenous cell response to peroxidn.  Even though the detailed mechanism still needs to be elucidated, the authors demonstrated the activation of Nrf2 by PCs in response to oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEs5jvKtfiJrVg90H21EOLACvtfcHk0lh3s6zJ4cbbMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVertLbP&md5=0a3295e75e67a9a31ae6f56121edfafa</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.saa.2019.117570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.saa.2019.117570%26sid%3Dliteratum%253Aachs%26aulast%3DBarraza-Garza%26aufirst%3DG.%26aulast%3DP%25C3%25A9rez-Le%25C3%25B3n%26aufirst%3DJ.%2BA.%26aulast%3DCastillo-Michel%26aufirst%3DH.%26aulast%3Dde%2Bla%2BRosa%26aufirst%3DL.%2BA.%26aulast%3DMartinez-Martinez%26aufirst%3DA.%26aulast%3DCotte%26aufirst%3DM.%26aulast%3DAlvarez-Parrilla%26aufirst%3DE.%26atitle%3DAntioxidant%2520effect%2520of%2520phenolic%2520compounds%2520%2528PC%2529%2520at%2520different%2520concentrations%2520in%2520IEC-6%2520cells%253A%2520A%2520spectroscopic%2520analysis%26jtitle%3DSpectrochim.%2520Acta%252C%2520Part%2520A%26date%3D2020%26volume%3D227%26spage%3D117570%26doi%3D10.1016%2Fj.saa.2019.117570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C.-T.</span></span> <span> </span><span class="NLM_article-title">Capsaicin-The major bioactive ingredient of chili peppers: Bio-efficacy and delivery systems</span>. <i>Food Funct.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2848</span>– <span class="NLM_lpage">2860</span>, <span class="refDoi"> DOI: 10.1039/d0fo00351d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1039%2FD0FO00351D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=32246759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkslaqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=2848-2860&author=M.+Luauthor=C.+Chenauthor=Y.+Lanauthor=J.+Xiaoauthor=R.+Liauthor=J.+Huangauthor=Q.+Huangauthor=Y.+Caoauthor=C.-T.+Ho&title=Capsaicin-The+major+bioactive+ingredient+of+chili+peppers%3A+Bio-efficacy+and+delivery+systems&doi=10.1039%2Fd0fo00351d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Capsaicin-the major bioactive ingredient of chili peppers: bio-efficacy and delivery systems</span></div><div class="casAuthors">Lu, Muwen; Chen, Chengyu; Lan, Yaqi; Xiao, Jie; Li, Run; Huang, Junqing; Huang, Qingrong; Cao, Yong; Ho, Chi-Tang</div><div class="citationInfo"><span class="NLM_cas:title">Food & Function</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2848-2860</span>CODEN:
                <span class="NLM_cas:coden">FFOUAI</span>;
        ISSN:<span class="NLM_cas:issn">2042-6496</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Capsaicin is the primary bioactive substance in red chili peppers, which produces the pungent flavor.  During the past few decades, pharmacol. benefits of capsaicin and its underlying mechanisms have been examd. extensively.  In this paper, major biol. efficacies of capsaicin are reviewed, including analgesic, antioxidant, anti-inflammatory, anti-cancer, anti-obesity, cardio-protective, and metabolic modulation effects.  Novel delivery systems, such as liposomes, micelles, micro/nano-emulsions, colloidal capsules and solid nanoparticles, for enhancing the oral bioavailability of capsaicin are also evaluated depending on the stability, encapsulation efficiency and biol. properties.  This review provides a theor. basis for capsaicin to be further developed into a multi-functional ingredient with health-promoting functions in the nutraceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUu6aPOelYbVg90H21EOLACvtfcHk0lh3s6zJ4cbbMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkslaqurw%253D&md5=501ed8d3f6a0f5196a49baf8f272d880</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2FD0FO00351D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0FO00351D%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DHo%26aufirst%3DC.-T.%26atitle%3DCapsaicin-The%2520major%2520bioactive%2520ingredient%2520of%2520chili%2520peppers%253A%2520Bio-efficacy%2520and%2520delivery%2520systems%26jtitle%3DFood%2520Funct.%26date%3D2020%26volume%3D11%26spage%3D2848%26epage%3D2860%26doi%3D10.1039%2Fd0fo00351d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gour, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, S. I.</span></span> <span> </span><span class="NLM_article-title">Capsaicin has potent anti-oxidative effects <i>in vivo</i> through a mechanism which is non-receptor mediated</span>. <i>Arch. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1080/13813455.2019.1669056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1080%2F13813455.2019.1669056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=1-7&author=A.+Chaudharyauthor=J.+K.+Gourauthor=S.+I.+Rizvi&title=Capsaicin+has+potent+anti-oxidative+effects+in+vivo+through+a+mechanism+which+is+non-receptor+mediated&doi=10.1080%2F13813455.2019.1669056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1080%2F13813455.2019.1669056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13813455.2019.1669056%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhary%26aufirst%3DA.%26aulast%3DGour%26aufirst%3DJ.%2BK.%26aulast%3DRizvi%26aufirst%3DS.%2BI.%26atitle%3DCapsaicin%2520has%2520potent%2520anti-oxidative%2520effects%2520in%2520vivo%2520through%2520a%2520mechanism%2520which%2520is%2520non-receptor%2520mediated%26jtitle%3DArch.%2520Physiol.%2520Biochem.%26date%3D2019%26spage%3D1%26epage%3D7%26doi%3D10.1080%2F13813455.2019.1669056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yancheva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoyanov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anichina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velcheva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamboliyska, B.</span></span> <span> </span><span class="NLM_article-title">Combined infrared spectroscopic and computational study on simpler capsaicin derivatives and their anion intermediates in the scavenging of free radicals</span>. <i>Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>535</i></span>,  <span class="NLM_fpage">110763</span>, <span class="refDoi"> DOI: 10.1016/j.chemphys.2020.110763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.chemphys.2020.110763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmt1Sgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2020&pages=110763&author=D.+Yanchevaauthor=S.+Stoyanovauthor=K.+Anichinaauthor=S.+Nikolovaauthor=E.+Velchevaauthor=B.+Stamboliyska&title=Combined+infrared+spectroscopic+and+computational+study+on+simpler+capsaicin+derivatives+and+their+anion+intermediates+in+the+scavenging+of+free+radicals&doi=10.1016%2Fj.chemphys.2020.110763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Combined infrared spectroscopic and computational study on simpler capsaicin derivatives and their anion intermediates in the scavenging of free radicals</span></div><div class="casAuthors">Yancheva, D.; Stoyanov, S.; Anichina, K.; Nikolova, S.; Velcheva, E.; Stamboliyska, B.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Physics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110763</span>CODEN:
                <span class="NLM_cas:coden">CMPHC2</span>;
        ISSN:<span class="NLM_cas:issn">0301-0104</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two capsaicin analogs - N-(4-hydroxy-3-methoxybenzyl)acetamide and N-(4-hydroxy-3-methoxybenzyl)benzamide, were studied by DFT methods in order to est. their ability to act as antioxidants.  A comparative study on the stability of benzylic, phenoxyl and amide radicals has outlined the most reactive site for hydrogen atom abstraction and proton transfer.  The enthalpies related to the formation of those species were modeled in gas phase, benzene, DMSO and water in order to det. the most probable mechanism of antioxidant action in polar and nonpolar medium.  The formation of phenoxyl anion, energetically favored in polar medium, was investigated by IR spectroscopy methods based on the conversion of the benzamide deriv.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ4mdAyXDmRbVg90H21EOLACvtfcHk0lh3s6zJ4cbbMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmt1Sgsb0%253D&md5=dac8431338707868bfd7ad0b75d7e795</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.chemphys.2020.110763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chemphys.2020.110763%26sid%3Dliteratum%253Aachs%26aulast%3DYancheva%26aufirst%3DD.%26aulast%3DStoyanov%26aufirst%3DS.%26aulast%3DAnichina%26aufirst%3DK.%26aulast%3DNikolova%26aufirst%3DS.%26aulast%3DVelcheva%26aufirst%3DE.%26aulast%3DStamboliyska%26aufirst%3DB.%26atitle%3DCombined%2520infrared%2520spectroscopic%2520and%2520computational%2520study%2520on%2520simpler%2520capsaicin%2520derivatives%2520and%2520their%2520anion%2520intermediates%2520in%2520the%2520scavenging%2520of%2520free%2520radicals%26jtitle%3DChem.%2520Phys.%26date%3D2020%26volume%3D535%26spage%3D110763%26doi%3D10.1016%2Fj.chemphys.2020.110763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dairam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limson, J. L.</span></span> <span> </span><span class="NLM_article-title">Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3350</span>– <span class="NLM_lpage">3356</span>, <span class="refDoi"> DOI: 10.1021/jf0734931</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf0734931" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVKgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=3350-3356&author=A.+Dairamauthor=R.+Fogelauthor=S.+Dayaauthor=J.+L.+Limson&title=Antioxidant+and+iron-binding+properties+of+curcumin%2C+capsaicin%2C+and+S-allylcysteine+reduce+oxidative+stress+in+rat+brain+homogenate&doi=10.1021%2Fjf0734931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant and Iron-Binding Properties of Curcumin, Capsaicin, and S-Allylcysteine Reduce Oxidative Stress in Rat Brain Homogenate</span></div><div class="casAuthors">Dairam, Amichand; Fogel, Ronen; Daya, Santy; Limson, Janice L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3350-3356</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Research demonstrates that antioxidants and metal chelators may be of beneficial use in the treatment of neurodegenerative diseases, such as Alzheimer's disease (AD).  This study investigated the antioxidant and metal-binding properties of curcumin, capsaicin, and S-allylcysteine, which are major components found in commonly used dietary spice ingredients turmeric, chilli, and garlic, resp.  The DPPH assay demonstrates that these compds. readily scavenge free radicals.  These compds. significantly curtail iron- (Fe2+) and quinolinic acid (QA)-induced lipid peroxidn. and potently scavenge the superoxide anion generated by 1 mM cyanide in rat brain homogenate.  The ferrozine assay was used to measure the extent of Fe2+ chelation, and electrochem. was employed to measure the Fe3+ binding activity of curcumin, capsaicin, and S-allylcysteine.  Both assays demonstrate that these compds. bind Fe2+ and Fe3+ and prevent the redox cycling of iron, suggesting that this may be an addnl. method through which these agents reduce Fe2+-induced lipid peroxidn.  This study demonstrates the antioxidant and metal-binding properties of these spice ingredients, and it is hereby postulate that these compds. have important implications in the prevention or treatment of neurodegenerative diseases such as AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXsr1lxtGA8bVg90H21EOLACvtfcHk0ljuey3XMvTahA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVKgu7w%253D&md5=69dbd1cf4b85319308878a04774e79b4</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjf0734931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf0734931%26sid%3Dliteratum%253Aachs%26aulast%3DDairam%26aufirst%3DA.%26aulast%3DFogel%26aufirst%3DR.%26aulast%3DDaya%26aufirst%3DS.%26aulast%3DLimson%26aufirst%3DJ.%2BL.%26atitle%3DAntioxidant%2520and%2520iron-binding%2520properties%2520of%2520curcumin%252C%2520capsaicin%252C%2520and%2520S-allylcysteine%2520reduce%2520oxidative%2520stress%2520in%2520rat%2520brain%2520homogenate%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2008%26volume%3D56%26spage%3D3350%26epage%3D3356%26doi%3D10.1021%2Fjf0734931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer’s disease</span>. <i>Aging Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>19</i></span>, <span class="NLM_elocation-id">e13113</span> <span class="refDoi"> DOI: 10.1111/acel.13113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1111%2Facel.13113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=32061032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtVegsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2020&author=Y.+Duauthor=M.+Fuauthor=Z.+Huangauthor=X.+Tianauthor=J.+Liauthor=Y.+Pangauthor=W.+Songauthor=Y.+Tian+Wangauthor=Z.+Dong&title=TRPV1+activation+alleviates+cognitive+and+synaptic+plasticity+impairments+through+inhibiting+AMPAR+endocytosis+in+APP23%2FPS45+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1111%2Facel.13113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer's disease</span></div><div class="casAuthors">Du, Yehong; Fu, Min; Huang, Zhilin; Tian, Xin; Li, Junjie; Pang, Yayan; Song, Weihong; Wang, Yu Tian; Dong, Zhifang</div><div class="citationInfo"><span class="NLM_cas:title">Aging Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e13113</span>CODEN:
                <span class="NLM_cas:coden">ACGECQ</span>;
        ISSN:<span class="NLM_cas:issn">1474-9718</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is one of the most common causes of neurodegenerative diseases in the elderly.  The accumulation of amyloid-β (Aβ) peptides is one of the pathol. hallmarks of AD and leads to the impairments of synaptic plasticity and cognitive function.  The transient receptor potential vanilloid 1 (TRPV1), a nonselective cation channel, is involved in synaptic plasticity and memory.  However, the role of TRPV1 in AD pathogenesis remains largely elusive.  Here, we reported that the expression of TRPV1 was decreased in the brain of APP23/PS45 double transgenic AD model mice.  Genetic upregulation of TRPV1 by adeno-assocd. virus (AAV) inhibited the APP processing and Aβ deposition in AD model mice.  Meanwhile, upregulation of TRPV1 ameliorated the deficits of hippocampal CA1 long-term potentiation (LTP) and spatial learning and memory through inhibiting GluA2-contg. α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) endocytosis.  Furthermore, pharmacol. activation of TRPV1 by capsaicin (1 mg/kg, i.p.), an agonist of TRPV1, dramatically reversed the impairments of hippocampal CA1 LTP and spatial learning and memory in AD model mice.  Taken together, these results indicate that TRPV1 activation effectively ameliorates cognitive and synaptic functions through inhibiting AMPAR endocytosis in AD model mice and could be a novel mol. for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH7jCguBiqS7Vg90H21EOLACvtfcHk0ljuey3XMvTahA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtVegsLo%253D&md5=46fcc27cfb5357583d0af9e1650aa953</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Facel.13113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Facel.13113%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DTian%2BWang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DTRPV1%2520activation%2520alleviates%2520cognitive%2520and%2520synaptic%2520plasticity%2520impairments%2520through%2520inhibiting%2520AMPAR%2520endocytosis%2520in%2520APP23%252FPS45%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAging%2520Cell%26date%3D2020%26volume%3D19%26doi%3D10.1111%2Facel.13113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">Capsaicin attenuates amyloid-β-induced synapse loss and cognitive impairments in mice</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.3233/JAD-170337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3233%2FJAD-170337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=28671132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A280%3ADC%252BC1cjjvFWqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2017&pages=683-694&author=L.+Chenauthor=Z.+Huangauthor=Y.+Duauthor=M.+Fuauthor=H.+Hanauthor=Y.+Wangauthor=Z.+Dong&title=Capsaicin+attenuates+amyloid-%CE%B2-induced+synapse+loss+and+cognitive+impairments+in+mice&doi=10.3233%2FJAD-170337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Capsaicin Attenuates Amyloid-β-Induced Synapse Loss and Cognitive Impairments in Mice</span></div><div class="casAuthors">Chen Long; Huang Zhilin; Du Yehong; Fu Min; Han Huili; Wang Yutian; Dong Zhifang; Chen Long; Huang Zhilin; Du Yehong; Fu Min; Han Huili; Wang Yutian; Dong Zhifang; Wang Yutian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">683-694</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is the most common cause of progressive cognitive impairment in the aged.  The aggregation of the amyloid β-protein (Aβ) is a hallmark of AD and is linked to synapse loss and cognitive impairment.  Capsaicin, a specific agonist of the transient receptor potential vanilloid 1 (TRPV1), has been proven to ameliorate stress-induced AD-like pathological and cognitive impairments, but it is unclear whether TRPV1 activation can affect cognitive and synaptic functions in Aβ-induced mouse model of AD.  In this study, we investigated the effects of TRPV1 activation on spatial memory and synaptic plasticity in mice treated with Aβ.  To induce AD-like pathological and cognitive impairments, adult C57Bl/6 mice were microinjected with Aβ42 (100 μM, 2.5 μl/mouse, i.c.v.).  Two weeks after Aβ42 microinjection, spatial learning and memory as well as hippocampal long-term potentiation (LTP) were examined.  The results showed that Aβ42 microinjection significantly impaired spatial learning and memory in the Morris water maze and novel object recognition tests compared with controls.  These behavioral changes were accompanied by synapse loss and impaired LTP in the CA1 area of hippocampus.  More importantly, daily capsaicin (1 mg/kg, i.p.) treatment throughout the experiment dramatically improved spatial learning and memory and synaptic function, as reflected by enhanced hippocampal LTP and reduced synapse loss, whereas the TRPV1 antagonist capsazepine (1 mg/kg, i.p.) treatment had no effects on cognitive and synaptic function in Aβ42-treated mice.  These results indicate that TRPV1 activation by capsaicin rescues cognitive deficit in the Aβ42-induced mouse model of AD both structurely and functionally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeg7s44RTiDJNiNltV31zlfW6udTcc2eYLZHkCvSJpcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjjvFWqtg%253D%253D&md5=5c4989e9394442fa4cfb7fcf8c94d868</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3233%2FJAD-170337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-170337%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DCapsaicin%2520attenuates%2520amyloid-%25CE%25B2-induced%2520synapse%2520loss%2520and%2520cognitive%2520impairments%2520in%2520mice%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2017%26volume%3D59%26spage%3D683%26epage%3D694%26doi%3D10.3233%2FJAD-170337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span> <span> </span><span class="NLM_article-title">Bioactive compounds in Kimchi improve the cognitive and memory functions impaired by amyloid beta</span>. <i>Nutrients</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1554</span>, <span class="refDoi"> DOI: 10.3390/nu10101554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3390%2Fnu10101554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntFSgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=1554&author=M.+Wooauthor=M.+Kimauthor=Y.+Song&title=Bioactive+compounds+in+Kimchi+improve+the+cognitive+and+memory+functions+impaired+by+amyloid+beta&doi=10.3390%2Fnu10101554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactive compounds in kimchi improve the cognitive and memory functions impaired by amyloid beta</span></div><div class="casAuthors">Woo, Minji; Kim, Mi Jeong; Song, Yeong Ok</div><div class="citationInfo"><span class="NLM_cas:title">Nutrients</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1554/1-1554/11</span>CODEN:
                <span class="NLM_cas:coden">NUTRHU</span>;
        ISSN:<span class="NLM_cas:issn">2072-6643</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">This study investigated the abilities of kimchi and its bioactive compds. to ameliorate amyloid beta (Aβ)-induced memory and cognitive impairments.  Mice were given a single intracerebroventricular injection of Aβ25-35, followed by a daily oral administration of capsaicin (10 mg·kg-bw-1), 3-(40-hydroxyl-3',5'-dimethoxyphenyl)propionic acid (50 mg/kg bw), quercetin (50 mg/kg bw), ascorbic acid (50 mg/kg bw), or kimchi methanol ext. (KME; 200 mg/kg bw) for 2 wk (n = 7 per group).  CM-cellulose was used as a vehicle for the normal and control groups.  Behavioral task tests showed that the learning and memory abilities were significantly waned by the injected Aβ25-35, but these cognitive deficits were recovered by the administrated KME and kimchi bioactive compds. (p < 0.05).  The reactive oxygen species, peroxynitrite, and thiobarbituric acid reactive substances levels were lower, and the glutathione level was higher, in the KME and bioactive compd. groups than in the control group (p < 0.05).  In the KME and bioactive compd. groups, the protein expression levels of antioxidant enzymes (nuclear factor (erythroid-derived 2)-like 2-regulated superoxide dismutase-1 and glutathione peroxidase) were increased, whereas those of inflammation-related enzymes (nuclear factor-kappaB -regulated inducible nitric oxide synthase and cyclooxygenase-2) were decreased (p < 0.05).  Thus, the antioxidative and anti-inflammatory properties of bioactive compds.-rich kimchi might help to attenuate the symptoms of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhMtzgvgqSo7Vg90H21EOLACvtfcHk0lhAo-umft5wBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntFSgsbg%253D&md5=9f7c02c26f9de6b9293f7fe85ed75b0f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3390%2Fnu10101554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fnu10101554%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DBioactive%2520compounds%2520in%2520Kimchi%2520improve%2520the%2520cognitive%2520and%2520memory%2520functions%2520impaired%2520by%2520amyloid%2520beta%26jtitle%3DNutrients%26date%3D2018%26volume%3D10%26spage%3D1554%26doi%3D10.3390%2Fnu10101554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noh, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y. O.</span></span> <span> </span><span class="NLM_article-title">Bioactive compounds of Kimchi inhibit apoptosis by attenuating endoplasmic reticulum stress in the brain of amyloid β-injected mice</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">4883</span>– <span class="NLM_lpage">4890</span>, <span class="refDoi"> DOI: 10.1021/acs.jafc.8b01686</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jafc.8b01686" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVertr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2018&pages=4883-4890&author=M.+Wooauthor=J.+S.+Nohauthor=E.+J.+Choauthor=Y.+O.+Song&title=Bioactive+compounds+of+Kimchi+inhibit+apoptosis+by+attenuating+endoplasmic+reticulum+stress+in+the+brain+of+amyloid+%CE%B2-injected+mice&doi=10.1021%2Facs.jafc.8b01686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactive Compounds of Kimchi Inhibit Apoptosis by Attenuating Endoplasmic Reticulum Stress in the Brain of Amyloid β-Injected Mice</span></div><div class="casAuthors">Woo, Minji; Noh, Jeong Sook; Cho, Eun Ju; Song, Yeong Ok</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4883-4890</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This study investigated the inhibitory effects of kimchi bioactive compds. against endoplasmic reticulum (ER) stress-induced apoptosis in amyloid beta (Aβ)-injected mice.  Mice received a single intracerebroventricular injection of Aβ25-35, except for the normal group.  Mice were subjected to oral administration of 10 mg of capsaicin, 50 mg of 3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid (HDMPPA), 50 mg of quercetin, 50 mg of ascorbic acid, or 200 mg of kimchi methanol ext. (KME) per kg of body wt. for 2 wk (n = 7 per group).  In the in vitro blood-brain barrier (BBB) permeability test, all bioactive compds. penetrated the BBB except ascorbic acid.  The protein expression level of APP, BACE, and p-Tau elevated by Aβ injection was decreased by kimchi bioactive compds. (P < 0.05).  Quercetin, HDMPPA, and KME decreased oxidative stress, as indicated by ROS and TBARS levels (P < 0.05).  The protein expression level of ER stress markers GRP78, p-PERK, p-eIF2α, XBP1, and CHOP and the proapoptotic mols. Bax, p-JNK, and cleaved caspases-3 and -9 decreased (P < 0.05).  In contrast, the protein expression level of antiapoptotic mols. Bcl2 and cIAP increased (P < 0.05).  These results were supported by histol. anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq80ecAFqjsCrVg90H21EOLACvtfcHk0lhAo-umft5wBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVertr0%253D&md5=a678f64aa7b7cfde402eeb451965a7ef</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jafc.8b01686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jafc.8b01686%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DM.%26aulast%3DNoh%26aufirst%3DJ.%2BS.%26aulast%3DCho%26aufirst%3DE.%2BJ.%26aulast%3DSong%26aufirst%3DY.%2BO.%26atitle%3DBioactive%2520compounds%2520of%2520Kimchi%2520inhibit%2520apoptosis%2520by%2520attenuating%2520endoplasmic%2520reticulum%2520stress%2520in%2520the%2520brain%2520of%2520amyloid%2520%25CE%25B2-injected%2520mice%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2018%26volume%3D66%26spage%3D4883%26epage%3D4890%26doi%3D10.1021%2Facs.jafc.8b01686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-J.</span></span> <span> </span><span class="NLM_article-title">The associations between a capsaicin-rich diet and blood amyloid-β levels and cognitive function</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1088</span>, <span class="refDoi"> DOI: 10.3233/JAD-151079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3233%2FJAD-151079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=27079706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A280%3ADC%252BC28bgtVOqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=1081-1088&author=C.-H.+Liuauthor=X.-L.+Buauthor=J.+Wangauthor=T.+Zhangauthor=Y.+Xiangauthor=L.-L.+Shenauthor=Q.-H.+Wangauthor=B.+Dengauthor=X.+Wangauthor=C.+Zhuauthor=X.-Q.+Yaoauthor=M.+Zhangauthor=H.-D.+Zhouauthor=Y.-J.+Wang&title=The+associations+between+a+capsaicin-rich+diet+and+blood+amyloid-%CE%B2+levels+and+cognitive+function&doi=10.3233%2FJAD-151079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function</span></div><div class="casAuthors">Liu Cheng-Hui; Bu Xian-Le; Wang Jun; Zhang Tao; Xiang Yang; Shen Lin-Lin; Wang Qing-Hua; Deng Bo; Wang Xin; Zhu Chi; Yao Xiu-Qing; Zhang Meng; Zhou Hua-Dong; Wang Yan-Jiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1081-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Capsaicin-rich diets are common worldwide.  Capsaicin has been shown to have favorable effects on various diseases including atherosclerosis, cardiovascular diseases, stroke, obesity, hypertension, cancer, and gastrointestinal and inflammatory diseases.  The impact of capsaicin on Alzheimer's disease (AD), which is the most common form of dementia in the elderly, remains unknown.  OBJECTIVE:  To investigate the correlations of capsaicin intake with cognition and blood markers of AD.  METHODS:  A total of 338 participants aged 40 years or older were enrolled from communities.  Dietary habits regarding chili pepper consumption were collected using a Food Frequency Questionnaire (FFQ).  Cognitive function was measured using the Chinese version of the Mini-Mental State Examination (MMSE).  Blood amyloid-β (Aβ)40 and Aβ42 were measured with ELISA kits.  RESULTS:  In univariate analysis, MMSE scores (r = 0.209, p < 0.001), serum Aβ40 levels (r = -0.149, p = 0.006), the ratio of Aβ42/Aβ40 (r = 0.11, p = 0.043) and total serum Aβ levels (r = -0.097, p = 0.075), but not serum Aβ42 levels (r = 0.17, p = 0.757), were significantly correlated with total capsaicin diet scores.  In multivariate analysis, total capsaicin diet scores were positively associated with MMSE scores and inversely associated with serum Aβ40 levels, and total serum Aβ levels, but not serum Aβ42 levels and the ratio of Aβ42/Aβ40, after adjustment for age, gender, educational level, smoking history, alcohol consumption, body mass index (BMI) and comorbidities.  CONCLUSION:  These findings suggest that a capsaicin-rich diet may exert favorable effects on AD blood biomarkers and cognitive function in middle-aged and elderly adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSp3zRpgU0SovKgEt20y1XfW6udTcc2eYLZHkCvSJpcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bgtVOqsQ%253D%253D&md5=87f957b8e66bd2f51ba92457d7f7a842</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.3233%2FJAD-151079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-151079%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.-H.%26aulast%3DBu%26aufirst%3DX.-L.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DL.-L.%26aulast%3DWang%26aufirst%3DQ.-H.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DYao%26aufirst%3DX.-Q.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.-D.%26aulast%3DWang%26aufirst%3DY.-J.%26atitle%3DThe%2520associations%2520between%2520a%2520capsaicin-rich%2520diet%2520and%2520blood%2520amyloid-%25CE%25B2%2520levels%2520and%2520cognitive%2520function%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2016%26volume%3D52%26spage%3D1081%26epage%3D1088%26doi%3D10.3233%2FJAD-151079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.-W.</span></span> <span> </span><span class="NLM_article-title">Capsaicin ameliorates stress-induced Alzheimer’s disease-like pathological and cognitive impairments in rats</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.3233/JAD-121837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3233%2FJAD-121837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=23340038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A280%3ADC%252BC3szhsV2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2013&pages=91-105&author=X.+Jiangauthor=L.-W.+Jiaauthor=X.-H.+Liauthor=X.-S.+Chengauthor=J.-Z.+Xieauthor=Z.-W.+Maauthor=W.-J.+Xuauthor=Y.+Liuauthor=Y.+Yaoauthor=L.-L.+Duauthor=X.-W.+Zhou&title=Capsaicin+ameliorates+stress-induced+Alzheimer%E2%80%99s+disease-like+pathological+and+cognitive+impairments+in+rats&doi=10.3233%2FJAD-121837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Capsaicin ameliorates stress-induced Alzheimer's disease-like pathological and cognitive impairments in rats</span></div><div class="casAuthors">Jiang Xia; Jia Lin-Wei; Li Xiao-Hong; Cheng Xiang-Shu; Xie Jia-Zhao; Ma Zhi-Wei; Xu Wei-Jie; Liu Yue; Yao Yun; Du Lai-Ling; Zhou Xin-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-105</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hyperphosphorylated tau aggregated into neurofibrillary tangles is a hallmark lesion of Alzheimer's disease (AD) and is linked to synaptic and cognitive impairments.  In animal models, cold water stress (CWS) can cause cognitive disorder and tau hyperphosphorylation.  Capsaicin (CAP), a specific TRPV1 agonist, is neuroprotective against stress-induced impairment, but the detailed mechanisms are still elusive.  Here, we investigated whether CAP mitigates CWS-induced cognitive and AD-like pathological alterations in rats.  The animals were administered CAP (10 mg/kg in 0.2 ml, 0.1% ethanol) or a control (0.2 ml normal saline, 0.1% ethanol) by intragastric infusion 1 h before CWS treatment.  Our results showed that CAP significantly attenuated CWS-induced spatial memory impairment and suppression of PP-DG long-term potentiation; CAP abolished CWS-induced dendritic regression and enhanced several memory-associated proteins decreased by CWS, such as synapsin I and PSD93; CAP also prevented CWS-induced tau hyperphosphorylation by abolishing inhibition of protein phosphatase 2A.  Taken together, this study demonstrated that activation of TRPV1 can mitigate CWS-induced AD-like neuropathological alterations and cognitive impairment and may be a promising target for therapeutic intervention in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOFtVP-kWcL8K3uFsUIZtkfW6udTcc2earU-RNtQtD-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szhsV2hsQ%253D%253D&md5=47007316cb4860024cd180bdf1b47da8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3233%2FJAD-121837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-121837%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DL.-W.%26aulast%3DLi%26aufirst%3DX.-H.%26aulast%3DCheng%26aufirst%3DX.-S.%26aulast%3DXie%26aufirst%3DJ.-Z.%26aulast%3DMa%26aufirst%3DZ.-W.%26aulast%3DXu%26aufirst%3DW.-J.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DL.-L.%26aulast%3DZhou%26aufirst%3DX.-W.%26atitle%3DCapsaicin%2520ameliorates%2520stress-induced%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathological%2520and%2520cognitive%2520impairments%2520in%2520rats%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2013%26volume%3D35%26spage%3D91%26epage%3D105%26doi%3D10.3233%2FJAD-121837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Achab, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morral, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baños, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivas, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span> <span> </span><span class="NLM_article-title">New tacrine–huperzine a hybrids (huprines): Highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4657</span>– <span class="NLM_lpage">4666</span>, <span class="refDoi"> DOI: 10.1021/jm000980y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000980y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4657-4666&author=P.+Campsauthor=R.+El+Achabauthor=J.+Morralauthor=D.+Mu%C3%B1oz-Torreroauthor=A.+Badiaauthor=J.+E.+Ba%C3%B1osauthor=N.+M.+Vivasauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luque&title=New+tacrine%E2%80%93huperzine+a+hybrids+%28huprines%29%3A+Highly+potent+tight-binding+acetylcholinesterase+inhibitors+of+interest+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm000980y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Camps, Pelayo; El Achab, Rachid; Morral, Jordi; Munoz-Torrero, Diego; Badia, Albert; Banos, Josep Eladi; Vivas, Nuria Maria; Barril, Xavier; Orozco, Modesto; Luque, Francisco Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4657-4666</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several new 12-amino-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline derivs. (tacrine-huperzine A hybrids, huprines) (I) (R = Me, Et; R1, R3 = H, F, Me, Cl; R2 = H, Cl) have been synthesized and tested as acetylcholinesterase (AChE) inhibitors.  All of the new compds. contain either a Me or Et group at position 9 and one or two (chloro, fluoro, or methyl) substituents at positions 1, 2, or 3.  Among the monosubstituted derivs., the more active are those substituted at position 3, their activity following the order 3-chloro > 3-fluoro > 3-Me > 3-hydrogen.  For the 1,3-difluoro and 1,3-di-Me derivs., the effect of the substituents is roughly additive.  No significant differences were obsd. for the inhibitory activity of 9-Me vs 9-Et derivs. mono- or disubstituted at positions 1 and/or 3.  The levorotatory enantiomers of these hybrid compds. are much more active (eutomers) than the dextrorotatory forms (distomers) as AChE inhibitors.  Compds. rac- and (-)-I (R = Me, R3 = Cl) (II), rac- and (-)-I (R = Et, R3 = F) (III), rac- and (-)-I (R = Et, R3 = Cl) (IV) and rac-I (R = Et; R1, R3 = Cl) (V) showed human AChE inhibitory activities up to 28.5-fold higher than for the corresponding bovine enzyme. Also, rac-I (R = Me; R1, R3 = F) , (-)-II, (-)-IV, and rac-V were very selective for human AChE vs butyrylcholinesterase (BChE), the AChE inhibitory activities being 438-871-fold higher than for BChE.  Several hybrid compds., specially (-)-II and (-)-IV, exhibited tight-binding character, showing higher activity after incubation of the enzyme with the inhibitor than without incubation, though the reversible nature of the enzyme-inhibitor interaction was demonstrated by dialysis.  The results of the ex vivo expts. also supported the tight-binding character of compds. (-)-II and (-)-IV and showed their ability to cross the blood-brain barrier.  Mol. modeling simulations of the AChE-inhibitor complex provided a basis to explain the differences in inhibitory activity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsF13Zjc-Ak7Vg90H21EOLACvtfcHk0lis33jDZbN21w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbk%253D&md5=6ec0e45bc36f91124d1ba17f1c1f4957</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm000980y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000980y%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DEl%2BAchab%26aufirst%3DR.%26aulast%3DMorral%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DBa%25C3%25B1os%26aufirst%3DJ.%2BE.%26aulast%3DVivas%26aufirst%3DN.%2BM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DNew%2520tacrine%25E2%2580%2593huperzine%2520a%2520hybrids%2520%2528huprines%2529%253A%2520Highly%2520potent%2520tight-binding%2520acetylcholinesterase%2520inhibitors%2520of%2520interest%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4657%26epage%3D4666%26doi%3D10.1021%2Fjm000980y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusack, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallender, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Achab, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morral, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberry, T. L.</span></span> <span> </span><span class="NLM_article-title">Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer’s disease</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10648652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVaktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=409-417&author=P.+Campsauthor=B.+Cusackauthor=W.+D.+Mallenderauthor=R.+El+Achabauthor=D.+Morralauthor=D.+Mu%C3%B1oz-Torreroauthor=T.+L.+Rosenberry&title=Huprine+X+is+a+novel+high-affinity+inhibitor+of+acetylcholinesterase+that+is+of+interest+for+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease</span></div><div class="casAuthors">Camps, Pelayo; Cusack, Bernadette; Mallender, William D.; El Achab, Rachid; Morral, Jordi; Munoz-Torrero, Diego; Rosenberry, Terrone L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">409-417</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Inhibitors of the enzyme acetylcholinesterase (AChE) slow and sometimes reverse the cognitive decline experienced by individuals with Alzheimer's disease.  Huperzine A, a natural product used in traditional Chinese herbal medicine, and tacrine (Cognex) are among the potent AChE inhibitors used in this treatment, but the search for more selective inhibitors continues.  The authors report herein the synthesis and characterization of (-)-12-amino-3-chloro-9-ethyl-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline hydrochloride (huprine X), a hybrid that combines the carbobicyclic substructure of huperzine A with the 4-aminoquinoline substructure of tacrine.  Huprine X inhibited human AChE with an inhibition const. K1 of 26 pM, indicating that it binds to this enzyme with one of the highest affinities yet reported.  Under equiv. assay conditions, this affinity was 180 times that of huperzine A, 1200 times that of tacrine, and 40 times that of E2020 (donepezil, Aricept), the most selective AChE inhibitor currently approved for therapeutic use.  The assocn. and dissocn. rate consts. for huprine X with AChE were detd., and the location of its binding site on the enzyme was probed in competition studies with the peripheral site inhibitor propidium and the acylation site inhibitor edrophonium.  Huprine X showed no detectable affinity for the edrophonium-AChE complex.  In contrast, huprine X did form a ternary complex with propidium and AChE, although its affinity for the free enzyme was 17 times its affinity for the propidium-AChE complex.  These data indicated that huprine X binds to the enzyme acylation site in the active site gorge but interferes slightly with the binding of peripheral site ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2bDHx0sMs77Vg90H21EOLACvtfcHk0lis33jDZbN21w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVaktL8%253D&md5=67367a2cb8be3aac53791ec23662efd8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DCusack%26aufirst%3DB.%26aulast%3DMallender%26aufirst%3DW.%2BD.%26aulast%3DEl%2BAchab%26aufirst%3DR.%26aulast%3DMorral%26aufirst%3DD.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26atitle%3DHuprine%2520X%2520is%2520a%2520novel%2520high-affinity%2520inhibitor%2520of%2520acetylcholinesterase%2520that%2520is%2520of%2520interest%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D409%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alcalá, M. d. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivas, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hospital, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span> <span> </span><span class="NLM_article-title">Characterisation of the anticholinesterase activity of two new tacrine–huperzine A hybrids</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(03)00071-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2FS0028-3908%2803%2900071-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=12681373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1yqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=749-755&author=M.+d.+M.+Alcal%C3%A1author=N.+M.+Vivasauthor=S.+Hospitalauthor=P.+Campsauthor=D.+Mu%C3%B1oz-Torreroauthor=A.+Badia&title=Characterisation+of+the+anticholinesterase+activity+of+two+new+tacrine%E2%80%93huperzine+A+hybrids&doi=10.1016%2FS0028-3908%2803%2900071-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids</span></div><div class="casAuthors">Alcala, Maria del Mar; Vivas, Nuria Maria; Hospital, Susana; Camps, Pelayo; Munoz-Torrero, Diego; Badia, Albert</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">749-755</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The effects of two tacrine-huperzine A hybrids, (±)-huprine Y and (±)-huprine Z, have been evaluated.  Bovine and human acetylcholinesterase (AChE) and human butyrylcholinesterase (BChE) inhibition were assayed by Ellman's method.  The two huprines were more active than both tacrine and (-)-huperzine A as inhibitors of both human and bovine AChE, and they acted as mixed-type AChE inhibitors.  Moreover, (±)-huprine Y exhibited a tight binding character seen in the expts. of reversibility of bovine AChE inhibitory activity.  In addn., both compds. were more active toward AChE than toward BChE.  Also, the selectivity for the human AChE was greater than for the bovine enzyme.  In ex vivo studies performed in mice, both drugs showed a clear inhibitory activity of brain AChE, 20 min after i.p. injection, (±)-huprine Y being more potent than (±)-huprine Z [ID50 1.09 (0.39-2.98) vs. 5.77 (3.29-10.30) μmol/kg].  The time-course study of the inhibitory effect displayed a t1/2 of 1 h for the two compds.  These results show that these drugs are two potent, central AChE inhibitors of potential interest in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUGWagi5oe2LVg90H21EOLACvtfcHk0lg3SdXdHR_koQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1yqs7s%253D&md5=0caba6a05b0b611199c3920e304e46e1</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2803%2900071-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252803%252900071-6%26sid%3Dliteratum%253Aachs%26aulast%3DAlcal%25C3%25A1%26aufirst%3DM.%2Bd.%2BM.%26aulast%3DVivas%26aufirst%3DN.%2BM.%26aulast%3DHospital%26aufirst%3DS.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DBadia%26aufirst%3DA.%26atitle%3DCharacterisation%2520of%2520the%2520anticholinesterase%2520activity%2520of%2520two%2520new%2520tacrine%25E2%2580%2593huperzine%2520A%2520hybrids%26jtitle%3DNeuropharmacology%26date%3D2003%26volume%3D44%26spage%3D749%26epage%3D755%26doi%3D10.1016%2FS0028-3908%2803%2900071-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span> <span> </span><span class="NLM_article-title">Huprines for Alzheimer’s disease drug development</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1517/17460441.3.1.65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1517%2F17460441.3.1.65" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=23480140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVGnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=65-81&author=D.+Mu%C3%B1oz-Torreroauthor=P.+Camps&title=Huprines+for+Alzheimer%E2%80%99s+disease+drug+development&doi=10.1517%2F17460441.3.1.65"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Huprines for Alzheimer's disease drug development</span></div><div class="casAuthors">Munoz-Torrero, Diego; Camps, Pelayo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-81</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: So far, acetylcholinesterase (AChE) inhibitors have dominated the therapeutic arsenal for Alzheimer's disease.  Although conceptually developed as symptomatic drugs, mounting evidence suggests that these compds. can pos. modify the disease progression, which has spurred the development of novel classes of AChE inhibitors.  Objective: This article reviews the development of novel classes of high affinity AChE inhibitors following a design strategy based on mol. hybridization by stepwise incorporation of different fragments of the known AChE inhibitors (-)-huperzine A and tacrine.  Methods: This review covers the existing literature dealing with the design, synthesis and structural and pharmacol. characterization of the title compds.  Results/conclusion: Three novel classes of AChE inhibitors of increasing structural complexity and affinity have been developed, namely huprines, 13-amidohuprines and huprine-tacrine heterodimers.  Particularly, huprines and huprine-tacrine heterodimers exhibit a unique profile encompassing both cholinergic and non-cholinergic disease-modifying effects and, thus, constitute promising anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaOXBUowHpHbVg90H21EOLACvtfcHk0lg3SdXdHR_koQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVGnt7g%253D&md5=b447bd51d96791d19b378ef7cf47a5c4</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1517%2F17460441.3.1.65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.3.1.65%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DP.%26atitle%3DHuprines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520drug%2520development%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D65%26epage%3D81%26doi%3D10.1517%2F17460441.3.1.65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapia-Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juárez-Jiménez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2549</span>– <span class="NLM_lpage">2567</span>, <span class="refDoi"> DOI: 10.1021/jm401824w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401824w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2549-2567&author=E.+Viaynaauthor=I.+Solaauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=C.+Tapia-Rojasauthor=F.+G.+Serranoauthor=R.+Sabat%C3%A9author=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=B.+P%C3%A9rezauthor=F.+J.+Luqueauthor=V.+Andrisanoauthor=M.+V.+Closauthor=N.+C.+Inestrosaauthor=D.+Mu%C3%B1oz-Torrero&title=Synthesis+and+multitarget+biological+profiling+of+a+novel+family+of+rhein+derivatives+as+disease-modifying+anti-Alzheimer+agents&doi=10.1021%2Fjm401824w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span></div><div class="casAuthors">Viayna, Elisabet; Sola, Irene; Bartolini, Manuela; De Simone, Angela; Tapia-Rojas, Cheril; Serrano, Felipe G.; Sabate, Raimon; Juarez-Jimenez, Jordi; Perez, Belen; Luque, F. Javier; Andrisano, Vincenza; Clos, M. Victoria; Inestrosa, Nibaldo C.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2549-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a family of rhein-huprine hybrids I [X = (CH2)n, n = 5-11; X = CH2-p-phenylene-CH2] to hit several key targets for Alzheimer's disease.  Biol. screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Aβ42 and tau antiaggregating activity, and brain permeability.  Ex vivo studies with the leads (+)- and (-)-I [X = (CH2)9] (II) in brain slices of C57bl6 mice have revealed that they efficiently protect against the Aβ-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a pos. effect on the induction of long-term potentiation.  In vivo studies in APP-PS1 transgenic mice treated i.p. for 4 wk with (+)- and (-)-II have shown a central sol. Aβ lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP).  Thus, (+)- and (-)-II emerge as very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeoyGkrcOQArVg90H21EOLACvtfcHk0lg3SdXdHR_koQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D&md5=711450b3c2289a3fb2037d536e9a7a7b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401824w%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520multitarget%2520biological%2520profiling%2520of%2520a%2520novel%2520family%2520of%2520rhein%2520derivatives%2520as%2520disease-modifying%2520anti-Alzheimer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2549%26epage%3D2567%26doi%3D10.1021%2Fjm401824w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formosa, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minguillón, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Muñoz, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidon-Chanal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Huprine–tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer’s and prion diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1021/jm200840c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200840c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ersLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=661-669&author=C.+Galdeanoauthor=E.+Viaynaauthor=I.+Solaauthor=X.+Formosaauthor=P.+Campsauthor=A.+Badiaauthor=M.+V.+Closauthor=J.+Relatauthor=M.+Ratiaauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+Salmonaauthor=C.+Minguill%C3%B3nauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Huprine%E2%80%93tacrine+heterodimers+as+anti-amyloidogenic+compounds+of+potential+interest+against+Alzheimer%E2%80%99s+and+prion+diseases&doi=10.1021%2Fjm200840c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Huprine-Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer's and Prion Diseases</span></div><div class="casAuthors">Galdeano, Carles; Viayna, Elisabet; Sola, Irene; Formosa, Xavier; Camps, Pelayo; Badia, Albert; Clos, M. Victoria; Relat, Julia; Ratia, Miriam; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Salmona, Mario; Minguillon, Cristina; Gonzalez-Munoz, Gema C.; Rodriguez-Franco, M. Isabel; Bidon-Chanal, Axel; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">661-669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A family of huprine-tacrine heterodimers has been developed to simultaneously block the active and peripheral sites of acetylcholinesterase (AChE).  Their dual site binding for AChE, supported by kinetic and mol. modeling studies, results in a highly potent inhibition of the catalytic activity of human AChE and, more importantly, in the in vitro neutralization of the pathol. chaperoning effect of AChE toward the aggregation of both the β-amyloid peptide (Aβ) and a prion peptide with a key role in the aggregation of the prion protein.  Huprine-tacrine heterodimers take on added value in that they display a potent in vitro inhibitory activity toward human butyrylcholinesterase, self-induced Aβ aggregation, and β-secretase.  Finally, they are able to cross the blood-brain barrier, as predicted in an artificial membrane model assay and demonstrated in ex vivo expts. with OF1 mice, reaching their multiple biol. targets in the central nervous system.  Overall, these compds. are promising lead compds. for the treatment of Alzheimer's and prion diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSrojS0ckMVLVg90H21EOLACvtfcHk0liG3QaJBHGAGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ersLnN&md5=e0fbec47bca527df4e8ed73c847383e9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm200840c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200840c%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DRelat%26aufirst%3DJ.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DMinguill%25C3%25B3n%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DHuprine%25E2%2580%2593tacrine%2520heterodimers%2520as%2520anti-amyloidogenic%2520compounds%2520of%2520potential%2520interest%2520against%2520Alzheimer%25E2%2580%2599s%2520and%2520prion%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D661%26epage%3D669%26doi%3D10.1021%2Fjm200840c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramírez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdaguer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junyent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallàs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arce, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidon-Chanal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1855</span>– <span class="NLM_lpage">1870</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fcmdc.201000322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=20859987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlClu73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1855-1870&author=E.+Viaynaauthor=T.+G%C3%B3mezauthor=C.+Galdeanoauthor=L.+Ram%C3%ADrezauthor=M.+Ratiaauthor=A.+Badiaauthor=M.+V.+Closauthor=E.+Verdaguerauthor=F.+Junyentauthor=A.+Caminsauthor=M.+Pall%C3%A0sauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=P.+Campsauthor=D.+Mu%C3%B1oz-Torrero&title=Novel+huprine+derivatives+with+inhibitory+activity+toward+%CE%B2-amyloid+aggregation+and+formation+as+disease-modifying+anti-Alzheimer+drug+candidates&doi=10.1002%2Fcmdc.201000322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Huprine Derivatives with Inhibitory Activity toward β-Amyloid Aggregation and Formation as Disease-Modifying Anti-Alzheimer Drug Candidates</span></div><div class="casAuthors">Viayna, Elisabet; Gomez, Tania; Galdeano, Carles; Ramirez, Lorena; Ratia, Miriam; Badia, Albert; Clos, M. Victoria; Verdaguer, Ester; Junyent, Felix; Camins, Antoni; Pallas, Merce; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Arce, Mariana P.; Rodriguez-Franco, Maria Isabel; Bidon-Chanal, Axel; Luque, F. Javier; Camps, Pelayo; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1855-1870</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A new family of dual binding site acetylcholinesterase (AChE) inhibitors has been designed, synthesized, and tested for their ability to inhibit AChE, butyrylcholinesterase (BChE), AChE-induced and self-induced β-amyloid (Aβ) aggregation and β-secretase (BACE-1), and to cross the blood-brain barrier.  The new heterodimers consist of a unit of racemic or enantiopure huprine Y or X and a donepezil-related 5,6-dimethoxy-2-[(4-piperidinyl)methyl]indane moiety as the active site and peripheral site to mid-gorge-interacting moieties, resp., connected through a short oligomethylene linker.  Mol. dynamics simulations and kinetics studies support the dual site binding to AChE.  The new heterodimers are potent inhibitors of human AChE and moderately potent inhibitors of human BChE, AChE-induced and self-induced Aβ aggregation, and BACE-1, and are predicted to be able to enter the central nervous system (CNS), thus constituting promising multitarget anti-Alzheimer drug candidates with the potential to modify the natural course of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHqjappn2Nv7Vg90H21EOLACvtfcHk0liG3QaJBHGAGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlClu73F&md5=1e25a3705b61ce71762508198a10f044</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000322%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DG%25C3%25B3mez%26aufirst%3DT.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DRam%25C3%25ADrez%26aufirst%3DL.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DVerdaguer%26aufirst%3DE.%26aulast%3DJunyent%26aufirst%3DF.%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DNovel%2520huprine%2520derivatives%2520with%2520inhibitory%2520activity%2520toward%2520%25CE%25B2-amyloid%2520aggregation%2520and%2520formation%2520as%2520disease-modifying%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1855%26epage%3D1870%26doi%3D10.1002%2Fcmdc.201000322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foucault, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span> <span> </span><span class="NLM_article-title">New huprine derivatives functionalized at position 9 as highly potent acetylcholinesterase inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000523</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fcmdc.201000523" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=21344648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=876-888&author=C.+Roncoauthor=R.+Foucaultauthor=E.+Gillonauthor=P.+Bohnauthor=F.+Nachonauthor=L.+Jeanauthor=P.-Y.+Renard&title=New+huprine+derivatives+functionalized+at+position+9+as+highly+potent+acetylcholinesterase+inhibitors&doi=10.1002%2Fcmdc.201000523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">New Huprine Derivatives Functionalized at Position 9 as Highly Potent Acetylcholinesterase Inhibitors</span></div><div class="casAuthors">Ronco, Cyril; Foucault, Richard; Gillon, Emilie; Bohn, Pierre; Nachon, Florian; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">876-888</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of 24 huprine derivs. diversely functionalized at position 9 have been synthesized and evaluated for their inhibitory activity against human recombinant acetylcholinesterase (AChE).  These derivs. were prepd. in one to five steps from huprine 1 bearing an ester function at position 9.  Ten analogs (1, 2, 6-9, 13-15, and 23) are active in the low nanomolar range (IC50 <5 nM), very close to the parent compd. huprine X.  Compds. 2, 6, and 7 show a very good selectivity for AChE, with AChE inhibitory activities 700-1160-fold higher than those for butyrylcholinesterase (BChE).  The inhibitory potency of these compds. decreases with the steric bulk of the substituents at position 9.  According to docking simulations, small substituents fit into the acyl-binding pocket, whereas the larger ones stick out of the active site gorge of AChE.  Detn. of the kinetic parameters of three of the most potent huprines (2, 6, and 7) showed that most of the difference in KD is accounted by a decrease in kon, which is correlated to the increase of the substituent size.  A first in vivo evaluation has been performed in mice for the most active compd. 2 (I, IC50=1.1 nM) and showed a rather weak toxicity (LD50=40 mg kg-1) and an ability to cross the blood-brain barrier with doses above 15 mg kg-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmJUII0bHstbVg90H21EOLACvtfcHk0lhKB55tabxLrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFGis7Y%253D&md5=bea8949ab5693c5698a106965160688f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000523%26sid%3Dliteratum%253Aachs%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DFoucault%26aufirst%3DR.%26aulast%3DGillon%26aufirst%3DE.%26aulast%3DBohn%26aufirst%3DP.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DNew%2520huprine%2520derivatives%2520functionalized%2520at%2520position%25209%2520as%2520highly%2520potent%2520acetylcholinesterase%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D876%26epage%3D888%26doi%3D10.1002%2Fcmdc.201000523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colletier, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span> <span> </span><span class="NLM_article-title">Huprine derivatives as sub-nanomolar human acetylcholinesterase inhibitors: From rational design to validation by X-ray crystallography</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">400</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fcmdc.201100438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=22052791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSkurzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=400-405&author=C.+Roncoauthor=E.+Carlettiauthor=J.-P.+Colletierauthor=M.+Weikauthor=F.+Nachonauthor=L.+Jeanauthor=P.-Y.+Renard&title=Huprine+derivatives+as+sub-nanomolar+human+acetylcholinesterase+inhibitors%3A+From+rational+design+to+validation+by+X-ray+crystallography&doi=10.1002%2Fcmdc.201100438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Huprine Derivatives as Sub-Nanomolar Human Acetylcholinesterase Inhibitors: From Rational Design to Validation by X-ray Crystallography</span></div><div class="casAuthors">Ronco, Cyril; Carletti, Eugenie; Colletier, Jacques-Philippe; Weik, Martin; Nachon, Florian; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">400-405</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Huprine derivs. were prepd. and tested for acetylcholinesterase inhibitory activity.  The X-ray crystal structure of the most active analog with mAChE was detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouCO4a9sKh5rVg90H21EOLACvtfcHk0lhKB55tabxLrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSkurzK&md5=87fb10ade229545e62b6cb5228ea7914</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100438%26sid%3Dliteratum%253Aachs%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DCarletti%26aufirst%3DE.%26aulast%3DColletier%26aufirst%3DJ.-P.%26aulast%3DWeik%26aufirst%3DM.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DHuprine%2520derivatives%2520as%2520sub-nanomolar%2520human%2520acetylcholinesterase%2520inhibitors%253A%2520From%2520rational%2520design%2520to%2520validation%2520by%2520X-ray%2520crystallography%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D400%26epage%3D405%26doi%3D10.1002%2Fcmdc.201100438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carr, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wease, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ryssen, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agate, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roderick, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span> <span> </span><span class="NLM_article-title">In vitro photo-release of a TRPV1 agonist</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">208</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bmcl.2005.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=16213723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1CitrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=208-212&author=J.+L.+Carrauthor=K.+N.+Weaseauthor=M.+P.+Van+Ryssenauthor=S.+Patersonauthor=B.+Agateauthor=K.+A.+Gallagherauthor=C.+T.+A.+Brownauthor=H.+S.+Roderickauthor=S.+J.+Conway&title=In+vitro+photo-release+of+a+TRPV1+agonist&doi=10.1016%2Fj.bmcl.2005.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro photo-release of a TRPV1 agonist</span></div><div class="casAuthors">Carr, James L.; Wease, Kerrie N.; Van Ryssen, Michael P.; Paterson, Suzanne; Agate, Ben; Gallagher, Katherine A.; Brown, C. Tom A.; Scott, Roderick H.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">208-212</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Intracellular photolysis of a novel 'caged' capsaicin analog results in in vitro activation of the capsaicin receptor TRPV1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJu4EHI00657Vg90H21EOLACvtfcHk0lhKB55tabxLrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1CitrzO&md5=37552ee365337d99a6bf26a68d6817d6</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DJ.%2BL.%26aulast%3DWease%26aufirst%3DK.%2BN.%26aulast%3DVan%2BRyssen%26aufirst%3DM.%2BP.%26aulast%3DPaterson%26aufirst%3DS.%26aulast%3DAgate%26aufirst%3DB.%26aulast%3DGallagher%26aufirst%3DK.%2BA.%26aulast%3DBrown%26aufirst%3DC.%2BT.%2BA.%26aulast%3DRoderick%26aufirst%3DH.%2BS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DIn%2520vitro%2520photo-release%2520of%2520a%2520TRPV1%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D208%26epage%3D212%26doi%3D10.1016%2Fj.bmcl.2005.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallverdú-Queralt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragusa, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamuela-Raventós, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5298</span>– <span class="NLM_lpage">5307</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.07.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bmc.2014.07.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=25156301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCjurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5298-5307&author=F.+J.+P%C3%A9rez-Arealesauthor=O.+Di+Pietroauthor=A.+Espargar%C3%B3author=A.+Vallverd%C3%BA-Queraltauthor=C.+Galdeanoauthor=I.+M.+Ragusaauthor=E.+Viaynaauthor=C.+Guillouauthor=M.+V.+Closauthor=B.+P%C3%A9rezauthor=R.+Sabat%C3%A9author=R.+M.+Lamuela-Ravent%C3%B3sauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Shogaol-huprine+hybrids%3A+dual+antioxidant+and+anticholinesterase+agents+with+%CE%B2-amyloid+and+tau+anti-aggregating+properties&doi=10.1016%2Fj.bmc.2014.07.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Shogaol-huprine hybrids: Dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties</span></div><div class="casAuthors">Perez-Areales, F. Javier; Di Pietro, Ornella; Espargaro, Alba; Vallverdu-Queralt, Anna; Galdeano, Carles; Ragusa, Ilaria M.; Viayna, Elisabet; Guillou, Catherine; Clos, M. Victoria; Perez, Belen; Sabate, Raimon; Lamuela-Raventos, Rosa M.; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5298-5307</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Multitarget compds. are increasingly being pursued for the effective treatment of complex diseases.  Herein, the authors describe the design and synthesis of a novel class of shogaol-huprine hybrids, e.g. I [R = H, Me2NCH2], purported to hit several key targets involved in Alzheimer's disease.  The hybrids have been tested in vitro for their inhibitory activity against human acetylcholinesterase and butyrylcholinesterase and antioxidant activity (ABTS·+, DPPH and Folin-Ciocalteu assays), and in intact Escherichia coli cells for their Aβ42 and tau antiaggregating activity.  Also, their brain penetration has been assessed (PAMPA-BBB assay).  Even though the hybrids are not as potent AChE inhibitors or antioxidant agents as the parent huprine Y and [4]-shogaol, resp., they still exhibit very potent anticholinesterase and antioxidant activities and are much more potent Aβ42 and tau antiaggregating agents than the parent compds.  Overall, the shogaol-huprine hybrids emerge as interesting brain permeable multitarget anti-Alzheimer leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoviJP_RhoyE7Vg90H21EOLACvtfcHk0li4xFewpK4Wqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCjurbK&md5=7dca605e8747562c21962d7cb4a7b5df</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DVallverd%25C3%25BA-Queralt%26aufirst%3DA.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DRagusa%26aufirst%3DI.%2BM.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DGuillou%26aufirst%3DC.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DLamuela-Ravent%25C3%25B3s%26aufirst%3DR.%2BM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DShogaol-huprine%2520hybrids%253A%2520dual%2520antioxidant%2520and%2520anticholinesterase%2520agents%2520with%2520%25CE%25B2-amyloid%2520and%2520tau%2520anti-aggregating%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5298%26epage%3D5307%26doi%3D10.1016%2Fj.bmc.2014.07.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubbs, R. H.</span></span> <span> </span><span class="NLM_article-title">Prevention of undesirable isomerization during olefin metathesis</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">17160</span>– <span class="NLM_lpage">17161</span>, <span class="refDoi"> DOI: 10.1021/ja052939w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja052939w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Srsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=17160-17161&author=S.+H.+Hongauthor=D.+P.+Sandersauthor=C.+W.+Leeauthor=R.+H.+Grubbs&title=Prevention+of+undesirable+isomerization+during+olefin+metathesis&doi=10.1021%2Fja052939w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of Undesirable Isomerization during Olefin Metathesis</span></div><div class="casAuthors">Hong, Soon Hyeok; Sanders, Daniel P.; Lee, Choon Woo; Grubbs, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">17160-17161</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In olefin metathesis, ring-closing olefin metathesis, and cross-metathesis reactions catalyzed by ruthenium carbene complexes, the addn. of benzoquinones such as 1,4-benzoquinone to the reaction mixts. inhibits isomerization reactions of the products.  Stereoselective isomerizations of (Z)-Me3CSi(Me)2OCH2CH2CH:CHCO2Me and (Z)-Me3CSi(Me)2OCH2CH:CHCH2OSi(Me)2CMe3 to their corresponding (E)-isomers yield 81% and >95% of silyl enol ether products derived from olefin isomerization in the absence of an additive, while isomerization in the presence of 1,4-benzoquinone yields >95% yields of the desired products.  The ring closing metathesis reactions of N,N-diallylaniline and of diallyl ether in the presence of the 2nd generation Grubbs olefin metathesis catalyst provide >90% yields of the dihydropyrrole and dihydrofuran products in the presence of 1,4-benzoquinone, while yielding 16% and <5% yields of the desired products in the absence of an additive.  Cross-metathesis reactions of meadow foam Me esters RCH:CH(CH2)3CO2Me [R = Me(CH2)13, Me(CH2)15, Me(CH2)7CH:CH(CH2)6] and of Me(CH2)5CH:CH(CH2)10OAc with ethylene in the presence of (benzylidene)bis(tricyclohexylphosphino)ruthenium dichloride provide Me 5-hexenoate and 1-decene and 11-dodecen-1-yl acetate with 1-2% isomerization in the presence of 1,4-benzoquinone, while providing products with 30-49% isomerization in the absence of an additive.  Nine benzoquinones are tried as isomerization inhibitors for ruthenium-catalyzed olefin metathesis reactions; benzoquinones with electron-withdrawing substituents such as tetrafluoro-1,4-benzoquinone and 2,6-dichloro-1,4-benzoquinones are the most effective additives of those tried for inhibiting olefin isomerization reactions.  1,4-Benzoquinone is not effective at preventing isomerization reactions in the ring-closing metathesis of either N-Me diallylamine or N-benzyldiallylamine.  Acetic acid is an effective additive for preventing olefin shifts in the isomerization of (Z)-Me3CSi(Me)2OCH2CH2CH:CHCO2Me and in the ring-closing metathesis of diallyl ether, but is ineffective at preventing undesired isomerization in the stereoisomerization of (Z)-Me3CSi(Me)2OCH2CH:CHCH2OSi(Me)2CMe3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrznNbMnmnI07Vg90H21EOLACvtfcHk0li4xFewpK4Wqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Srsb3N&md5=21381b4688a152a1475686db44cfc26c</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fja052939w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja052939w%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DS.%2BH.%26aulast%3DSanders%26aufirst%3DD.%2BP.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DPrevention%2520of%2520undesirable%2520isomerization%2520during%2520olefin%2520metathesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D17160%26epage%3D17161%26doi%3D10.1021%2Fja052939w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oukoloff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieslikiewicz-Bouet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mougeot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span> <span> </span><span class="NLM_article-title">Improved access to huprine derivatives functionalized at position 9</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">1337</span>– <span class="NLM_lpage">1343</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201501433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fejoc.201501433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC28XitF2qtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=1337-1343&author=K.+Oukoloffauthor=S.+Chaoauthor=M.+Cieslikiewicz-Bouetauthor=R.+Mougeotauthor=L.+Jeanauthor=P.-Y.+Renard&title=Improved+access+to+huprine+derivatives+functionalized+at+position+9&doi=10.1002%2Fejoc.201501433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Access to Huprine Derivatives Functionalized at Position 9</span></div><div class="casAuthors">Oukoloff, Killian; Chao, Sovy; Cieslikiewicz-Bouet, Monika; Mougeot, Romain; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1337-1343</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Herein, we present an improved synthetic pathway to huprine derivs. (the most potent family of non-covalent acetylcholinesterase inhibitors described to date) with different functional groups at the C9-position of the scaffold.  Our approach enables selection of the desired terminal function prior to construction of the huprine scaffold and consists of three main steps: enol formation from a bicyclic ketone, Suzuki-Miyaura cross coupling with different borane derivs. and a Friedlaender condensation to access to the quinoline moiety.  This synthetic route was found particularly useful for construction of huprine scaffolds equipped with methylene chains bearing different terminal groups such as hydroxy, azide, nitro, amino and carboxylic groups.  These functionalized huprines are used as key intermediates in the prepn. of multi-target directed ligands for the treatment of Alzheimer's disease or in the prepn. of resins for purifn. of cholinesterases by affinity chromatog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbAdl9DvOCObVg90H21EOLACvtfcHk0li4xFewpK4Wqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitF2qtbY%253D&md5=cd986a7cbb4c52a1378beba8c9b4ed2d</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201501433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201501433%26sid%3Dliteratum%253Aachs%26aulast%3DOukoloff%26aufirst%3DK.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DCieslikiewicz-Bouet%26aufirst%3DM.%26aulast%3DMougeot%26aufirst%3DR.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DImproved%2520access%2520to%2520huprine%2520derivatives%2520functionalized%2520at%2520position%25209%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2016%26volume%3D2016%26spage%3D1337%26epage%3D1343%26doi%3D10.1002%2Fejoc.201501433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brescia, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appell, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brain, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganju, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denholm, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wareing, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacGloinn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBryde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oakley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunez, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gstach, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolle, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, I.</span></span> <span> </span><span class="NLM_article-title">Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bmcl.2008.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=19014884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFCg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=119-122&author=A.+G.+Coleauthor=A.+Metzgerauthor=M.-R.+Bresciaauthor=L.-Y.+Qinauthor=K.+C.+Appellauthor=C.+T.+Brainauthor=A.+Halletauthor=P.+Ganjuauthor=A.+A.+Denholmauthor=J.+R.+Wareingauthor=T.+J.+Ritchieauthor=G.+M.+Drakeauthor=S.+J.+Bevanauthor=A.+MacGloinnauthor=A.+McBrydeauthor=V.+Patelauthor=P.+J.+Oakleyauthor=X.+Nunezauthor=H.+Gstachauthor=P.+Schneiderauthor=J.+J.+Baldwinauthor=R.+E.+Dolleauthor=E.+McDonaldauthor=I.+Henderson&title=Sulfonamido-aryl+ethers+as+bradykinin+B1+receptor+antagonists&doi=10.1016%2Fj.bmcl.2008.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists</span></div><div class="casAuthors">Cole, Andrew G.; Metzger, Axel; Brescia, Marc-Raleigh; Qin, Lan-Ying; Appell, Kenneth C.; Brain, Christopher T.; Hallett, Allan; Ganju, Pam; Denholm, Alastair A.; Wareing, James R.; Ritchie, Timothy J.; Drake, Gillian M.; Bevan, Stuart J.; MacGloinn, Aisling; McBryde, Andrew; Patel, Viral; Oakley, Paul J.; Nunez, Ximena; Gstach, Hubert; Schneider, Peter; Baldwin, John J.; Dolle, Roland E.; McDonald, Edward; Henderson, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-122</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The synthesis and identification of sulfonamido-aryl ethers, i.e. I, as potent bradykinin B1 receptor antagonists from a ∼60,000 member encoded combinatorial library are reported.  Two distinct series of compds. exhibiting different structure-activity relationships were identified in a bradykinin B1 whole-cell receptor-binding assay.  Specific examples exhibit Ki values of ∼10 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozveD1ETF8sbVg90H21EOLACvtfcHk0li4xFewpK4Wqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFCg&md5=f243411a7fc3fe10c8e9c7df087195e4</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DMetzger%26aufirst%3DA.%26aulast%3DBrescia%26aufirst%3DM.-R.%26aulast%3DQin%26aufirst%3DL.-Y.%26aulast%3DAppell%26aufirst%3DK.%2BC.%26aulast%3DBrain%26aufirst%3DC.%2BT.%26aulast%3DHallet%26aufirst%3DA.%26aulast%3DGanju%26aufirst%3DP.%26aulast%3DDenholm%26aufirst%3DA.%2BA.%26aulast%3DWareing%26aufirst%3DJ.%2BR.%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DDrake%26aufirst%3DG.%2BM.%26aulast%3DBevan%26aufirst%3DS.%2BJ.%26aulast%3DMacGloinn%26aufirst%3DA.%26aulast%3DMcBryde%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DOakley%26aufirst%3DP.%2BJ.%26aulast%3DNunez%26aufirst%3DX.%26aulast%3DGstach%26aufirst%3DH.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26aulast%3DDolle%26aufirst%3DR.%2BE.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DHenderson%26aufirst%3DI.%26atitle%3DSulfonamido-aryl%2520ethers%2520as%2520bradykinin%2520B1%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D119%26epage%3D122%26doi%3D10.1016%2Fj.bmcl.2008.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, V.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Featherstone, R. M.</span></span> <span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(61)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity&doi=10.1016%2F0006-2952%2861%2990145-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0lhTZp1xXqYhww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95%26doi%3D10.1016%2F0006-2952%2861%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khorana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markmee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingkaninan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruchirawat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitbunnadaj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullagurla, M. R.</span></span> <span> </span><span class="NLM_article-title">Evaluation of a new lead for acetylcholinesterase inhibition</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1007/s00044-008-9122-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1007%2Fs00044-008-9122-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVShur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=231-241&author=N.+Khoranaauthor=S.+Markmeeauthor=K.+Ingkaninanauthor=S.+Ruchirawatauthor=R.+Kitbunnadajauthor=M.+R.+Pullagurla&title=Evaluation+of+a+new+lead+for+acetylcholinesterase+inhibition&doi=10.1007%2Fs00044-008-9122-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a new lead for acetylcholinesterase inhibition</span></div><div class="casAuthors">Khorana, Nantaka; Markmee, Sutthatip; Ingkaninan, Kornkanok; Ruchirawat, Somsak; Kitbunnadaj, Ruengwit; Pullagurla, Manik Reddy</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-241</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">Acetylcholine is the most common neurotransmitter of the parasympathetic nervous system.  Several cholinergic drugs are widely used in Alzheimer's disease, urinary retention, glaucoma, and myasthenia gravis.  Acetylcholinesterase is the enzyme which destroys naturally occurring acetylcholine, and acetylcholinesterase inhibitors (AChEIs) which block the enzyme are currently used in the treatment of several diseases, most importantly Alzheimer's disease.  Previous studies from our lab. have shown a few isoquinoline analogs to be potential acetylcholinesterase inhibitors.  In the present study we have extended anal. of the structure-activity relationship (SAR) of the isoquinoline ring system as an AChEI.  The corresponding reduced form of 1-(3,4-dimethoxybenzyl)-6,7-dimethoxyisoquinoline, ring-opened analog, and related analogs were evaluated for AChE inhibitory activity.  Our results showed that the dihydroisoquinoline ring analog compd. 6 (IC50 = 7.0 ± 1.4 μM) and compd. 4 (IC50 = 5.5 ± 1.0 μM) displayed potent AChE inhibition.  These compds. are currently the lead compds. for further studies in our lab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA7F-DJD0JwbVg90H21EOLACvtfcHk0lhTZp1xXqYhww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVShur0%253D&md5=9e083abb01be5514d3bf9577ff560c31</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1007%2Fs00044-008-9122-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-008-9122-3%26sid%3Dliteratum%253Aachs%26aulast%3DKhorana%26aufirst%3DN.%26aulast%3DMarkmee%26aufirst%3DS.%26aulast%3DIngkaninan%26aufirst%3DK.%26aulast%3DRuchirawat%26aufirst%3DS.%26aulast%3DKitbunnadaj%26aufirst%3DR.%26aulast%3DPullagurla%26aufirst%3DM.%2BR.%26atitle%3DEvaluation%2520of%2520a%2520new%2520lead%2520for%2520acetylcholinesterase%2520inhibition%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2009%26volume%3D18%26spage%3D231%26epage%3D241%26doi%3D10.1007%2Fs00044-008-9122-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornish-Bowden, A.</span></span> <span> </span><span class="NLM_article-title">A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1042/bj1370143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1042%2Fbj1370143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=4206907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaE2cXnvFGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1974&pages=143-144&author=A.+Cornish-Bowden&title=A+simple+graphical+method+for+determining+the+inhibition+constants+of+mixed%2C+uncompetitive+and+non-competitive+inhibitors&doi=10.1042%2Fbj1370143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Simple graphical method for determining the inhibition constants of mixed, uncompetitive, and noncompetitive inhibitors</span></div><div class="casAuthors">Cornish-Bowden, Athel</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">143-4</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">The title Ki values are obtained from a plot of s/v against i, where s is substrate concn., v is reaction velocity, and i is inhibitor concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBv0H1VCMLP7Vg90H21EOLACvtfcHk0lhTZp1xXqYhww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXnvFGrtQ%253D%253D&md5=c5b5738ba2b3343efbde493cdfbe59bc</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1042%2Fbj1370143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj1370143%26sid%3Dliteratum%253Aachs%26aulast%3DCornish-Bowden%26aufirst%3DA.%26atitle%3DA%2520simple%2520graphical%2520method%2520for%2520determining%2520the%2520inhibition%2520constants%2520of%2520mixed%252C%2520uncompetitive%2520and%2520non-competitive%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D1974%26volume%3D137%26spage%3D143%26epage%3D144%26doi%3D10.1042%2Fbj1370143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappi, S.</span></span> <span> </span><span class="NLM_article-title">Interactions of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1989</span>– <span class="NLM_lpage">1997</span>, <span class="refDoi"> DOI: 10.1021/bi00680a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00680a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaE2MXktVemu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=1989-1997&author=P.+Taylorauthor=S.+Lappi&title=Interactions+of+fluorescence+probes+with+acetylcholinesterase.+The+site+and+specificity+of+propidium+binding&doi=10.1021%2Fbi00680a029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of fluorescence probes with acetylcholinesterase.  Site and specificity of propidium binding</span></div><div class="casAuthors">Taylor, Palmer; Lappi, Shelley</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1989-97</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">A bis-quaternary fluorescence probe, propidium diiodide, exhibited a 10-fold enhancement of fluorescence when bound to acetylcholinesterase from Torpedo californica.  The complex was characterized by a high affinity, KD = 3.0 × 10-7M, and 1:1 stoichiometry with the 82,000 mol. wt. subunit of acetylcholinesterase.  A wide variety of other quaternary ammonium ligands such as decamethonium, gallamine, d-tubocurarine, tetraethylammonium, and tetramethylammonium completely dissocd. propidium from the enzyme as did monovalent and divalent inorg. cations.  Whereas a directly competitive relation was illustrated macroscopically, the various quaternary ligands showed a different susceptibility toward inorg. cation displacement.  The affinity of propidium relative to gallamine increased with ionic strength, indicating that there is not complete equivalence in the neg. subsites to which quaternary groups bind.  Although edrophonium also displaced propidium from the enzyme, the dissocn. const. obtained from this competitive relation was 3 5 orders of magnitude greater than the consts. obtained for inhibition of catalysis.  Based on competitve displacement titrns., the primary binding site of edrophonium was distinct from that of propidium and a ternary complex with the 2 ligands can form on each subunit.  In contrast to edrophonium, the binding of propidium was unaffected by methanesulfonylation of the active center serine and was uncompetitive with the carbamylating substrate, N-methyl-7-dimethylcarbamoxyquinolinium.  Thus, propidium associates with a peripheral anionic center on the enzyme.  Although propidium and edrophonium assocd. at sep. sites on acetylcholinesterase, bis-quaternary ligands where the quaternary N atoms are sepd. by 14 Å displaced both ligands from the enzyme with equal effectiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqaxfzE7WsY7Vg90H21EOLACvtfcHk0lhW31Wwo7_l7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXktVemu74%253D&md5=0c4b7b9afdc79270927cb12f79d4168a</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fbi00680a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00680a029%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DLappi%26aufirst%3DS.%26atitle%3DInteractions%2520of%2520fluorescence%2520probes%2520with%2520acetylcholinesterase.%2520The%2520site%2520and%2520specificity%2520of%2520propidium%2520binding%26jtitle%3DBiochemistry%26date%3D1975%26volume%3D14%26spage%3D1989%26epage%3D1997%26doi%3D10.1021%2Fbi00680a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lwebuga-Mukasa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademacher, J.</span></span> <span> </span><span class="NLM_article-title">Propidium – A fluorescent probe for a peripheral anionic site on acetylcholinesterase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">708</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaE2cXltFKmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1974&pages=703-708&author=P.+Taylorauthor=J.+Lwebuga-Mukasaauthor=S.+Lappiauthor=J.+Rademacher&title=Propidium+%E2%80%93+A+fluorescent+probe+for+a+peripheral+anionic+site+on+acetylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Propidium.  Fluorescence probe for a peripheral anionic site on acetylcholinesterase</span></div><div class="casAuthors">Taylor, Palmer; Lwebuga-Mukasa, Jamson; Lappi, Shelley; Rademacher, James</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">703-8</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Propidium [(3,8-diamino-5-(3-diethylmethylaminopropyl)-6-phenylphenanthridium diiodide] (I) was bound with high affinity to a purified acetylcholinesterase isolated by lytic procedures from Torpedo californica.  Complex formation resulted in a 10-fold enhancement of fluorescence for the ligand in the bound state.  The fluorescent ligand could be dissocd. from the enzyme by back-titrn. with d-tubocurarine and gallamine under conditions of low ionic strength (γ/2 ≃ 0.001).  At higher ionic strength, in 0.1M NaCl, 0.04M MgCl2, and 0.01M Tris-Cl, pH 8.0 (γ/2 = 0.23), the above ligands were relatively ineffective in dissocg. propidium from the enzyme.  Edrophonium, an inhibitor that appears specific for the active center, did not dissoc. propidium under conditions of high and low ionic strength.  This specificity is consistent with propidium acting as a fluorescence probe for a peripheral anionic site on acetylcholinesterase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy22LfQ6F2j7Vg90H21EOLACvtfcHk0lhW31Wwo7_l7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXltFKmu70%253D&md5=3256818b8da823e9154f830b796616fa</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DLwebuga-Mukasa%26aufirst%3DJ.%26aulast%3DLappi%26aufirst%3DS.%26aulast%3DRademacher%26aufirst%3DJ.%26atitle%3DPropidium%2520%25E2%2580%2593%2520A%2520fluorescent%2520probe%2520for%2520a%2520peripheral%2520anionic%2520site%2520on%2520acetylcholinesterase%26jtitle%3DMol.%2520Pharmacol.%26date%3D1974%26volume%3D10%26spage%3D703%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dvir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberry, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">3D Structure of <i>Torpedo californica</i> acetylcholinesterase complexed with huprine X at 2.1 Å resolution: Kinetic and molecular dynamics correlates</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2970</span>– <span class="NLM_lpage">2981</span>, <span class="refDoi"> DOI: 10.1021/bi011652i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi011652i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1altw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2970-2981&author=H.+Dvirauthor=D.+M.+Wongauthor=M.+Harelauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torreroauthor=P.+Campsauthor=T.+L.+Rosenberryauthor=I.+Silmanauthor=J.+L.+Sussman&title=3D+Structure+of+Torpedo+californica+acetylcholinesterase+complexed+with+huprine+X+at+2.1+%C3%85+resolution%3A+Kinetic+and+molecular+dynamics+correlates&doi=10.1021%2Fbi011652i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">3D Structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 Å resolution: Kinetic and molecular dynamic correlates</span></div><div class="casAuthors">Dvir, H.; Wong, D. M.; Harel, M.; Barril, X.; Orozco, M.; Luque, F. J.; Munoz-Torrero, D.; Camps, P.; Rosenberry, T. L.; Silman, I.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2970-2981</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Huprine X (HX) is a novel acetylcholinesterase (AChE) inhibitor, with one of the highest affinities reported for a reversible inhibitor.  HX is a synthetic hybrid that contains the 4-aminoquinoline substructure of one anti-Alzheimer drug, tacrine, and a carbobicyclic moiety resembling that of another AChE inhibitor, (-)-huperzine A.  Cocrystn. of HX with T. californica AChE yielded crystals whose 3-dimensional (3D) structure was detd. to 2.1 Å resoln.  The inhibitor was found to bind to the anionic site and also to hinder access to the esteratic site.  Its arom. portion occupied the same binding site as tacrine, stacking between the arom. rings of Trp-84 and Phe-330, whereas the carbobicyclic unit occupied the same binding pocket as (-)-huperzine A.  Its Cl substituent was found to lie in a hydrophobic pocket interacting with the rings of arom. residues Trp-432 and Phe-330 and with the Me groups of Met-436 and Ile-439.  Steady-state inhibition data showed that HX bound to human AChE and Torpedo AChE 28- and 54-fold, resp., more tightly than tacrine.  This difference apparently stems from the fact that the aminoquinoline moiety of HX makes interactions similar to those made by tacrine, but that addnl. bonds to the enzyme are made by the huperzine-like substructure and the Cl atom.  Furthermore, both tacrine and HX bound more tightly to Torpedo AChE than to human AChE, suggesting that their quinoline substructures interact better with Phe-330 than with Tyr-337, the corresponding residue in the human AChE structure.  Both (-)-huperzine A and HX displayed slow binding properties, but only binding of the former caused a peptide flip of Gly-117.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqVXtCPjzM1LVg90H21EOLACvtfcHk0lhW31Wwo7_l7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1altw%253D%253D&md5=ea8b56b44818d899843be48d59fa2553</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fbi011652i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi011652i%26sid%3Dliteratum%253Aachs%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DD.%2BM.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3D3D%2520Structure%2520of%2520Torpedo%2520californica%2520acetylcholinesterase%2520complexed%2520with%2520huprine%2520X%2520at%25202.1%2520%25C3%2585%2520resolution%253A%2520Kinetic%2520and%2520molecular%2520dynamics%2520correlates%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D2970%26epage%3D2981%26doi%3D10.1021%2Fbi011652i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaeta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattorusso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catalanotti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiasserini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellerano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKissic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, A.</span></span> <span> </span><span class="NLM_article-title">Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1021/jm0255668</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0255668" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1yntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1-4&author=L.+Saviniauthor=A.+Gaetaauthor=C.+Fattorussoauthor=B.+Catalanottiauthor=G.+Campianiauthor=L.+Chiasseriniauthor=C.+Pelleranoauthor=E.+Novellinoauthor=D.+McKissicauthor=A.+Saxena&title=Specific+targeting+of+acetylcholinesterase+and+butyrylcholinesterase+recognition+sites.+Rational+design+of+novel%2C+selective%2C+and+highly+potent+cholinesterase+inhibitors&doi=10.1021%2Fjm0255668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Targeting of Acetylcholinesterase and Butyrylcholinesterase Recognition Sites. Rational Design of Novel, Selective, and Highly Potent Cholinesterase Inhibitors</span></div><div class="casAuthors">Savini, Luisa; Gaeta, Alessandra; Fattorusso, Caterina; Catalanotti, Bruno; Campiani, Giuseppe; Chiasserini, Luisa; Pellerano, Cesare; Novellino, Ettore; McKissic, Dawn; Saxena, Ashima</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tacrine-based AChE and BuChE inhibitors were designed by investigating the topol. of the active site gorge of the two enzymes.  The homobivalent ligands characterized by a nitrogen-bridged atom at the tether level could be considered among the most potent and selective cholinesterase inhibitors described to date.  The nitrogen-contg. homobivalent ligands and the sulfur-contg. ligand validated the hypothesis of extra sites of interaction in the AChE and BuChE active site gorges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-lepg2tVtZLVg90H21EOLACvtfcHk0lhWEDcAlW4-Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1yntb8%253D&md5=1d9abc2e1f63f01686a7c4a79bab57c9</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm0255668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0255668%26sid%3Dliteratum%253Aachs%26aulast%3DSavini%26aufirst%3DL.%26aulast%3DGaeta%26aufirst%3DA.%26aulast%3DFattorusso%26aufirst%3DC.%26aulast%3DCatalanotti%26aufirst%3DB.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DChiasserini%26aufirst%3DL.%26aulast%3DPellerano%26aufirst%3DC.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMcKissic%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DA.%26atitle%3DSpecific%2520targeting%2520of%2520acetylcholinesterase%2520and%2520butyrylcholinesterase%2520recognition%2520sites.%2520Rational%2520design%2520of%2520novel%252C%2520selective%252C%2520and%2520highly%2520potent%2520cholinesterase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1%26epage%3D4%26doi%3D10.1021%2Fjm0255668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elsinghorst, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieslik, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tränkle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gütschow, M.</span></span> <span> </span><span class="NLM_article-title">First gallamine-tacrine hybrid: Design and characterization at cholinesterases and the M<sub>2</sub> muscarinic receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5685</span>– <span class="NLM_lpage">5695</span>, <span class="refDoi"> DOI: 10.1021/jm070859s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070859s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOitbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5685-5695&author=P.+W.+Elsinghorstauthor=J.+S.+Cieslikauthor=K.+Mohrauthor=C.+Tr%C3%A4nkleauthor=M.+G%C3%BCtschow&title=First+gallamine-tacrine+hybrid%3A+Design+and+characterization+at+cholinesterases+and+the+M2+muscarinic+receptor&doi=10.1021%2Fjm070859s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">First Gallamine-Tacrine Hybrid: Design and Characterization at Cholinesterases and the M2 Muscarinic Receptor</span></div><div class="casAuthors">Elsinghorst, Paul W.; Cieslik, Julia S.; Mohr, Klaus; Traenkle, Christian; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5685-5695</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gallamine and tacrine are allosteric antagonists at muscarinic M2 acetylcholine receptors and inhibitors of acetylcholinesterase.  At both acetylcholine-binding proteins, gallamine and tacrine are known to occupy two different binding sites: in M2 receptors within the allosteric binding area and in acetylcholinesterase at its catalytic and its peripheral site.  To find new ligands of both targets, the authors designed a gallamine-tacrine dimer and several derived hybrid compds. to address the two binding sites.  Their M2 receptor allosteric and acetylcholinesterase inhibitory potential was detd.  The hybrid compds. revealed an allosteric potency in the low nanomolar range exceeding the allosteric potency of gallamine and tacrine by factors of 100 and 4800, resp.  Cholinesterase inhibition was augmented by hybrid formation, and all compds. exhibited IC50 values in the lower nanomolar range.  Thus, gallamine-tacrine hybrid formation is a valuable approach toward high affinity ligands concurrently targeting these acetylcholine-binding proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Rozawsc7bLVg90H21EOLACvtfcHk0lhWEDcAlW4-Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOitbvN&md5=a6497e4ea0a428470c3476ea5ad2700e</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm070859s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070859s%26sid%3Dliteratum%253Aachs%26aulast%3DElsinghorst%26aufirst%3DP.%2BW.%26aulast%3DCieslik%26aufirst%3DJ.%2BS.%26aulast%3DMohr%26aufirst%3DK.%26aulast%3DTr%25C3%25A4nkle%26aufirst%3DC.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DFirst%2520gallamine-tacrine%2520hybrid%253A%2520Design%2520and%2520characterization%2520at%2520cholinesterases%2520and%2520the%2520M2%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5685%26epage%3D5695%26doi%3D10.1021%2Fjm070859s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brazzolotto, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wandhammer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trovaslet-Leroy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darvesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span> <span> </span><span class="NLM_article-title">Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: A crystallographic, kinetic and calorimetric study</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2098</span>, <span class="refDoi"> DOI: 10.3390/molecules22122098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3390%2Fmolecules22122098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslSqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=2098&author=T.+Rosenberryauthor=X.+Brazzolottoauthor=I.+Macdonaldauthor=M.+Wandhammerauthor=M.+Trovaslet-Leroyauthor=S.+Darveshauthor=F.+Nachon&title=Comparison+of+the+binding+of+reversible+inhibitors+to+human+butyrylcholinesterase+and+acetylcholinesterase%3A+A+crystallographic%2C+kinetic+and+calorimetric+study&doi=10.3390%2Fmolecules22122098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: a crystallographic, kinetic and calorimetric study</span></div><div class="casAuthors">Rosenberry, Terrone L.; Brazzolotto, Xavier; MacDonald, Ian R.; Wandhammer, Marielle; Trovaslet-Leroy, Marie; Darvesh, Sultan; Nachon, Florian</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2098/1-2098/20</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) hydrolyze the neurotransmitter acetylcholine and, thereby, function as coregulators of cholinergic neurotransmission.  Although closely related, these enzymes display very different substrate specificities that only partially overlap.  This disparity is largely due to differences in the no. of arom. residues lining the active site gorge, which leads to large differences in the shape of the gorge and potentially to distinct interactions with an individual ligand.  Considerable structural information is available for the binding of a wide diversity of ligands to AChE.  In contrast, structural data on the binding of reversible ligands to BChE are lacking.  In a recent effort, an inhibitor competition approach was used to probe the overlap of ligand binding sites in BChE.  Here, we extend this study by solving the crystal structures of human BChE in complex with five reversible ligands, namely, decamethonium, thioflavin T, propidium, huprine, and ethopropazine.  We compare these structures to equiv. AChE complexes when available in the protein data bank and supplement this comparison with kinetic data and observations from isothermal titrn. calorimetry.  This new information now allows us to define the binding mode of various ligand families and will be of importance in designing specific reversible ligands of BChE that behave as inhibitors or reactivators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTCieO8Tc3bbVg90H21EOLACvtfcHk0lhWEDcAlW4-Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslSqu70%253D&md5=ede4274ad70a13acfee81bec1da90eb1</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22122098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22122098%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberry%26aufirst%3DT.%26aulast%3DBrazzolotto%26aufirst%3DX.%26aulast%3DMacdonald%26aufirst%3DI.%26aulast%3DWandhammer%26aufirst%3DM.%26aulast%3DTrovaslet-Leroy%26aufirst%3DM.%26aulast%3DDarvesh%26aufirst%3DS.%26aulast%3DNachon%26aufirst%3DF.%26atitle%3DComparison%2520of%2520the%2520binding%2520of%2520reversible%2520inhibitors%2520to%2520human%2520butyrylcholinesterase%2520and%2520acetylcholinesterase%253A%2520A%2520crystallographic%252C%2520kinetic%2520and%2520calorimetric%2520study%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D2098%26doi%3D10.3390%2Fmolecules22122098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juárez-Jiménez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span> <span> </span><span class="NLM_article-title">Unveiling a novel transient druggable pocket in BACE-1 through molecular simulations: conformational analysis and binding mode of multisite inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">e0177683</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0177683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1371%2Fjournal.pone.0177683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=28505196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsF2nsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&author=O.+Di%0APietroauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=D.+Mu%C3%B1oz-Torreroauthor=C.+A.+Laughtonauthor=F.+J.+Luque&title=Unveiling+a+novel+transient+druggable+pocket+in+BACE-1+through+molecular+simulations%3A+conformational+analysis+and+binding+mode+of+multisite+inhibitors&doi=10.1371%2Fjournal.pone.0177683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Unveiling a novel transient druggable pocket in bace-1 through molecular simulations: conformational analysis and binding mode of multisite inhibitors</span></div><div class="casAuthors">Di Pietro, Ornella; Juarez-Jimenez, Jordi; Munoz-Torrero, Diego; Laughton, Charles A.; Luque, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0177683/1-e0177683/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The crit. role of BACE-1 in the formation of neurotoxic β-amyloid peptides in the brain makes it an attractive target for an efficacious treatment of Alzheimer's disease.  However, the development of clin. useful BACE-1 inhibitors has proven to be extremely challenging.  In this study we examine the binding mode of a novel potent inhibitor (compd. 1, with IC50 80 nM) designed by synergistic combination of two fragments-huprine and rhein- that individually are endowed with very low activity against BACE-1.  Examn. of crystal structures reveals no appropriate binding site large enough to accommodate 1.  Therefore we have examd. the conformational flexibility of BACE-1 through extended mol. dynamics simulations, paying attention to the highly flexible region shaped by loops 8-14, 154-169 and 307-318.  The anal. of the protein dynamics, together with studies of pocket druggability, has allowed us to detect the transient formation of a secondary binding site, which contains Arg307 as a key residue for the interaction with small mols., at the edge of the catalytic cleft.  The formation of this druggable "floppy" pocket would enable the binding of multisite inhibitors targeting both catalytic and secondary sites.  Mol. dynamics simulations of BACE-1 bound to huprine-rhein hybrid compds. support the feasibility of this hypothesis.  The results provide a basis to explain the high inhibitory potency of the two enantiomeric forms of 1, together with the large dependence on the length of the oligomethylenic linker.  Furthermore, the multisite hypothesis has allowed us to rationalize the inhibitory potency of a series of tacrine-chromene hybrid compds., specifically regarding the apparent lack of sensitivity of the inhibition const. to the chem. modifications introduced in the chromene unit.  Overall, these findings pave the way for the exploration of novel functionalities in the design of optimized BACE-1 multisite inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPkTHdHnmrSrVg90H21EOLACvtfcHk0lj-Rh-w2Hn9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsF2nsrrL&md5=bf8948c5989a213ae21b2570ae96d993</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0177683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0177683%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DLaughton%26aufirst%3DC.%2BA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DUnveiling%2520a%2520novel%2520transient%2520druggable%2520pocket%2520in%2520BACE-1%2520through%2520molecular%2520simulations%253A%2520conformational%2520analysis%2520and%2520binding%2520mode%2520of%2520multisite%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26doi%3D10.1371%2Fjournal.pone.0177683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, R. L.</span></span> <span> </span><span class="NLM_article-title">The chemistry behind antioxidant capacity assays</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1841</span>– <span class="NLM_lpage">1856</span>, <span class="refDoi"> DOI: 10.1021/jf030723c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf030723c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslaltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2005&pages=1841-1856&author=D.+Huangauthor=B.+Ouauthor=R.+L.+Prior&title=The+chemistry+behind+antioxidant+capacity+assays&doi=10.1021%2Fjf030723c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The Chemistry behind Antioxidant Capacity Assays</span></div><div class="casAuthors">Huang, Dejian; Ou, Boxin; Prior, Ronald L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1841-1856</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review summarizing the multifaceted aspects of antioxidants and the basic kinetic models of inhibited autoxidn. and analyzes the chem. principles of antioxidant capacity assays.  Depending upon the reactions involved, these assays can roughly be classified into two types: assays based on hydrogen atom transfer (HAT) reactions and assays based on electron transfer (ET).  The majority of HAT-based assays apply a competitive reaction scheme, in which antioxidant and substrate compete for thermally generated peroxyl radicals through the decompn. of azo compds.  These assays include inhibition of induced low-d. lipoprotein autoxidn., oxygen radical absorbance capacity (ORAC), total radical trapping antioxidant parameter (TRAP), and crocin bleaching assays.  ET-based assays measure the capacity of an antioxidant in the redn. of an oxidant, which changes color when reduced.  The degree of color change is correlated with the sample's antioxidant concns.  ET-based assays include the total phenols assay by Folin-Ciocalteu reagent (FCR), Trolox equivalence antioxidant capacity (TEAC), ferric ion reducing antioxidant power (FRAP), "total antioxidant potential" assay using a Cu(II) complex as an oxidant, and DPPH.  In addn., other assays intended to measure a sample's scavenging capacity of biol. relevant oxidants such as singlet oxygen, superoxide anion, peroxynitrite, and hydroxyl radical are also summarized.  On the basis of this anal., it is suggested that the total phenols assay by FCR be used to quantify an antioxidant's reducing capacity and the ORAC assay to quantify peroxyl radical scavenging capacity.  To comprehensively study different aspects of antioxidants, validated and specific assays are needed in addn. to these two commonly accepted assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJFACfeXfIw7Vg90H21EOLACvtfcHk0lj-Rh-w2Hn9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslaltLo%253D&md5=52074f4022f9d83ff8333f31f3d6cc4b</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjf030723c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf030723c%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DOu%26aufirst%3DB.%26aulast%3DPrior%26aufirst%3DR.%2BL.%26atitle%3DThe%2520chemistry%2520behind%2520antioxidant%2520capacity%2520assays%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2005%26volume%3D53%26spage%3D1841%26epage%3D1856%26doi%3D10.1021%2Fjf030723c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood-brain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/s0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood-brain+barrier&doi=10.1016%2Fs0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lj-Rh-w2Hn9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2Fs0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Justice, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConlogue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Games, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. G. M.</span></span> <span> </span><span class="NLM_article-title">A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">979</span>, <span class="refDoi"> DOI: 10.1038/35050103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1038%2F35050103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=11140684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=975-979&author=G.+Chenauthor=K.+S.+Chenauthor=J.+Knoxauthor=J.+Inglisauthor=A.+Bernardauthor=S.+J.+Martinauthor=A.+Justiceauthor=L.+McConlogueauthor=D.+Gamesauthor=S.+B.+Freedmanauthor=R.+G.+M.+Morris&title=A+learning+deficit+related+to+age+and+%CE%B2-amyloid+plaques+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1038%2F35050103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Chen, Gulquan; Chen, Karen S.; Knox, Jane; Inglis, Jennifer; Bernard, Andrew; Martin, Stephen J.; Justice, Alan; McConlogue, Lisa; Games, Dora; Freedman, Stephen B.; Morris, Richard G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">975-979</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mice that overexpress the human mutant amyloid precursor protein (hAPP) show learning deficits, but the apparent lack of a relation between these deficits and the progressive β amyloid plaque formation that the hAPP mice display is puzzling.  In the water maze, hAPP mice are impaired before and after amyloid plaque deposition.  Here the authors show, using a new water-maze training protocol, that PDAPP mice also exhibit a sep. age-related deficit in learning a series of spatial locations.  This impairment correlates with β-amyloid plaque burden and is shown in both cross-sectional and longitudinal exptl. designs.  Cued navigation and object-recognition memory are normal.  These findings indicate that Aβ overexpression and/or Aβ plaques are assocd. with disturbed cognitive function and, importantly, suggest that some but not all forms of learning and memory are suitable behavioral assays of the progressive cognitive deficits assocd. with Alzheimer's-disease-type pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPiCvEhUwqt7Vg90H21EOLACvtfcHk0liJMT43Ezf9jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslWjsQ%253D%253D&md5=873eb06b98d0bc5a68f8b25e6b14329f</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2F35050103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050103%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DKnox%26aufirst%3DJ.%26aulast%3DInglis%26aufirst%3DJ.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26aulast%3DJustice%26aufirst%3DA.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DMorris%26aufirst%3DR.%2BG.%2BM.%26atitle%3DA%2520learning%2520deficit%2520related%2520to%2520age%2520and%2520%25CE%25B2-amyloid%2520plaques%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D975%26epage%3D979%26doi%3D10.1038%2F35050103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease is a synaptic failure</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>298</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1126/science.1074069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1126%2Fscience.1074069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=12399581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFSnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=789-791&author=D.+J.+Selkoe&title=Alzheimer%E2%80%99s+disease+is+a+synaptic+failure&doi=10.1126%2Fscience.1074069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease Is a Synaptic Failure</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5594</span>),
    <span class="NLM_cas:pages">789-791</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In its earliest clin. phase, Alzheimer's disease characteristically produces a remarkably pure impairment of memory.  Mounting evidence suggests that this syndrome begins with subtle alterations of hippocampal synaptic efficacy prior to frank neuronal degeneration, and that the synaptic dysfunction is caused by diffusible oligomeric assemblies of the amyloid β protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsFVFyrx-gM7Vg90H21EOLACvtfcHk0liJMT43Ezf9jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFSnur0%253D&md5=5927195bd25a2d0fdf1663972f32a139</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1126%2Fscience.1074069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1074069%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520is%2520a%2520synaptic%2520failure%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D789%26epage%3D791%26doi%3D10.1126%2Fscience.1074069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanzi, R. E.</span></span> <span> </span><span class="NLM_article-title">The synaptic Aβ hypothesis of Alzheimer disease</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">977</span>– <span class="NLM_lpage">979</span>, <span class="refDoi"> DOI: 10.1038/nn0805-977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1038%2Fnn0805-977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=16047022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFWmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=977-979&author=R.+E.+Tanzi&title=The+synaptic+A%CE%B2+hypothesis+of+Alzheimer+disease&doi=10.1038%2Fnn0805-977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">The synaptic Aβ hypothesis of Alzheimer disease</span></div><div class="casAuthors">Tanzi, Rudolph E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">977-979</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgtcPxmCwJV7Vg90H21EOLACvtfcHk0liJMT43Ezf9jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFWmtrk%253D&md5=5dc2b2c612a6e2d02bc0bee695cff5a3</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fnn0805-977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn0805-977%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26atitle%3DThe%2520synaptic%2520A%25CE%25B2%2520hypothesis%2520of%2520Alzheimer%2520disease%26jtitle%3DNat.%2520Neurosci.%26date%3D2005%26volume%3D8%26spage%3D977%26epage%3D979%26doi%3D10.1038%2Fnn0805-977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mango, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cisale, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feligioni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nisticò, R.</span></span> <span> </span><span class="NLM_article-title">Targeting synaptic plasticity in experimental models of Alzheimer’s disease</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">778</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3389%2Ffphar.2019.00778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31379566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVart70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=778&author=D.+Mangoauthor=A.+Saidiauthor=G.+Y.+Cisaleauthor=M.+Feligioniauthor=M.+Corboauthor=R.+Nistic%C3%B2&title=Targeting+synaptic+plasticity+in+experimental+models+of+Alzheimer%E2%80%99s+disease&doi=10.3389%2Ffphar.2019.00778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting synaptic plasticity in experimental models of Alzheimer's disease</span></div><div class="casAuthors">Mango, Dalila; Sai, Amira; Cisale, Giusy Ylenia; Feligioni, Marco; Corbo, Massimo; Nistico, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">778</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Long-term potentiation (LTP) and long-term depression (LTD) of hippocampal synaptic transmission represent the principal exptl. models underlying learning and memory.  Alterations of synaptic plasticity are obsd. in several neurodegenerative disorders, including Alzheimer's disease (AD).  Indeed, synaptic dysfunction is an early event in AD, making it an attractive therapeutic target for pharmaceutical intervention.  To date, intensive investigations have characterized hippocampal synaptic transmission, LTP, and LTD in in vitro and in murine models of AD.  In this review, we describe the synaptic alterations across the main AD models generated so far.  We then examine the clin. perspective of LTP/LTD studies and discuss the limitations of non-clin. models and how to improve their predictive validity in the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIifnDt6xTG7Vg90H21EOLACvtfcHk0liJMT43Ezf9jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVart70%253D&md5=c520a1fbe96df03bac063eab694feb3d</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00778%26sid%3Dliteratum%253Aachs%26aulast%3DMango%26aufirst%3DD.%26aulast%3DSaidi%26aufirst%3DA.%26aulast%3DCisale%26aufirst%3DG.%2BY.%26aulast%3DFeligioni%26aufirst%3DM.%26aulast%3DCorbo%26aufirst%3DM.%26aulast%3DNistic%25C3%25B2%26aufirst%3DR.%26atitle%3DTargeting%2520synaptic%2520plasticity%2520in%2520experimental%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D778%26doi%3D10.3389%2Ffphar.2019.00778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trinchese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaglia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span> <span> </span><span class="NLM_article-title">Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">814</span>, <span class="refDoi"> DOI: 10.1002/ana.20101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Fana.20101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=15174014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVCktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=801-814&author=F.+Trincheseauthor=S.+Liuauthor=F.+Battagliaauthor=S.+Walterauthor=P.+M.+Mathewsauthor=O.+Arancio&title=Progressive+age-related+development+of+Alzheimer-like+pathology+in+APP%2FPS1+mice&doi=10.1002%2Fana.20101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice</span></div><div class="casAuthors">Trinchese, Fabrizio; Liu, Shumin; Battaglia, Fortunato; Walter, Sean; Mathews, Paul M.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">801-814</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Increasing evidence points to synaptic plasticity impairment as one of the first events in Alzheimer's disease (AD).  However, studies on synaptic dysfunction in different transgenic AD models that overexpress familial AD mutant forms of amyloid precursor protein (APP) and/or presenilin (PS) have provided conflicting results.  Both long-term potentiation (LTP) and basal synaptic transmission (BST) have been found to be both unchanged and altered in different models and under differing exptl. conditions.  Because of their more robust amyloid-β (Aβ) deposition, double transgenic mice currently are used by several labs. as an AD model.  Here, we report that mice overexpressing APP (K670N: M671L) together with PS1 (M146L) have abnormal LTP as early as 3 mo of age.  Interestingly, reduced LTP paralleled plaque appearance and increased Aβ levels and abnormal short-term memory (working memory).  BST and long-term memory (ref. memory) are impaired only later (approx. 6 mo) as amyloid burden increases.  Aβ pathol. across different ages did not correlate with synaptic and cognitive deficits, suggesting that Aβ levels are not a marker of memory decline.  In contrast, progression of LTP impairment correlated with the deterioration of working memory, suggesting that percentage of potentiation might be an indicator of the cognitive decline and disease progression in the APP/PS1 mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-0Sep8mnVgLVg90H21EOLACvtfcHk0lie8bXPgasSwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVCktbc%253D&md5=87f7a6dea17b0d35a775712088213641</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fana.20101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20101%26sid%3Dliteratum%253Aachs%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DBattaglia%26aufirst%3DF.%26aulast%3DWalter%26aufirst%3DS.%26aulast%3DMathews%26aufirst%3DP.%2BM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DProgressive%2520age-related%2520development%2520of%2520Alzheimer-like%2520pathology%2520in%2520APP%252FPS1%2520mice%26jtitle%3DAnn.%2520Neurol.%26date%3D2004%26volume%3D55%26spage%3D801%26epage%3D814%26doi%3D10.1002%2Fana.20101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cisternas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliva, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrera, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Presymptomatic treatment with andrographolide improves brain metabolic markers and cognitive behavior in a model of early-onset Alzheimer’s disease</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">295</span>, <span class="refDoi"> DOI: 10.3389/fncel.2019.00295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.3389%2Ffncel.2019.00295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=31379502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktV2ksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2019&pages=295&author=P.+Cisternasauthor=C.+A.+Olivaauthor=V.+I.+Torresauthor=D.+P.+Barreraauthor=N.+C.+Inestrosa&title=Presymptomatic+treatment+with+andrographolide+improves+brain+metabolic+markers+and+cognitive+behavior+in+a+model+of+early-onset+Alzheimer%E2%80%99s+disease&doi=10.3389%2Ffncel.2019.00295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Presymptomatic treatment with andrographolide improves brain metabolic markers and cognitive behavior in a model of early-onset Alzheimer's disease</span></div><div class="casAuthors">Cisternas, Pedro; Oliva, Carolina A.; Torres, Viviana I.; Barrera, Daniela P.; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">295</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common type of dementia.  The onset and progression of this pathol. are correlated with several changes in the brain, including the formation of extracellular aggregates of amyloid-βeta (Aβ) peptide and the intracellular accumulation of hyperphosphorylated tau protein.  In addn., dysregulated neuronal plasticity, synapse loss, and a redn. in cellular energy metab. have also been described.  Canonical Wnt signaling has also been shown to be downregulated in AD.  Remarkably, we showed previously that the in vivo inhibition of Wnt signaling accelerates the appearance of AD markers in transgenic (Tg) and wild-type (WT) mice.  Addnl., we found that Wnt signaling stimulates energy metab., which is crit. for the ability of Wnt to promote the recovery of cognitive function in AD.  Therefore, we hypothesized that activation of canonical Wnt signaling in a presymptomatic transgenic animal model of AD would improve some symptoms.  To explore the latter, we used a transgenic mouse model (J20 Tg) with mild AD phenotype expression (high levels of amyloid aggregates) and studied the effect of andrographolide (ANDRO), an activator of canonical Wnt signaling.  We found that presymptomatic administration of ANDRO in J20 Tg mice prevented the redn. in cellular energy metab. markers.  Moreover, treated animals showed improvement in cognitive performance.  At the synaptic level, J20 Tg animals showed severe deficiencies in presynaptic function as detd. by electrophysiol. parameters, all of which were completely restored to normal by ANDRO administration.  Finally, an anal. of hippocampal synaptosomes by electron microscopy revealed that the length of synapses was restored with ANDRO treatment.  Altogether, these data support the idea that the activation of canonical Wnt signaling during presymptomatic stages could represent an interesting pharmacol. strategy to delay the onset of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6qgcSjvcr6bVg90H21EOLACvtfcHk0lie8bXPgasSwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktV2ksr4%253D&md5=7fee3919f5b24643541eb59d61361316</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2019.00295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2019.00295%26sid%3Dliteratum%253Aachs%26aulast%3DCisternas%26aufirst%3DP.%26aulast%3DOliva%26aufirst%3DC.%2BA.%26aulast%3DTorres%26aufirst%3DV.%2BI.%26aulast%3DBarrera%26aufirst%3DD.%2BP.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DPresymptomatic%2520treatment%2520with%2520andrographolide%2520improves%2520brain%2520metabolic%2520markers%2520and%2520cognitive%2520behavior%2520in%2520a%2520model%2520of%2520early-onset%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2019%26volume%3D13%26spage%3D295%26doi%3D10.3389%2Ffncel.2019.00295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition</span>. <i>BMC Complement Altern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">167</span>, <span class="refDoi"> DOI: 10.1186/s12906-018-2237-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1186%2Fs12906-018-2237-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=29843688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjsVCmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=167&author=J.-H.+Zhangauthor=L.-J.+Yuauthor=H.+Yangauthor=Z.+Huiauthor=S.+Jiangauthor=L.+Chenauthor=Y.+Zhaoauthor=S.-L.+Wangauthor=Y.+Liuauthor=Y.+Xu&title=Huatuo+Zaizao+pill+ameliorates+cognitive+impairment+of+APP%2FPS1+transgenic+mice+by+improving+synaptic+plasticity+and+reducing+A%CE%B2+deposition&doi=10.1186%2Fs12906-018-2237-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition</span></div><div class="casAuthors">Zhang, Jing-Hua; Yu, Lin-Jie; Yang, Hui; Hui, Zhen; Jiang, Su; Chen, Ling; Zhao, Yang; Wang, Su-Lei; Liu, Yi; Xu, Yun</div><div class="citationInfo"><span class="NLM_cas:title">BMC Complementary and Alternative Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">167/1-167/13</span>CODEN:
                <span class="NLM_cas:coden">BCAMCV</span>;
        ISSN:<span class="NLM_cas:issn">1472-6882</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: It is well known that Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by memory deficits and cognitive decline.  Amyloid-β (Aβ) deposition and synaptic dysfunction play important roles in the pathophysiol. of Alzheimer's disease (AD).  The Huatuo Zaizao pill (HT) is a Traditional Chinese Medicine (TCM) that has been used clin. for many years in China, mainly for post-stroke rehabilitation and cognitive decline; however, the mechanism of cognitive function is not clear.  In this study, we investigated the effect of HT on hippocampal synaptic function, Amyloid-β (Aβ) deposition in APP/PS1 AD transgenic mice.  Method: Six-month-old APP/PS1 transgenic (Tg) mice were randomly divided into control, HT-treated, and memantine (MEM)-treated groups.  Then, these groups were orally administered vehicle (for the control), HT (0.25 g/kg) and MEM (5 mg/kg) resp. for 4 wk.  The Morris water maze, Novel Object Recognition, and Open field tests were used to assess cognitive behavioral changes.  We evaluated the effects of HT on neuronal excitability, membrane ion channel activity, and synaptic plasticity in acute hippocampal slices by combining electrophysiol. extracellular tests.  Synaptic morphol. in the hippocampus was investigated by electron microscopy.  Western blotting was used to assess synaptic-assocd. protein and Aβ prodn. and degrading levels.  Immunofluorescence staining was used to det. the relative integrated d.  Results: HT can ameliorate hippocampus-dependent memory deficits and improve synaptic dysfunction by reversing LTP impairment in APP/PS1 transgenic mice.  Moreover, HT reduces amyloid plaque deposition by regulating α-secretase and γ-secretase levels.  Conclusion: HT can improve the learning and memory function of APP/PS1 transgenic mice by improving synaptic function and reducing amyloid plaque deposition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF5TAYUOk3ALVg90H21EOLACvtfcHk0lie8bXPgasSwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjsVCmtb0%253D&md5=ac5fe8c162a62a311f4eb56daa9c3473</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1186%2Fs12906-018-2237-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12906-018-2237-2%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DYu%26aufirst%3DL.-J.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHui%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.-L.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DHuatuo%2520Zaizao%2520pill%2520ameliorates%2520cognitive%2520impairment%2520of%2520APP%252FPS1%2520transgenic%2520mice%2520by%2520improving%2520synaptic%2520plasticity%2520and%2520reducing%2520A%25CE%25B2%2520deposition%26jtitle%3DBMC%2520Complement%2520Altern.%2520Med.%26date%3D2018%26volume%3D18%26spage%3D167%26doi%3D10.1186%2Fs12906-018-2237-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapia-Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerpa, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">61</span>, <span class="refDoi"> DOI: 10.1186/1750-1326-9-61</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1186%2F1750-1326-9-61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=25524173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislOhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=61&author=F.+G.+Serranoauthor=C.+Tapia-Rojasauthor=F.+J.+Carvajalauthor=J.+Hanckeauthor=W.+Cerpaauthor=N.+C.+Inestrosa&title=Andrographolide+reduces+cognitive+impairment+in+young+and+mature+A%CE%B2PPswe%2FPS-1+mice&doi=10.1186%2F1750-1326-9-61"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice</span></div><div class="casAuthors">Serrano, Felipe G.; Tapia-Rojas, Cheril; Carvajal, Francisco J.; Hancke, Juan; Cerpa, Waldo; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61/1-61/32, 32 pp.</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder in which the amyloid-β (Aβ) oligomers are a key factor in synaptic impairment and in spatial memory decline assocd. with neuronal dysfunction.  This impairment includes synaptic failure assocd. with the loss of synaptic proteins that contribute to AD progression.  Interestingly, the use of natural compds. is an emergent conceptual strategy in the search for drugs with therapeutic potentials for treating neurodegenerative disorders.  In the present study, we report that andrographolide (ANDRO), which is a labdane diterpene extd. from Andrographis paniculata, increases slope of field excitatory postsynaptic potentials (fEPSP) in the CA1 region of hippocampal slices and inhibits long-term depression (LTD), protecting the longterm potentiation (LTP) against the damage induced by Aβ oligomers in vitro, most likely by inhibiting glycogen synthase kinase-3β (GSK-3β).  Addnl., ANDRO prevents changes in neuropathol. in two different age groups (7- and 12-mo-old mice) of an AβPPswe/PS-1 Alzheimer's model.  ANDRO reduces the Aβ levels, changing the ontogeny of amyloid plaques in hippocampi and cortices in 7-mo-old mice, and reduces tau phosphorylation around the Aβ oligomeric species in both age groups.  Addnl., we obsd. that ANDRO recovers spatial memory functions that correlate with protecting synaptic plasticity and synaptic proteins in two different age groups.  Our results suggest that ANDRO could be used in a potential preventive therapy during AD progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWLPjpr6oJrVg90H21EOLACvtfcHk0lh3YiWuHQMhsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislOhu78%253D&md5=00cf5de1a1db358a1b71fdcc2df84324</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-9-61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-9-61%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DCarvajal%26aufirst%3DF.%2BJ.%26aulast%3DHancke%26aufirst%3DJ.%26aulast%3DCerpa%26aufirst%3DW.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DAndrographolide%2520reduces%2520cognitive%2520impairment%2520in%2520young%2520and%2520mature%2520A%25CE%25B2PPswe%252FPS-1%2520mice%26jtitle%3DMol.%2520Neurodegener.%26date%3D2014%26volume%3D9%26spage%3D61%26doi%3D10.1186%2F1750-1326-9-61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perluigi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coccia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterfield, D. A.</span></span> <span> </span><span class="NLM_article-title">4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: A toxic combination illuminated by redox proteomics studies</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1590</span>– <span class="NLM_lpage">1609</span>, <span class="refDoi"> DOI: 10.1089/ars.2011.4406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1089%2Fars.2011.4406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=22114878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1590-1609&author=M.+Perluigiauthor=R.+Cocciaauthor=D.+A.+Butterfield&title=4-Hydroxy-2-nonenal%2C+a+reactive+product+of+lipid+peroxidation%2C+and+neurodegenerative+diseases%3A+A+toxic+combination+illuminated+by+redox+proteomics+studies&doi=10.1089%2Fars.2011.4406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">4-Hydroxy-2-Nonenal, a Reactive Product of Lipid Peroxidation, and Neurodegenerative Diseases: A Toxic Combination Illuminated by Redox Proteomics Studies</span></div><div class="casAuthors">Perluigi, Marzia; Coccia, Raffaella; Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1590-1609</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Significance: Among different forms of oxidative stress, lipid peroxidn. comprises the interaction of free radicals with polyunsatd. fatty acids, which in turn leads to the formation of highly reactive electrophilic aldehydes.  Among these, the most abundant aldehydes are 4-hydroxy-2-nonenal (HNE) and malondialdehyde, while acrolein is the most reactive.  HNE is considered a robust marker of oxidative stress and a toxic compd. for several cell types.  Proteins are particularly susceptible to modification caused by HNE, and adduct formation plays a crit. role in multiple cellular processes.  Recent Advances: With the outstanding progress of proteomics, the identification of putative biomarkers for neurodegenerative disorders has been the main focus of several studies and will continue to be a difficult task.  Crit. Issues: The present review focuses on the role of lipid peroxidn., particularly of HNE-induced protein modification, in neurodegenerative diseases.  By comparing results obtained in different neurodegenerative diseases, it may be possible to identify both similarities and specific differences in addn. to better characterize selective neurodegenerative phenomena assocd. with protein dysfunction.  Results obtained in our lab. and others support the common deregulation of energy metab. and mitochondrial function in neurodegeneration.  Future Directions: Research towards a better understanding of the mol. mechanisms involved in neurodegeneration together with identification of specific targets of oxidative damage is urgently required.  Redox proteomics will contribute to broaden the knowledge in regard to potential biomarkers for disease diagnosis and may also provide insight into damaged metabolic networks and potential targets for modulation of disease progression.  Antioxid. Redox Signal. 17, 1590-1609.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8xhgvE-K1VbVg90H21EOLACvtfcHk0lh3YiWuHQMhsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsLnK&md5=92ed19fca59d7759cacfb93eb8646af2</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1089%2Fars.2011.4406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2011.4406%26sid%3Dliteratum%253Aachs%26aulast%3DPerluigi%26aufirst%3DM.%26aulast%3DCoccia%26aufirst%3DR.%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3D4-Hydroxy-2-nonenal%252C%2520a%2520reactive%2520product%2520of%2520lipid%2520peroxidation%252C%2520and%2520neurodegenerative%2520diseases%253A%2520A%2520toxic%2520combination%2520illuminated%2520by%2520redox%2520proteomics%2520studies%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2012%26volume%3D17%26spage%3D1590%26epage%3D1609%26doi%3D10.1089%2Fars.2011.4406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamphuis, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middeldorp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooijman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sluijs, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooi, E.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freriks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizee, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, E. M.</span></span> <span> </span><span class="NLM_article-title">Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">510</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2013.09.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.neurobiolaging.2013.09.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=24269023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Oqs7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=492-510&author=W.+Kamphuisauthor=J.+Middeldorpauthor=L.+Kooijmanauthor=J.+A.+Sluijsauthor=E.-J.+Kooiauthor=M.+Moetonauthor=M.+Freriksauthor=M.+R.+Mizeeauthor=E.+M.+Hol&title=Glial+fibrillary+acidic+protein+isoform+expression+in+plaque+related+astrogliosis+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2013.09.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease</span></div><div class="casAuthors">Kamphuis, Willem; Middeldorp, Jinte; Kooijman, Lieneke; Sluijs, Jacqueline A.; Kooi, Evert-Jan; Moeton, Martina; Freriks, Michel; Mizee, Mark R.; Hol, Elly M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">492-510</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In Alzheimer's disease (AD), amyloid plaques are surrounded by reactive astrocytes with an increased expression of intermediate filaments including glial fibrillary acidic protein (GFAP).  Different GFAP isoforms have been identified that are differentially expressed by specific subpopulations of astrocytes and that impose different properties to the intermediate filament network.  We studied transcript levels and protein expression patterns of all known GFAP isoforms in human hippocampal AD tissue at different stages of the disease.  Ten different transcripts for GFAP isoforms were detected at different abundancies.  Transcript levels of most isoforms increased with AD progression.  GFAPδ-immunopos. astrocytes were obsd. in subgranular zone, hilus, and stratum-lacunosum-moleculare.  GFAPδ-pos. cells also stained for GFAPα.  In AD donors, astrocytes near plaques displayed increased staining of both GFAPα and GFAPδ.  The reading-frame-shifted isoform, GFAP+1, staining was confined to a subset of astrocytes with long processes, and their no. increased in the course of AD.  In conclusion, the various GFAP isoforms show differential transcript levels and are upregulated in a concerted manner in AD.  The GFAP+1 isoform defines a unique subset of astrocytes, with nos. increasing with AD progression.  These data indicate the need for future exploration of underlying mechanisms concerning the functions of GFAPδ and GFAP+1 isoforms in astrocytes and their possible role in AD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFD1oM8p0UdbVg90H21EOLACvtfcHk0lh3YiWuHQMhsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Oqs7nJ&md5=269c53d302ffe32f57a5fb68e9945d4c</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2013.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2013.09.035%26sid%3Dliteratum%253Aachs%26aulast%3DKamphuis%26aufirst%3DW.%26aulast%3DMiddeldorp%26aufirst%3DJ.%26aulast%3DKooijman%26aufirst%3DL.%26aulast%3DSluijs%26aufirst%3DJ.%2BA.%26aulast%3DKooi%26aufirst%3DE.-J.%26aulast%3DMoeton%26aufirst%3DM.%26aulast%3DFreriks%26aufirst%3DM.%26aulast%3DMizee%26aufirst%3DM.%2BR.%26aulast%3DHol%26aufirst%3DE.%2BM.%26atitle%3DGlial%2520fibrillary%2520acidic%2520protein%2520isoform%2520expression%2520in%2520plaque%2520related%2520astrogliosis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2014%26volume%3D35%26spage%3D492%26epage%3D510%26doi%3D10.1016%2Fj.neurobiolaging.2013.09.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nordberg, A.</span>; <span class="NLM_string-name">Ballard, C.</span>; <span class="NLM_string-name">Bullock, R.</span>; <span class="NLM_string-name">Darreh-Shori, T.</span>; <span class="NLM_string-name">Somogyi, M.</span></span> <span> </span><span class="NLM_article-title">A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer’s disease</span>.  <i>Prime Care Companion CNS Disord.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume">15</span>, <span class="refDoi"> DOI: 10.4088/PCC.12r01412</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.4088%2FPCC.12r01412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=23930233" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&author=A.+Nordberg&author=C.+Ballard&author=R.+Bullock&author=T.+Darreh-Shori&author=M.+Somogyi&title=A+review+of+butyrylcholinesterase+as+a+therapeutic+target+in+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.4088%2FPCC.12r01412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.4088%2FPCC.12r01412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FPCC.12r01412%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DA.%26atitle%3DA%2520review%2520of%2520butyrylcholinesterase%2520as%2520a%2520therapeutic%2520target%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPrime%2520Care%2520Companion%2520CNS%2520Disord.%26date%3D2013%26volume%3D15%26doi%3D10.4088%2FPCC.12r01412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <i>The Organic Chemistry of Enzyme-Catalyzed Reactions</i>. <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_publisher-loc">San Diego</span>, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=R.+B.+Silverman&title=The+Organic+Chemistry+of+Enzyme-Catalyzed+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26btitle%3DThe%2520Organic%2520Chemistry%2520of%2520Enzyme-Catalyzed%2520Reactions%26pub%3DAcademic%2520Press%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nunes-Tavares, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nery da Matta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista e Silva, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araújo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louro, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassón-Voloch, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of acetylcholinesterase from Electrophorus electricus (L.) by tricyclic antidepressants</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1016/S1357-2725(02)00027-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2FS1357-2725%2802%2900027-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=12009302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFynsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=1071-1079&author=N.+Nunes-Tavaresauthor=A.+Nery+da+Mattaauthor=C.+M.+Batista+e+Silvaauthor=G.+M.+Ara%C3%BAjoauthor=S.+R.+Louroauthor=A.+Hass%C3%B3n-Voloch&title=Inhibition+of+acetylcholinesterase+from+Electrophorus+electricus+%28L.%29+by+tricyclic+antidepressants&doi=10.1016%2FS1357-2725%2802%2900027-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acetylcholinesterase from Electrophorus electricus (L.) by tricyclic antidepressants</span></div><div class="casAuthors">Nunes-Tavares, N.; Nery da Matta, A.; Batista e Silva, C. M.; Araujo, G. M. N.; Louro, S. R. W.; Hasson-Voloch, A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1071-1079</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The effects of tricyclic antidepressants drugs (TCA) amitriptyline, imipramine and nortriptyline, on purified Electrophorus electricus (L.) acetylcholinesterase (AChE; acetylcholine hydrolase, EC 3.1.1.7) were studied using kinetic methods and specific fluorescent probe propidium.  The antidepressants inhibited AChE activity by a non-competitive mechanism.  Inhibition consts. range from 200 to 400 μM.  Dimethylated amitriptyline and imipramine were more potent inhibitors than the monomethylated nortriptyline.  Fluorescence measurements using bis-quaternary ligand propidium were used to monitor ligand-binding properties of these cationic antidepressants to the AChE peripheral anionic site (PAS).  This ligand exhibited an eight-fold fluorescence enhancement upon binding to the peripheral anionic site of AChE from E. electricus (L.) with KD=7×10-7 M.  It was obsd. that TCA drugs displaced propidium from the enzyme.  On the basis of the displacement expts. antidepressant dissocn. consts. were detd.  Similar values for the inhibition consts. suggest that these drugs have similar affinity to the peripheral anionic site.  The results also indicate that the catalytic active center of AChE does not participate in the interaction of enzyme with tricyclic antidepressants.  These studies suggest that the binding site for tricyclic antidepressants is located at the peripheral anionic site of E. electricus (L.) acetylcholinesterase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryPgDAp502jbVg90H21EOLACvtfcHk0ljePi69Dntwow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFynsrw%253D&md5=b9516cc41f34d8d811af0bdf0a73e572</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2FS1357-2725%2802%2900027-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-2725%252802%252900027-4%26sid%3Dliteratum%253Aachs%26aulast%3DNunes-Tavares%26aufirst%3DN.%26aulast%3DNery%2Bda%2BMatta%26aufirst%3DA.%26aulast%3DBatista%2Be%2BSilva%26aufirst%3DC.%2BM.%26aulast%3DAra%25C3%25BAjo%26aufirst%3DG.%2BM.%26aulast%3DLouro%26aufirst%3DS.%2BR.%26aulast%3DHass%25C3%25B3n-Voloch%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520acetylcholinesterase%2520from%2520Electrophorus%2520electricus%2520%2528L.%2529%2520by%2520tricyclic%2520antidepressants%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2002%26volume%3D34%26spage%3D1071%26epage%3D1079%26doi%3D10.1016%2FS1357-2725%2802%2900027-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brand-Williams, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuvelier, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berset, C.</span></span> <span> </span><span class="NLM_article-title">Use of a free radical method to evaluate antioxidant activity</span>. <i>LWT–Food Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/S0023-6438(95)80008-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2FS0023-6438%2895%2980008-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaK2MXjvV2itLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1995&pages=25-30&author=W.+Brand-Williamsauthor=M.+E.+Cuvelierauthor=C.+Berset&title=Use+of+a+free+radical+method+to+evaluate+antioxidant+activity&doi=10.1016%2FS0023-6438%2895%2980008-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a free radical method to evaluate antioxidant activity</span></div><div class="casAuthors">Brand-WIlliams, W.; Cuvelier, M. E.; Berset, C.</div><div class="citationInfo"><span class="NLM_cas:title">Food Science & Technology (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-30</span>CODEN:
                <span class="NLM_cas:coden">LBWTAP</span>;
        ISSN:<span class="NLM_cas:issn">0023-6438</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The antiradical activities of various antioxidants were detd. using the free radical, 2,2-Diphenyl-1-picrylhydrazyl (DPPH•).  In its radical form, DPPH• has an absorption band at 515 nm which disappears upon redn. by an antiradical compd.  Twenty compds. were reacted with the DPPH• and shown to follow one of three possible reaction kinetic types.  Ascorbic acid, isoascorbic acid and isoeugenol reacted quickly with the DPPH•, reaching a steady state immediately.  Rosmarinic acid and δ-tocopherol reacted a little slower and reached a steady state within 30 min.  The remaining compds. reacted more progressively with the DPPH•, reaching a steady state in 1-6 h.  Caffeic acid, gentisic acid and gallic acid showed the highest antiradical activities with a stoichiometry of 4 to 6 reduced DPPH• mols. per mol. of antioxidant.  Vanillin, phenol, γ-resorcylic acid and vanillic acid were found to be poor antiradical compds.  The stoichiometry for the other 13 phenolic compds. varied from one to three reduced DPPH• mols. per mol. of antioxidant.  Possible mechanisms are proposed to explain the exptl. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdgt6zsPPpvLVg90H21EOLACvtfcHk0ljePi69Dntwow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvV2itLw%253D&md5=0568c73ee9d55ec1d5b72153416e7e4a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2FS0023-6438%2895%2980008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0023-6438%252895%252980008-5%26sid%3Dliteratum%253Aachs%26aulast%3DBrand-Williams%26aufirst%3DW.%26aulast%3DCuvelier%26aufirst%3DM.%2BE.%26aulast%3DBerset%26aufirst%3DC.%26atitle%3DUse%2520of%2520a%2520free%2520radical%2520method%2520to%2520evaluate%2520antioxidant%2520activity%26jtitle%3DLWT%25E2%2580%2593Food%2520Sci.%2520Technol.%26date%3D1995%26volume%3D28%26spage%3D25%26epage%3D30%26doi%3D10.1016%2FS0023-6438%2895%2980008-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavakkoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saso, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firuzi, O.</span></span> <span> </span><span class="NLM_article-title">Alkyl esters of acids with improved antioxidant activity and lipophilicity protect PC12 cells against oxidative stress</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">961</span>– <span class="NLM_lpage">967</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2011.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.biochi.2011.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=22210493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSgtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2012&pages=961-967&author=J.+Garridoauthor=A.+Gasparauthor=E.+M.+Garridoauthor=R.+Miriauthor=M.+Tavakkoliauthor=S.+Pouraliauthor=L.+Sasoauthor=F.+Borgesauthor=O.+Firuzi&title=Alkyl+esters+of+acids+with+improved+antioxidant+activity+and+lipophilicity+protect+PC12+cells+against+oxidative+stress&doi=10.1016%2Fj.biochi.2011.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Alkyl esters of hydroxycinnamic acids with improved antioxidant activity and lipophilicity protect PC12 cells against oxidative stress</span></div><div class="casAuthors">Garrido, Jorge; Gaspar, Alexandra; Garrido, E. Manuela; Miri, Ramin; Tavakkoli, Marjan; Pourali, Samaneh; Saso, Luciano; Borges, Fernanda; Firuzi, Omidreza</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">961-967</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Hydroxycinnamic acids (HCAs) are phenolic compds. present in dietary plants, which possess considerable antioxidant activity.  In order to increase the lipophilicity of HCAs, with the aim of improving their cellular absorption and expansion of their use in lipophilic media, Me, Et, Pr and Bu esters of caffeic acid and ferulic acid have been synthesized.  All caffeate esters had a slightly lower DPPH IC50 (13.5-14.5 μM) and higher ferric reducing antioxidant power (FRAP) values (1490-1588 mM quercetin/mol [mMQ/mol]) compared to caffeic acid (16.6 μM and 1398 mMQ/mol, resp.) in antioxidant assays.  In contrast, ferulate esters were less active in DPPH (56.3-74.7 μM) and FRAP assays (193-262 mMQ/mol) compared to ferulic acid (44.6 μM and 324 mMQ/mol, resp.).  Redox properties of HCAs were in line with their antioxidant capacities, so that compds. with higher antioxidant activities had lower oxidn. potentials.  Measurement of partition coeffs. disclosed the higher lipophilicity of the esters compared to parent compds.  All esters of caffeic acid significantly inhibited hydrogen peroxide-induced neuronal PC12 cell death assessed by MTT assay at 5 and 25 μM.  However, caffeic acid, ferulic acid and ferulate esters were not able to protect the cells.  In conclusion, these findings suggest that alkyl esterification of some HCAs augments their antioxidant properties as well as their lipophilicity and as a consequence, improves their cell protective activity against oxidative stress.  These compds. could have useful applications in conditions where oxidative stress plays a pathogenic role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF02j2Bw-IabVg90H21EOLACvtfcHk0ljePi69Dntwow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSgtrk%253D&md5=602237a94bc021ca41758fe54c96b5ad</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2011.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2011.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DGarrido%26aufirst%3DJ.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DGarrido%26aufirst%3DE.%2BM.%26aulast%3DMiri%26aufirst%3DR.%26aulast%3DTavakkoli%26aufirst%3DM.%26aulast%3DPourali%26aufirst%3DS.%26aulast%3DSaso%26aufirst%3DL.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DFiruzi%26aufirst%3DO.%26atitle%3DAlkyl%2520esters%2520of%2520acids%2520with%2520improved%2520antioxidant%2520activity%2520and%2520lipophilicity%2520protect%2520PC12%2520cells%2520against%2520oxidative%2520stress%26jtitle%3DBiochimie%26date%3D2012%26volume%3D94%26spage%3D961%26epage%3D967%26doi%3D10.1016%2Fj.biochi.2011.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frolow, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span> <span> </span><span class="NLM_article-title">Purification and crystallization of a dimeric form of acetylcholinesterase from <i>Torpedo californica</i> subsequent to solubilization with phosphatidylinositol-specific phospholipase C</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">823</span>, <span class="refDoi"> DOI: 10.1016/0022-2836(88)90213-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2F0022-2836%2888%2990213-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=2850366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADyaL1MXjs12h" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=1988&pages=821-823&author=J.+L.+Sussmanauthor=M.+Harelauthor=F.+Frolowauthor=L.+Varonauthor=L.+Tokerauthor=A.+H.+Futermanauthor=I.+Silman&title=Purification+and+crystallization+of+a+dimeric+form+of+acetylcholinesterase+from+Torpedo+californica+subsequent+to+solubilization+with+phosphatidylinositol-specific+phospholipase+C&doi=10.1016%2F0022-2836%2888%2990213-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and crystallization of a dimeric form of acetylcholinesterase from Torpedo californica subsequent to solubilization with phosphatidylinositol-specific phospholipase C</span></div><div class="casAuthors">Sussman, J. L.; Harel, M.; Frolow, F.; Varon, L.; Toker, L.; Futerman, A. H.; Silman, I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">821-3</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">A dimeric form of acetylcholinesterase from T. californica was purified to homogeneity by affinity chromatog. subsequent to solubilization with a phosphatidylinositol-specific phospholipase C of bacterial origin.  Bipyramidal crystals of the enzyme were obtained from solns. in polyethylene glycol 200.  The crystals diffract to 2.0 Å resoln.  They were orthorhombic, space group P2221, with a = 163.4, b = 112.1, and c = 81.3 Å.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreLFBumZz6FrVg90H21EOLACvtfcHk0ljRLLDPFE2gow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXjs12h&md5=977c3d50bccc11592e687b25cc6347b1</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2F0022-2836%2888%2990213-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-2836%252888%252990213-6%26sid%3Dliteratum%253Aachs%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DFrolow%26aufirst%3DF.%26aulast%3DVaron%26aufirst%3DL.%26aulast%3DToker%26aufirst%3DL.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26aulast%3DSilman%26aufirst%3DI.%26atitle%3DPurification%2520and%2520crystallization%2520of%2520a%2520dimeric%2520form%2520of%2520acetylcholinesterase%2520from%2520Torpedo%2520californica%2520subsequent%2520to%2520solubilization%2520with%2520phosphatidylinositol-specific%2520phospholipase%2520C%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1988%26volume%3D203%26spage%3D821%26epage%3D823%26doi%3D10.1016%2F0022-2836%2888%2990213-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brazzolotto, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wandhammer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trovaslet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockridge, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span> <span> </span><span class="NLM_article-title">Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">2905</span>– <span class="NLM_lpage">2916</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2012.08672.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1111%2Fj.1742-4658.2012.08672.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=22726956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOhtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2012&pages=2905-2916&author=X.+Brazzolottoauthor=M.+Wandhammerauthor=C.+Roncoauthor=M.+Trovasletauthor=L.+Jeanauthor=O.+Lockridgeauthor=P.-Y.+Renardauthor=F.+Nachon&title=Human+butyrylcholinesterase+produced+in+insect+cells%3A+huprine-based+affinity+purification+and+crystal+structure&doi=10.1111%2Fj.1742-4658.2012.08672.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure</span></div><div class="casAuthors">Brazzolotto, Xavier; Wandhammer, Marielle; Ronco, Cyril; Trovaslet, Marie; Jean, Ludovic; Lockridge, Oksana; Renard, Pierre-Yves; Nachon, Florian</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2905-2916</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Butyrylcholinesterase (BChE) is a serine hydrolase that is present in all mammalian tissues.  It can accommodate larger substrates or inhibitors than acetylcholinesterase (AChE), the enzyme responsible for hydrolysis of the neurotransmitter acetylcholine in the central nervous system and neuromuscular junctions.  AChE is the specific target of organophosphorous pesticides and warfare nerve agents, and BChE is a stoichiometric bioscavenger.  Conversion of BChE into a catalytic bioscavenger by rational design or designing reactivators specific to BChE required structural data obtained using a recombinant low-glycosylated human BChE expressed in Chinese hamster ovary cells.  This expression system yields ∼ 1 mg of pure enzyme per L of cell culture.  Here, we report an improved expression system using insect cells with a fourfold higher yield for truncated human BChE with all glycosylation sites present.  We developed a fast purifn. protocol for the recombinant protein using huprine-based affinity chromatog., which is superior to the classical procainamide-based affinity.  The purified BChE crystd. under different conditions and space group than the recombinant low-glycosylated protein produced in Chinese hamster ovary cells.  The crystals diffracted to 2.5 Å.  The overall monomer structure is similar to the low-glycosylated structure except for the presence of the addnl. glycans.  Remarkably, the carboxylic acid mol. systematically bound to the catalytic serine in the low-glycosylated structure is also present in this new structure, despite the different expression system, purifn. protocol and crystn. conditions.  Database Structural data have been submitted to the Protein Data Bank under accession no. pdb.  DNA sequence data for the synthetic gene have been submitted to GenBank under accession no.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNCaql_IyZuLVg90H21EOLACvtfcHk0ljRLLDPFE2gow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOhtr%252FP&md5=197231a2815a654344ad4d1bdf01e4ad</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2012.08672.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2012.08672.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrazzolotto%26aufirst%3DX.%26aulast%3DWandhammer%26aufirst%3DM.%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DTrovaslet%26aufirst%3DM.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DLockridge%26aufirst%3DO.%26aulast%3DRenard%26aufirst%3DP.-Y.%26aulast%3DNachon%26aufirst%3DF.%26atitle%3DHuman%2520butyrylcholinesterase%2520produced%2520in%2520insect%2520cells%253A%2520huprine-based%2520affinity%2520purification%2520and%2520crystal%2520structure%26jtitle%3DFEBS%2520J.%26date%3D2012%26volume%3D279%26spage%3D2905%26epage%3D2916%26doi%3D10.1111%2Fj.1742-4658.2012.08672.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span> <span> </span><span class="NLM_article-title">Rapid and sensitive determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry: Application to a pharmacokinetic study</span>. <i>Rapid Commun. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3193</span>– <span class="NLM_lpage">3198</span>, <span class="refDoi"> DOI: 10.1002/rcm.2718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1002%2Frcm.2718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=17016805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKktLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=3193-3198&author=Z.+Xieauthor=Q.+Liaoauthor=X.+Xuauthor=M.+Yaoauthor=J.+Wanauthor=D.+Liu&title=Rapid+and+sensitive+determination+of+donepezil+in+human+plasma+by+liquid+chromatography%2Ftandem+mass+spectrometry%3A+Application+to+a+pharmacokinetic+study&doi=10.1002%2Frcm.2718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid and sensitive determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study</span></div><div class="casAuthors">Xie, Zhiyong; Liao, Qiongfeng; Xu, Xinjun; Yao, Meicun; Wan, Jinzhi; Liu, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3193-3198</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A liq. chromatog./tandem mass spectrometry (LC/MS/MS) method was developed and validated for the detn. of donepezil in human plasma samples.  Diphenhydramine was used as the internal std.  The collision-induced transition m/z 380 → 91 was used to analyze donepezil in selected reaction monitoring mode.  The signal intensity of the m/z 380 → 91 transition was found to relate linearly with donepezil concns. in plasma from 0.1-20.0 ng/mL.  The lower limit of quantification of the LC/MS/MS method was 0.1 ng/mL.  The intra- and inter-day precisions were below 10.2% and the accuracy was between -2.3% and +2.8%.  The validated LC/MS/MS method was applied to a pharmacokinetic study in which healthy Chinese volunteers each received a single oral dose of 5 mg donepezil hydrochloride.  The non-compartmental pharmacokinetic model was used to fit the donepezil plasma concn.-time curve.  Maximum plasma concn. was 12.3 ± 2.73 ng/mL which occurred at 3.50 ± 1.61 h post-dosing.  The apparent elimination half-life and the area under the curve were, resp., 60.86 ± 12.05 h and 609.3 ± 122.2 ng · h/mL.  LC/MS/MS is a rapid, sensitive and specific method for detg. donepezil in human plasma samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeHdiWh6zzOrVg90H21EOLACvtfcHk0ljRLLDPFE2gow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKktLnO&md5=498843a6bb42514cde648b064a604b3b</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1002%2Frcm.2718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.2718%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26atitle%3DRapid%2520and%2520sensitive%2520determination%2520of%2520donepezil%2520in%2520human%2520plasma%2520by%2520liquid%2520chromatography%252Ftandem%2520mass%2520spectrometry%253A%2520Application%2520to%2520a%2520pharmacokinetic%2520study%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2006%26volume%3D20%26spage%3D3193%26epage%3D3198%26doi%3D10.1002%2Frcm.2718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, R. A.</span></span> <span> </span><span class="NLM_article-title">The open-field test: A critical review</span>. <i>Psychol. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1037/0033-2909.83.3.482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1037%2F0033-2909.83.3.482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=17582919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A280%3ADC%252BD2szmvVCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1976&pages=482-504&author=R.+N.+Walshauthor=R.+A.+Cummins&title=The+open-field+test%3A+A+critical+review&doi=10.1037%2F0033-2909.83.3.482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The Open-Field Test: a critical review</span></div><div class="casAuthors">Walsh R N; Cummins R A</div><div class="citationInfo"><span class="NLM_cas:title">Psychological bulletin</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">482-504</span>
        ISSN:<span class="NLM_cas:issn">0033-2909</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYvoIgIf3zKFm8bhe6roZYfW6udTcc2eYRRWuWfEpH-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szmvVCrsg%253D%253D&md5=60c00d3638695d81c9a738e39a8c4b3d</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1037%2F0033-2909.83.3.482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252F0033-2909.83.3.482%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DR.%2BN.%26aulast%3DCummins%26aufirst%3DR.%2BA.%26atitle%3DThe%2520open-field%2520test%253A%2520A%2520critical%2520review%26jtitle%3DPsychol.%2520Bull.%26date%3D1976%26volume%3D83%26spage%3D482%26epage%3D504%26doi%3D10.1037%2F0033-2909.83.3.482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cisternas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsay, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva-Alvarez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retamales, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vio, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer’s disease</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1852</i></span>,  <span class="NLM_fpage">2630</span>– <span class="NLM_lpage">2644</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2015.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bbadis.2015.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=26391254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeit7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1852&publication_year=2015&pages=2630-2644&author=P.+Cisternasauthor=C.+B.+Lindsayauthor=P.+Salazarauthor=C.+Silva-Alvarezauthor=R.+M.+Retamalesauthor=F.+G.+Serranoauthor=C.+P.+Vioauthor=N.+C.+Inestrosa&title=The+increased+potassium+intake+improves+cognitive+performance+and+attenuates+histopathological+markers+in+a+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bbadis.2015.09.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer's disease</span></div><div class="casAuthors">Cisternas, Pedro; Lindsay, Carolina B.; Salazar, Paulina; Silva-Alvarez, Carmen; Retamales, Rocio M.; Serrano, Felipe G.; Vio, Carlos P.; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1852</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2630-2644</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder characterized by hallmarks that include an accumulation of amyloid-β peptide (Aβ), inflammation, oxidative stress and synaptic dysfunction, which lead to a decrease in cognitive function.  To date, the onset and progression of AD have been assocd. with pathologies such as hypertension and diabetes.  Hypertension, a disease with a high incidence worldwide, is characterized by a chronic increase in blood pressure.  Interestingly, this disease has a close relationship to the eating behavior of patients because high Na+ intake is a significant risk factor for hypertension.  In fact, a decrease in Na+ consumption, along with an increase in K+ intake, is a primary non-pharmacol. approach to preventing hypertension.  In the present work, we examd. whether an increase in K+ intake affects the expression of certain neuropathol. markers or the cognitive performance of a murine model of AD.  We obsd. that an increase in K+ intake leads to a change in the aggregation pattern of the Aβ peptide, a partial decrease in some epitopes of tau phosphorylation and improvement in the cognitive performance.  The recovery in cognitive performance was correlated with a significant improvement in the generation of long-term potentiation.  We also obsd. a decrease in markers related to inflammation and oxidative stress such as glial fibrillary acidic protein (GFAP), interleukin 6 (IL-6) and 4-hydroxynonenal (4-HNE).  Together, our data support the idea that changes in diet, such as an increase in K+ intake, may be important in the prevention of AD onset as a non-pharmacol. therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolFjIznAZrSrVg90H21EOLACvtfcHk0liP-T6O27TxuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeit7nO&md5=2adfd4e1284a22ab3bcdca6a2a8d63d5</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2015.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2015.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DCisternas%26aufirst%3DP.%26aulast%3DLindsay%26aufirst%3DC.%2BB.%26aulast%3DSalazar%26aufirst%3DP.%26aulast%3DSilva-Alvarez%26aufirst%3DC.%26aulast%3DRetamales%26aufirst%3DR.%2BM.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DVio%26aufirst%3DC.%2BP.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DThe%2520increased%2520potassium%2520intake%2520improves%2520cognitive%2520performance%2520and%2520attenuates%2520histopathological%2520markers%2520in%2520a%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2015%26volume%3D1852%26spage%3D2630%26epage%3D2644%26doi%3D10.1016%2Fj.bbadis.2015.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bevins, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besheer, J.</span></span> <span> </span><span class="NLM_article-title">Object recognition in rats and mice: A one-trial non-matching-to-sample learning task to study “recognition memory”</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1306</span>– <span class="NLM_lpage">1311</span>, <span class="refDoi"> DOI: 10.1038/nprot.2006.205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1038%2Fnprot.2006.205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=17406415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A280%3ADC%252BD2s3gsVaisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1306-1311&author=R.+A.+Bevinsauthor=J.+Besheer&title=Object+recognition+in+rats+and+mice%3A+A+one-trial+non-matching-to-sample+learning+task+to+study+%E2%80%9Crecognition+memory%E2%80%9D&doi=10.1038%2Fnprot.2006.205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'</span></div><div class="casAuthors">Bevins Rick A; Besheer Joyce</div><div class="citationInfo"><span class="NLM_cas:title">Nature protocols</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1306-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Rats and mice have a tendency to interact more with a novel object than with a familiar object.  This tendency has been used by behavioral pharmacologists and neuroscientists to study learning and memory.  A popular protocol for such research is the object-recognition task.  Animals are first placed in an apparatus and allowed to explore an object.  After a prescribed interval, the animal is returned to the apparatus, which now contains the familiar object and a novel object.  Object recognition is distinguished by more time spent interacting with the novel object.  Although the exact processes that underlie this 'recognition memory' requires further elucidation, this method has been used to study mutant mice, aging deficits, early developmental influences, nootropic manipulations, teratological drug exposure and novelty seeking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCO9YXRnurMlZoq0fPSOTvfW6udTcc2eYRRWuWfEpH-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3gsVaisw%253D%253D&md5=6de357de8e39a8e5076563bbc8f7041d</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.205%26sid%3Dliteratum%253Aachs%26aulast%3DBevins%26aufirst%3DR.%2BA.%26aulast%3DBesheer%26aufirst%3DJ.%26atitle%3DObject%2520recognition%2520in%2520rats%2520and%2520mice%253A%2520A%2520one-trial%2520non-matching-to-sample%2520learning%2520task%2520to%2520study%2520%25E2%2580%259Crecognition%2520memory%25E2%2580%259D%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26spage%3D1306%26epage%3D1311%26doi%3D10.1038%2Fnprot.2006.205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuenzalida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer’s disease model</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2191</span>– <span class="NLM_lpage">2202</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0862-13.2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1523%2FJNEUROSCI.0862-13.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=24501359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVGrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=2191-2202&author=J.+Y.+Vargasauthor=M.+Fuenzalidaauthor=N.+C.+Inestrosa&title=In+vivo+activation+of+Wnt+signaling+pathway+enhances+cognitive+function+of+adult+mice+and+reverses+cognitive+deficits+in+an+Alzheimer%E2%80%99s+disease+model&doi=10.1523%2FJNEUROSCI.0862-13.2014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer's disease model</span></div><div class="casAuthors">Vargas, Jessica Y.; Fuenzalida, Marco; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2191-2202</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The role of the Wnt signaling pathway during synaptic development has been well established.  In the adult brain, different components of Wnt signaling are expressed, but little is known about its role in mature synapses.  Emerging in vitro studies have implicated Wnt signaling in synaptic plasticity.  Furthermore, activation of Wnt signaling has shown to protect against amyloid-β-induced synaptic impairment.  The present study provides the first evidence that in vivo activation of Wnt signaling improves episodic memory, increases excitatory synaptic transmission, and enhances long-term potentiation in adult wild-type mice.  Moreover, the activation of Wnt signaling also rescues memory loss and improves synaptic dysfunction in APP/PS1-transgenic mice that model the amyloid pathol. of Alzheimer's diseases.  These findings indicate that Wnt signaling modulates cognitive function in the adult brain and could be a novel promising target for Alzheimer's disease therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ70P4_bMKjrVg90H21EOLACvtfcHk0ljkS8ud3H1S6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVGrtr4%253D&md5=633b19f0057d4a7faa75962f948b69d1</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0862-13.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0862-13.2014%26sid%3Dliteratum%253Aachs%26aulast%3DVargas%26aufirst%3DJ.%2BY.%26aulast%3DFuenzalida%26aufirst%3DM.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DIn%2520vivo%2520activation%2520of%2520Wnt%2520signaling%2520pathway%2520enhances%2520cognitive%2520function%2520of%2520adult%2520mice%2520and%2520reverses%2520cognitive%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2014%26volume%3D34%26spage%3D2191%26epage%3D2202%26doi%3D10.1523%2FJNEUROSCI.0862-13.2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cisternas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codocedo, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Induction of hypothyroidism during early postnatal stages triggers a decrease in cognitive performance by decreasing hippocampal synaptic plasticity</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">870</span>– <span class="NLM_lpage">883</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2017.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.bbadis.2017.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=28088629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2017&pages=870-883&author=P.+Salazarauthor=P.+Cisternasauthor=J.+F.+Codocedoauthor=N.+C.+Inestrosa&title=Induction+of+hypothyroidism+during+early+postnatal+stages+triggers+a+decrease+in+cognitive+performance+by+decreasing+hippocampal+synaptic+plasticity&doi=10.1016%2Fj.bbadis.2017.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of hypothyroidism during early postnatal stages triggers a decrease in cognitive performance by decreasing hippocampal synaptic plasticity</span></div><div class="casAuthors">Salazar, Paulina; Cisternas, Pedro; Codocedo, Juan Francisco; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">870-883</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Thyroid hormones are vital in the control of multiple body functions, including the correct performance of the brain.  Multiple diseases are assocd. with thyroid gland functioning, including hypothyroidism.  To date, little is known regarding the effects of the establishment of this condition at a young age on brain function.  Here, we evaluated the effect of hypothyroidism in an early postnatal stage in cognitive abilities with focus on the hippocampus.  In our model, hypothyroidism was induced in young rats at 21 days of age using 0.05% 6-propyl-2-thiouracil (PTU) for 4 wk reaching significantly lower levels of fT4 (control: 1.337 ng/dL ± 0.115, PTU: 0.050 ng/dL ± 0.001).  Following the induction of hypothyroidism, several cognitive tasks were assessed to investigate the effects of hypothyroidism on cognition performance.  We detd. that hypothyroidism triggers a significant dysfunction in learning and memory processes obsd. in the Morris Water Maze were the latency times were higher in PTU rats (controls: 37 s; PTU: 57 s).  The cognitive impairment was correlated with a redn. in hippocampal plasticity with respect to both long-term potentiation (LTP) (control: 1.45, PTU: 1.00) and depression (LTD) (control: 0.71, PTU: 1.01).  Furthermore, a decrease in the rate of glucose utilization (control: 223 nmol * mg of protein, PTU:148 nmol * mg of protein) was obsd., along with an increase in oxidative stress and a decrease in MAP2 marker in the hippocampus.  Our findings suggest that the induction of hypothyroidism in a young rat model alters numerous functions at the level of the hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI6VB7ByzC6rVg90H21EOLACvtfcHk0ljkS8ud3H1S6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKjtLo%253D&md5=bd4bbb3108404ee39638e31bd849e0ee</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2017.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DSalazar%26aufirst%3DP.%26aulast%3DCisternas%26aufirst%3DP.%26aulast%3DCodocedo%26aufirst%3DJ.%2BF.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DInduction%2520of%2520hypothyroidism%2520during%2520early%2520postnatal%2520stages%2520triggers%2520a%2520decrease%2520in%2520cognitive%2520performance%2520by%2520decreasing%2520hippocampal%2520synaptic%2520plasticity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2017%26volume%3D1863%26spage%3D870%26epage%3D883%26doi%3D10.1016%2Fj.bbadis.2017.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codocedo, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cisternas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozinovic, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span> <span> </span><span class="NLM_article-title">Andrographolide recovers cognitive impairment in a natural model of Alzheimer’s disease (<i>Octodon degus</i>)</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2016.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=10.1016%2Fj.neurobiolaging.2016.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=27505720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1agt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2016&pages=204-220&author=D.+S.+Riveraauthor=C.+Lindsayauthor=J.+F.+Codocedoauthor=I.+Morelauthor=C.+Pintoauthor=P.+Cisternasauthor=F.+Bozinovicauthor=N.+C.+Inestrosa&title=Andrographolide+recovers+cognitive+impairment+in+a+natural+model+of+Alzheimer%E2%80%99s+disease+%28Octodon+degus%29&doi=10.1016%2Fj.neurobiolaging.2016.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide recovers cognitive impairment in a natural model of Alzheimer's disease (Octodon degus)</span></div><div class="casAuthors">Rivera, Daniela S.; Lindsay, Carolina; Codocedo, Juan Francisco; Morel, Isidora; Pinto, Claudio; Cisternas, Pedro; Bozinovic, Francisco; Inestrosa, Nibaldo C.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">204-220</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The social species Octodon degus (degu) is the only wild-type South American rodent that develops Alzheimer's-like pathol. with age.  Here, we evaluated the ability of a natural product (Andrographolide, ANDRO), a diterpene of the labdane family obtained from the Asian plant Andrographis paniculata, to recover the cognitive decline in this long-lived animal model.  We administered ANDRO to aged degus (56-mo old) for 3 mo.  In addn., in 2 control groups (young degus: 12-mo old and aged degus: 56-mo old), we administrated saline soln. as a vehicle.  We evaluated cognitive performance through several behavioral tests.  We also performed a series of physiol. and biochem. analyses (e.g., electrophysiol. and immunoblotting assessment) to identify possible mechanisms underlying cognitive performance assocd. with age.  Our results suggest that there is an effect of aging on the loss of cognitive function, and this decrease in cognitive function was also related to a decrease in the synaptic functions and an increase in the main hallmarks of Alzheimer's disease (AD).  More importantly, ANDRO treatments showed the following beneficial effects: (1) recovery of spatial memory and learning performance; (2) recovery of synaptic basal transmission; (3) partial or complete protection of certain synaptic proteins; and (4) a specific neuroprotective effect, including the redn. of phosphorylated tau protein and amyloid beta aggregate maturation in aged degus.  Taken together, our results suggest that ANDRO could be used as a potential therapy for AD and support the use of O. degus as a natural model in which to study both neural damage assocd. with aging processes and the behavioral and neuropathol. hallmarks of aging-related diseases such as AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphAg7SLv1Fe7Vg90H21EOLACvtfcHk0ljkS8ud3H1S6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1agt7bO&md5=6144cbf19bbf30a0b9521669234d8fdf</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2016.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2016.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DD.%2BS.%26aulast%3DLindsay%26aufirst%3DC.%26aulast%3DCodocedo%26aufirst%3DJ.%2BF.%26aulast%3DMorel%26aufirst%3DI.%26aulast%3DPinto%26aufirst%3DC.%26aulast%3DCisternas%26aufirst%3DP.%26aulast%3DBozinovic%26aufirst%3DF.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DAndrographolide%2520recovers%2520cognitive%2520impairment%2520in%2520a%2520natural%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520%2528Octodon%2520degus%2529%26jtitle%3DNeurobiol.%2520Aging%26date%3D2016%26volume%3D46%26spage%3D204%26epage%3D220%26doi%3D10.1016%2Fj.neurobiolaging.2016.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TPK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TPK','PDB','4TPK'); return false;">PDB: 4TPK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XI4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XI4','PDB','2XI4'); return false;">PDB: 2XI4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIS','PDB','7AIS'); return false;">PDB: 7AIS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIT','PDB','7AIT'); return false;">PDB: 7AIT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIU','PDB','7AIU'); return false;">PDB: 7AIU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIV','PDB','7AIV'); return false;">PDB: 7AIV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIW','PDB','7AIW'); return false;">PDB: 7AIW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIX','PDB','7AIX'); return false;">PDB: 7AIX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AIY','PDB','7AIY'); return false;">PDB: 7AIY</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i62"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01775">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_04203"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01775?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01775</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional data of the crystal structures of target compounds in complex with <i>Tc</i>AChE and hBChE, PAMPA-BBB, biodistribution, hippocampal Aβ levels, and electrophysiological studies, copies of <sup>1</sup>H and <sup>13</sup>C NMR spectra, elemental analysis and HPLC data, and PDB files of the crystal structures of the complexes of compounds <b>5b</b>, <b>5c</b>, <b>5d</b>, <b>5f</b>, <b>5h</b>, and <b>5i</b> with <i>Tc</i>AChE and of compound <b>5i</b> with hBChE (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Inhibitory activities of <b>5a</b>, <b>5b</b>, <b>5c</b>, <b>5d</b>, <b>5e</b>, <b>5f</b>, <b>5g</b>, <b>5h</b>, and <b>5i</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_002.csv">CSV</a>)</p></li><li><p class="inline">PDB files of the crystal structures of the complexes of compounds <b>5b</b>, <b>5c</b>, <b>5d</b>, <b>5f</b>, <b>5h</b>, and <b>5i</b> with <i>Tc</i>AChE and of compound <b>5i</b> with hBChE (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_003.zip">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_001.pdf">jm0c01775_si_001.pdf (1.69 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_002.csv">jm0c01775_si_002.csv (1.05 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01775/suppl_file/jm0c01775_si_003.zip">jm0c01775_si_003.zip (1.32 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01775&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-1%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01775%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01775" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                10MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679903899b183d42","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
